data_2mqo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mqo _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.227 0.537 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 t -163.19 148.92 9.7 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.743 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.88 -7.4 21.03 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.802 2.335 . . . . 0.0 109.926 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.33 143.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.092 0.957 . . . . 0.0 110.439 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.46 139.83 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.628 0.728 . . . . 0.0 111.853 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.34 137.37 37.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.935 1.694 . . . . 0.0 109.843 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 63.3 mt -116.29 140.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.393 0.677 . . . . 0.0 109.772 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -145.84 150.9 37.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.051 0.54 . . . . 0.0 110.505 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.12 0.51 77.25 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.879 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.53 174.69 5.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.13 0.965 . . . . 0.0 111.041 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.512 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.04 157.03 13.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.254 0.622 . . . . 0.0 109.7 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -67.47 -7.31 24.48 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.25 -11.04 85.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.23 149.47 11.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.66 169.68 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.393 1.077 . . . . 0.0 109.621 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -59.59 -32.84 70.76 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.302 -0.249 . . . . 0.0 111.074 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.43 72.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.611 0.365 . . . . 0.0 111.27 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -74.86 -31.63 61.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.28 -41.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.41 -34.66 58.9 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -74.97 -24.66 58.48 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 117.731 0.242 . . . . 0.0 111.2 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.12 35.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.14 -9.28 8.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.54 -21.99 66.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.328 0.967 . . . . 0.0 110.875 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.03 -12.23 61.41 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.222 -0.299 . . . . 0.0 111.209 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -92.06 -16.75 25.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.48 173.91 27.5 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.76 125.7 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.654 2.903 . . . . 0.0 110.8 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 142.92 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.786 0.434 . . . . 0.0 110.583 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -107.64 -32.35 7.7 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.523 0.729 . . . . 0.0 111.956 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -162.94 160.5 24.88 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.8 143.18 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.886 0.875 . . . . 0.0 109.239 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.11 154.91 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.215 0.606 . . . . 0.0 111.516 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.05 141.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.13 0.572 . . . . 0.0 112.179 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.76 88.76 45.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 123.153 0.581 . . . . 0.0 110.439 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.76 -6.5 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.888 2.392 . . . . 0.0 110.832 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.83 -31.76 71.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.439 0.696 . . . . 0.0 110.608 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -116.94 5.71 12.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.617 0.767 . . . . 0.0 112.584 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 57.95 49.82 11.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.345 0.658 . . . . 0.0 110.544 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -144.13 171.61 14.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.958 0.903 . . . . 0.0 111.283 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.16 40.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.195 0.598 . . . . 0.0 110.368 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.13 149.16 50.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.9 144.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -125.29 138.84 54.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.881 0.472 . . . . 0.0 109.797 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -102.48 155.73 18.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -72.8 -13.8 61.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.212 -0.305 . . . . 0.0 110.356 174.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -143.08 143.34 31.81 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.308 1.443 . . . . 0.0 113.451 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.5 p -62.9 -21.84 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 111.714 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.3 tp -69.81 -35.03 74.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.81 0.444 . . . . 0.0 110.761 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.07 -38.15 48.18 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.21 86.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -70.13 -35.52 74.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.24 -34.83 79.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.949 -0.469 . . . . 0.0 111.141 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.23 -37.43 69.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 121.325 -0.15 . . . . 0.0 111.214 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.31 -33.55 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 O-C-N 122.156 -0.34 . . . . 0.0 110.751 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -70.67 -28.39 64.74 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.17 0.441 . . . . 0.0 111.801 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.33 -33.05 61.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.76 -30.32 69.94 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.64 0.776 . . . . 0.0 111.675 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.12 -16.06 63.57 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -108.9 -27.17 9.85 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -160.06 154.8 24.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.003 0.521 . . . . 0.0 109.823 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.65 141.08 41.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.41 134.87 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.292 10.8 m-85 -84.77 129.08 34.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.9 mm -126.62 120.57 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.483 1.113 . . . . 0.0 108.254 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.17 34.31 2.93 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.811 0.844 . . . . 0.0 112.08 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 90.34 11.17 63.04 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.619 0.628 . . . . 0.0 112.993 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -136.3 139.53 30.07 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.358 0.663 . . . . 0.0 110.452 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.32 144.57 62.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.411 2.74 . . . . 0.0 112.156 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.49 171.86 16.39 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.458 0.703 . . . . 0.0 110.073 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.09 161.16 18.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.24 149.41 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.575 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -68.74 144.21 54.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.836 0.743 . . . . 0.0 109.544 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.3 t -76.39 153.86 35.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.4 -2.76 17.61 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.6 t -127.69 152.93 47.09 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.454 0.702 . . . . 0.0 110.496 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -88.46 -3.75 58.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.196 0.598 . . . . 0.0 112.525 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.38 150.87 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.353 0.524 . . . . 0.0 111.019 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mt . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.928 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -164.85 151.19 9.17 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.291 0.637 . . . . 0.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.46 -7.34 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.724 2.282 . . . . 0.0 110.446 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t -102.36 143.52 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.324 1.05 . . . . 0.0 110.657 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.35 140.92 46.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.713 0.768 . . . . 0.0 111.72 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.28 137.54 37.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.129 1.772 . . . . 0.0 110.058 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.7 mt -117.75 140.7 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.325 0.65 . . . . 0.0 109.554 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -144.49 151.49 39.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.074 0.55 . . . . 0.0 110.176 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.99 0.15 85.77 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.612 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.14 171.36 9.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.588 0.694 . . . . 0.0 110.881 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.21 154.33 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.221 0.608 . . . . 0.0 109.997 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -70.77 -10.98 60.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.76 -10.75 86.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.507 0.575 . . . . 0.0 111.705 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.1 148.72 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 169.85 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 124.273 1.029 . . . . 0.0 109.755 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.23 -32.75 70.25 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.175 -0.328 . . . . 0.0 111.085 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.67 -31.42 72.07 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.303 -0.248 . . . . 0.0 111.043 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.5 -32.09 60.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.13 -43.07 68.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.12 -34.65 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.61 -24.0 58.8 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.11 -0.369 . . . . 0.0 111.178 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.37 -17.11 31.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -123.74 -8.91 7.87 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.88 -21.93 66.49 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.448 1.022 . . . . 0.0 110.751 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.02 -10.43 58.63 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.09 -15.84 24.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.75 174.77 26.9 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.28 123.37 10.5 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.634 2.889 . . . . 0.0 110.92 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.44 141.93 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.021 0.528 . . . . 0.0 110.395 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -101.38 -34.24 9.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.21 0.604 . . . . 0.0 111.734 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -167.21 162.02 14.83 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 151.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 124.131 0.972 . . . . 0.0 111.945 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.6 p -151.13 155.94 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.179 0.592 . . . . 0.0 112.042 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.21 141.95 36.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.221 0.608 . . . . 0.0 112.287 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.91 81.75 57.15 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 123.63 0.772 . . . . 0.0 110.12 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -59.83 -12.48 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.389 2.726 . . . . 0.0 112.371 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -27.58 67.77 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.823 0.449 . . . . 0.0 111.136 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -116.81 5.74 13.09 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.685 0.794 . . . . 0.0 112.028 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 56.68 48.57 16.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.555 0.742 . . . . 0.0 110.285 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.58 168.84 18.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.882 0.873 . . . . 0.0 111.193 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.59 158.25 40.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.483 0.713 . . . . 0.0 110.441 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 mp -131.33 154.12 48.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.893 0.378 . . . . 0.0 110.131 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.2 t -143.33 143.07 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -118.41 130.76 56.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.13 154.5 17.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -72.64 -12.85 61.21 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.185 -0.322 . . . . 0.0 110.487 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -143.89 145.56 32.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 113.413 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.87 -23.37 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.4 tp -67.47 -36.69 81.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.393 0.277 . . . . 0.0 111.055 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.47 60.73 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.47 91.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.16 0.505 . . . . 0.0 109.893 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.7 t -69.34 -35.41 75.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.281 0.633 . . . . 0.0 110.827 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -65.54 -34.29 77.92 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.064 -0.398 . . . . 0.0 110.904 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.57 -33.39 69.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.472 0.124 . . . . 0.0 111.086 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -81.06 -33.7 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 122.12 -0.363 . . . . 0.0 111.158 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.142 0.428 . . . . 0.0 111.265 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -79.06 -33.04 45.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.247 0.619 . . . . 0.0 111.117 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.98 -17.4 63.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.47 0.308 . . . . 0.0 111.703 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -109.1 -24.1 11.33 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -159.94 155.65 25.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.294 0.638 . . . . 0.0 109.301 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.73 136.59 39.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.62 134.03 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.9 m-85 -85.61 131.27 34.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.08 125.31 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 0.0 108.357 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.81 34.58 5.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.3 0.64 . . . . 0.0 112.498 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.39 8.86 77.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.062 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -135.35 148.99 68.43 Favored Pre-proline 0 CA--C 1.527 0.083 0 CA-C-N 118.418 1.109 . . . . 0.0 111.75 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.54 151.68 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.53 2.82 . . . . 0.0 111.713 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.96 174.61 13.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -123.62 156.09 36.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.34 138.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.593 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -148.62 168.71 22.09 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 125.669 1.587 . . . . 0.0 108.621 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.65 149.89 48.59 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.7 t -84.83 156.27 21.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.344 0.658 . . . . 0.0 110.662 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.93 -16.03 62.64 Favored 'General case' 0 C--N 1.335 -0.045 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 84.1 p -92.06 152.77 19.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.255 0.622 . . . . 0.0 109.629 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -97.11 -5.51 37.17 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -161.91 149.02 14.1 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.12 0.568 . . . . 0.0 109.951 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.945 0.402 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.4 m -156.46 152.41 22.9 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.946 0.898 . . . . 0.0 109.445 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.25 -10.62 22.61 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.063 2.508 . . . . 0.0 109.756 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.96 146.37 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 124.473 1.109 . . . . 0.0 110.789 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.39 139.62 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 121.421 0.629 . . . . 0.0 111.566 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -100.04 137.4 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.762 1.625 . . . . 0.0 110.263 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.7 mt -117.4 140.49 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 110.151 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -144.21 155.51 43.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.287 0.635 . . . . 0.0 110.058 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.18 -1.09 87.62 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.77 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.64 173.44 8.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.679 0.739 . . . . 0.0 110.976 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.6 pt -98.89 153.92 4.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 C-N-CA 123.499 0.72 . . . . 0.0 109.52 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -72.89 -9.69 58.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.57 -10.75 86.04 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.5 149.62 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.69 169.3 22.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.117 0.967 . . . . 0.0 109.512 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.85 -32.73 69.71 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.239 -0.288 . . . . 0.0 111.119 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.62 -31.4 72.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.596 0.358 . . . . 0.0 111.041 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -74.38 -34.36 63.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -39.7 67.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.63 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -71.2 -34.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.9 -23.39 55.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.145 -0.347 . . . . 0.0 110.862 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.26 -17.14 31.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.97 -8.06 7.77 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.96 -21.81 65.95 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.407 1.003 . . . . 0.0 110.794 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.76 -10.49 59.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.515 0.326 . . . . 0.0 111.344 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -93.77 -14.96 25.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.37 173.59 24.25 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.54 125.66 13.08 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.744 2.963 . . . . 0.0 110.56 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.9 mt -93.35 141.37 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 122.898 0.479 . . . . 0.0 110.338 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.2 t -102.75 -33.68 9.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.518 0.727 . . . . 0.0 111.796 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -164.0 161.37 22.65 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -146.5 145.39 19.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.0 0.92 . . . . 0.0 109.187 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.62 156.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.254 0.622 . . . . 0.0 111.556 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.82 141.9 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 C-N-CA 123.291 0.636 . . . . 0.0 112.193 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -134.24 82.09 48.33 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.4 0.68 . . . . 0.0 110.263 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.941 2.427 . . . . 0.0 111.217 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.38 -26.41 67.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.851 0.86 . . . . 0.0 110.756 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -117.05 4.85 12.76 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.828 0.851 . . . . 0.0 112.371 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 55.64 51.73 12.12 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.726 0.811 . . . . 0.0 110.293 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -144.99 171.4 14.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.804 0.842 . . . . 0.0 111.1 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.58 158.26 40.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.146 0.579 . . . . 0.0 110.966 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -127.56 149.53 50.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.039 0.536 . . . . 0.0 109.637 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.9 t -143.42 144.53 23.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -126.37 137.98 53.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.686 0.394 . . . . 0.0 110.095 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -100.29 155.14 17.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -71.47 -12.69 61.52 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.782 0.264 . . . . 0.0 110.338 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -143.09 143.05 31.69 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 125.759 1.624 . . . . 0.0 112.93 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.06 -21.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 120.822 0.344 . . . . 0.0 111.509 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -69.8 -35.16 74.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 110.859 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.86 -37.96 60.66 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.15 85.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.76 -33.81 71.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.306 0.642 . . . . 0.0 111.129 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -66.17 -35.06 79.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.056 0.389 . . . . 0.0 111.124 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.27 71.15 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.655 0.207 . . . . 0.0 111.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.8 t -77.34 -33.49 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 O-C-N 122.311 -0.243 . . . . 0.0 111.088 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -68.03 -32.67 73.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 122.065 -0.397 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.75 -32.93 64.08 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.7 -30.34 69.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.344 0.658 . . . . 0.0 111.549 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.43 63.6 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.85 -28.2 8.89 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -159.95 154.34 23.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.962 0.505 . . . . 0.0 109.853 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.72 139.96 40.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.12 -0.362 . . . . 0.0 110.139 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.4 mt -83.39 136.13 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 14.2 m-85 -88.17 130.66 34.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.2 mm -129.04 124.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.743 1.217 . . . . 0.0 108.601 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.51 34.47 4.89 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.59 8.34 73.94 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.974 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -136.2 148.95 66.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.541 1.17 . . . . 0.0 111.402 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.84 152.4 80.55 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.38 2.72 . . . . 0.0 111.485 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 174.64 13.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.419 1.088 . . . . 0.0 109.569 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.37 156.4 42.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.28 144.34 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.082 0.553 . . . . 0.0 111.952 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -148.88 169.83 19.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.34 1.456 . . . . 0.0 108.639 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -68.64 146.94 52.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.9 t -79.27 154.21 29.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.456 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.8 t -71.2 -2.54 16.27 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.7 t -125.34 151.24 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.476 0.71 . . . . 0.0 110.568 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -86.22 -6.93 58.88 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -159.64 148.19 17.59 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.673 0.67 . . . . 0.0 110.875 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.221 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.84 0.352 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -153.17 152.72 28.42 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.822 0.849 . . . . 0.0 109.803 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.56 -3.91 14.33 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.697 2.931 . . . . 0.0 110.635 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.6 149.49 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 112.469 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.58 145.85 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -99.16 137.42 37.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.789 2.036 . . . . 0.0 110.282 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.6 mt -116.9 140.61 38.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.878 0.871 . . . . 0.0 109.749 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -143.77 152.03 40.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.423 0.689 . . . . 0.0 110.276 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.09 2.63 80.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.845 -0.419 . . . . 0.0 112.818 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.62 -173.96 1.6 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.543 0.671 . . . . 0.0 110.325 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.07 157.53 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.55 0.74 . . . . 0.0 110.6 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.97 -12.01 51.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 -10.83 85.25 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.19 148.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.69 168.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.153 0.981 . . . . 0.0 109.422 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -58.71 -32.67 69.39 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.141 -0.35 . . . . 0.0 110.95 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.39 71.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.46 0.304 . . . . 0.0 111.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -73.54 -31.67 63.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.97 -43.28 71.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -71.99 -34.54 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -75.21 -21.29 58.77 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.969 -0.457 . . . . 0.0 111.498 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.22 -17.24 25.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.18 -8.6 8.72 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.97 -21.77 66.43 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.346 0.975 . . . . 0.0 110.696 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -70.5 -10.8 60.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.152 -0.343 . . . . 0.0 111.486 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.96 -14.78 24.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.37 172.93 25.15 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.28 124.99 12.32 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.495 2.797 . . . . 0.0 110.666 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.67 142.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.025 0.53 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.6 t -105.25 -34.01 8.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.418 0.687 . . . . 0.0 111.566 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -165.91 159.33 15.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.89 151.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.071 0.948 . . . . 0.0 112.221 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.12 154.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.321 0.648 . . . . 0.0 111.382 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.93 141.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.048 0.539 . . . . 0.0 112.144 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.43 88.05 40.59 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 123.138 0.575 . . . . 0.0 110.223 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.44 -8.28 21.67 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.039 2.493 . . . . 0.0 110.473 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.59 -32.41 73.97 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.651 0.78 . . . . 0.0 110.1 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.98 4.96 12.81 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.673 0.789 . . . . 0.0 112.226 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 57.78 51.48 9.21 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.231 0.612 . . . . 0.0 110.262 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -146.21 170.16 17.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.795 0.838 . . . . 0.0 111.34 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.69 158.37 40.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.632 0.773 . . . . 0.0 110.692 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.98 152.91 48.92 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-O 121.155 0.502 . . . . 0.0 110.132 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.76 144.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -122.48 136.34 54.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.05 0.54 . . . . 0.0 110.106 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -101.65 156.64 17.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -73.24 -11.07 60.38 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.175 -0.328 . . . . 0.0 110.5 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -144.38 146.3 32.44 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.692 1.597 . . . . 0.0 113.481 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.6 -23.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.337 0.049 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.26 -37.38 83.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.252 0.221 . . . . 0.0 110.626 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 -38.44 65.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.97 89.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.059 0.457 . . . . 0.0 109.949 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.55 -33.46 71.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.09 0.556 . . . . 0.0 111.11 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.21 -34.62 78.44 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.112 0.415 . . . . 0.0 110.873 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -38.7 72.9 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.516 0.144 . . . . 0.0 110.85 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.27 -33.55 23.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 O-C-N 122.33 -0.231 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.16 -32.29 71.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.192 -0.317 . . . . 0.0 110.961 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.7 -32.94 64.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.22 70.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.528 0.731 . . . . 0.0 111.058 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.77 3.28 2.64 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.073 0.549 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.11 -28.67 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -156.72 152.57 27.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -76.75 141.35 40.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.12 136.15 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.304 16.2 m-85 -88.81 130.64 35.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -129.02 125.05 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.607 1.163 . . . . 0.0 108.453 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.95 34.52 5.57 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.322 0.649 . . . . 0.0 112.373 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.36 9.03 80.23 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.171 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -134.08 148.82 69.58 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 118.342 1.071 . . . . 0.0 111.726 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.92 149.96 83.01 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.295 2.663 . . . . 0.0 111.397 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 174.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 109.549 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -128.52 161.0 30.59 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -142.34 147.8 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 123.44 0.696 . . . . 0.0 111.294 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -155.73 166.48 33.37 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -68.84 151.04 47.12 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.142 0.883 . . . . 0.0 108.708 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -85.48 159.06 20.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.886 0.474 . . . . 0.0 111.281 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.6 -2.75 15.26 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.1 t -125.73 154.04 43.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.312 0.645 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -86.78 -0.44 56.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -158.46 158.88 34.96 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.782 0.719 . . . . 0.0 110.942 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.219 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.006 0.431 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -161.52 149.86 12.68 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 123.297 0.639 . . . . 0.0 109.697 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.35 -7.35 21.11 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.864 2.376 . . . . 0.0 109.897 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -104.06 141.59 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.058 0.943 . . . . 0.0 111.187 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.8 m -135.08 144.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.638 0.732 . . . . 0.0 111.412 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -102.01 137.48 40.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.986 1.714 . . . . 0.0 110.578 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.38 140.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.736 0.814 . . . . 0.0 109.676 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -144.66 153.82 42.15 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.919 0.488 . . . . 0.0 110.603 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.64 4.59 88.94 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.801 -0.444 . . . . 0.0 112.614 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.36 173.77 8.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.737 0.768 . . . . 0.0 110.481 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.563 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.33 158.38 12.77 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.047 0 CA-C-O 121.363 0.602 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -68.93 -7.97 39.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -174.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.563 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.19 -11.04 85.75 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.94 146.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.64 166.46 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.239 1.016 . . . . 0.0 109.445 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.8 -32.7 69.58 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.182 -0.324 . . . . 0.0 111.281 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.08 -31.4 72.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.542 0.156 . . . . 0.0 110.955 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.89 -29.48 61.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.05 -44.24 69.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -71.95 -34.79 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -74.89 -20.4 59.74 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.212 0.46 . . . . 0.0 111.808 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.7 -16.98 22.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.48 -8.31 9.59 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.16 -21.83 66.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.111 0.869 . . . . 0.0 110.702 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.19 -12.85 61.89 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.861 -0.524 . . . . 0.0 111.284 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -90.77 -15.03 30.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.73 173.76 24.77 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.94 125.6 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.534 2.823 . . . . 0.0 110.364 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.32 142.74 12.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 122.722 0.409 . . . . 0.0 110.268 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.9 t -104.65 -34.03 8.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.347 0.659 . . . . 0.0 111.92 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -166.43 157.42 12.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -143.02 151.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 C-N-CA 124.088 0.955 . . . . 0.0 112.31 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.77 156.25 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.435 0.694 . . . . 0.0 110.53 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.99 141.96 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -133.32 81.84 54.52 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.446 0.699 . . . . 0.0 109.85 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.75 -13.62 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.054 2.503 . . . . 0.0 110.597 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -67.68 -22.22 65.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.182 0.593 . . . . 0.0 110.992 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -117.0 4.11 12.79 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.804 0.842 . . . . 0.0 112.097 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 59.13 40.23 22.11 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.375 0.67 . . . . 0.0 110.869 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.8 169.05 18.36 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.838 0.855 . . . . 0.0 111.088 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.18 40.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.153 0.581 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.6 mt -125.24 150.33 47.14 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 123.013 0.525 . . . . 0.0 110.458 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.8 t -143.76 144.42 23.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -126.74 139.28 53.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.964 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.23 154.18 19.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.37 -16.34 62.96 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.854 0.297 . . . . 0.0 110.39 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -137.19 143.09 42.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.342 1.457 . . . . 0.0 113.044 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.77 -21.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.708 0.289 . . . . 0.0 111.561 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -70.62 -35.59 73.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.873 0.469 . . . . 0.0 110.727 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.31 -39.62 61.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.37 -36.84 83.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.166 0.508 . . . . 0.0 110.238 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.6 -36.27 78.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.218 0.607 . . . . 0.0 110.598 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.97 -35.35 80.89 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.191 -0.318 . . . . 0.0 110.991 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.61 -32.76 68.37 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.556 0.162 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 93.9 t -81.51 -33.48 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 122.12 -0.363 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.0 -31.65 68.23 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.999 0.363 . . . . 0.0 111.506 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -77.93 -33.17 51.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.28 71.35 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 110.649 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.18 3.54 5.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.37 0.668 . . . . 0.0 112.105 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.41 -27.29 1.57 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -155.27 155.83 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.256 0.622 . . . . 0.0 109.565 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -76.86 133.95 39.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.2 mt -83.86 134.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 16.5 m-85 -85.26 130.65 34.56 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.94 124.15 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.34 34.67 6.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.51 9.68 75.03 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.838 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -135.8 148.78 66.65 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.328 1.064 . . . . 0.0 111.537 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.8 149.77 78.52 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.32 2.68 . . . . 0.0 111.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.76 174.74 13.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.655 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -124.1 161.25 26.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.66 145.34 25.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 C-N-CA 123.458 0.703 . . . . 0.0 110.907 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -154.94 166.19 34.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -68.65 147.65 51.57 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.944 0.793 . . . . 0.0 111.299 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.2 t -82.92 156.89 23.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.695 0.398 . . . . 0.0 110.871 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -2.75 17.32 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -131.43 153.6 49.54 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.138 0.575 . . . . 0.0 110.868 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -85.48 -3.43 58.85 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -158.9 149.23 19.6 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.542 0.61 . . . . 0.0 111.777 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -156.41 153.05 24.21 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.513 1.125 . . . . 0.0 109.293 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.38 8.38 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.854 3.036 . . . . 0.0 111.073 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.95 146.22 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.56 144.38 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.576 0.703 . . . . 0.0 111.626 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -100.72 137.46 39.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.482 1.913 . . . . 0.0 110.059 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.4 mt -115.64 140.74 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.879 0.872 . . . . 0.0 109.612 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -144.29 153.81 42.41 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.89 0.476 . . . . 0.0 110.247 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.45 2.01 80.21 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.637 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.79 174.63 8.17 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.727 0.763 . . . . 0.0 110.64 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.55 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.45 160.07 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-O 121.312 0.577 . . . . 0.0 109.946 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -67.34 -7.58 25.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.55 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.64 -11.05 85.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -65.77 146.87 12.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 m -132.54 168.27 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 124.24 1.016 . . . . 0.0 109.796 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.61 -32.77 70.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.085 -0.384 . . . . 0.0 110.999 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.51 72.09 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.42 0.288 . . . . 0.0 111.145 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -73.53 -30.09 62.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.69 -45.3 68.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.18 -34.66 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.63 -21.53 57.63 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.053 -0.405 . . . . 0.0 111.576 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.09 -17.14 25.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -121.51 -8.73 9.06 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.94 -21.97 66.92 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 119.023 0.829 . . . . 0.0 110.914 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -69.73 -12.65 61.8 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.301 -0.249 . . . . 0.0 111.455 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.66 -16.34 27.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.77 24.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.63 125.79 13.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.355 2.703 . . . . 0.0 110.7 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -93.51 142.77 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.837 0.455 . . . . 0.0 110.42 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 t -105.49 -32.99 8.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.385 0.674 . . . . 0.0 112.009 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -166.43 157.7 13.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.96 150.97 17.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 124.121 0.968 . . . . 0.0 112.084 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.77 157.27 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.483 0.713 . . . . 0.0 111.239 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.2 141.87 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.037 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -130.66 82.88 63.49 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 122.995 0.518 . . . . 0.0 110.212 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.19 -9.52 23.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.108 2.538 . . . . 0.0 110.413 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -65.02 -32.88 74.82 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.8 0.84 . . . . 0.0 110.284 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -116.94 7.18 13.15 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 56.65 48.06 17.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.808 0.843 . . . . 0.0 110.665 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -139.98 171.47 14.15 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.009 0.924 . . . . 0.0 110.847 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.8 158.3 42.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.168 0.587 . . . . 0.0 110.689 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.98 145.39 50.83 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -143.67 136.85 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -116.17 139.46 50.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.081 0.552 . . . . 0.0 110.384 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -101.64 154.95 18.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -71.26 -13.0 61.76 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.096 -0.378 . . . . 0.0 110.211 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -143.9 143.37 31.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.725 1.61 . . . . 0.0 113.361 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.32 -21.72 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.646 0.26 . . . . 0.0 111.394 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 66.8 tp -69.85 -34.05 73.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.854 0.461 . . . . 0.0 110.812 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.42 -39.42 56.91 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.48 83.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.172 0.51 . . . . 0.0 109.895 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.41 -33.75 73.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.619 0.768 . . . . 0.0 111.18 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -68.14 -34.31 76.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.056 -0.403 . . . . 0.0 110.855 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.77 68.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.74 -35.76 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 122.037 -0.415 . . . . 0.0 111.508 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.0 -24.62 61.59 Favored 'General case' 0 N--CA 1.458 -0.037 0 CA-C-N 118.511 0.596 . . . . 0.0 112.299 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.31 -33.78 49.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.69 -30.2 71.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.035 0.534 . . . . 0.0 110.667 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.89 4.79 3.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 112.265 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -136.11 -27.13 1.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -155.57 153.4 30.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -76.76 137.96 39.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.93 -0.482 . . . . 0.0 110.367 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -85.73 134.58 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 18.3 m-85 -87.31 130.89 34.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.4 mm -129.0 124.52 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.68 34.55 7.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.78 77.01 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.363 -0.687 . . . . 0.0 114.086 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -135.4 148.96 68.21 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 118.432 1.116 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.34 151.53 80.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.376 2.717 . . . . 0.0 111.606 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.7 174.82 13.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.104 0.961 . . . . 0.0 109.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.93 157.54 34.06 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.5 139.69 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.928 0.491 . . . . 0.0 111.867 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -147.42 167.33 24.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.705 1.602 . . . . 0.0 108.404 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.03 149.47 48.73 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.5 t -78.99 154.54 29.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.814 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -69.72 -12.92 62.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 46.4 t -100.43 158.3 16.0 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 110.116 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -94.86 -5.64 44.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -162.76 153.07 16.45 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.432 0.56 . . . . 0.0 110.928 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 CA--C 1.529 0.145 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.086 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -161.43 149.28 12.29 Favored Pre-proline 0 C--O 1.232 0.183 0 C-N-CA 123.374 0.67 . . . . 0.0 110.288 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.23 -6.56 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.93 2.42 . . . . 0.0 110.104 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.4 t -105.42 143.41 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.89 0.876 . . . . 0.0 110.86 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.32 141.75 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.709 0.766 . . . . 0.0 112.368 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -99.17 137.63 37.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.423 1.889 . . . . 0.0 109.702 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.5 mt -117.8 140.6 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 122.946 0.498 . . . . 0.0 109.806 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -146.28 154.39 41.65 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.69 0.796 . . . . 0.0 110.092 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.3 1.7 88.05 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 119.729 -0.484 . . . . 0.0 112.494 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.05 174.52 7.78 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.721 0.76 . . . . 0.0 110.318 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.532 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.18 159.45 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.067 0.461 . . . . 0.0 109.844 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.88 -17.39 63.14 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.06 -10.73 73.86 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.351 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -66.65 147.68 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.51 169.06 22.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.39 1.076 . . . . 0.0 109.488 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -60.04 -32.65 71.11 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.002 -0.436 . . . . 0.0 110.734 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.32 70.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.636 0.374 . . . . 0.0 111.503 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -73.99 -31.87 63.16 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.9 mt -73.26 -40.12 64.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.121 0.168 . . . . 0.0 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.78 -34.56 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.03 -23.9 58.22 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.06 -0.4 . . . . 0.0 111.44 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.29 -17.05 29.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.66 -10.05 9.26 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.1 -21.87 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.247 0.931 . . . . 0.0 111.017 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.96 -11.34 60.91 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.228 -0.295 . . . . 0.0 111.371 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -93.72 -16.79 23.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.16 173.38 26.5 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.66 126.17 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.663 2.908 . . . . 0.0 110.796 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.75 141.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 122.883 0.473 . . . . 0.0 110.716 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.6 t -101.63 -34.23 9.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.273 0.629 . . . . 0.0 111.891 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -164.48 163.04 22.22 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.86 0.3 . . . . 0.0 110.537 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -145.9 142.11 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 123.736 0.814 . . . . 0.0 109.568 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.3 155.02 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 110.85 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.19 141.82 40.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -130.59 84.02 60.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 123.304 0.642 . . . . 0.0 110.424 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.21 -7.59 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.683 2.256 . . . . 0.0 111.322 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -27.4 66.21 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.068 0.547 . . . . 0.0 111.03 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.78 2.99 12.95 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.476 0.71 . . . . 0.0 111.108 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 56.98 52.23 9.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.917 0.887 . . . . 0.0 110.657 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -145.05 172.02 13.65 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.171 0.989 . . . . 0.0 110.898 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.92 39.46 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.653 0.381 . . . . 0.0 110.836 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.63 144.78 48.9 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.729 0.811 . . . . 0.0 109.221 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.9 t -143.03 143.03 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -126.32 138.64 53.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.66 155.72 17.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -71.36 -13.36 61.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.241 -0.287 . . . . 0.0 110.401 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -143.19 144.04 32.02 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.409 1.484 . . . . 0.0 113.227 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.45 -21.68 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 120.928 0.394 . . . . 0.0 111.615 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.1 tp -69.37 -35.84 76.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.841 0.456 . . . . 0.0 110.699 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.8 -37.98 56.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -36.74 83.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 109.907 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.64 -35.81 75.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.23 0.612 . . . . 0.0 110.718 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -65.42 -35.01 79.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.139 -0.351 . . . . 0.0 111.187 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.46 68.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.345 -0.222 . . . . 0.0 111.241 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 98.2 t -80.8 -33.51 13.42 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 O-C-N 122.243 -0.286 . . . . 0.0 110.917 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -68.35 -32.08 71.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.107 -0.371 . . . . 0.0 110.573 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -78.09 -33.21 50.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.21 71.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.977 0.511 . . . . 0.0 110.582 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.3 3.87 4.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.291 0.636 . . . . 0.0 112.384 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -134.34 -25.84 1.5 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -156.94 155.24 31.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.153 0.581 . . . . 0.0 109.495 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.66 135.35 39.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 110.395 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.5 mt -84.75 133.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.6 m-85 -85.05 130.48 34.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mm -128.95 123.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.686 1.194 . . . . 0.0 108.603 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.18 34.55 6.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.56 10.1 74.05 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -136.16 148.89 66.4 Favored Pre-proline 0 C--N 1.339 0.115 0 CA-C-N 118.335 1.067 . . . . 0.0 111.005 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.35 150.07 81.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.363 2.709 . . . . 0.0 111.436 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.08 13.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.186 0.994 . . . . 0.0 109.978 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -124.58 157.73 34.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.5 t -139.48 138.22 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.327 0.651 . . . . 0.0 110.7 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -145.73 167.44 23.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.321 1.048 . . . . 0.0 108.535 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.86 149.07 49.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.588 -0.695 . . . . 0.0 110.47 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.3 t -78.68 155.99 29.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.224 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -72.1 -2.75 19.66 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.4 t -131.94 153.43 50.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.613 0.765 . . . . 0.0 110.723 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -84.86 -4.76 59.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -160.63 150.46 17.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.445 0.566 . . . . 0.0 111.127 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.445 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.043 0.449 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -159.84 150.76 15.83 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.5 0.72 . . . . 0.0 109.966 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.66 -8.32 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.463 2.108 . . . . 0.0 109.703 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.02 142.04 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.203 1.001 . . . . 0.0 111.837 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.65 143.13 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.459 0.647 . . . . 0.0 111.234 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -99.5 137.56 37.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.919 1.687 . . . . 0.0 110.099 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -115.65 140.52 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.22 0.608 . . . . 0.0 109.585 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -143.48 151.28 40.11 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 122.728 0.411 . . . . 0.0 110.591 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.31 86.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.798 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.07 170.07 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.634 0.717 . . . . 0.0 111.201 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.57 155.57 3.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.396 0.678 . . . . 0.0 109.976 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -70.71 -12.62 61.66 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.68 -10.81 85.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.505 0.574 . . . . 0.0 111.953 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.25 148.61 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 m -132.71 170.57 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 124.3 1.04 . . . . 0.0 109.331 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.17 -32.77 70.19 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 122.101 -0.374 . . . . 0.0 111.013 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.92 -31.55 72.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.582 0.353 . . . . 0.0 111.198 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -75.54 -32.87 60.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.761 -0.587 . . . . 0.0 112.538 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.71 -39.23 64.47 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.334 0.253 . . . . 0.0 110.564 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.03 -34.64 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -76.19 -24.45 54.73 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.94 -0.475 . . . . 0.0 111.119 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.74 -17.07 32.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.9 mt -122.01 -8.66 8.81 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.42 -21.7 66.22 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.449 1.022 . . . . 0.0 110.872 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.5 -11.34 60.86 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.142 -0.349 . . . . 0.0 111.202 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.93 -16.96 24.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.97 174.08 26.22 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -68.97 126.56 13.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.502 2.801 . . . . 0.0 110.703 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -94.0 142.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.981 0.512 . . . . 0.0 110.425 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 t -104.77 -34.21 8.18 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.696 0.798 . . . . 0.0 112.015 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -163.39 161.39 24.38 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -146.77 143.63 20.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 124.08 0.952 . . . . 0.0 109.541 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.77 154.25 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.62 141.91 39.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.061 0.544 . . . . 0.0 111.415 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -126.79 87.34 56.76 Favored Pre-proline 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.649 . . . . 0.0 109.984 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -12.93 36.94 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.002 2.468 . . . . 0.0 111.077 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -68.05 -25.87 65.57 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.626 0.37 . . . . 0.0 110.942 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.91 3.55 12.86 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 58.43 46.49 15.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.409 0.684 . . . . 0.0 110.828 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -140.47 170.08 16.46 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.866 0.866 . . . . 0.0 111.425 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.67 158.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.187 0.595 . . . . 0.0 110.984 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -128.35 148.64 50.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.959 0.504 . . . . 0.0 109.712 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -142.03 144.34 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -126.35 138.15 53.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.785 0.434 . . . . 0.0 110.096 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -100.91 155.02 18.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.8 -13.74 61.78 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.338 -0.226 . . . . 0.0 110.545 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -139.62 144.36 37.67 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.527 1.531 . . . . 0.0 112.964 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.18 -24.43 35.7 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -66.74 -35.98 81.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.431 0.292 . . . . 0.0 110.955 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -38.85 59.5 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.91 82.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.67 -35.96 73.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.183 0.593 . . . . 0.0 110.694 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.68 -35.08 79.73 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.007 0.367 . . . . 0.0 111.057 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.43 -32.55 66.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 71.1 t -81.36 -35.02 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.1 -0.375 . . . . 0.0 110.26 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -30.58 68.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.288 0.494 . . . . 0.0 111.714 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -77.72 -33.21 53.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.4 71.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.262 0.625 . . . . 0.0 110.714 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.4 4.47 3.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.591 0.756 . . . . 0.0 112.402 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.82 -26.12 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -156.3 154.54 30.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.86 137.25 39.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.231 -0.293 . . . . 0.0 110.251 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.8 mt -85.25 134.6 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 13.9 m-85 -85.51 130.27 34.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.7 mm -128.96 124.5 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.509 1.124 . . . . 0.0 108.507 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.05 34.53 5.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.016 0.526 . . . . 0.0 112.365 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.6 7.73 74.93 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.353 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -136.1 148.95 66.77 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 118.559 1.179 . . . . 0.0 111.846 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.32 153.02 79.63 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.72 2.946 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 172.84 16.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.185 0.994 . . . . 0.0 109.853 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -120.42 157.44 29.32 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.98 137.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.305 0.642 . . . . 0.0 111.272 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -148.99 171.17 16.81 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.644 1.178 . . . . 0.0 108.448 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -68.67 149.1 49.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.8 t -85.43 158.21 20.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.587 0.355 . . . . 0.0 111.259 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -2.78 18.98 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.8 t -131.57 152.35 50.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 111.0 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -83.36 -3.63 57.7 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.532 0.733 . . . . 0.0 112.675 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.06 148.3 20.32 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.249 0.477 . . . . 0.0 110.969 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 172.759 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.727 0.299 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.5 m -155.19 154.74 29.15 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 123.837 0.855 . . . . 0.0 109.717 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.72 -6.1 17.74 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.405 2.737 . . . . 0.0 110.66 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.81 145.86 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.32 144.39 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.475 0.655 . . . . 0.0 111.063 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.73 137.45 38.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.168 1.787 . . . . 0.0 110.341 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -116.47 140.7 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.204 1.002 . . . . 0.0 109.361 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -142.83 152.18 41.91 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.865 0.466 . . . . 0.0 111.188 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.58 7.55 66.75 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.546 -0.586 . . . . 0.0 112.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.58 177.69 8.59 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.911 0.856 . . . . 0.0 109.649 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.507 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.03 157.0 12.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 CA-C-O 121.347 0.594 . . . . 0.0 109.648 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -67.81 -4.71 13.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.99 -10.78 85.86 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.8 147.56 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.68 168.74 23.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 124.338 1.055 . . . . 0.0 109.984 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -60.32 -32.64 71.43 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.128 -0.357 . . . . 0.0 111.065 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.35 71.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.079 0.152 . . . . 0.0 111.072 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -71.99 -32.18 66.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.24 -44.71 71.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.66 -34.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -75.03 -23.45 58.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 122.074 -0.391 . . . . 0.0 111.435 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.02 -17.07 26.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.45 -9.15 9.04 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.35 -21.87 66.74 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.12 0.873 . . . . 0.0 110.91 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.28 -10.97 60.53 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -92.72 -13.79 28.87 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.5 173.02 22.25 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.24 126.13 14.57 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.465 2.776 . . . . 0.0 110.58 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.38 142.35 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.018 0.527 . . . . 0.0 110.294 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.33 -34.1 8.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.584 0.754 . . . . 0.0 111.857 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -167.14 160.4 13.83 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.29 151.47 17.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.169 0.988 . . . . 0.0 112.454 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.88 155.9 6.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 123.3 0.64 . . . . 0.0 111.186 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.14 141.88 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -136.09 81.11 39.57 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.811 0.444 . . . . 0.0 110.32 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.47 -6.63 15.61 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.18 2.586 . . . . 0.0 110.458 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.19 -32.1 73.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 110.215 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -117.12 7.22 12.98 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.891 0.876 . . . . 0.0 113.068 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 55.73 51.27 12.7 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.508 0.595 . . . . 0.0 111.362 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -143.24 164.72 29.42 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.394 0.678 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.27 40.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.415 0.686 . . . . 0.0 110.475 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -127.66 147.01 50.37 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.55 144.15 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -127.37 135.92 51.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -97.16 157.81 15.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.35 -13.35 61.84 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.857 0.299 . . . . 0.0 110.437 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -143.38 143.89 31.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.402 1.481 . . . . 0.0 113.113 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 p -61.49 -21.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.723 0.297 . . . . 0.0 111.496 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.4 tp -68.6 -35.82 77.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.806 0.442 . . . . 0.0 110.702 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 -38.14 58.37 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.66 87.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.01 -31.96 68.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 111.074 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.38 -35.7 80.99 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.997 -0.439 . . . . 0.0 111.007 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.16 70.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.414 -0.179 . . . . 0.0 110.917 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.15 -33.69 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 O-C-N 122.363 -0.211 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -70.18 -30.79 68.0 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.191 -0.318 . . . . 0.0 110.746 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -74.84 -32.96 62.07 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.31 70.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.56 1.9 3.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.393 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -132.1 -28.79 1.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -157.05 152.33 26.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.805 0.442 . . . . 0.0 109.86 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.81 138.37 39.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.6 mt -82.78 140.02 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.6 m-85 -92.27 131.21 37.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.02 124.68 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.624 1.17 . . . . 0.0 108.429 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.47 34.51 6.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.181 0.592 . . . . 0.0 112.464 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.08 10.16 78.9 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.787 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -134.99 148.81 68.41 Favored Pre-proline 0 C--N 1.339 0.11 0 CA-C-N 118.151 0.975 . . . . 0.0 111.311 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 150.46 82.76 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.36 2.706 . . . . 0.0 111.198 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.07 13.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.922 0.889 . . . . 0.0 109.709 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.72 158.63 39.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -142.34 145.52 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -152.4 168.9 23.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.716 1.606 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -68.93 150.5 47.66 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.8 t -81.08 162.34 23.77 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.205 0.602 . . . . 0.0 111.31 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -2.89 22.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.6 t -125.15 157.75 35.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.584 0.754 . . . . 0.0 110.082 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.41 -6.67 59.2 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -161.09 157.62 26.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.714 0.688 . . . . 0.0 111.67 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.405 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 t -162.05 148.8 11.1 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.527 0.731 . . . . 0.0 109.761 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.87 -9.72 26.27 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.663 2.242 . . . . 0.0 109.65 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.02 140.91 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.521 0.728 . . . . 0.0 110.924 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 m -134.97 141.71 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.997 0.903 . . . . 0.0 111.77 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -99.15 137.43 37.68 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.315 1.846 . . . . 0.0 110.412 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -116.02 140.8 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.829 0.851 . . . . 0.0 109.735 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -144.65 152.77 40.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.86 0.464 . . . . 0.0 110.582 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.15 86.66 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.75 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.45 173.94 7.26 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 117.86 0.83 . . . . 0.0 110.898 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 pt -104.03 153.4 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.04 0 C-N-CA 123.317 0.647 . . . . 0.0 109.296 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -71.46 -8.54 54.51 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.09 -10.85 85.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.79 150.02 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.66 166.88 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 C-N-CA 124.064 0.946 . . . . 0.0 109.522 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.85 -32.67 67.87 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 122.247 -0.283 . . . . 0.0 111.455 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.49 72.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.433 0.293 . . . . 0.0 111.48 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -74.33 -30.83 62.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.35 -44.24 68.54 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.8 -34.68 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.18 -21.57 58.65 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.091 0.405 . . . . 0.0 111.22 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.54 -17.09 26.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -121.97 -9.52 8.74 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.06 -21.95 66.9 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.185 0.902 . . . . 0.0 110.813 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -69.23 -12.72 61.91 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.201 0.2 . . . . 0.0 111.409 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.71 -17.65 25.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.07 172.26 25.02 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.24 128.84 19.17 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.253 2.635 . . . . 0.0 110.795 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.88 142.84 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.079 0.552 . . . . 0.0 110.781 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 t -103.73 -33.99 8.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.626 0.77 . . . . 0.0 111.914 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -167.0 159.68 13.46 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.77 152.7 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.314 1.046 . . . . 0.0 112.045 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.0 154.93 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.307 0.643 . . . . 0.0 111.052 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -138.02 141.88 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.141 0.577 . . . . 0.0 112.313 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -133.66 84.31 45.47 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 123.453 0.701 . . . . 0.0 109.741 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.55 -8.53 22.52 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.131 2.554 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -65.84 -30.56 71.19 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.416 0.686 . . . . 0.0 109.931 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.9 5.79 13.0 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.823 0.849 . . . . 0.0 111.897 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 57.13 48.59 15.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.889 0.875 . . . . 0.0 110.996 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -141.85 169.01 18.4 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.676 0.79 . . . . 0.0 110.841 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.5 157.71 40.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.163 0.585 . . . . 0.0 110.06 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 mt -128.46 150.29 50.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.5 144.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -124.33 131.6 53.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.836 0.454 . . . . 0.0 109.787 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.02 155.34 17.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -71.93 -15.58 62.09 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -140.16 143.03 35.94 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.263 1.425 . . . . 0.0 113.688 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.72 -21.78 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.9 tp -68.99 -36.12 77.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.861 0.464 . . . . 0.0 110.638 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.57 -39.11 61.27 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.88 84.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.042 0.448 . . . . 0.0 109.985 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.8 t -70.95 -33.29 70.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 110.904 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.52 -35.02 78.29 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.211 -0.306 . . . . 0.0 110.961 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.86 -38.51 70.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.559 0.163 . . . . 0.0 111.433 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.73 -35.45 43.74 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 O-C-N 122.229 -0.294 . . . . 0.0 111.125 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -76.87 -21.36 55.08 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.468 0.576 . . . . 0.0 112.488 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -74.68 -32.96 62.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.07 -30.25 70.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.555 0.742 . . . . 0.0 111.7 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.55 -16.7 63.96 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.33 -28.6 9.78 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -159.97 152.4 20.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.23 0.612 . . . . 0.0 109.606 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.79 140.02 40.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -82.74 133.56 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.8 m-85 -86.51 129.38 34.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mm -128.88 124.49 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.572 1.149 . . . . 0.0 108.343 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.39 34.51 6.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.07 8.73 78.3 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.227 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -135.83 148.91 67.16 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.494 1.147 . . . . 0.0 111.849 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.25 150.89 81.64 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.349 2.699 . . . . 0.0 111.703 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.92 174.95 13.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.767 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.5 162.82 24.04 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.4 p -142.21 148.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.254 0.622 . . . . 0.0 111.956 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -156.02 166.79 32.42 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.84 148.48 50.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.222 0.919 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 t -85.05 160.61 19.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.974 0.51 . . . . 0.0 110.956 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -2.77 18.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.7 t -133.62 154.05 51.19 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.056 0.542 . . . . 0.0 111.043 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -85.11 -2.69 58.28 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.414 0.686 . . . . 0.0 112.243 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.76 151.85 20.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 111.479 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 73.5 mt . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.167 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -163.09 149.62 10.34 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 123.464 0.706 . . . . 0.0 110.011 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.39 -9.59 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 110.027 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.93 139.7 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.673 0.789 . . . . 0.0 110.621 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.38 139.02 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.625 0.726 . . . . 0.0 111.395 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.18 137.31 37.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.416 1.886 . . . . 0.0 110.296 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.3 mt -116.37 140.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.784 0.833 . . . . 0.0 109.911 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.138 0.575 . . . . 0.0 110.449 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.3 85.53 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.098 0.38 . . . . 0.0 112.705 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.96 173.99 7.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.448 0.624 . . . . 0.0 110.972 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.7 pt -100.71 154.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.599 0.76 . . . . 0.0 109.705 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -72.76 -10.48 59.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.71 -10.9 85.93 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.88 149.8 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.56 169.92 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 124.018 0.927 . . . . 0.0 109.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 60.3 mp0 -57.9 -32.84 68.13 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.407 0.283 . . . . 0.0 111.205 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.4 70.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.746 0.418 . . . . 0.0 111.722 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -72.97 -35.67 66.97 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.949 -0.469 . . . . 0.0 112.095 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.5 -38.48 65.35 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.488 0.315 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.93 -34.88 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.63 -25.0 56.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.148 -0.345 . . . . 0.0 111.007 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.0 35.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.6 mt -122.84 -9.62 8.31 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.62 -21.86 66.12 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.372 0.987 . . . . 0.0 110.915 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -68.96 -11.5 60.76 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.264 -0.273 . . . . 0.0 111.406 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.68 -16.09 23.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.68 172.43 23.97 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.17 129.26 17.9 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.499 2.799 . . . . 0.0 110.981 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.9 mt -97.81 142.78 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.604 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.8 t -104.71 -32.12 9.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.328 0.651 . . . . 0.0 111.641 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -163.0 161.88 25.71 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -147.26 143.96 19.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 109.319 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.5 p -151.03 153.3 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.335 0.654 . . . . 0.0 111.651 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.6 141.7 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.1 78.89 75.47 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 123.332 0.653 . . . . 0.0 109.811 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.22 -7.71 18.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.093 2.529 . . . . 0.0 111.201 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -65.35 -33.2 75.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.267 0.627 . . . . 0.0 110.097 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -117.1 7.5 13.07 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.743 0.817 . . . . 0.0 112.537 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 55.77 53.39 9.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.216 0.606 . . . . 0.0 110.58 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -144.76 172.87 12.41 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.923 0.889 . . . . 0.0 110.977 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.55 158.26 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.123 0.569 . . . . 0.0 110.82 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.4 mt -128.81 146.65 50.86 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.324 0.65 . . . . 0.0 109.657 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.7 t -141.56 144.22 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -126.76 126.81 44.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -87.19 156.94 19.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.66 -14.32 61.56 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 122.205 -0.309 . . . . 0.0 110.344 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -143.07 143.04 31.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.292 1.437 . . . . 0.0 113.382 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.51 -21.94 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.6 -36.72 79.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.866 0.466 . . . . 0.0 110.587 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -36.2 58.11 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.57 92.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 97.5 m -71.29 -28.71 64.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -68.04 -36.44 79.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.222 0.465 . . . . 0.0 110.932 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.461 0.119 . . . . 0.0 110.968 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.6 t -76.99 -33.43 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.358 -0.214 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -66.8 -34.48 77.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.176 0.443 . . . . 0.0 110.379 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.24 -32.99 63.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.28 -29.99 69.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.501 0.72 . . . . 0.0 111.862 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.61 -10.68 5.51 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.41 5.04 1.23 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -149.83 156.1 41.22 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -94.04 137.03 33.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.8 mt -90.04 135.1 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.299 24.7 m-85 -87.42 128.83 35.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.96 123.33 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.458 1.103 . . . . 0.0 108.578 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.05 34.41 4.2 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 112.562 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.47 8.8 70.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.459 -0.634 . . . . 0.0 114.105 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -136.05 148.91 66.7 Favored Pre-proline 0 N--CA 1.461 0.09 0 CA-C-N 118.355 1.078 . . . . 0.0 111.684 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.64 149.34 79.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.32 2.68 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.08 13.22 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.414 1.086 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -129.46 161.92 29.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.3 149.23 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.396 0.678 . . . . 0.0 110.894 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -154.2 167.66 29.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.97 150.79 47.31 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.39 -0.819 . . . . 0.0 109.103 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 40.9 t -84.21 160.02 20.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.941 0.496 . . . . 0.0 111.19 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.34 -2.66 17.08 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.2 t -133.91 152.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.248 0.619 . . . . 0.0 110.913 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -82.46 -2.7 54.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.47 0.708 . . . . 0.0 112.486 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -157.84 153.42 26.37 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.381 0.537 . . . . 0.0 111.608 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.6 mt . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.196 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.224 0 CA-C-O 121.014 0.435 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.8 t -164.05 149.86 9.34 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.531 0.732 . . . . 0.0 109.753 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.89 -9.22 25.3 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.887 2.392 . . . . 0.0 110.033 172.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.12 142.88 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.637 0.775 . . . . 0.0 110.68 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.31 141.17 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.495 0.664 . . . . 0.0 111.817 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -104.93 137.47 42.64 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.397 1.879 . . . . 0.0 109.996 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -115.19 140.7 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.232 1.013 . . . . 0.0 110.004 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -141.71 154.8 45.54 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.12 0.568 . . . . 0.0 110.11 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.24 83.13 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.713 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.18 174.96 7.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.872 0.836 . . . . 0.0 110.584 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.523 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.8 160.86 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.104 0.561 . . . . 0.0 110.087 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.68 -19.04 64.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -70.41 -10.78 67.03 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.092 0.377 . . . . 0.0 112.561 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.73 146.61 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.57 166.79 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 C-N-CA 124.098 0.959 . . . . 0.0 109.827 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.45 -32.73 70.49 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.248 -0.282 . . . . 0.0 111.2 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.38 72.0 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.212 0.205 . . . . 0.0 111.09 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -74.01 -30.19 62.33 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.74 -45.02 72.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.38 -34.65 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -74.96 -21.57 59.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.998 -0.438 . . . . 0.0 111.754 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.74 -17.02 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.4 -8.74 9.58 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.5 -21.97 66.68 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.112 0.869 . . . . 0.0 110.993 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.0 -12.37 61.56 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.142 -0.349 . . . . 0.0 111.485 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -91.3 -16.09 28.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.21 23.45 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.01 130.67 22.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.496 2.798 . . . . 0.0 110.764 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.0 mt -98.52 142.79 14.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.211 0.604 . . . . 0.0 110.894 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.4 t -104.7 -33.7 8.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.615 0.766 . . . . 0.0 112.278 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -165.0 157.04 15.54 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.69 151.37 16.64 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 123.911 0.884 . . . . 0.0 111.941 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.07 157.97 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.317 0.647 . . . . 0.0 111.804 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.05 141.94 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -133.05 82.66 53.96 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 123.288 0.635 . . . . 0.0 110.328 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.02 -10.17 27.63 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.919 2.413 . . . . 0.0 111.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -69.98 -24.49 63.32 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 117.841 0.291 . . . . 0.0 111.065 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -116.8 3.34 12.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.503 0.721 . . . . 0.0 111.769 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 57.3 51.12 10.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.31 170.93 15.06 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.966 0.906 . . . . 0.0 110.873 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.23 40.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.13 0.572 . . . . 0.0 110.537 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.51 150.89 49.97 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.34 144.56 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -125.35 133.08 52.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.852 0.461 . . . . 0.0 109.968 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -95.37 155.3 16.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -71.42 -14.51 62.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -143.61 143.54 31.53 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.566 1.546 . . . . 0.0 113.415 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.17 -21.9 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 0.0 111.658 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.69 -35.31 77.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.687 0.395 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.06 -38.88 55.01 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.82 85.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.013 0.435 . . . . 0.0 109.852 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.96 -33.61 68.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.218 0.607 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.41 -34.75 79.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.118 0.417 . . . . 0.0 111.015 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.57 68.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.494 -0.128 . . . . 0.0 111.107 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.6 -33.6 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.046 0 O-C-N 122.069 -0.395 . . . . 0.0 110.876 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -71.68 -30.8 66.1 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.031 -0.418 . . . . 0.0 110.566 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.75 -32.93 64.07 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.35 69.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.635 0.774 . . . . 0.0 111.5 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.96 -14.91 63.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -109.99 -27.18 9.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -160.01 153.86 22.93 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.101 0.56 . . . . 0.0 109.587 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.72 137.04 39.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -81.37 137.61 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.286 13.9 m-85 -90.45 130.8 36.48 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.7 mm -128.79 124.43 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.62 1.168 . . . . 0.0 108.072 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.46 34.56 6.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.192 0.597 . . . . 0.0 112.528 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.19 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.871 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -135.65 148.8 67.05 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 118.54 1.17 . . . . 0.0 111.4 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.15 149.82 81.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.175 2.583 . . . . 0.0 111.791 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.78 175.1 13.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.162 0.985 . . . . 0.0 109.888 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -128.12 159.71 34.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 144.56 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -146.47 164.37 32.73 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.465 1.106 . . . . 0.0 108.257 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -68.88 150.7 47.48 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.4 t -85.12 159.12 20.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.883 0.473 . . . . 0.0 111.475 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.87 -2.66 15.74 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.9 t -131.05 152.03 50.79 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.199 0.6 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -82.54 -4.22 57.22 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -158.56 150.37 21.25 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.401 0.546 . . . . 0.0 111.228 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.117 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 m -152.81 151.17 26.06 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 110.418 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 -1.84 11.76 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.905 3.07 . . . . 0.0 110.599 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.9 149.73 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.803 0.841 . . . . 0.0 112.391 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.41 146.84 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.778 0.799 . . . . 0.0 111.932 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -100.94 137.59 39.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.216 2.206 . . . . 0.0 110.058 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.71 140.65 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.429 1.092 . . . . 0.0 110.25 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -144.32 154.3 42.9 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.203 0.601 . . . . 0.0 110.155 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.48 82.69 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.717 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.28 173.27 9.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.758 0.779 . . . . 0.0 110.398 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.523 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.19 160.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.022 0.529 . . . . 0.0 109.831 -178.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.15 -18.88 63.94 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.35 -10.96 75.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.784 -0.454 . . . . 0.0 112.609 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.68 146.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -132.66 167.1 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.483 1.113 . . . . 0.0 109.376 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -58.83 -32.55 69.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.149 -0.344 . . . . 0.0 111.399 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.18 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.473 0.309 . . . . 0.0 111.178 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -74.89 -31.44 61.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.0 mt -71.85 -40.58 68.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.247 0.219 . . . . 0.0 110.648 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -71.86 -34.79 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.04 -22.7 58.24 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 122.267 -0.271 . . . . 0.0 111.421 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.7 -17.07 24.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.92 -9.02 10.17 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.63 -21.73 66.6 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.852 0.751 . . . . 0.0 110.834 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.59 -12.27 61.46 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.066 -0.396 . . . . 0.0 111.262 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -90.58 -17.87 26.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.87 173.86 26.84 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.11 127.75 16.46 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.667 2.912 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 77.4 mt -95.34 142.95 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.07 0.548 . . . . 0.0 110.542 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.5 t -108.5 -33.21 7.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.23 0.612 . . . . 0.0 112.07 -176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -161.86 159.75 27.24 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.64 145.82 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.102 0.961 . . . . 0.0 109.413 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.78 154.21 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.567 0.747 . . . . 0.0 110.921 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.05 141.74 39.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -131.22 84.19 57.75 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 123.293 0.637 . . . . 0.0 110.221 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.41 -9.85 25.51 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.758 2.306 . . . . 0.0 110.452 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.26 -30.73 71.77 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.15 0.98 . . . . 0.0 110.22 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -117.02 3.73 12.76 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.261 1.025 . . . . 0.0 112.706 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 56.5 44.8 23.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.341 0.656 . . . . 0.0 110.585 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -140.48 169.54 17.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 110.431 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.36 40.84 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.874 0.47 . . . . 0.0 111.192 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.4 149.64 50.46 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -142.34 144.42 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.32 134.53 53.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.179 0.592 . . . . 0.0 109.936 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -98.77 154.92 17.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.15 -13.72 61.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.101 0.409 . . . . 0.0 110.691 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -141.28 143.1 33.9 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.219 1.407 . . . . 0.0 113.624 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.76 -22.04 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 111.557 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.7 tp -69.01 -36.53 77.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.378 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.37 -38.35 58.39 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.02 86.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.4 t -71.59 -33.78 69.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.258 0.623 . . . . 0.0 111.075 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.25 -34.55 78.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.107 0.412 . . . . 0.0 111.029 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.54 -40.13 70.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.316 -0.24 . . . . 0.0 110.829 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -75.13 -33.8 29.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 122.329 -0.232 . . . . 0.0 110.524 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.42 -29.58 66.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.055 0.389 . . . . 0.0 110.887 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -75.46 -33.05 60.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.44 71.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.236 0.614 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.99 2.83 3.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 112.455 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.48 -27.8 1.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.94 153.95 27.03 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -76.71 142.14 40.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.657 0.265 . . . . 0.0 110.671 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.6 mt -83.88 138.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.31 19.2 m-85 -91.37 129.12 37.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.73 123.49 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.508 1.123 . . . . 0.0 108.333 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.44 34.56 6.84 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.219 0.608 . . . . 0.0 112.241 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 9.44 74.75 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.079 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.0 148.94 66.92 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 118.418 1.109 . . . . 0.0 111.394 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.9 148.35 76.35 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.333 2.688 . . . . 0.0 111.278 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.93 175.0 13.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.228 1.011 . . . . 0.0 109.822 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -128.15 163.4 24.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.1 148.12 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.321 0.649 . . . . 0.0 111.56 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -155.1 166.5 33.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -68.62 151.01 47.31 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.413 -0.804 . . . . 0.0 112.351 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.2 t -84.7 164.9 18.31 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.773 0.32 . . . . 0.0 111.096 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.99 -2.9 19.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.3 t -137.99 156.6 47.67 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.094 0.558 . . . . 0.0 111.312 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -82.46 -0.05 44.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -157.56 154.77 29.09 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 118.281 0.491 . . . . 0.0 110.942 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.077 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.965 0.412 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -153.63 151.99 26.35 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 123.748 0.819 . . . . 0.0 109.665 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.68 6.63 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.993 3.129 . . . . 0.0 110.908 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -137.62 147.47 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.23 148.12 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.934 0.873 . . . . 0.0 111.426 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -99.1 137.61 37.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.149 1.78 . . . . 0.0 109.866 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mt -114.6 140.47 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.487 0.715 . . . . 0.0 109.435 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -145.25 153.19 41.05 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.625 0.37 . . . . 0.0 110.613 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.16 90.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.684 -0.509 . . . . 0.0 112.766 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.23 172.46 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.91 157.29 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.331 0.653 . . . . 0.0 110.289 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.82 -22.42 66.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.83 -10.95 73.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.257 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.41 147.7 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -132.57 166.59 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.233 1.013 . . . . 0.0 109.804 174.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.42 -32.64 67.08 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 122.113 -0.367 . . . . 0.0 111.392 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -31.28 71.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.433 0.293 . . . . 0.0 111.184 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.04 -31.11 62.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.59 -43.06 73.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 121.937 0.095 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.03 -34.49 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.65 -22.08 57.1 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.949 0.34 . . . . 0.0 111.468 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.09 -17.38 26.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.79 -7.63 9.53 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -65.57 -21.71 66.62 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.17 0.895 . . . . 0.0 110.884 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.53 -12.26 61.45 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.214 -0.304 . . . . 0.0 111.488 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -92.05 -15.43 27.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.39 173.03 23.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.85 126.73 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.667 2.912 . . . . 0.0 110.804 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.3 mt -93.65 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.993 0.517 . . . . 0.0 110.616 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.6 -34.1 8.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.482 0.713 . . . . 0.0 111.761 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -166.36 159.0 14.35 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.41 151.19 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.23 1.012 . . . . 0.0 111.797 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.77 155.06 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.055 0.542 . . . . 0.0 111.355 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.16 141.76 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -133.87 87.41 35.49 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.457 0.703 . . . . 0.0 110.027 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.43 -12.71 36.73 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.944 2.429 . . . . 0.0 111.419 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.41 -23.85 65.6 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.894 0.478 . . . . 0.0 111.046 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.91 4.69 12.88 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.537 0.735 . . . . 0.0 112.258 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 tpp85 56.5 45.74 21.89 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.412 0.685 . . . . 0.0 110.473 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -140.5 165.59 27.03 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.892 0.877 . . . . 0.0 111.363 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.57 158.18 40.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.232 0.613 . . . . 0.0 110.647 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.06 149.88 50.19 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -143.41 139.82 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -121.74 140.91 51.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.83 0.452 . . . . 0.0 110.397 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -103.1 154.81 18.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -71.73 -13.54 61.75 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.665 0.211 . . . . 0.0 110.557 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -141.61 143.16 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.273 1.429 . . . . 0.0 113.553 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.07 -21.97 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.702 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -69.37 -35.34 75.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.748 0.419 . . . . 0.0 110.66 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.12 -38.92 59.16 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.43 83.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 109.996 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.9 t -70.39 -34.84 73.03 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.87 0.468 . . . . 0.0 110.867 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -66.3 -33.99 76.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.013 0.37 . . . . 0.0 110.928 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.32 69.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.545 0.157 . . . . 0.0 111.301 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.0 t -81.38 -33.56 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.941 0.337 . . . . 0.0 110.984 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.3 -30.64 67.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.253 -0.28 . . . . 0.0 110.741 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.83 -33.03 46.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.33 71.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.027 0.531 . . . . 0.0 110.795 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.26 4.5 3.6 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.442 0.697 . . . . 0.0 112.151 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.63 -27.8 1.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -155.74 155.58 33.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -76.73 135.63 39.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.635 0.255 . . . . 0.0 110.357 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.11 135.16 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 11.2 m-85 -85.85 130.46 34.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.4 mm -128.82 126.3 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.43 34.45 6.68 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.96 0.504 . . . . 0.0 112.048 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.63 9.62 80.97 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.053 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -136.09 148.94 66.76 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 118.558 1.179 . . . . 0.0 111.809 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.06 149.43 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.594 2.863 . . . . 0.0 111.718 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 170.92 19.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.282 1.033 . . . . 0.0 109.914 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -114.17 158.2 21.63 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.61 142.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.583 0.753 . . . . 0.0 109.969 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -155.55 167.64 29.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.72 147.82 51.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.392 -0.817 . . . . 0.0 110.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -77.09 152.46 35.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.225 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -71.03 -2.77 16.55 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 72.8 m -127.85 155.18 44.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.183 0.993 . . . . 0.0 109.642 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -83.92 -4.99 59.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.84 156.79 25.65 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.624 0.647 . . . . 0.0 111.516 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.439 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.905 0.383 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 t -161.59 148.47 11.48 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.296 0.638 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.87 -7.68 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.1 2.533 . . . . 0.0 110.037 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.0 t -106.08 141.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.121 0.969 . . . . 0.0 110.569 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.95 142.44 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 121.802 0.811 . . . . 0.0 112.242 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -99.68 137.67 37.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.857 1.663 . . . . 0.0 110.383 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.53 140.54 36.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.63 0.772 . . . . 0.0 109.782 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -143.26 153.03 42.38 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.734 0.414 . . . . 0.0 110.491 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.49 6.13 89.47 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.65 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.33 170.07 12.56 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.584 0.692 . . . . 0.0 110.854 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -93.39 153.93 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.996 0.518 . . . . 0.0 110.328 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.12 -22.29 65.81 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.57 -10.72 82.86 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.616 0.626 . . . . 0.0 112.486 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.3 147.83 10.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.53 168.14 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.974 0.91 . . . . 0.0 109.866 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.3 -32.74 68.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.169 -0.332 . . . . 0.0 111.369 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.41 72.13 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.152 0.181 . . . . 0.0 111.125 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.18 -31.46 62.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.24 -42.85 68.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.053 0.141 . . . . 0.0 110.776 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.93 -34.58 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -75.44 -22.89 56.97 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.137 -0.352 . . . . 0.0 111.256 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.66 -17.07 27.47 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -120.68 -8.45 9.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.11 -21.84 66.37 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.083 0.856 . . . . 0.0 110.979 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.48 -11.27 60.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.48 0.312 . . . . 0.0 111.584 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.72 -14.94 25.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.29 23.97 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.35 125.86 13.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.067 2.512 . . . . 0.0 110.678 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -93.31 142.67 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.875 0.47 . . . . 0.0 110.197 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.2 t -101.51 -34.2 9.64 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.06 0.544 . . . . 0.0 111.491 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -167.18 160.73 14.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.91 150.73 19.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.61 1.164 . . . . 0.0 111.929 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.09 155.8 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.108 0.563 . . . . 0.0 111.412 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.05 141.93 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.103 0.561 . . . . 0.0 112.363 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.77 79.32 72.08 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.837 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.61 -25.95 77.05 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.0 113.755 -175.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -12.0 61.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.408 0.549 . . . . 0.0 111.277 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -116.76 2.89 12.95 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.523 0.729 . . . . 0.0 112.327 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 58.77 38.97 24.68 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.259 0.624 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -140.81 167.28 22.55 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 112.114 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.18 40.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.286 0.634 . . . . 0.0 111.089 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.52 152.14 47.97 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -144.77 144.49 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -124.13 138.03 54.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.41 154.12 18.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.43 -15.41 62.34 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.125 -0.359 . . . . 0.0 110.148 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -139.24 142.94 37.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.487 1.515 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.53 -21.77 28.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 120.774 0.321 . . . . 0.0 111.583 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -69.94 -35.25 74.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.107 0.563 . . . . 0.0 110.79 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.9 -37.9 56.5 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 109.86 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.9 t -69.9 -34.82 74.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.168 0.587 . . . . 0.0 110.832 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.78 -34.54 78.05 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 117.973 0.351 . . . . 0.0 111.182 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.52 0.146 . . . . 0.0 111.38 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.32 -33.77 12.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 O-C-N 122.111 -0.368 . . . . 0.0 110.856 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -69.94 -33.12 71.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.955 -0.466 . . . . 0.0 110.528 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -77.34 -33.0 55.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.24 71.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.359 0.663 . . . . 0.0 111.188 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.01 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.545 0.338 . . . . 0.0 111.865 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.7 -23.58 10.98 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.99 155.34 25.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.28 0.632 . . . . 0.0 109.467 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -76.79 133.98 39.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.14 134.49 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.285 10.9 m-85 -84.7 129.83 34.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.3 mm -129.02 126.12 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.737 1.215 . . . . 0.0 107.898 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.31 34.42 6.33 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.058 0.543 . . . . 0.0 112.3 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.48 79.86 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.231 -0.76 . . . . 0.0 114.35 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.3 149.05 66.7 Favored Pre-proline 0 CA--C 1.528 0.125 0 CA-C-N 118.481 1.14 . . . . 0.0 111.767 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.64 151.05 85.74 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.491 2.794 . . . . 0.0 111.881 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 173.41 15.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.329 1.052 . . . . 0.0 109.889 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.32 156.98 27.95 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.3 144.89 25.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.582 0.753 . . . . 0.0 110.841 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -155.02 168.91 25.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.72 148.6 50.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.403 -0.811 . . . . 0.0 110.501 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.3 t -78.05 154.75 31.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 111.021 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.4 t -71.98 -2.62 18.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -130.68 149.25 52.42 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.01 0.924 . . . . 0.0 110.051 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -83.59 -2.73 56.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.981 0.512 . . . . 0.0 111.615 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -149.25 150.57 32.79 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.063 0.545 . . . . 0.0 112.008 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.4 mt . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.475 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.0 m -153.53 152.43 27.36 Favored Pre-proline 0 CA--C 1.528 0.13 0 C-N-CA 123.234 0.614 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.47 3.59 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.928 3.085 . . . . 0.0 110.646 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.91 148.38 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.72 146.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 121.659 0.743 . . . . 0.0 110.672 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -101.37 137.48 39.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.093 1.757 . . . . 0.0 110.562 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.5 mt -114.75 140.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.174 0.99 . . . . 0.0 109.651 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -147.29 152.82 38.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.328 0.651 . . . . 0.0 110.233 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.28 78.65 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.932 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.27 176.79 6.34 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.081 0.94 . . . . 0.0 111.271 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -110.2 154.4 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 123.194 0.598 . . . . 0.0 109.522 177.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -69.43 -4.47 18.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -76.75 -10.86 85.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.02 148.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.57 168.42 24.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 123.984 0.914 . . . . 0.0 109.533 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.75 -32.67 69.47 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.158 -0.339 . . . . 0.0 111.496 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -31.42 72.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.329 0.252 . . . . 0.0 111.123 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.1 -30.59 60.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -72.27 -42.18 65.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.51 -34.61 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -75.19 -23.98 57.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.125 -0.359 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.35 -17.05 31.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.4 mt -123.77 -9.14 7.84 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.96 -21.79 66.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.258 0.936 . . . . 0.0 110.632 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -11.74 61.12 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.154 -0.342 . . . . 0.0 111.389 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -92.26 -15.08 27.94 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.13 173.47 24.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.42 127.18 15.27 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.426 2.75 . . . . 0.0 110.621 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.1 mt -93.56 140.96 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.843 0.457 . . . . 0.0 110.327 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.3 t -102.12 -34.09 9.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.729 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -163.48 161.48 24.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.5 t -145.66 145.27 20.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.009 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.63 153.42 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.168 0.587 . . . . 0.0 111.206 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.28 141.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.261 0.624 . . . . 0.0 111.495 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.11 89.55 23.55 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.736 0.414 . . . . 0.0 110.435 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -6.55 17.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.885 2.39 . . . . 0.0 110.809 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -64.03 -34.41 77.95 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.387 0.675 . . . . 0.0 110.313 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -117.0 7.25 13.09 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.884 0.874 . . . . 0.0 112.471 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 57.73 52.96 7.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.398 0.679 . . . . 0.0 110.76 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -144.69 169.59 17.72 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.471 0.709 . . . . 0.0 111.57 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.62 158.32 40.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.444 0.698 . . . . 0.0 110.324 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.0 152.29 51.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.015 0.435 . . . . 0.0 110.463 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.9 t -143.57 140.58 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -122.39 138.08 54.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -99.09 154.8 17.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -72.33 -14.2 61.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.872 0.305 . . . . 0.0 110.236 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -139.06 143.23 38.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.051 1.34 . . . . 0.0 113.142 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.21 -23.05 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.695 0.283 . . . . 0.0 111.282 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.6 tp -68.05 -35.53 78.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.766 0.427 . . . . 0.0 110.432 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.27 -37.36 59.36 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.55 88.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 96.7 m -70.96 -30.12 66.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -67.62 -35.63 79.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.174 0.443 . . . . 0.0 110.892 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.61 76.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 121.299 -0.16 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 -33.48 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.705 0.23 . . . . 0.0 111.492 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.8 -31.68 70.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.992 0.36 . . . . 0.0 110.651 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -75.05 -32.87 61.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.24 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.34 0.656 . . . . 0.0 111.025 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.44 5.5 1.76 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 112.333 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -135.93 -29.52 1.02 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -156.64 153.54 28.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.77 140.53 40.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.8 135.18 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.288 10.1 m-85 -84.87 129.5 34.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.4 mm -126.25 121.55 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.464 1.106 . . . . 0.0 108.359 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.33 33.96 2.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.67 0.788 . . . . 0.0 112.172 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 89.58 12.26 62.94 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.34 0.495 . . . . 0.0 112.738 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -136.22 139.4 29.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.552 0.741 . . . . 0.0 110.516 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.37 143.57 58.58 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.335 2.69 . . . . 0.0 112.183 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.74 174.41 12.21 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.521 0.729 . . . . 0.0 110.111 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -120.14 158.77 26.22 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.28 148.71 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.648 0.779 . . . . 0.0 111.03 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -155.2 170.07 22.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -68.6 145.2 54.16 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.544 -0.722 . . . . 0.0 109.489 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.4 t -74.67 154.29 38.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.34 -2.78 17.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.2 t -129.07 156.2 44.23 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.213 1.005 . . . . 0.0 110.018 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -84.91 -6.51 59.34 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -161.03 156.58 24.87 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.742 0.701 . . . . 0.0 111.734 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.376 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.6 m -155.64 156.27 30.55 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.269 1.028 . . . . 0.0 109.799 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.68 0.14 8.59 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.828 3.019 . . . . 0.0 110.917 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.05 145.6 33.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.67 147.26 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.451 0.643 . . . . 0.0 111.647 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -105.86 137.52 43.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.316 1.846 . . . . 0.0 110.046 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.43 140.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 124.234 1.014 . . . . 0.0 109.749 -174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -142.75 153.68 43.53 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.193 0.597 . . . . 0.0 110.159 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.07 0.12 81.18 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.694 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.12 173.5 10.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 110.818 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.532 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -110.23 157.34 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-O 121.359 0.599 . . . . 0.0 109.599 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -68.87 -5.18 19.59 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.4 -10.76 86.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 176.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 p -65.31 146.72 13.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.67 169.39 22.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 124.383 1.073 . . . . 0.0 109.8 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.15 -32.71 70.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.176 -0.328 . . . . 0.0 111.516 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.57 -31.31 71.29 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.479 0.312 . . . . 0.0 111.045 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -74.1 -31.42 62.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.01 -43.6 71.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.47 -34.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.27 -22.98 57.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.972 0.351 . . . . 0.0 111.435 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.26 26.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.8 mt -122.44 -7.58 8.66 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.55 -21.83 66.15 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.278 0.944 . . . . 0.0 110.725 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.27 -10.6 59.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.507 0.323 . . . . 0.0 111.441 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.09 -14.34 27.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.21 175.05 24.19 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.53 125.2 12.47 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.498 2.799 . . . . 0.0 110.496 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -93.47 141.62 14.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.877 0.471 . . . . 0.0 110.391 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 t -101.18 -34.15 9.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.466 0.706 . . . . 0.0 111.76 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -167.21 160.46 13.72 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.15 150.31 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.165 0.986 . . . . 0.0 111.822 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.59 156.57 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.086 0.554 . . . . 0.0 111.683 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.6 141.84 38.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.99 78.42 65.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 122.863 0.465 . . . . 0.0 110.813 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.64 -16.31 42.42 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.437 2.758 . . . . 0.0 111.566 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -64.39 -28.22 69.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 111.319 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -116.88 5.03 12.93 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.124 0.57 . . . . 0.0 111.933 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 56.77 51.75 10.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.72 0.808 . . . . 0.0 110.743 -176.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -145.06 171.27 14.71 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.901 0.88 . . . . 0.0 110.671 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.56 158.12 40.76 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.992 0.517 . . . . 0.0 110.521 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -129.86 152.05 49.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.152 0.501 . . . . 0.0 110.056 176.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.38 142.03 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -122.29 139.1 54.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -102.32 155.98 17.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -71.58 -11.4 60.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.75 0.25 . . . . 0.0 110.622 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -143.52 145.59 32.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.646 1.578 . . . . 0.0 112.843 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.08 -24.99 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.0 tp -65.05 -36.31 83.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.204 -0.31 . . . . 0.0 110.896 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.61 -37.3 61.94 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.68 89.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 93.5 m -68.95 -32.35 71.87 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.491 0.316 . . . . 0.0 111.614 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.49 -32.98 74.18 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.901 0.318 . . . . 0.0 111.196 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.94 67.47 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.374 -0.204 . . . . 0.0 111.239 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.5 t -81.45 -37.78 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.968 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -74.43 -19.24 60.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.895 0.77 . . . . 0.0 111.396 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -81.08 -33.02 33.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.17 70.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.163 0.585 . . . . 0.0 110.969 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.95 -9.17 19.35 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -140.87 -0.31 1.51 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -159.02 149.06 19.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.76 138.39 39.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.8 mt -91.54 133.63 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.297 16.9 m-85 -84.84 130.87 34.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.3 mm -128.96 124.54 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.496 1.118 . . . . 0.0 108.228 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.12 34.55 5.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.237 0.615 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.75 74.3 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.86 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -135.76 148.95 67.46 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 118.38 1.09 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -67.47 150.68 80.52 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.54 2.827 . . . . 0.0 111.504 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 174.96 13.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.168 0.987 . . . . 0.0 109.925 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -128.02 157.15 41.42 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.6 t -141.94 139.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -148.21 167.84 24.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.517 1.527 . . . . 0.0 108.431 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -68.89 151.59 46.37 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.7 t -81.9 158.0 24.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.883 0.473 . . . . 0.0 110.842 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -9.29 55.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -108.14 161.67 14.76 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.756 0.822 . . . . 0.0 110.173 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -94.12 -5.5 47.11 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -163.1 156.49 19.56 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.376 0.534 . . . . 0.0 111.325 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.782 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.893 0.378 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.6 m -153.59 153.16 28.65 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 124.146 0.978 . . . . 0.0 109.457 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.26 -0.28 9.86 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 110.727 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 p -123.16 145.09 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.48 147.32 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.71 0.767 . . . . 0.0 110.529 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -101.14 137.78 39.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.278 1.831 . . . . 0.0 110.697 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.1 mt -114.62 140.52 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 123.506 0.722 . . . . 0.0 109.741 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -145.9 152.7 39.87 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.458 0.703 . . . . 0.0 110.295 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.82 85.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.644 -0.531 . . . . 0.0 112.608 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.08 175.16 4.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.65 0.725 . . . . 0.0 110.687 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.571 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.44 160.93 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 CA-C-O 121.366 0.603 . . . . 0.0 110.089 -178.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -66.77 -9.58 38.35 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.33 -10.98 85.78 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.032 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.4 p -63.97 145.05 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 m -132.73 166.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.138 0.975 . . . . 0.0 109.557 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.96 -32.82 69.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.254 -0.279 . . . . 0.0 111.145 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.39 71.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.381 0.272 . . . . 0.0 111.172 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.18 -29.06 62.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.28 -44.26 68.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.5 -34.72 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.76 -22.37 58.82 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.035 -0.415 . . . . 0.0 111.454 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.45 -17.12 24.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.1 mt -121.68 -7.45 9.08 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.85 -21.79 66.49 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -70.24 -11.54 60.97 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.659 -0.21 . . . . 0.0 111.475 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -92.27 -14.48 28.83 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.73 173.37 22.78 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.29 129.06 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.612 2.874 . . . . 0.0 110.468 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.29 141.57 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.202 0.601 . . . . 0.0 110.712 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.2 t -101.14 -34.12 9.83 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.457 0.703 . . . . 0.0 112.205 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -166.53 158.27 13.3 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.52 148.97 20.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.046 0.938 . . . . 0.0 112.083 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.23 156.34 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.282 0.633 . . . . 0.0 111.181 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.14 141.74 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -131.05 82.02 64.92 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 123.215 0.606 . . . . 0.0 110.078 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.39 -8.67 21.36 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.223 2.615 . . . . 0.0 110.39 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.23 -29.73 69.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.882 0.873 . . . . 0.0 110.579 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -116.99 5.29 12.84 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.895 0.878 . . . . 0.0 113.09 176.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 58.17 48.64 12.53 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.449 0.7 . . . . 0.0 110.891 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -144.81 170.39 16.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.504 0.722 . . . . 0.0 111.488 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.34 40.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.287 0.635 . . . . 0.0 110.67 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.33 151.93 51.06 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.949 0.404 . . . . 0.0 110.166 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.94 144.01 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -126.02 137.7 53.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.557 0.343 . . . . 0.0 110.193 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.34 156.4 16.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -72.04 -14.05 61.77 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.221 -0.299 . . . . 0.0 110.224 175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -139.79 143.12 36.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.251 1.42 . . . . 0.0 113.3 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.04 -21.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 111.565 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.4 tp -69.27 -36.29 76.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.941 0.496 . . . . 0.0 110.682 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -37.7 57.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.22 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.53 -33.03 70.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.445 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.84 -33.82 76.45 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.062 -0.399 . . . . 0.0 110.851 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.82 70.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.488 0.131 . . . . 0.0 111.2 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.43 -35.15 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 122.198 -0.314 . . . . 0.0 111.441 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -70.76 -28.42 64.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.054 0.388 . . . . 0.0 111.688 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -76.4 -33.1 58.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.52 71.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.07 0.548 . . . . 0.0 110.662 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.59 3.42 6.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.352 0.661 . . . . 0.0 112.117 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -132.26 -29.64 1.59 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -154.25 149.22 26.75 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.95 132.87 39.27 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.169 -0.332 . . . . 0.0 110.255 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.4 mt -81.18 145.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 C-N-CA 122.68 0.392 . . . . 0.0 110.079 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.252 19.9 m-85 -100.05 132.25 45.53 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 175.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.9 mm -128.97 126.99 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.57 34.39 6.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.176 0.59 . . . . 0.0 112.406 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.04 79.21 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.731 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -136.14 148.88 66.42 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 118.439 1.119 . . . . 0.0 111.529 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.5 143.56 69.64 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.717 2.945 . . . . 0.0 111.285 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.15 26.72 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.852 0.861 . . . . 0.0 110.456 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -112.2 159.21 18.79 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.6 t -141.11 142.5 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.688 0.795 . . . . 0.0 110.964 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -156.31 166.34 33.73 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -68.85 150.91 47.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.5 t -82.8 158.64 22.7 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.128 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.15 -2.68 10.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.3 t -124.04 160.42 27.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.085 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -89.39 -5.56 57.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -162.39 154.19 18.53 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.542 0.61 . . . . 0.0 111.188 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.6 mt . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.303 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.815 0.34 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -152.83 152.32 28.17 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 109.657 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.97 -3.7 14.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.399 2.732 . . . . 0.0 110.458 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.63 149.48 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.991 0.916 . . . . 0.0 112.246 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 m -132.71 148.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.56 0.695 . . . . 0.0 112.043 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.068 1.747 . . . . 0.0 109.77 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.34 140.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.228 1.011 . . . . 0.0 109.575 -174.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -143.01 152.71 42.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.89 0.476 . . . . 0.0 111.063 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.02 5.01 71.22 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.659 -0.523 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.76 -175.78 5.96 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.964 0.882 . . . . 0.0 109.58 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.515 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -122.02 158.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.82 -3.52 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.515 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -79.42 -10.96 85.4 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.99 148.63 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.56 168.77 23.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.255 1.022 . . . . 0.0 110.258 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.8 -33.0 68.1 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.241 -0.287 . . . . 0.0 111.176 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.55 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 -33.83 66.62 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.54 -39.86 64.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.935 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.54 -34.35 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -75.39 -25.66 57.8 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.019 -0.426 . . . . 0.0 111.187 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.06 -17.13 33.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.76 -9.47 8.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.44 -21.91 66.21 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.208 0.913 . . . . 0.0 110.974 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.55 -11.49 60.96 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.422 -0.174 . . . . 0.0 111.372 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.47 -16.15 26.19 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.5 172.33 23.72 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.86 126.41 14.56 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.58 2.853 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.99 142.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.183 0.593 . . . . 0.0 110.331 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -106.24 -34.15 7.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.661 0.784 . . . . 0.0 111.764 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -162.75 161.42 26.25 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -146.75 144.04 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.918 0.887 . . . . 0.0 109.389 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.71 150.8 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.19 0.596 . . . . 0.0 111.774 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.45 141.74 45.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -131.65 76.48 74.69 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.544 0.737 . . . . 0.0 109.493 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.22 -12.5 35.08 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.217 2.611 . . . . 0.0 111.156 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -67.38 -23.11 65.54 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.487 0.715 . . . . 0.0 111.138 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.91 6.82 13.11 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.363 0.665 . . . . 0.0 112.756 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.45 43.46 28.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.364 0.529 . . . . 0.0 111.326 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -139.62 163.9 31.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.207 0.603 . . . . 0.0 111.096 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.65 158.22 40.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.103 0.561 . . . . 0.0 110.066 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.9 mp -124.33 149.26 46.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.6 t -141.88 143.47 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -121.76 135.03 54.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.296 0.638 . . . . 0.0 109.897 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -99.81 154.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -72.07 -13.42 61.58 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.199 -0.313 . . . . 0.0 110.17 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -142.24 143.1 32.71 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.341 1.456 . . . . 0.0 113.57 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.8 p -63.42 -21.9 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.15 -34.8 75.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.945 0.498 . . . . 0.0 110.733 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -38.99 55.83 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.22 -37.61 87.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.092 0.472 . . . . 0.0 109.857 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.08 -36.7 77.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.373 0.669 . . . . 0.0 110.613 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -65.05 -33.67 76.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.107 -0.371 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.01 -38.7 72.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.675 0.216 . . . . 0.0 110.977 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.2 t -75.81 -33.43 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 122.201 -0.312 . . . . 0.0 111.079 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.84 -26.6 64.3 Favored 'General case' 0 C--O 1.231 0.096 0 O-C-N 122.002 -0.436 . . . . 0.0 111.641 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -77.38 -33.06 55.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.2 71.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.036 0.535 . . . . 0.0 110.81 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.88 3.14 2.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.538 0.735 . . . . 0.0 112.244 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -133.8 -28.91 1.36 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -157.53 152.41 25.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.84 139.36 40.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.7 mt -83.31 135.08 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 20.4 m-85 -89.01 129.62 35.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.3 mm -129.14 123.57 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.528 1.131 . . . . 0.0 108.773 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.41 34.55 6.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.6 74.74 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.837 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -135.78 148.8 66.78 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 118.248 1.024 . . . . 0.0 111.192 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.92 150.35 78.17 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 0.0 111.189 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 175.09 13.26 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 110.115 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -130.12 162.21 29.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.04 148.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 123.388 0.675 . . . . 0.0 111.356 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -155.2 166.85 32.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -68.82 145.78 53.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.5 t -75.33 155.59 36.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.9 t -71.54 -2.59 17.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.494 0.717 . . . . 0.0 112.78 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 43.5 t -127.36 154.55 44.84 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.602 0.761 . . . . 0.0 110.332 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -87.1 -0.34 56.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.37 158.87 33.06 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.275 0.489 . . . . 0.0 111.288 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 175.786 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.2 t -163.66 150.57 10.34 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.0 109.699 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.9 -10.47 27.72 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.755 2.304 . . . . 0.0 109.805 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.9 t -99.17 141.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.628 0.771 . . . . 0.0 111.36 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.11 141.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.952 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -99.23 137.5 37.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 110.43 -176.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -114.85 140.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.827 0.851 . . . . 0.0 109.73 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -144.57 148.98 35.06 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 123.11 0.564 . . . . 0.0 111.031 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.63 75.63 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.973 -0.349 . . . . 0.0 112.733 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -76.19 178.17 6.63 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.565 0.682 . . . . 0.0 110.129 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.509 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -116.07 157.99 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.062 0.545 . . . . 0.0 109.929 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.87 -17.94 58.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.509 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -71.77 -10.9 72.78 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.681 -0.51 . . . . 0.0 112.606 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.02 146.63 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.9 m -132.67 168.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 C-N-CA 124.154 0.981 . . . . 0.0 110.071 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.42 -32.63 68.85 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.306 -0.246 . . . . 0.0 111.337 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.5 71.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.529 0.331 . . . . 0.0 111.232 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -73.6 -30.57 63.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.24 -42.51 68.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.76 -34.66 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -74.98 -23.11 58.22 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.141 -0.349 . . . . 0.0 111.443 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.1 -17.09 26.76 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.2 mt -121.83 -8.24 8.94 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.93 -21.89 66.46 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 119.367 0.985 . . . . 0.0 110.816 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -69.38 -10.44 57.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.262 -0.274 . . . . 0.0 111.523 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -95.07 -16.09 22.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.63 174.03 25.0 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.22 131.48 23.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.699 2.932 . . . . 0.0 110.779 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.94 142.19 15.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.968 0.507 . . . . 0.0 110.572 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.0 t -103.65 -34.08 8.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 112.094 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -165.84 156.27 13.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.9 149.24 17.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.331 1.053 . . . . 0.0 112.052 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 p -152.05 153.42 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.151 0.58 . . . . 0.0 111.186 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -126.61 141.76 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.043 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -136.12 79.12 44.81 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.247 0.619 . . . . 0.0 109.686 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.22 -4.94 12.6 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.288 2.659 . . . . 0.0 111.352 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.27 -27.62 68.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.268 0.627 . . . . 0.0 110.538 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -116.96 6.15 12.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.891 0.876 . . . . 0.0 112.591 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 55.47 51.38 12.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.405 0.548 . . . . 0.0 110.724 -171.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -142.21 163.88 31.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.71 158.1 40.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.062 0.545 . . . . 0.0 110.618 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.88 143.53 46.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.48 144.1 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -130.24 134.38 47.21 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.779 0.432 . . . . 0.0 110.158 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -93.97 155.1 17.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -71.5 -13.35 61.78 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.029 -0.419 . . . . 0.0 110.431 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -142.08 143.8 33.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.323 1.449 . . . . 0.0 113.216 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.26 -24.86 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 65.9 tp -67.08 -36.31 81.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.477 0.311 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.05 57.88 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.25 89.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.15 -34.95 75.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.382 0.673 . . . . 0.0 110.746 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.73 -34.51 78.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.037 -0.415 . . . . 0.0 110.999 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.1 73.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.642 0.201 . . . . 0.0 110.807 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.0 t -74.62 -33.68 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.193 -0.317 . . . . 0.0 110.791 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.31 -26.29 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.239 0.472 . . . . 0.0 111.606 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -76.24 -32.87 59.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.6 -30.23 69.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.299 0.64 . . . . 0.0 111.076 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.79 1.59 4.2 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.295 0.638 . . . . 0.0 112.17 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -130.11 -31.83 1.86 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -156.5 146.31 20.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.877 0.471 . . . . 0.0 109.735 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.78 134.66 39.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -75.01 145.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 122.878 0.471 . . . . 0.0 110.373 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.265 20.6 m-85 -96.95 131.71 43.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 175.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.6 mm -128.92 124.86 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.465 1.106 . . . . 0.0 108.385 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.77 34.64 5.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 8.28 76.92 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.992 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.1 148.29 64.07 Favored Pre-proline 0 CA--C 1.528 0.111 0 CA-C-N 118.49 1.145 . . . . 0.0 111.306 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.73 141.99 56.48 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.264 2.643 . . . . 0.0 110.964 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 159.04 43.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.31 0.644 . . . . 0.0 110.918 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -91.24 160.06 15.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.39 140.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -156.72 165.62 35.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -68.84 148.18 50.65 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.152 0.887 . . . . 0.0 109.706 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.5 t -83.99 159.95 21.13 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.946 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -71.33 -2.75 17.35 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.4 t -131.41 152.5 50.59 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.022 0.529 . . . . 0.0 110.961 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -83.26 -4.75 58.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.01 147.79 18.39 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.452 0.569 . . . . 0.0 111.472 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.22 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.229 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.84 -17.31 62.75 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.339 0.255 . . . . 0.0 111.033 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 59.2 176.39 0.08 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.492 1.117 . . . . 0.0 113.473 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -141.3 158.07 44.38 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 p30 -149.7 158.45 44.18 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -71.22 147.6 93.36 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.26 -9.23 25.03 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.817 3.011 . . . . 0.0 111.55 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -73.29 -18.31 61.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.389 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -86.25 135.68 33.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.621 0.368 . . . . 0.0 110.982 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -132.46 154.22 81.48 Favored Pre-proline 0 C--O 1.231 0.117 0 C-N-CA 123.872 0.869 . . . . 0.0 113.259 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.99 152.75 76.49 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.104 2.536 . . . . 0.0 111.064 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.08 152.18 45.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.227 0.537 . . . . 0.0 112.132 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 t -163.19 148.92 9.7 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.743 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.88 -7.4 21.03 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.802 2.335 . . . . 0.0 109.926 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.33 143.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.092 0.957 . . . . 0.0 110.439 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.46 139.83 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.628 0.728 . . . . 0.0 111.853 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.34 137.37 37.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.935 1.694 . . . . 0.0 109.843 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 63.3 mt -116.29 140.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.393 0.677 . . . . 0.0 109.772 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -145.84 150.9 37.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.051 0.54 . . . . 0.0 110.505 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.12 0.51 77.25 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.879 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.53 174.69 5.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.13 0.965 . . . . 0.0 111.041 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.512 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.04 157.03 13.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.254 0.622 . . . . 0.0 109.7 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -67.47 -7.31 24.48 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.25 -11.04 85.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.23 149.47 11.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.66 169.68 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.393 1.077 . . . . 0.0 109.621 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -59.59 -32.84 70.76 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.302 -0.249 . . . . 0.0 111.074 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.43 72.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.611 0.365 . . . . 0.0 111.27 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -74.86 -31.63 61.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.28 -41.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.41 -34.66 58.9 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -74.97 -24.66 58.48 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 117.731 0.242 . . . . 0.0 111.2 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.12 35.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.14 -9.28 8.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.54 -21.99 66.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.328 0.967 . . . . 0.0 110.875 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.03 -12.23 61.41 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.222 -0.299 . . . . 0.0 111.209 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -92.06 -16.75 25.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.48 173.91 27.5 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.76 125.7 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.654 2.903 . . . . 0.0 110.8 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 142.92 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.786 0.434 . . . . 0.0 110.583 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -107.64 -32.35 7.7 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.523 0.729 . . . . 0.0 111.956 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -162.94 160.5 24.88 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.8 143.18 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.886 0.875 . . . . 0.0 109.239 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.11 154.91 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.215 0.606 . . . . 0.0 111.516 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.05 141.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.13 0.572 . . . . 0.0 112.179 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.76 88.76 45.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 123.153 0.581 . . . . 0.0 110.439 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.76 -6.5 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.888 2.392 . . . . 0.0 110.832 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.83 -31.76 71.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.439 0.696 . . . . 0.0 110.608 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -116.94 5.71 12.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.617 0.767 . . . . 0.0 112.584 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 57.95 49.82 11.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.345 0.658 . . . . 0.0 110.544 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -144.13 171.61 14.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.958 0.903 . . . . 0.0 111.283 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.16 40.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.195 0.598 . . . . 0.0 110.368 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.13 149.16 50.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.9 144.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -125.29 138.84 54.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.881 0.472 . . . . 0.0 109.797 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -102.48 155.73 18.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -72.8 -13.8 61.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.212 -0.305 . . . . 0.0 110.356 174.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -143.08 143.34 31.81 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.308 1.443 . . . . 0.0 113.451 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.5 p -62.9 -21.84 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 111.714 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.3 tp -69.81 -35.03 74.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.81 0.444 . . . . 0.0 110.761 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.07 -38.15 48.18 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.21 86.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -70.13 -35.52 74.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.24 -34.83 79.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.949 -0.469 . . . . 0.0 111.141 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.23 -37.43 69.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 121.325 -0.15 . . . . 0.0 111.214 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.31 -33.55 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 O-C-N 122.156 -0.34 . . . . 0.0 110.751 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -70.67 -28.39 64.74 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.17 0.441 . . . . 0.0 111.801 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.33 -33.05 61.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.76 -30.32 69.94 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.64 0.776 . . . . 0.0 111.675 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.12 -16.06 63.57 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -108.9 -27.17 9.85 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -160.06 154.8 24.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.003 0.521 . . . . 0.0 109.823 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.65 141.08 41.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.41 134.87 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.292 10.8 m-85 -84.77 129.08 34.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.9 mm -126.62 120.57 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.483 1.113 . . . . 0.0 108.254 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.17 34.31 2.93 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.811 0.844 . . . . 0.0 112.08 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 90.34 11.17 63.04 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.619 0.628 . . . . 0.0 112.993 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -136.3 139.53 30.07 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.358 0.663 . . . . 0.0 110.452 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.32 144.57 62.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.411 2.74 . . . . 0.0 112.156 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.49 171.86 16.39 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.458 0.703 . . . . 0.0 110.073 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.09 161.16 18.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.24 149.41 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.575 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -68.74 144.21 54.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.836 0.743 . . . . 0.0 109.544 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.3 t -76.39 153.86 35.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.4 -2.76 17.61 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.6 t -127.69 152.93 47.09 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.454 0.702 . . . . 0.0 110.496 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -88.46 -3.75 58.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.196 0.598 . . . . 0.0 112.525 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.38 150.87 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.353 0.524 . . . . 0.0 111.019 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mt -96.56 142.98 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.7 m -70.33 128.24 35.54 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.02 -0.425 . . . . 0.0 110.634 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -81.58 155.17 71.32 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.237 0.615 . . . . 0.0 109.947 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.45 -15.86 27.68 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.299 2.666 . . . . 0.0 110.075 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.04 141.81 3.83 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -106.68 8.01 30.83 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.8 t -152.38 148.32 27.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.273 0.629 . . . . 0.0 110.448 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -78.53 -4.59 49.39 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -67.93 -13.31 62.06 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 64.4 m -81.03 -8.77 59.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.879 0.472 . . . . 0.0 111.566 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -73.84 143.28 45.96 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.512 0.325 . . . . 0.0 110.321 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.8 m 61.5 159.53 0.05 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.482 1.513 . . . . 0.0 113.299 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.325 0.8 OUTLIER 54.97 1.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -154.49 -9.28 0.14 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.107 0.563 . . . . 0.0 111.89 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 117.85 -1.072 . . . . 0.0 111.369 179.47 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.727 1 C5'-C4'-C3' 109.483 -4.011 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.48 1 O4'-C1'-N19 113.981 5.781 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 1 C5'-C4'-C3' 108.528 -4.648 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.587 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.807 1 C5'-C4'-C3' 108.455 -4.697 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.585 1 C5'-C4'-C3' 108.858 -4.428 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 O4'-C1'-N19 111.649 3.449 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.128 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -66.93 161.32 24.39 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.011 0.524 . . . . 0.0 111.291 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 56.13 23.78 7.28 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.812 0.845 . . . . 0.0 112.684 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -141.77 150.6 41.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -145.67 156.5 43.68 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -75.74 149.7 83.51 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.86 -9.95 27.31 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.56 2.84 . . . . 0.0 111.6 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -75.99 -8.82 57.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.59 0.356 . . . . 0.0 111.581 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -69.11 134.8 49.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.915 0.486 . . . . 0.0 110.467 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -81.57 148.22 61.56 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.71 148.47 46.91 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.562 2.842 . . . . 0.0 111.028 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.15 144.43 56.92 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 111.66 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -164.85 151.19 9.17 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.291 0.637 . . . . 0.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.46 -7.34 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.724 2.282 . . . . 0.0 110.446 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t -102.36 143.52 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.324 1.05 . . . . 0.0 110.657 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.35 140.92 46.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.713 0.768 . . . . 0.0 111.72 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.28 137.54 37.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.129 1.772 . . . . 0.0 110.058 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.7 mt -117.75 140.7 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.325 0.65 . . . . 0.0 109.554 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -144.49 151.49 39.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.074 0.55 . . . . 0.0 110.176 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.99 0.15 85.77 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.612 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.14 171.36 9.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.588 0.694 . . . . 0.0 110.881 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.21 154.33 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.221 0.608 . . . . 0.0 109.997 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -70.77 -10.98 60.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.76 -10.75 86.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.507 0.575 . . . . 0.0 111.705 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.1 148.72 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 169.85 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 124.273 1.029 . . . . 0.0 109.755 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.23 -32.75 70.25 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.175 -0.328 . . . . 0.0 111.085 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.67 -31.42 72.07 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.303 -0.248 . . . . 0.0 111.043 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.5 -32.09 60.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.13 -43.07 68.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.12 -34.65 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.61 -24.0 58.8 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.11 -0.369 . . . . 0.0 111.178 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.37 -17.11 31.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -123.74 -8.91 7.87 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.88 -21.93 66.49 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.448 1.022 . . . . 0.0 110.751 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.02 -10.43 58.63 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.09 -15.84 24.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.75 174.77 26.9 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.28 123.37 10.5 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.634 2.889 . . . . 0.0 110.92 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.44 141.93 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.021 0.528 . . . . 0.0 110.395 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -101.38 -34.24 9.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.21 0.604 . . . . 0.0 111.734 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -167.21 162.02 14.83 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 151.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 124.131 0.972 . . . . 0.0 111.945 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.6 p -151.13 155.94 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.179 0.592 . . . . 0.0 112.042 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.21 141.95 36.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.221 0.608 . . . . 0.0 112.287 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.91 81.75 57.15 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 123.63 0.772 . . . . 0.0 110.12 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -59.83 -12.48 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.389 2.726 . . . . 0.0 112.371 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -27.58 67.77 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.823 0.449 . . . . 0.0 111.136 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -116.81 5.74 13.09 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.685 0.794 . . . . 0.0 112.028 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 56.68 48.57 16.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.555 0.742 . . . . 0.0 110.285 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.58 168.84 18.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.882 0.873 . . . . 0.0 111.193 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.59 158.25 40.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.483 0.713 . . . . 0.0 110.441 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 mp -131.33 154.12 48.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.893 0.378 . . . . 0.0 110.131 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.2 t -143.33 143.07 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -118.41 130.76 56.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.13 154.5 17.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -72.64 -12.85 61.21 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.185 -0.322 . . . . 0.0 110.487 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -143.89 145.56 32.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 113.413 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.87 -23.37 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.4 tp -67.47 -36.69 81.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.393 0.277 . . . . 0.0 111.055 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.47 60.73 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.47 91.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.16 0.505 . . . . 0.0 109.893 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.7 t -69.34 -35.41 75.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.281 0.633 . . . . 0.0 110.827 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -65.54 -34.29 77.92 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.064 -0.398 . . . . 0.0 110.904 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.57 -33.39 69.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.472 0.124 . . . . 0.0 111.086 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -81.06 -33.7 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 122.12 -0.363 . . . . 0.0 111.158 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.142 0.428 . . . . 0.0 111.265 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -79.06 -33.04 45.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.247 0.619 . . . . 0.0 111.117 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.98 -17.4 63.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.47 0.308 . . . . 0.0 111.703 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -109.1 -24.1 11.33 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -159.94 155.65 25.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.294 0.638 . . . . 0.0 109.301 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.73 136.59 39.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.62 134.03 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.9 m-85 -85.61 131.27 34.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.08 125.31 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 0.0 108.357 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.81 34.58 5.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.3 0.64 . . . . 0.0 112.498 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.39 8.86 77.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.062 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -135.35 148.99 68.43 Favored Pre-proline 0 CA--C 1.527 0.083 0 CA-C-N 118.418 1.109 . . . . 0.0 111.75 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.54 151.68 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.53 2.82 . . . . 0.0 111.713 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.96 174.61 13.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -123.62 156.09 36.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.34 138.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.593 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -148.62 168.71 22.09 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 125.669 1.587 . . . . 0.0 108.621 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.65 149.89 48.59 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.7 t -84.83 156.27 21.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.344 0.658 . . . . 0.0 110.662 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.93 -16.03 62.64 Favored 'General case' 0 C--N 1.335 -0.045 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 84.1 p -92.06 152.77 19.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.255 0.622 . . . . 0.0 109.629 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -97.11 -5.51 37.17 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -161.91 149.02 14.1 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.12 0.568 . . . . 0.0 109.951 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.37 144.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.8 m -71.2 124.75 25.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 32.8 ptt85 -156.04 149.02 18.25 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.748 0.419 . . . . 0.0 110.565 -174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.58 -16.55 27.01 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.435 2.757 . . . . 0.0 110.684 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.68 16.51 59.05 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.589 0.614 . . . . 0.0 111.873 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -63.04 -5.3 2.88 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 97.6 p -76.94 -3.49 39.07 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.482 0.713 . . . . 0.0 110.7 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.273 81.6 m-20 55.52 29.18 12.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.268 71.6 m-20 58.43 18.06 5.33 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.0 t 55.69 25.19 7.93 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.163 0.585 . . . . 0.0 111.307 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -64.02 137.81 58.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.059 -0.401 . . . . 0.0 110.656 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.7 m 58.24 10.18 1.2 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -73.19 139.54 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 55.35 20.03 3.36 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.638 0.775 . . . . 0.0 113.073 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.754 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 109.905 -3.73 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 1 O4'-C1'-N19 113.694 5.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.603 1 C5'-C4'-C3' 108.616 -4.59 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.537 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.96 1 C5'-C4'-C3' 108.394 -4.737 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 1 C5'-C4'-C3' 109.19 -4.207 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.787 0 C5'-C4'-C3' 110.743 -3.171 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.246 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -153.05 152.33 31.23 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.976 0.511 . . . . 0.0 110.058 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.67 158.08 34.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.925 0.49 . . . . 0.0 111.446 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -146.71 151.84 37.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -155.18 160.57 40.99 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -58.04 124.59 70.64 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.16 -14.97 45.13 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.07 2.513 . . . . 0.0 112.578 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -90.55 6.29 44.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.774 0.43 . . . . 0.0 111.646 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -62.16 144.19 55.74 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.888 0.475 . . . . 0.0 110.374 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.63 149.28 97.51 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.53 145.39 64.26 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.423 2.749 . . . . 0.0 110.505 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.22 141.55 58.73 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.945 0.402 . . . . 0.0 111.738 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.4 m -156.46 152.41 22.9 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.946 0.898 . . . . 0.0 109.445 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.25 -10.62 22.61 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.063 2.508 . . . . 0.0 109.756 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.96 146.37 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 124.473 1.109 . . . . 0.0 110.789 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.39 139.62 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 121.421 0.629 . . . . 0.0 111.566 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -100.04 137.4 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.762 1.625 . . . . 0.0 110.263 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.7 mt -117.4 140.49 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 110.151 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -144.21 155.51 43.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.287 0.635 . . . . 0.0 110.058 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.18 -1.09 87.62 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.77 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.64 173.44 8.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.679 0.739 . . . . 0.0 110.976 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.6 pt -98.89 153.92 4.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 C-N-CA 123.499 0.72 . . . . 0.0 109.52 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -72.89 -9.69 58.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.57 -10.75 86.04 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.5 149.62 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.69 169.3 22.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.117 0.967 . . . . 0.0 109.512 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.85 -32.73 69.71 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.239 -0.288 . . . . 0.0 111.119 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.62 -31.4 72.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.596 0.358 . . . . 0.0 111.041 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -74.38 -34.36 63.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -39.7 67.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.63 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -71.2 -34.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.9 -23.39 55.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.145 -0.347 . . . . 0.0 110.862 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.26 -17.14 31.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.97 -8.06 7.77 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.96 -21.81 65.95 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.407 1.003 . . . . 0.0 110.794 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.76 -10.49 59.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.515 0.326 . . . . 0.0 111.344 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -93.77 -14.96 25.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.37 173.59 24.25 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.54 125.66 13.08 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.744 2.963 . . . . 0.0 110.56 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.9 mt -93.35 141.37 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 122.898 0.479 . . . . 0.0 110.338 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.2 t -102.75 -33.68 9.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.518 0.727 . . . . 0.0 111.796 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -164.0 161.37 22.65 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -146.5 145.39 19.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.0 0.92 . . . . 0.0 109.187 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.62 156.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.254 0.622 . . . . 0.0 111.556 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.82 141.9 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 C-N-CA 123.291 0.636 . . . . 0.0 112.193 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -134.24 82.09 48.33 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.4 0.68 . . . . 0.0 110.263 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.941 2.427 . . . . 0.0 111.217 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.38 -26.41 67.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.851 0.86 . . . . 0.0 110.756 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -117.05 4.85 12.76 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.828 0.851 . . . . 0.0 112.371 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 55.64 51.73 12.12 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.726 0.811 . . . . 0.0 110.293 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -144.99 171.4 14.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.804 0.842 . . . . 0.0 111.1 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.58 158.26 40.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.146 0.579 . . . . 0.0 110.966 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -127.56 149.53 50.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.039 0.536 . . . . 0.0 109.637 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.9 t -143.42 144.53 23.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -126.37 137.98 53.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.686 0.394 . . . . 0.0 110.095 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -100.29 155.14 17.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -71.47 -12.69 61.52 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.782 0.264 . . . . 0.0 110.338 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -143.09 143.05 31.69 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 125.759 1.624 . . . . 0.0 112.93 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.06 -21.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 120.822 0.344 . . . . 0.0 111.509 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -69.8 -35.16 74.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 110.859 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.86 -37.96 60.66 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.15 85.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.76 -33.81 71.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.306 0.642 . . . . 0.0 111.129 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -66.17 -35.06 79.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.056 0.389 . . . . 0.0 111.124 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.27 71.15 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.655 0.207 . . . . 0.0 111.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.8 t -77.34 -33.49 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 O-C-N 122.311 -0.243 . . . . 0.0 111.088 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -68.03 -32.67 73.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 122.065 -0.397 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.75 -32.93 64.08 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.7 -30.34 69.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.344 0.658 . . . . 0.0 111.549 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.43 63.6 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.85 -28.2 8.89 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -159.95 154.34 23.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.962 0.505 . . . . 0.0 109.853 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.72 139.96 40.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.12 -0.362 . . . . 0.0 110.139 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.4 mt -83.39 136.13 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 14.2 m-85 -88.17 130.66 34.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.2 mm -129.04 124.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.743 1.217 . . . . 0.0 108.601 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.51 34.47 4.89 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.59 8.34 73.94 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.974 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -136.2 148.95 66.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.541 1.17 . . . . 0.0 111.402 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.84 152.4 80.55 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.38 2.72 . . . . 0.0 111.485 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 174.64 13.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.419 1.088 . . . . 0.0 109.569 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.37 156.4 42.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -178.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.28 144.34 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.082 0.553 . . . . 0.0 111.952 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -148.88 169.83 19.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.34 1.456 . . . . 0.0 108.639 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -68.64 146.94 52.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.9 t -79.27 154.21 29.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.456 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.8 t -71.2 -2.54 16.27 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.7 t -125.34 151.24 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.476 0.71 . . . . 0.0 110.568 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -86.22 -6.93 58.88 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -159.64 148.19 17.59 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.673 0.67 . . . . 0.0 110.875 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 58.8 mt -89.39 142.51 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.8 t -65.54 119.54 11.26 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.111 -0.368 . . . . 0.0 110.592 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 63.7 mmt-85 -80.36 155.81 74.03 Favored Pre-proline 0 C--O 1.233 0.234 0 C-N-CA 123.194 0.598 . . . . 0.0 109.618 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.1 -7.1 18.87 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.355 2.704 . . . . 0.0 111.358 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.46 20.32 4.68 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.997 0.808 . . . . 0.0 111.228 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -54.42 -30.04 51.2 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.9 m 55.17 23.79 5.68 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.0 t0 64.85 165.56 0.16 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.92 0.888 . . . . 0.0 112.838 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.95 -6.28 8.11 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 34.6 t -80.06 -14.28 58.65 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.11 0.564 . . . . 0.0 110.07 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -68.03 -19.42 64.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.858 0.863 . . . . 0.0 112.501 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.3 t 61.71 160.66 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.502 1.121 . . . . 0.0 112.13 -174.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.3 t 56.02 16.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -151.63 14.66 0.66 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.34 0.656 . . . . 0.0 110.243 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.553 -1.213 . . . . 0.0 110.57 -179.451 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.676 0 C5'-C4'-C3' 109.91 -3.727 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 1 O4'-C1'-N19 113.779 5.579 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.561 1 C5'-C4'-C3' 108.43 -4.713 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.553 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.977 1 C5'-C4'-C3' 108.56 -4.627 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 1 C5'-C4'-C3' 108.936 -4.376 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.783 0 O4'-C1'-N19 111.693 3.493 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.196 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -146.22 -10.82 0.49 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.658 0.383 . . . . 0.0 111.292 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -153.87 168.1 27.49 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.082 0.553 . . . . 0.0 110.397 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -142.03 138.06 31.54 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -82.59 119.31 24.1 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -76.11 140.78 70.1 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.02 -15.89 16.19 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.635 2.89 . . . . 0.0 111.997 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -78.33 -12.82 60.03 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.705 0.402 . . . . 0.0 111.587 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -80.4 143.21 33.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.514 0.726 . . . . 0.0 110.333 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 p -79.25 154.74 77.09 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.34 159.83 52.2 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.703 2.935 . . . . 0.0 110.452 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.17 142.48 58.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.84 0.352 . . . . 0.0 111.421 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -153.17 152.72 28.42 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.822 0.849 . . . . 0.0 109.803 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.56 -3.91 14.33 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.697 2.931 . . . . 0.0 110.635 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.6 149.49 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 112.469 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.58 145.85 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -99.16 137.42 37.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.789 2.036 . . . . 0.0 110.282 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.6 mt -116.9 140.61 38.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.878 0.871 . . . . 0.0 109.749 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -143.77 152.03 40.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.423 0.689 . . . . 0.0 110.276 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.09 2.63 80.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.845 -0.419 . . . . 0.0 112.818 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.8 pp -73.62 -173.96 1.6 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.543 0.671 . . . . 0.0 110.325 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.07 157.53 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.55 0.74 . . . . 0.0 110.6 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.97 -12.01 51.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 -10.83 85.25 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.19 148.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.69 168.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.153 0.981 . . . . 0.0 109.422 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -58.71 -32.67 69.39 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.141 -0.35 . . . . 0.0 110.95 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.39 71.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.46 0.304 . . . . 0.0 111.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -73.54 -31.67 63.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.97 -43.28 71.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -71.99 -34.54 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -75.21 -21.29 58.77 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.969 -0.457 . . . . 0.0 111.498 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.22 -17.24 25.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.18 -8.6 8.72 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.97 -21.77 66.43 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.346 0.975 . . . . 0.0 110.696 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -70.5 -10.8 60.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.152 -0.343 . . . . 0.0 111.486 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.96 -14.78 24.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.37 172.93 25.15 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.28 124.99 12.32 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.495 2.797 . . . . 0.0 110.666 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.67 142.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.025 0.53 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.6 t -105.25 -34.01 8.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.418 0.687 . . . . 0.0 111.566 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -165.91 159.33 15.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.89 151.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.071 0.948 . . . . 0.0 112.221 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.12 154.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.321 0.648 . . . . 0.0 111.382 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.93 141.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.048 0.539 . . . . 0.0 112.144 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.43 88.05 40.59 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 123.138 0.575 . . . . 0.0 110.223 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.44 -8.28 21.67 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.039 2.493 . . . . 0.0 110.473 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.59 -32.41 73.97 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.651 0.78 . . . . 0.0 110.1 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.98 4.96 12.81 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.673 0.789 . . . . 0.0 112.226 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 57.78 51.48 9.21 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.231 0.612 . . . . 0.0 110.262 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -146.21 170.16 17.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.795 0.838 . . . . 0.0 111.34 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.69 158.37 40.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.632 0.773 . . . . 0.0 110.692 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.98 152.91 48.92 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-O 121.155 0.502 . . . . 0.0 110.132 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.76 144.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -122.48 136.34 54.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.05 0.54 . . . . 0.0 110.106 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -101.65 156.64 17.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -73.24 -11.07 60.38 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.175 -0.328 . . . . 0.0 110.5 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -144.38 146.3 32.44 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.692 1.597 . . . . 0.0 113.481 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.6 -23.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.337 0.049 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.26 -37.38 83.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.252 0.221 . . . . 0.0 110.626 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 -38.44 65.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.97 89.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.059 0.457 . . . . 0.0 109.949 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.55 -33.46 71.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.09 0.556 . . . . 0.0 111.11 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.21 -34.62 78.44 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.112 0.415 . . . . 0.0 110.873 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -38.7 72.9 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.516 0.144 . . . . 0.0 110.85 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.27 -33.55 23.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 O-C-N 122.33 -0.231 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.16 -32.29 71.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.192 -0.317 . . . . 0.0 110.961 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.7 -32.94 64.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.22 70.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.528 0.731 . . . . 0.0 111.058 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.77 3.28 2.64 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.073 0.549 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.11 -28.67 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -156.72 152.57 27.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -76.75 141.35 40.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.12 136.15 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.304 16.2 m-85 -88.81 130.64 35.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -129.02 125.05 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.607 1.163 . . . . 0.0 108.453 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.95 34.52 5.57 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.322 0.649 . . . . 0.0 112.373 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.36 9.03 80.23 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.171 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -134.08 148.82 69.58 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 118.342 1.071 . . . . 0.0 111.726 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.92 149.96 83.01 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.295 2.663 . . . . 0.0 111.397 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 174.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 109.549 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -128.52 161.0 30.59 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -142.34 147.8 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 123.44 0.696 . . . . 0.0 111.294 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -155.73 166.48 33.37 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -68.84 151.04 47.12 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.142 0.883 . . . . 0.0 108.708 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -85.48 159.06 20.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.886 0.474 . . . . 0.0 111.281 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.6 -2.75 15.26 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.1 t -125.73 154.04 43.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.312 0.645 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -86.78 -0.44 56.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -158.46 158.88 34.96 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.782 0.719 . . . . 0.0 110.942 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt -98.34 136.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.3 t -67.83 130.8 44.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.62 0.247 . . . . 0.0 111.238 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.415 ' C ' ' H ' ' A' ' 178' ' ' GLY . 32.0 ptt-85 -164.33 155.6 13.66 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 123.609 0.764 . . . . 0.0 109.099 177.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.81 22.55 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.536 3.491 . . . . 0.0 112.451 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 176' ' ' ARG . . . -160.47 33.18 0.41 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 34.3 p30 -69.56 -9.44 53.99 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t 57.99 7.88 0.67 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.382 1.073 . . . . 0.0 113.151 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -68.48 128.06 35.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.683 -0.636 . . . . 0.0 111.236 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.254 89.7 m-20 53.96 36.84 25.39 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -175.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.5 m 61.58 19.9 10.8 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.295 1.038 . . . . 0.0 113.27 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -70.06 131.58 44.54 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.52 0.328 . . . . 0.0 110.672 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 24.4 t 54.77 -169.69 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.668 0.787 . . . . 0.0 111.959 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.274 1.2 t 60.41 17.17 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -152.11 10.96 0.54 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.08 0.552 . . . . 0.0 112.416 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.35 -1.31 . . . . 0.0 110.722 -179.611 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.592 0 C5'-C4'-C3' 109.656 -3.896 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 1 O4'-C1'-N19 113.616 5.416 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 1 C5'-C4'-C3' 108.221 -4.852 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.558 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.658 1 C5'-C4'-C3' 108.75 -4.5 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.741 0 O4'-C1'-N19 110.91 2.71 . 0.182 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.656 0 C5'-C4'-C3' 110.288 -3.474 . 0.311 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.095 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.62 163.42 27.04 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.703 0.401 . . . . 0.0 111.193 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -152.67 160.38 43.16 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.362 20.1 t80 62.82 -6.52 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -158.03 160.07 37.04 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.39 141.71 85.98 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.31 -11.65 20.93 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.52 2.813 . . . . 0.0 111.626 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -77.88 -10.14 59.42 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.016 0.526 . . . . 0.0 111.355 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -73.22 149.61 42.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.532 0.333 . . . . 0.0 110.737 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.87 151.78 79.14 Favored Pre-proline 0 C--O 1.231 0.112 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.51 154.68 60.24 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.353 2.702 . . . . 0.0 111.485 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.88 149.79 50.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.006 0.431 . . . . 0.0 111.578 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -161.52 149.86 12.68 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 123.297 0.639 . . . . 0.0 109.697 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.35 -7.35 21.11 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.864 2.376 . . . . 0.0 109.897 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -104.06 141.59 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.058 0.943 . . . . 0.0 111.187 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.8 m -135.08 144.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.638 0.732 . . . . 0.0 111.412 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -102.01 137.48 40.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.986 1.714 . . . . 0.0 110.578 -176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.38 140.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.736 0.814 . . . . 0.0 109.676 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -144.66 153.82 42.15 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.919 0.488 . . . . 0.0 110.603 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.64 4.59 88.94 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.801 -0.444 . . . . 0.0 112.614 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.36 173.77 8.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.737 0.768 . . . . 0.0 110.481 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.563 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.33 158.38 12.77 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.047 0 CA-C-O 121.363 0.602 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -68.93 -7.97 39.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -174.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.563 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.19 -11.04 85.75 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.94 146.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.64 166.46 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.239 1.016 . . . . 0.0 109.445 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.8 -32.7 69.58 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.182 -0.324 . . . . 0.0 111.281 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.08 -31.4 72.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.542 0.156 . . . . 0.0 110.955 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.89 -29.48 61.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.05 -44.24 69.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -71.95 -34.79 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -74.89 -20.4 59.74 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.212 0.46 . . . . 0.0 111.808 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.7 -16.98 22.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.48 -8.31 9.59 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.16 -21.83 66.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.111 0.869 . . . . 0.0 110.702 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.19 -12.85 61.89 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.861 -0.524 . . . . 0.0 111.284 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -90.77 -15.03 30.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.73 173.76 24.77 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.94 125.6 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.534 2.823 . . . . 0.0 110.364 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.32 142.74 12.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 122.722 0.409 . . . . 0.0 110.268 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.9 t -104.65 -34.03 8.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.347 0.659 . . . . 0.0 111.92 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -166.43 157.42 12.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -143.02 151.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 C-N-CA 124.088 0.955 . . . . 0.0 112.31 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.77 156.25 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.435 0.694 . . . . 0.0 110.53 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.99 141.96 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -133.32 81.84 54.52 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.446 0.699 . . . . 0.0 109.85 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.75 -13.62 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.054 2.503 . . . . 0.0 110.597 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -67.68 -22.22 65.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.182 0.593 . . . . 0.0 110.992 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -117.0 4.11 12.79 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.804 0.842 . . . . 0.0 112.097 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 59.13 40.23 22.11 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.375 0.67 . . . . 0.0 110.869 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.8 169.05 18.36 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.838 0.855 . . . . 0.0 111.088 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.18 40.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.153 0.581 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.6 mt -125.24 150.33 47.14 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 123.013 0.525 . . . . 0.0 110.458 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.8 t -143.76 144.42 23.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -126.74 139.28 53.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.964 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.23 154.18 19.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.37 -16.34 62.96 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.854 0.297 . . . . 0.0 110.39 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -137.19 143.09 42.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.342 1.457 . . . . 0.0 113.044 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.77 -21.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.708 0.289 . . . . 0.0 111.561 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -70.62 -35.59 73.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.873 0.469 . . . . 0.0 110.727 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.31 -39.62 61.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.37 -36.84 83.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.166 0.508 . . . . 0.0 110.238 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.6 -36.27 78.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.218 0.607 . . . . 0.0 110.598 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.97 -35.35 80.89 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.191 -0.318 . . . . 0.0 110.991 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.61 -32.76 68.37 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.556 0.162 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 93.9 t -81.51 -33.48 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 122.12 -0.363 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.0 -31.65 68.23 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.999 0.363 . . . . 0.0 111.506 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -77.93 -33.17 51.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.28 71.35 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 110.649 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.18 3.54 5.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.37 0.668 . . . . 0.0 112.105 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.41 -27.29 1.57 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -155.27 155.83 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.256 0.622 . . . . 0.0 109.565 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -76.86 133.95 39.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.2 mt -83.86 134.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 16.5 m-85 -85.26 130.65 34.56 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.94 124.15 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.34 34.67 6.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.51 9.68 75.03 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.838 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -135.8 148.78 66.65 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.328 1.064 . . . . 0.0 111.537 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.8 149.77 78.52 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.32 2.68 . . . . 0.0 111.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.76 174.74 13.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.655 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -124.1 161.25 26.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.66 145.34 25.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 C-N-CA 123.458 0.703 . . . . 0.0 110.907 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -154.94 166.19 34.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -68.65 147.65 51.57 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.944 0.793 . . . . 0.0 111.299 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.2 t -82.92 156.89 23.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.695 0.398 . . . . 0.0 110.871 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -2.75 17.32 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -131.43 153.6 49.54 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.138 0.575 . . . . 0.0 110.868 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -85.48 -3.43 58.85 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -158.9 149.23 19.6 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.542 0.61 . . . . 0.0 111.777 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.4 mt -92.98 147.77 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 70.0 m -73.66 131.95 42.21 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.725 -0.61 . . . . 0.0 111.642 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -85.64 159.34 55.56 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 123.323 0.649 . . . . 0.0 110.873 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.29 -10.92 26.32 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.408 2.739 . . . . 0.0 110.196 173.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.57 145.17 4.63 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -84.86 -2.26 57.55 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.9 t 61.34 161.07 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.015 1.326 . . . . 0.0 112.911 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 43.2 p30 -155.11 -177.93 6.89 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.167 0.587 . . . . 0.0 110.377 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -68.64 9.88 0.32 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 71.8 m -134.31 5.73 3.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.566 0.746 . . . . 0.0 111.469 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -71.63 -18.87 62.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.829 0.452 . . . . 0.0 111.951 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.3 m -62.71 147.18 50.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.722 0.409 . . . . 0.0 110.387 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.317 1.0 OUTLIER 52.94 13.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 66.0 t30 56.87 23.92 8.69 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.093 0.957 . . . . 0.0 111.457 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.854 1.262 . . . . 0.0 111.923 -179.294 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.482 0 C5'-C4'-C3' 109.711 -3.86 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.932 1 O4'-C1'-N19 113.462 5.262 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.633 2 C5'-C4'-C3' 109.35 -4.1 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.6 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.69 2 C5'-C4'-C3' 108.917 -4.389 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C5'-C4'-C3' 111.349 -2.767 . 0.144 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.883 0 C5'-C4'-C3' 111.233 -2.845 . 0.267 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.43 151.38 30.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.173 0.589 . . . . 0.0 109.832 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.51 149.95 46.64 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.78 0.324 . . . . 0.0 111.795 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -80.84 -4.75 55.82 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -79.15 156.68 28.13 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.48 155.81 92.83 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.28 -9.91 23.89 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.965 2.443 . . . . 0.0 111.647 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -77.23 -9.55 58.86 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 122.024 -0.422 . . . . 0.0 111.632 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -78.63 142.32 37.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.05 0.386 . . . . 0.0 110.533 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -132.3 151.56 78.54 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.57 148.92 67.36 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.372 2.715 . . . . 0.0 110.553 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.01 144.45 56.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -156.41 153.05 24.21 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.513 1.125 . . . . 0.0 109.293 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.38 8.38 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.854 3.036 . . . . 0.0 111.073 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.95 146.22 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.56 144.38 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.576 0.703 . . . . 0.0 111.626 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -100.72 137.46 39.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.482 1.913 . . . . 0.0 110.059 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.4 mt -115.64 140.74 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.879 0.872 . . . . 0.0 109.612 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -144.29 153.81 42.41 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.89 0.476 . . . . 0.0 110.247 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.45 2.01 80.21 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.637 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.79 174.63 8.17 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.727 0.763 . . . . 0.0 110.64 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.55 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.45 160.07 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-O 121.312 0.577 . . . . 0.0 109.946 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -67.34 -7.58 25.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.55 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.64 -11.05 85.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -65.77 146.87 12.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 m -132.54 168.27 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 124.24 1.016 . . . . 0.0 109.796 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.61 -32.77 70.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.085 -0.384 . . . . 0.0 110.999 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.51 72.09 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.42 0.288 . . . . 0.0 111.145 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -73.53 -30.09 62.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.69 -45.3 68.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.18 -34.66 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.63 -21.53 57.63 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.053 -0.405 . . . . 0.0 111.576 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.09 -17.14 25.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -121.51 -8.73 9.06 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.94 -21.97 66.92 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 119.023 0.829 . . . . 0.0 110.914 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -69.73 -12.65 61.8 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.301 -0.249 . . . . 0.0 111.455 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.66 -16.34 27.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.77 24.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.63 125.79 13.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.355 2.703 . . . . 0.0 110.7 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -93.51 142.77 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.837 0.455 . . . . 0.0 110.42 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 t -105.49 -32.99 8.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.385 0.674 . . . . 0.0 112.009 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -166.43 157.7 13.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.96 150.97 17.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 124.121 0.968 . . . . 0.0 112.084 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.77 157.27 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.483 0.713 . . . . 0.0 111.239 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.2 141.87 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.037 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -130.66 82.88 63.49 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 122.995 0.518 . . . . 0.0 110.212 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.19 -9.52 23.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.108 2.538 . . . . 0.0 110.413 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -65.02 -32.88 74.82 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.8 0.84 . . . . 0.0 110.284 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -116.94 7.18 13.15 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 56.65 48.06 17.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.808 0.843 . . . . 0.0 110.665 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -139.98 171.47 14.15 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.009 0.924 . . . . 0.0 110.847 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.8 158.3 42.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.168 0.587 . . . . 0.0 110.689 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.98 145.39 50.83 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -143.67 136.85 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -116.17 139.46 50.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.081 0.552 . . . . 0.0 110.384 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -101.64 154.95 18.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -71.26 -13.0 61.76 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.096 -0.378 . . . . 0.0 110.211 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -143.9 143.37 31.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.725 1.61 . . . . 0.0 113.361 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.32 -21.72 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.646 0.26 . . . . 0.0 111.394 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 66.8 tp -69.85 -34.05 73.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.854 0.461 . . . . 0.0 110.812 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.42 -39.42 56.91 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.48 83.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.172 0.51 . . . . 0.0 109.895 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.41 -33.75 73.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.619 0.768 . . . . 0.0 111.18 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -68.14 -34.31 76.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.056 -0.403 . . . . 0.0 110.855 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.77 68.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.74 -35.76 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 122.037 -0.415 . . . . 0.0 111.508 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.0 -24.62 61.59 Favored 'General case' 0 N--CA 1.458 -0.037 0 CA-C-N 118.511 0.596 . . . . 0.0 112.299 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.31 -33.78 49.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.69 -30.2 71.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.035 0.534 . . . . 0.0 110.667 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.89 4.79 3.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 112.265 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -136.11 -27.13 1.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -155.57 153.4 30.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -76.76 137.96 39.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.93 -0.482 . . . . 0.0 110.367 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -85.73 134.58 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 18.3 m-85 -87.31 130.89 34.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.4 mm -129.0 124.52 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.68 34.55 7.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.78 77.01 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.363 -0.687 . . . . 0.0 114.086 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -135.4 148.96 68.21 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 118.432 1.116 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.34 151.53 80.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.376 2.717 . . . . 0.0 111.606 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.7 174.82 13.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.104 0.961 . . . . 0.0 109.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.93 157.54 34.06 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.5 139.69 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.928 0.491 . . . . 0.0 111.867 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -147.42 167.33 24.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.705 1.602 . . . . 0.0 108.404 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.03 149.47 48.73 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.5 t -78.99 154.54 29.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.814 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -69.72 -12.92 62.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 46.4 t -100.43 158.3 16.0 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 110.116 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -94.86 -5.64 44.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -162.76 153.07 16.45 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.432 0.56 . . . . 0.0 110.928 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -88.91 144.4 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.2 t -65.41 132.47 49.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -160.53 149.16 13.38 Favored Pre-proline 0 C--O 1.231 0.099 0 C-N-CA 122.712 0.405 . . . . 0.0 109.959 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.87 -20.59 34.14 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.205 2.603 . . . . 0.0 111.534 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -74.47 -13.04 82.05 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -96.68 -5.83 37.9 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 43.5 t -66.91 123.7 20.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.256 90.1 m-20 56.03 2.04 0.07 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -177.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -114.97 -4.09 12.6 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.6 t -150.54 15.33 0.78 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.187 0.595 . . . . 0.0 110.38 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -68.88 167.91 14.65 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 122.73 0.412 . . . . 0.0 110.366 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.7 t -148.22 164.53 33.68 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.818 0.447 . . . . 0.0 110.329 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.259 1.4 t 58.38 14.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -144.1 10.31 1.51 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.944 0.898 . . . . 0.0 111.746 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.252 1.212 0 C-N-CA 124.479 1.112 . . . . 0.0 111.138 -178.147 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.472 0 C5'-C4'-C3' 109.782 -3.812 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.646 1 O4'-C1'-N19 114.183 5.983 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.839 1 C5'-C4'-C3' 107.935 -5.043 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.596 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.841 1 C5'-C4'-C3' 108.281 -4.813 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 0 O4'-C1'-N19 111.168 2.968 . 0.152 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.706 0 C5'-C4'-C3' 110.177 -3.549 . 0.343 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -66.78 151.01 48.3 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.116 0.566 . . . . 0.0 110.898 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -64.83 157.38 27.94 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.949 0.5 . . . . 0.0 111.606 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.82 153.95 41.47 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -126.98 137.09 53.05 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.92 152.49 96.77 Favored Pre-proline 0 C--O 1.232 0.136 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.9 -10.03 27.99 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.091 2.527 . . . . 0.0 110.967 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -82.32 -1.07 48.48 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.428 0.691 . . . . 0.0 112.162 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -145.71 162.54 37.35 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.201 0.601 . . . . 0.0 110.642 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -76.29 154.79 84.23 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.75 150.54 68.39 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.766 2.977 . . . . 0.0 110.269 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.42 143.41 53.34 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -161.43 149.28 12.29 Favored Pre-proline 0 C--O 1.232 0.183 0 C-N-CA 123.374 0.67 . . . . 0.0 110.288 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.23 -6.56 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.93 2.42 . . . . 0.0 110.104 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.4 t -105.42 143.41 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.89 0.876 . . . . 0.0 110.86 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.32 141.75 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.709 0.766 . . . . 0.0 112.368 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -99.17 137.63 37.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.423 1.889 . . . . 0.0 109.702 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.5 mt -117.8 140.6 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 122.946 0.498 . . . . 0.0 109.806 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -146.28 154.39 41.65 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.69 0.796 . . . . 0.0 110.092 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.3 1.7 88.05 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 119.729 -0.484 . . . . 0.0 112.494 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.9 pp -73.05 174.52 7.78 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.721 0.76 . . . . 0.0 110.318 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.532 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.18 159.45 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.067 0.461 . . . . 0.0 109.844 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.88 -17.39 63.14 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.06 -10.73 73.86 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.351 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -66.65 147.68 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.51 169.06 22.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.39 1.076 . . . . 0.0 109.488 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -60.04 -32.65 71.11 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.002 -0.436 . . . . 0.0 110.734 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.32 70.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.636 0.374 . . . . 0.0 111.503 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -73.99 -31.87 63.16 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.9 mt -73.26 -40.12 64.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.121 0.168 . . . . 0.0 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.78 -34.56 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.03 -23.9 58.22 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.06 -0.4 . . . . 0.0 111.44 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.29 -17.05 29.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.66 -10.05 9.26 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.1 -21.87 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.247 0.931 . . . . 0.0 111.017 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.96 -11.34 60.91 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.228 -0.295 . . . . 0.0 111.371 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -93.72 -16.79 23.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.16 173.38 26.5 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.66 126.17 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.663 2.908 . . . . 0.0 110.796 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.75 141.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 122.883 0.473 . . . . 0.0 110.716 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.6 t -101.63 -34.23 9.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.273 0.629 . . . . 0.0 111.891 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -164.48 163.04 22.22 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.86 0.3 . . . . 0.0 110.537 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -145.9 142.11 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 123.736 0.814 . . . . 0.0 109.568 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.3 155.02 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 110.85 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.19 141.82 40.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -130.59 84.02 60.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 123.304 0.642 . . . . 0.0 110.424 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.21 -7.59 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.683 2.256 . . . . 0.0 111.322 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -27.4 66.21 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.068 0.547 . . . . 0.0 111.03 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.78 2.99 12.95 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.476 0.71 . . . . 0.0 111.108 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 56.98 52.23 9.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.917 0.887 . . . . 0.0 110.657 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -145.05 172.02 13.65 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.171 0.989 . . . . 0.0 110.898 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.92 39.46 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.653 0.381 . . . . 0.0 110.836 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.63 144.78 48.9 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.729 0.811 . . . . 0.0 109.221 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.9 t -143.03 143.03 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -126.32 138.64 53.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.66 155.72 17.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -71.36 -13.36 61.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.241 -0.287 . . . . 0.0 110.401 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -143.19 144.04 32.02 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.409 1.484 . . . . 0.0 113.227 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.45 -21.68 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 120.928 0.394 . . . . 0.0 111.615 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.1 tp -69.37 -35.84 76.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.841 0.456 . . . . 0.0 110.699 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.8 -37.98 56.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -36.74 83.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 109.907 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.64 -35.81 75.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.23 0.612 . . . . 0.0 110.718 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -65.42 -35.01 79.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.139 -0.351 . . . . 0.0 111.187 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.46 68.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.345 -0.222 . . . . 0.0 111.241 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 98.2 t -80.8 -33.51 13.42 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 O-C-N 122.243 -0.286 . . . . 0.0 110.917 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -68.35 -32.08 71.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.107 -0.371 . . . . 0.0 110.573 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -78.09 -33.21 50.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.21 71.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.977 0.511 . . . . 0.0 110.582 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.3 3.87 4.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.291 0.636 . . . . 0.0 112.384 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -134.34 -25.84 1.5 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -156.94 155.24 31.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.153 0.581 . . . . 0.0 109.495 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.66 135.35 39.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 110.395 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.5 mt -84.75 133.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.6 m-85 -85.05 130.48 34.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mm -128.95 123.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.686 1.194 . . . . 0.0 108.603 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.18 34.55 6.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.56 10.1 74.05 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -136.16 148.89 66.4 Favored Pre-proline 0 C--N 1.339 0.115 0 CA-C-N 118.335 1.067 . . . . 0.0 111.005 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.35 150.07 81.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.363 2.709 . . . . 0.0 111.436 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.08 13.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.186 0.994 . . . . 0.0 109.978 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -124.58 157.73 34.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.5 t -139.48 138.22 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.327 0.651 . . . . 0.0 110.7 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -145.73 167.44 23.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.321 1.048 . . . . 0.0 108.535 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.86 149.07 49.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.588 -0.695 . . . . 0.0 110.47 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.3 t -78.68 155.99 29.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.224 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -72.1 -2.75 19.66 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.4 t -131.94 153.43 50.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.613 0.765 . . . . 0.0 110.723 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -84.86 -4.76 59.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -160.63 150.46 17.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.445 0.566 . . . . 0.0 111.127 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.9 mt -86.92 148.69 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 68.1 m -70.57 -33.11 70.73 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -173.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 58.06 160.0 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.452 1.101 . . . . 0.0 113.694 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.3 -9.21 24.95 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.56 2.84 . . . . 0.0 112.582 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.57 68.78 0.05 OUTLIER Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -70.98 -24.24 62.36 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 34.4 t -69.14 144.59 53.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.776 0.431 . . . . 0.0 111.056 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -65.67 -11.72 47.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -79.71 1.53 26.13 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 37.7 t -134.85 -12.59 2.24 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.746 0.418 . . . . 0.0 111.935 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -72.09 143.51 49.01 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 122.139 -0.351 . . . . 0.0 111.575 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 71.7 m 56.17 13.43 1.2 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.66 138.71 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 55.5 21.72 4.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.993 0.917 . . . . 0.0 112.814 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.253 1.251 0 CA-C-O 117.593 -1.194 . . . . 0.0 111.152 179.115 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 C5'-C4'-C3' 109.852 -3.765 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 1 O4'-C1'-N19 113.936 5.736 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.691 1 C5'-C4'-C3' 108.489 -4.674 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.582 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.656 1 C5'-C4'-C3' 107.854 -5.097 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.428 2 O4'-C1'-N19 112.348 4.148 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 O4'-C1'-N19 111.667 3.467 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -73.66 -23.78 59.9 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.644 0.377 . . . . 0.0 111.146 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -72.68 158.38 35.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.886 0.474 . . . . 0.0 110.916 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.96 -18.94 64.15 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -69.16 157.41 36.94 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -137.53 151.02 70.23 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.2 -9.27 25.16 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.236 2.624 . . . . 0.0 111.512 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -77.32 -8.12 57.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.73 0.412 . . . . 0.0 111.733 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -67.2 142.96 56.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.1 0.56 . . . . 0.0 111.082 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 p -80.66 149.43 67.87 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -67.42 150.85 80.81 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.626 2.884 . . . . 0.0 110.236 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.12 143.97 56.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.043 0.449 . . . . 0.0 111.721 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -159.84 150.76 15.83 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.5 0.72 . . . . 0.0 109.966 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.66 -8.32 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.463 2.108 . . . . 0.0 109.703 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.02 142.04 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.203 1.001 . . . . 0.0 111.837 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.65 143.13 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.459 0.647 . . . . 0.0 111.234 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -99.5 137.56 37.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.919 1.687 . . . . 0.0 110.099 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -115.65 140.52 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.22 0.608 . . . . 0.0 109.585 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -143.48 151.28 40.11 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 122.728 0.411 . . . . 0.0 110.591 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.31 86.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.798 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.07 170.07 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.634 0.717 . . . . 0.0 111.201 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.57 155.57 3.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.396 0.678 . . . . 0.0 109.976 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -70.71 -12.62 61.66 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.68 -10.81 85.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.505 0.574 . . . . 0.0 111.953 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.25 148.61 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 m -132.71 170.57 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 124.3 1.04 . . . . 0.0 109.331 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.17 -32.77 70.19 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 122.101 -0.374 . . . . 0.0 111.013 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.92 -31.55 72.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.582 0.353 . . . . 0.0 111.198 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -75.54 -32.87 60.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.761 -0.587 . . . . 0.0 112.538 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.71 -39.23 64.47 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.334 0.253 . . . . 0.0 110.564 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.03 -34.64 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -76.19 -24.45 54.73 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.94 -0.475 . . . . 0.0 111.119 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.74 -17.07 32.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.9 mt -122.01 -8.66 8.81 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.42 -21.7 66.22 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.449 1.022 . . . . 0.0 110.872 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.5 -11.34 60.86 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.142 -0.349 . . . . 0.0 111.202 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.93 -16.96 24.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.97 174.08 26.22 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -68.97 126.56 13.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.502 2.801 . . . . 0.0 110.703 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -94.0 142.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.981 0.512 . . . . 0.0 110.425 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 t -104.77 -34.21 8.18 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.696 0.798 . . . . 0.0 112.015 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -163.39 161.39 24.38 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -146.77 143.63 20.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 124.08 0.952 . . . . 0.0 109.541 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.77 154.25 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.62 141.91 39.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.061 0.544 . . . . 0.0 111.415 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -126.79 87.34 56.76 Favored Pre-proline 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.649 . . . . 0.0 109.984 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -12.93 36.94 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.002 2.468 . . . . 0.0 111.077 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -68.05 -25.87 65.57 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.626 0.37 . . . . 0.0 110.942 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.91 3.55 12.86 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 58.43 46.49 15.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.409 0.684 . . . . 0.0 110.828 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -140.47 170.08 16.46 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.866 0.866 . . . . 0.0 111.425 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.67 158.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.187 0.595 . . . . 0.0 110.984 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -128.35 148.64 50.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.959 0.504 . . . . 0.0 109.712 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -142.03 144.34 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -126.35 138.15 53.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.785 0.434 . . . . 0.0 110.096 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -100.91 155.02 18.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.8 -13.74 61.78 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.338 -0.226 . . . . 0.0 110.545 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -139.62 144.36 37.67 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.527 1.531 . . . . 0.0 112.964 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.18 -24.43 35.7 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -66.74 -35.98 81.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.431 0.292 . . . . 0.0 110.955 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -38.85 59.5 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.91 82.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.67 -35.96 73.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.183 0.593 . . . . 0.0 110.694 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.68 -35.08 79.73 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.007 0.367 . . . . 0.0 111.057 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.43 -32.55 66.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 71.1 t -81.36 -35.02 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.1 -0.375 . . . . 0.0 110.26 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -30.58 68.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.288 0.494 . . . . 0.0 111.714 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -77.72 -33.21 53.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.4 71.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.262 0.625 . . . . 0.0 110.714 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.4 4.47 3.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.591 0.756 . . . . 0.0 112.402 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.82 -26.12 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -156.3 154.54 30.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.86 137.25 39.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.231 -0.293 . . . . 0.0 110.251 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.8 mt -85.25 134.6 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 13.9 m-85 -85.51 130.27 34.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.7 mm -128.96 124.5 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.509 1.124 . . . . 0.0 108.507 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.05 34.53 5.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.016 0.526 . . . . 0.0 112.365 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.6 7.73 74.93 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.353 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -136.1 148.95 66.77 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 118.559 1.179 . . . . 0.0 111.846 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.32 153.02 79.63 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.72 2.946 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 172.84 16.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.185 0.994 . . . . 0.0 109.853 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -120.42 157.44 29.32 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.98 137.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.305 0.642 . . . . 0.0 111.272 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -148.99 171.17 16.81 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.644 1.178 . . . . 0.0 108.448 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -68.67 149.1 49.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.8 t -85.43 158.21 20.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.587 0.355 . . . . 0.0 111.259 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -2.78 18.98 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.8 t -131.57 152.35 50.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 111.0 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -83.36 -3.63 57.7 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.532 0.733 . . . . 0.0 112.675 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.06 148.3 20.32 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.249 0.477 . . . . 0.0 110.969 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.94 144.16 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.6 t -66.28 118.94 10.68 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.891 -0.506 . . . . 0.0 110.784 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 68.0 mmt-85 -81.43 159.04 68.12 Favored Pre-proline 0 CA--C 1.528 0.134 0 C-N-CA 123.494 0.717 . . . . 0.0 109.745 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.63 -14.37 41.82 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.654 2.236 . . . . 0.0 110.415 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.54 120.52 0.73 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -106.77 -3.34 20.56 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.8 m 52.61 28.92 6.59 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.77 0.428 . . . . 0.0 111.325 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.9 t0 54.51 62.72 2.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.097 0.559 . . . . 0.0 112.007 -175.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.259 62.2 m-20 55.92 26.8 10.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 70.9 m 58.39 19.08 6.08 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.388 1.075 . . . . 0.0 113.227 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 24.8 ttt85 -67.91 -15.98 63.86 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.161 0.584 . . . . 0.0 110.839 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.4 t -151.7 166.06 32.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.705 0.802 . . . . 0.0 109.465 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.306 1.0 OUTLIER 55.71 5.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -153.26 14.51 0.51 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.175 0.59 . . . . 0.0 110.505 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 C--O 1.252 1.196 0 CA-C-O 117.368 -1.301 . . . . 0.0 110.168 -179.452 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.65 0 C5'-C4'-C3' 109.813 -3.791 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.663 1 O4'-C1'-N19 112.443 4.243 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 1 C5'-C4'-C3' 108.428 -4.714 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.537 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.053 0 C5'-C4'-C3' 109.949 -3.701 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-C3' 109.62 -3.92 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C5'-C4'-C3' 110.166 -3.556 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.261 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.61 -17.8 61.65 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.67 0.388 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -152.63 162.18 41.58 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.414 0.686 . . . . 0.0 109.203 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.261 37.7 t80 -144.39 147.59 33.59 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -70.92 161.91 30.24 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -63.06 124.58 84.35 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.68 -16.21 41.9 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.266 2.644 . . . . 0.0 112.972 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -89.23 -12.79 39.78 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.217 0.462 . . . . 0.0 111.221 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -91.32 149.4 21.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.253 0.621 . . . . 0.0 110.095 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.0 144.86 98.96 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.72 139.39 30.71 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.369 2.713 . . . . 0.0 110.926 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.22 138.44 58.54 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.727 0.299 . . . . 0.0 111.237 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.5 m -155.19 154.74 29.15 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 123.837 0.855 . . . . 0.0 109.717 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.72 -6.1 17.74 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.405 2.737 . . . . 0.0 110.66 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.81 145.86 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.32 144.39 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.475 0.655 . . . . 0.0 111.063 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.73 137.45 38.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.168 1.787 . . . . 0.0 110.341 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -116.47 140.7 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.204 1.002 . . . . 0.0 109.361 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -142.83 152.18 41.91 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.865 0.466 . . . . 0.0 111.188 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.58 7.55 66.75 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.546 -0.586 . . . . 0.0 112.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.58 177.69 8.59 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.911 0.856 . . . . 0.0 109.649 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.507 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.03 157.0 12.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 CA-C-O 121.347 0.594 . . . . 0.0 109.648 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -67.81 -4.71 13.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.99 -10.78 85.86 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.8 147.56 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.68 168.74 23.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 124.338 1.055 . . . . 0.0 109.984 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -60.32 -32.64 71.43 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.128 -0.357 . . . . 0.0 111.065 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.35 71.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.079 0.152 . . . . 0.0 111.072 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -71.99 -32.18 66.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.24 -44.71 71.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.66 -34.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -75.03 -23.45 58.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 122.074 -0.391 . . . . 0.0 111.435 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.02 -17.07 26.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.45 -9.15 9.04 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.35 -21.87 66.74 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.12 0.873 . . . . 0.0 110.91 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.28 -10.97 60.53 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -92.72 -13.79 28.87 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.5 173.02 22.25 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.24 126.13 14.57 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.465 2.776 . . . . 0.0 110.58 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.38 142.35 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.018 0.527 . . . . 0.0 110.294 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.33 -34.1 8.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.584 0.754 . . . . 0.0 111.857 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -167.14 160.4 13.83 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.29 151.47 17.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.169 0.988 . . . . 0.0 112.454 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.88 155.9 6.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 123.3 0.64 . . . . 0.0 111.186 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.14 141.88 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -136.09 81.11 39.57 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.811 0.444 . . . . 0.0 110.32 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.47 -6.63 15.61 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.18 2.586 . . . . 0.0 110.458 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.19 -32.1 73.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 110.215 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -117.12 7.22 12.98 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.891 0.876 . . . . 0.0 113.068 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 55.73 51.27 12.7 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.508 0.595 . . . . 0.0 111.362 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -143.24 164.72 29.42 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.394 0.678 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.27 40.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.415 0.686 . . . . 0.0 110.475 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -127.66 147.01 50.37 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.55 144.15 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -127.37 135.92 51.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -97.16 157.81 15.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.35 -13.35 61.84 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.857 0.299 . . . . 0.0 110.437 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -143.38 143.89 31.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.402 1.481 . . . . 0.0 113.113 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 p -61.49 -21.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.723 0.297 . . . . 0.0 111.496 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.4 tp -68.6 -35.82 77.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.806 0.442 . . . . 0.0 110.702 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 -38.14 58.37 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.66 87.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.01 -31.96 68.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 111.074 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.38 -35.7 80.99 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.997 -0.439 . . . . 0.0 111.007 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.16 70.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.414 -0.179 . . . . 0.0 110.917 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.15 -33.69 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 O-C-N 122.363 -0.211 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -70.18 -30.79 68.0 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.191 -0.318 . . . . 0.0 110.746 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -74.84 -32.96 62.07 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.31 70.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.56 1.9 3.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.393 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -132.1 -28.79 1.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -157.05 152.33 26.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.805 0.442 . . . . 0.0 109.86 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.81 138.37 39.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.6 mt -82.78 140.02 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.6 m-85 -92.27 131.21 37.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.02 124.68 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.624 1.17 . . . . 0.0 108.429 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.47 34.51 6.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.181 0.592 . . . . 0.0 112.464 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.08 10.16 78.9 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.787 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -134.99 148.81 68.41 Favored Pre-proline 0 C--N 1.339 0.11 0 CA-C-N 118.151 0.975 . . . . 0.0 111.311 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 150.46 82.76 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.36 2.706 . . . . 0.0 111.198 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.07 13.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.922 0.889 . . . . 0.0 109.709 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.72 158.63 39.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -142.34 145.52 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -152.4 168.9 23.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.716 1.606 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -68.93 150.5 47.66 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.8 t -81.08 162.34 23.77 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.205 0.602 . . . . 0.0 111.31 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -2.89 22.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.6 t -125.15 157.75 35.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.584 0.754 . . . . 0.0 110.082 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.41 -6.67 59.2 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -161.09 157.62 26.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.714 0.688 . . . . 0.0 111.67 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt -85.76 148.91 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.9 t -62.42 134.22 56.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.431 0.293 . . . . 0.0 111.274 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -148.56 149.54 31.48 Favored Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 123.782 0.833 . . . . 0.0 110.618 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.08 -21.77 15.36 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.629 2.886 . . . . 0.0 111.292 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.76 -13.93 64.0 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.7 -0.5 . . . . 0.0 112.542 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -85.9 -4.97 59.29 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.2 m 54.81 32.31 17.36 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.383 0.673 . . . . 0.0 112.602 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -56.73 152.68 11.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -55.24 112.01 0.99 Allowed 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 70.6 m 57.42 11.42 1.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.818 1.247 . . . . 0.0 114.017 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -86.53 153.1 22.08 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.225 0.61 . . . . 0.0 112.068 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.9 m 56.59 14.87 1.86 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.35 134.64 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.6 17.4 2.29 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.227 1.011 . . . . 0.0 113.722 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.8 m . . . . . 0 C--O 1.254 1.314 0 C-N-CA 123.975 0.91 . . . . 0.0 111.772 -179.449 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 C5'-C4'-C3' 109.57 -3.953 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.555 1 O4'-C1'-N19 113.744 5.544 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 1 C5'-C4'-C3' 108.505 -4.663 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.581 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.711 2 C5'-C4'-C3' 108.367 -4.756 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 O4'-C1'-N19 110.676 2.476 . 0.167 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.981 0 C5'-C4'-C3' 110.602 -3.266 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -73.33 -28.57 62.15 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 122.644 -0.327 . . . . 0.0 111.542 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -97.76 -19.41 18.21 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -153.65 146.43 24.32 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -67.4 158.07 32.59 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -137.7 152.52 72.77 Favored Pre-proline 0 C--O 1.232 0.171 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.7 -9.54 26.48 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.139 2.559 . . . . 0.0 111.734 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -77.44 -12.21 59.93 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.586 0.354 . . . . 0.0 111.32 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -70.73 152.19 44.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.584 0.754 . . . . 0.0 110.234 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -125.81 146.67 56.01 Favored Pre-proline 0 C--O 1.232 0.178 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.12 160.24 42.96 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.759 2.973 . . . . 0.0 111.102 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.77 147.24 53.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 111.047 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 t -162.05 148.8 11.1 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.527 0.731 . . . . 0.0 109.761 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.87 -9.72 26.27 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.663 2.242 . . . . 0.0 109.65 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.02 140.91 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.521 0.728 . . . . 0.0 110.924 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 m -134.97 141.71 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.997 0.903 . . . . 0.0 111.77 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -99.15 137.43 37.68 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.315 1.846 . . . . 0.0 110.412 -177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -116.02 140.8 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.829 0.851 . . . . 0.0 109.735 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -144.65 152.77 40.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.86 0.464 . . . . 0.0 110.582 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.15 86.66 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.75 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -71.45 173.94 7.26 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 117.86 0.83 . . . . 0.0 110.898 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 pt -104.03 153.4 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.04 0 C-N-CA 123.317 0.647 . . . . 0.0 109.296 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -71.46 -8.54 54.51 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.09 -10.85 85.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.79 150.02 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.66 166.88 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 C-N-CA 124.064 0.946 . . . . 0.0 109.522 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.85 -32.67 67.87 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 122.247 -0.283 . . . . 0.0 111.455 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.49 72.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.433 0.293 . . . . 0.0 111.48 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -74.33 -30.83 62.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.35 -44.24 68.54 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.8 -34.68 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.18 -21.57 58.65 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.091 0.405 . . . . 0.0 111.22 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.54 -17.09 26.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -121.97 -9.52 8.74 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.06 -21.95 66.9 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.185 0.902 . . . . 0.0 110.813 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -69.23 -12.72 61.91 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.201 0.2 . . . . 0.0 111.409 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.71 -17.65 25.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.07 172.26 25.02 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.24 128.84 19.17 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.253 2.635 . . . . 0.0 110.795 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.88 142.84 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.079 0.552 . . . . 0.0 110.781 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 t -103.73 -33.99 8.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.626 0.77 . . . . 0.0 111.914 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -167.0 159.68 13.46 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.77 152.7 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.314 1.046 . . . . 0.0 112.045 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.0 154.93 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.307 0.643 . . . . 0.0 111.052 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -138.02 141.88 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.141 0.577 . . . . 0.0 112.313 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -133.66 84.31 45.47 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 123.453 0.701 . . . . 0.0 109.741 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.55 -8.53 22.52 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.131 2.554 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -65.84 -30.56 71.19 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.416 0.686 . . . . 0.0 109.931 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.9 5.79 13.0 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.823 0.849 . . . . 0.0 111.897 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 57.13 48.59 15.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.889 0.875 . . . . 0.0 110.996 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -141.85 169.01 18.4 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.676 0.79 . . . . 0.0 110.841 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.5 157.71 40.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.163 0.585 . . . . 0.0 110.06 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 26.4 mt -128.46 150.29 50.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.5 144.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -124.33 131.6 53.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.836 0.454 . . . . 0.0 109.787 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.02 155.34 17.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -71.93 -15.58 62.09 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -140.16 143.03 35.94 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.263 1.425 . . . . 0.0 113.688 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.72 -21.78 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.9 tp -68.99 -36.12 77.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.861 0.464 . . . . 0.0 110.638 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.57 -39.11 61.27 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.88 84.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.042 0.448 . . . . 0.0 109.985 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.8 t -70.95 -33.29 70.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 110.904 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.52 -35.02 78.29 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.211 -0.306 . . . . 0.0 110.961 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.86 -38.51 70.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.559 0.163 . . . . 0.0 111.433 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.73 -35.45 43.74 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 O-C-N 122.229 -0.294 . . . . 0.0 111.125 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -76.87 -21.36 55.08 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.468 0.576 . . . . 0.0 112.488 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -74.68 -32.96 62.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.07 -30.25 70.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.555 0.742 . . . . 0.0 111.7 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.55 -16.7 63.96 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.33 -28.6 9.78 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -159.97 152.4 20.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.23 0.612 . . . . 0.0 109.606 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.79 140.02 40.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -82.74 133.56 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.8 m-85 -86.51 129.38 34.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mm -128.88 124.49 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.572 1.149 . . . . 0.0 108.343 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.39 34.51 6.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.07 8.73 78.3 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.227 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -135.83 148.91 67.16 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.494 1.147 . . . . 0.0 111.849 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.25 150.89 81.64 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.349 2.699 . . . . 0.0 111.703 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.92 174.95 13.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.767 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.5 162.82 24.04 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.4 p -142.21 148.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.254 0.622 . . . . 0.0 111.956 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -156.02 166.79 32.42 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.84 148.48 50.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.222 0.919 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 t -85.05 160.61 19.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.974 0.51 . . . . 0.0 110.956 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -2.77 18.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.7 t -133.62 154.05 51.19 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.056 0.542 . . . . 0.0 111.043 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -85.11 -2.69 58.28 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.414 0.686 . . . . 0.0 112.243 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.76 151.85 20.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 111.479 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 73.5 mt -93.95 140.74 15.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 69.0 m -72.91 138.46 46.22 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 122.05 -0.406 . . . . 0.0 110.881 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 ptt-85 -160.56 142.47 9.31 Favored Pre-proline 0 N--CA 1.456 -0.135 0 C-N-CA 123.215 0.606 . . . . 0.0 109.897 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.39 -16.32 27.74 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.8 3.0 . . . . 0.0 111.846 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -74.67 -20.44 79.52 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -106.57 -3.03 21.21 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.2 m 60.57 161.52 0.05 Allowed 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.999 1.32 . . . . 0.0 113.824 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -112.85 11.23 19.2 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.277 70.8 m-20 59.51 2.57 0.34 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 116.89 2.182 . . . . 0.0 116.89 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.6 t -155.84 12.84 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.559 0.743 . . . . 0.0 110.33 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -64.92 145.96 55.6 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.123 0.569 . . . . 0.0 110.797 -174.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.3 t 54.2 19.08 2.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.793 0.837 . . . . 0.0 112.226 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.284 1.1 t 56.9 22.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -144.57 -5.43 0.74 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.166 -0.333 . . . . 0.0 111.792 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.626 -1.654 . . . . 0.0 111.487 -179.53 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.608 0 C5'-C4'-C3' 109.835 -3.776 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.611 1 O4'-C1'-N19 114.03 5.83 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.563 1 C5'-C4'-C3' 108.42 -4.72 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.583 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.01 1 C5'-C4'-C3' 108.628 -4.582 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . 0.425 " H4'" ' C2 ' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.553 1 C5'-C4'-C3' 108.09 -4.94 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . 0.425 ' C2 ' " H4'" ' B' ' 5' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -2.975 0 C5'-C4'-C3' 110.435 -3.377 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -70.54 161.77 30.05 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.951 0.405 . . . . 0.0 111.063 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -69.04 156.84 37.96 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.62 0.368 . . . . 0.0 111.128 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -146.02 151.03 37.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -148.01 156.72 42.97 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -65.17 151.29 94.11 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.93 178.09 4.39 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.646 2.897 . . . . 0.0 111.034 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 91' ' ' HIS . 18.7 m-70 -79.14 2.07 22.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.121 1.368 . . . . 0.0 112.071 -175.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -68.8 134.98 50.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.802 0.441 . . . . 0.0 110.595 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -85.92 151.46 54.86 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -71.36 157.18 57.38 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.502 2.801 . . . . 0.0 110.863 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.83 148.42 49.39 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 111.887 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -163.09 149.62 10.34 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 123.464 0.706 . . . . 0.0 110.011 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.39 -9.59 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 110.027 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.93 139.7 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.673 0.789 . . . . 0.0 110.621 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.38 139.02 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.625 0.726 . . . . 0.0 111.395 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.18 137.31 37.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.416 1.886 . . . . 0.0 110.296 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.3 mt -116.37 140.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.784 0.833 . . . . 0.0 109.911 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.138 0.575 . . . . 0.0 110.449 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.3 85.53 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.098 0.38 . . . . 0.0 112.705 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.96 173.99 7.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.448 0.624 . . . . 0.0 110.972 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.7 pt -100.71 154.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.599 0.76 . . . . 0.0 109.705 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -72.76 -10.48 59.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.71 -10.9 85.93 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.88 149.8 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.56 169.92 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 124.018 0.927 . . . . 0.0 109.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 60.3 mp0 -57.9 -32.84 68.13 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.407 0.283 . . . . 0.0 111.205 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.4 70.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.746 0.418 . . . . 0.0 111.722 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -72.97 -35.67 66.97 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.949 -0.469 . . . . 0.0 112.095 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.5 -38.48 65.35 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.488 0.315 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.93 -34.88 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.63 -25.0 56.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.148 -0.345 . . . . 0.0 111.007 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.0 35.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.6 mt -122.84 -9.62 8.31 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.62 -21.86 66.12 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.372 0.987 . . . . 0.0 110.915 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -68.96 -11.5 60.76 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.264 -0.273 . . . . 0.0 111.406 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.68 -16.09 23.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.68 172.43 23.97 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.17 129.26 17.9 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.499 2.799 . . . . 0.0 110.981 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.9 mt -97.81 142.78 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.604 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.8 t -104.71 -32.12 9.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.328 0.651 . . . . 0.0 111.641 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -163.0 161.88 25.71 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -147.26 143.96 19.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 109.319 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.5 p -151.03 153.3 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.335 0.654 . . . . 0.0 111.651 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.6 141.7 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.1 78.89 75.47 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 123.332 0.653 . . . . 0.0 109.811 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.22 -7.71 18.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.093 2.529 . . . . 0.0 111.201 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -65.35 -33.2 75.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.267 0.627 . . . . 0.0 110.097 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -117.1 7.5 13.07 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.743 0.817 . . . . 0.0 112.537 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 55.77 53.39 9.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.216 0.606 . . . . 0.0 110.58 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -144.76 172.87 12.41 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.923 0.889 . . . . 0.0 110.977 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.55 158.26 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.123 0.569 . . . . 0.0 110.82 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.4 mt -128.81 146.65 50.86 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.324 0.65 . . . . 0.0 109.657 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.7 t -141.56 144.22 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -126.76 126.81 44.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -87.19 156.94 19.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.66 -14.32 61.56 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 122.205 -0.309 . . . . 0.0 110.344 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -143.07 143.04 31.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.292 1.437 . . . . 0.0 113.382 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.51 -21.94 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.6 -36.72 79.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.866 0.466 . . . . 0.0 110.587 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -36.2 58.11 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.57 92.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 97.5 m -71.29 -28.71 64.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -68.04 -36.44 79.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.222 0.465 . . . . 0.0 110.932 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.461 0.119 . . . . 0.0 110.968 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.6 t -76.99 -33.43 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.358 -0.214 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -66.8 -34.48 77.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.176 0.443 . . . . 0.0 110.379 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.24 -32.99 63.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.28 -29.99 69.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.501 0.72 . . . . 0.0 111.862 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.61 -10.68 5.51 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.41 5.04 1.23 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -149.83 156.1 41.22 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -94.04 137.03 33.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.8 mt -90.04 135.1 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.299 24.7 m-85 -87.42 128.83 35.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.96 123.33 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.458 1.103 . . . . 0.0 108.578 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.05 34.41 4.2 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 112.562 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.47 8.8 70.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.459 -0.634 . . . . 0.0 114.105 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -136.05 148.91 66.7 Favored Pre-proline 0 N--CA 1.461 0.09 0 CA-C-N 118.355 1.078 . . . . 0.0 111.684 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.64 149.34 79.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.32 2.68 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.08 13.22 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.414 1.086 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -129.46 161.92 29.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.3 149.23 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.396 0.678 . . . . 0.0 110.894 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -154.2 167.66 29.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.97 150.79 47.31 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.39 -0.819 . . . . 0.0 109.103 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 40.9 t -84.21 160.02 20.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.941 0.496 . . . . 0.0 111.19 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.34 -2.66 17.08 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.2 t -133.91 152.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.248 0.619 . . . . 0.0 110.913 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -82.46 -2.7 54.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.47 0.708 . . . . 0.0 112.486 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -157.84 153.42 26.37 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.381 0.537 . . . . 0.0 111.608 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.6 mt -95.05 147.33 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.5 m -68.97 116.98 10.05 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -160.64 150.41 14.4 Favored Pre-proline 0 CA--C 1.528 0.117 0 C-N-CA 123.436 0.695 . . . . 0.0 109.976 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.63 -13.95 30.08 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.308 2.672 . . . . 0.0 111.722 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -73.78 -6.69 73.08 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.898 -0.39 . . . . 0.0 112.285 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -83.77 8.45 14.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.591 0.696 . . . . 0.0 110.307 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 41.3 t -149.99 151.41 33.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.539 -0.725 . . . . 0.0 111.228 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.319 0.8 OUTLIER 54.62 172.29 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.273 7.1 t0 61.78 -73.19 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.7 t -74.62 -27.29 60.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.236 -0.29 . . . . 0.0 111.227 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -77.87 157.4 29.87 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.868 0.467 . . . . 0.0 111.488 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 36.6 t 60.51 163.39 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.238 1.415 . . . . 0.0 113.374 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.78 9.14 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.93 0.892 . . . . 0.0 112.968 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -145.68 5.35 1.03 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.0 177.379 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 C5'-C4'-C3' 109.795 -3.803 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 1 O4'-C1'-N19 113.915 5.715 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 1 C5'-C4'-C3' 108.332 -4.779 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.522 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.413 -3.356 1 C5'-C4'-C3' 109.14 -4.24 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.254 1 C5'-C4'-C3' 108.624 -4.584 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.901 0 C5'-C4'-C3' 109.644 -3.904 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 57.41 -179.14 0.06 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.297 1.039 . . . . 0.0 112.564 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -75.85 1.51 14.82 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.075 0.55 . . . . 0.0 112.147 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.264 38.9 t80 -62.72 148.54 46.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.76 156.09 36.39 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -66.36 124.38 87.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.15 -16.81 40.42 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.954 2.436 . . . . 0.0 112.502 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -98.3 4.34 48.71 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.113 0.565 . . . . 0.0 111.581 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -66.69 139.52 57.85 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.648 0.379 . . . . 0.0 110.731 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -91.77 148.48 37.24 Favored Pre-proline 0 CA--C 1.529 0.173 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.06 151.22 55.5 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.611 2.874 . . . . 0.0 110.86 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.46 144.39 57.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.014 0.435 . . . . 0.0 111.704 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.8 t -164.05 149.86 9.34 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.531 0.732 . . . . 0.0 109.753 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.89 -9.22 25.3 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.887 2.392 . . . . 0.0 110.033 172.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.12 142.88 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.637 0.775 . . . . 0.0 110.68 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.31 141.17 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.495 0.664 . . . . 0.0 111.817 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -104.93 137.47 42.64 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.397 1.879 . . . . 0.0 109.996 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -115.19 140.7 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.232 1.013 . . . . 0.0 110.004 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -141.71 154.8 45.54 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.12 0.568 . . . . 0.0 110.11 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.24 83.13 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.713 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -73.18 174.96 7.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.872 0.836 . . . . 0.0 110.584 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.523 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.8 160.86 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.104 0.561 . . . . 0.0 110.087 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.68 -19.04 64.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -70.41 -10.78 67.03 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.092 0.377 . . . . 0.0 112.561 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.73 146.61 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.57 166.79 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 C-N-CA 124.098 0.959 . . . . 0.0 109.827 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.45 -32.73 70.49 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.248 -0.282 . . . . 0.0 111.2 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.38 72.0 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.212 0.205 . . . . 0.0 111.09 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -74.01 -30.19 62.33 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.74 -45.02 72.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.38 -34.65 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -74.96 -21.57 59.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.998 -0.438 . . . . 0.0 111.754 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.74 -17.02 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.4 -8.74 9.58 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.5 -21.97 66.68 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.112 0.869 . . . . 0.0 110.993 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.0 -12.37 61.56 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.142 -0.349 . . . . 0.0 111.485 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -91.3 -16.09 28.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.21 23.45 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.01 130.67 22.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.496 2.798 . . . . 0.0 110.764 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.0 mt -98.52 142.79 14.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.211 0.604 . . . . 0.0 110.894 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.4 t -104.7 -33.7 8.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.615 0.766 . . . . 0.0 112.278 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -165.0 157.04 15.54 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.69 151.37 16.64 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 123.911 0.884 . . . . 0.0 111.941 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.07 157.97 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.317 0.647 . . . . 0.0 111.804 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.05 141.94 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -133.05 82.66 53.96 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 123.288 0.635 . . . . 0.0 110.328 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.02 -10.17 27.63 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.919 2.413 . . . . 0.0 111.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -69.98 -24.49 63.32 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 117.841 0.291 . . . . 0.0 111.065 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -116.8 3.34 12.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.503 0.721 . . . . 0.0 111.769 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 57.3 51.12 10.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.31 170.93 15.06 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.966 0.906 . . . . 0.0 110.873 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.23 40.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.13 0.572 . . . . 0.0 110.537 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.51 150.89 49.97 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.34 144.56 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -125.35 133.08 52.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.852 0.461 . . . . 0.0 109.968 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -95.37 155.3 16.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -71.42 -14.51 62.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -143.61 143.54 31.53 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.566 1.546 . . . . 0.0 113.415 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.17 -21.9 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 0.0 111.658 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.69 -35.31 77.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.687 0.395 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.06 -38.88 55.01 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.82 85.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.013 0.435 . . . . 0.0 109.852 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.96 -33.61 68.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.218 0.607 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.41 -34.75 79.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.118 0.417 . . . . 0.0 111.015 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.57 68.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.494 -0.128 . . . . 0.0 111.107 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.6 -33.6 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.046 0 O-C-N 122.069 -0.395 . . . . 0.0 110.876 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -71.68 -30.8 66.1 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.031 -0.418 . . . . 0.0 110.566 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.75 -32.93 64.07 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.35 69.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.635 0.774 . . . . 0.0 111.5 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.96 -14.91 63.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -109.99 -27.18 9.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -160.01 153.86 22.93 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.101 0.56 . . . . 0.0 109.587 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.72 137.04 39.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -81.37 137.61 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.286 13.9 m-85 -90.45 130.8 36.48 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.7 mm -128.79 124.43 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.62 1.168 . . . . 0.0 108.072 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.46 34.56 6.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.192 0.597 . . . . 0.0 112.528 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.19 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.871 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -135.65 148.8 67.05 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 118.54 1.17 . . . . 0.0 111.4 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.15 149.82 81.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.175 2.583 . . . . 0.0 111.791 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.78 175.1 13.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.162 0.985 . . . . 0.0 109.888 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -128.12 159.71 34.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 144.56 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -146.47 164.37 32.73 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.465 1.106 . . . . 0.0 108.257 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -68.88 150.7 47.48 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.4 t -85.12 159.12 20.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.883 0.473 . . . . 0.0 111.475 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.87 -2.66 15.74 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.9 t -131.05 152.03 50.79 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.199 0.6 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -82.54 -4.22 57.22 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -158.56 150.37 21.25 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.401 0.546 . . . . 0.0 111.228 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.2 mt -90.36 146.9 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 41.6 t -65.69 136.17 55.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.92 -0.488 . . . . 0.0 110.517 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -91.29 162.95 30.76 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.093 0.557 . . . . 0.0 110.194 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.16 -13.73 41.15 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.718 2.945 . . . . 0.0 112.044 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.75 -3.35 0.08 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.358 -0.69 . . . . 0.0 112.916 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -65.45 -10.97 38.52 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t 55.19 13.54 0.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.251 1.02 . . . . 0.0 111.841 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.255 14.6 t70 61.3 -33.43 0.09 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.135 2.174 . . . . 0.0 116.293 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -68.17 -26.75 65.91 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.4 t -84.31 -24.45 29.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.325 0.25 . . . . 0.0 110.677 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -81.26 -25.43 36.58 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.961 0.505 . . . . 0.0 110.511 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.2 t 52.82 22.46 2.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.312 1.045 . . . . 0.0 112.593 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.315 0.4 OUTLIER 54.29 12.05 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -177.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -158.03 74.96 0.74 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.41 0.684 . . . . 0.0 109.368 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.58 -1.2 . . . . 0.0 111.789 179.695 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 C5'-C4'-C3' 110.071 -3.619 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 1 O4'-C1'-N19 114.25 6.05 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 1 C5'-C4'-C3' 108.453 -4.698 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.577 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.726 1 C5'-C4'-C3' 108.646 -4.569 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 O4'-C1'-N19 111.178 2.978 . 0.193 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 109.932 -3.712 . 0.318 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -69.15 158.95 33.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.885 0.474 . . . . 0.0 111.189 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -76.37 -2.8 33.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.057 0.543 . . . . 0.0 111.608 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -63.65 150.67 43.71 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -146.47 154.54 41.7 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -75.64 155.18 85.41 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.2 -16.36 45.88 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.168 2.579 . . . . 0.0 112.589 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -80.71 -5.84 57.6 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.769 0.828 . . . . 0.0 112.393 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -66.0 141.62 58.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.019 0.372 . . . . 0.0 110.442 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 p -74.24 141.28 77.22 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.68 159.11 35.43 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 124.144 3.23 . . . . 0.0 110.212 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.73 143.71 52.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 m -152.81 151.17 26.06 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 110.418 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 -1.84 11.76 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.905 3.07 . . . . 0.0 110.599 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.9 149.73 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.803 0.841 . . . . 0.0 112.391 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.41 146.84 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.778 0.799 . . . . 0.0 111.932 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -100.94 137.59 39.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.216 2.206 . . . . 0.0 110.058 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.71 140.65 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.429 1.092 . . . . 0.0 110.25 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -144.32 154.3 42.9 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.203 0.601 . . . . 0.0 110.155 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.48 82.69 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.717 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.28 173.27 9.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.758 0.779 . . . . 0.0 110.398 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.523 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.19 160.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.022 0.529 . . . . 0.0 109.831 -178.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.15 -18.88 63.94 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.523 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.35 -10.96 75.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.784 -0.454 . . . . 0.0 112.609 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.68 146.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -132.66 167.1 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.483 1.113 . . . . 0.0 109.376 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -58.83 -32.55 69.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.149 -0.344 . . . . 0.0 111.399 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.18 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.473 0.309 . . . . 0.0 111.178 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -74.89 -31.44 61.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.0 mt -71.85 -40.58 68.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.247 0.219 . . . . 0.0 110.648 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -71.86 -34.79 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.04 -22.7 58.24 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 122.267 -0.271 . . . . 0.0 111.421 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.7 -17.07 24.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.92 -9.02 10.17 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.63 -21.73 66.6 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.852 0.751 . . . . 0.0 110.834 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.59 -12.27 61.46 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.066 -0.396 . . . . 0.0 111.262 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -90.58 -17.87 26.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.87 173.86 26.84 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.11 127.75 16.46 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.667 2.912 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 77.4 mt -95.34 142.95 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.07 0.548 . . . . 0.0 110.542 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.5 t -108.5 -33.21 7.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.23 0.612 . . . . 0.0 112.07 -176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -161.86 159.75 27.24 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.64 145.82 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.102 0.961 . . . . 0.0 109.413 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.78 154.21 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.567 0.747 . . . . 0.0 110.921 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.05 141.74 39.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -131.22 84.19 57.75 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 123.293 0.637 . . . . 0.0 110.221 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.41 -9.85 25.51 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.758 2.306 . . . . 0.0 110.452 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.26 -30.73 71.77 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.15 0.98 . . . . 0.0 110.22 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -117.02 3.73 12.76 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.261 1.025 . . . . 0.0 112.706 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 56.5 44.8 23.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.341 0.656 . . . . 0.0 110.585 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -140.48 169.54 17.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 110.431 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.36 40.84 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.874 0.47 . . . . 0.0 111.192 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.4 149.64 50.46 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -142.34 144.42 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.32 134.53 53.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.179 0.592 . . . . 0.0 109.936 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -98.77 154.92 17.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.15 -13.72 61.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.101 0.409 . . . . 0.0 110.691 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -141.28 143.1 33.9 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.219 1.407 . . . . 0.0 113.624 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.76 -22.04 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 111.557 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.7 tp -69.01 -36.53 77.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.378 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.37 -38.35 58.39 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.02 86.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.4 t -71.59 -33.78 69.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.258 0.623 . . . . 0.0 111.075 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.25 -34.55 78.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.107 0.412 . . . . 0.0 111.029 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.54 -40.13 70.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.316 -0.24 . . . . 0.0 110.829 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -75.13 -33.8 29.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 122.329 -0.232 . . . . 0.0 110.524 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.42 -29.58 66.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.055 0.389 . . . . 0.0 110.887 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -75.46 -33.05 60.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.44 71.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.236 0.614 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.99 2.83 3.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 112.455 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.48 -27.8 1.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.94 153.95 27.03 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -76.71 142.14 40.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.657 0.265 . . . . 0.0 110.671 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.6 mt -83.88 138.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.31 19.2 m-85 -91.37 129.12 37.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.73 123.49 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.508 1.123 . . . . 0.0 108.333 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.44 34.56 6.84 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.219 0.608 . . . . 0.0 112.241 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 9.44 74.75 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.079 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.0 148.94 66.92 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 118.418 1.109 . . . . 0.0 111.394 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.9 148.35 76.35 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.333 2.688 . . . . 0.0 111.278 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.93 175.0 13.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.228 1.011 . . . . 0.0 109.822 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -128.15 163.4 24.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.1 148.12 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.321 0.649 . . . . 0.0 111.56 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -155.1 166.5 33.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -68.62 151.01 47.31 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.413 -0.804 . . . . 0.0 112.351 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.2 t -84.7 164.9 18.31 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.773 0.32 . . . . 0.0 111.096 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.99 -2.9 19.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.3 t -137.99 156.6 47.67 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.094 0.558 . . . . 0.0 111.312 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -82.46 -0.05 44.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -157.56 154.77 29.09 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 118.281 0.491 . . . . 0.0 110.942 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -91.1 138.78 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.5 t -69.01 135.97 51.7 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.367 -0.208 . . . . 0.0 111.319 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 28.4 ptt-85 -164.43 149.34 8.51 Favored Pre-proline 0 C--O 1.231 0.099 0 C-N-CA 123.803 0.841 . . . . 0.0 109.473 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.98 -14.61 29.33 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.113 2.542 . . . . 0.0 111.309 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -75.48 -8.49 83.98 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.813 -0.437 . . . . 0.0 112.643 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -77.57 -4.73 47.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.976 0.888 . . . . 0.0 108.682 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.4 m 54.27 35.09 21.92 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.179 0.992 . . . . 0.0 112.637 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -55.04 160.03 2.19 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.285 6.2 t0 65.17 -58.33 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.7 m -77.56 9.84 3.05 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.747 0.819 . . . . 0.0 111.933 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -77.12 11.85 1.67 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.946 0.898 . . . . 0.0 113.043 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 73.7 m 52.47 28.54 6.02 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.862 0.465 . . . . 0.0 112.239 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.318 1.0 OUTLIER 55.47 14.19 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 178.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -148.86 -16.58 0.31 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.481 -1.247 . . . . 0.0 110.935 178.062 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.596 0 C5'-C4'-C3' 109.949 -3.701 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.89 1 O4'-C1'-N19 112.91 4.71 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 2 C5'-C4'-C3' 108.89 -4.407 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.563 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.104 1 C5'-C4'-C3' 108.39 -4.74 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 1 C5'-C4'-C3' 109.421 -4.052 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 C5'-C4'-C3' 110.589 -3.274 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.099 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 57.16 25.87 11.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.804 0.842 . . . . 0.0 111.715 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -66.85 157.2 33.65 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.918 -0.488 . . . . 0.0 111.125 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -68.77 158.57 34.07 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -70.98 160.28 33.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -63.89 124.7 85.92 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.9 -14.16 43.22 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.046 2.497 . . . . 0.0 112.952 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -86.62 -11.84 50.24 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.077 0.399 . . . . 0.0 111.939 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -79.51 132.27 36.27 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 117.892 0.314 . . . . 0.0 111.197 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -132.33 153.11 81.12 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 124.296 1.039 . . . . 0.0 113.169 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.93 154.39 67.13 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.119 2.546 . . . . 0.0 110.914 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.06 146.79 53.95 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.965 0.412 . . . . 0.0 111.87 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -153.63 151.99 26.35 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 123.748 0.819 . . . . 0.0 109.665 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.68 6.63 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.993 3.129 . . . . 0.0 110.908 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -137.62 147.47 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.23 148.12 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.934 0.873 . . . . 0.0 111.426 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -99.1 137.61 37.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.149 1.78 . . . . 0.0 109.866 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mt -114.6 140.47 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.487 0.715 . . . . 0.0 109.435 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -145.25 153.19 41.05 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.625 0.37 . . . . 0.0 110.613 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.16 90.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.684 -0.509 . . . . 0.0 112.766 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.23 172.46 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.91 157.29 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.331 0.653 . . . . 0.0 110.289 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.82 -22.42 66.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.83 -10.95 73.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.257 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.41 147.7 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -132.57 166.59 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.233 1.013 . . . . 0.0 109.804 174.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.42 -32.64 67.08 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 122.113 -0.367 . . . . 0.0 111.392 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -31.28 71.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.433 0.293 . . . . 0.0 111.184 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.04 -31.11 62.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.59 -43.06 73.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 121.937 0.095 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.03 -34.49 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.65 -22.08 57.1 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.949 0.34 . . . . 0.0 111.468 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.09 -17.38 26.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.79 -7.63 9.53 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -65.57 -21.71 66.62 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.17 0.895 . . . . 0.0 110.884 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.53 -12.26 61.45 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.214 -0.304 . . . . 0.0 111.488 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -92.05 -15.43 27.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.39 173.03 23.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.85 126.73 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.667 2.912 . . . . 0.0 110.804 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.3 mt -93.65 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.993 0.517 . . . . 0.0 110.616 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.6 -34.1 8.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.482 0.713 . . . . 0.0 111.761 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -166.36 159.0 14.35 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.41 151.19 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.23 1.012 . . . . 0.0 111.797 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.77 155.06 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.055 0.542 . . . . 0.0 111.355 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.16 141.76 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -133.87 87.41 35.49 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.457 0.703 . . . . 0.0 110.027 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.43 -12.71 36.73 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.944 2.429 . . . . 0.0 111.419 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.41 -23.85 65.6 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.894 0.478 . . . . 0.0 111.046 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.91 4.69 12.88 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.537 0.735 . . . . 0.0 112.258 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 tpp85 56.5 45.74 21.89 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.412 0.685 . . . . 0.0 110.473 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -140.5 165.59 27.03 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.892 0.877 . . . . 0.0 111.363 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.57 158.18 40.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.232 0.613 . . . . 0.0 110.647 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.06 149.88 50.19 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -143.41 139.82 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -121.74 140.91 51.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.83 0.452 . . . . 0.0 110.397 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -103.1 154.81 18.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -71.73 -13.54 61.75 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.665 0.211 . . . . 0.0 110.557 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -141.61 143.16 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.273 1.429 . . . . 0.0 113.553 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.07 -21.97 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.702 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -69.37 -35.34 75.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.748 0.419 . . . . 0.0 110.66 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.12 -38.92 59.16 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.43 83.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 109.996 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.9 t -70.39 -34.84 73.03 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.87 0.468 . . . . 0.0 110.867 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -66.3 -33.99 76.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.013 0.37 . . . . 0.0 110.928 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.32 69.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.545 0.157 . . . . 0.0 111.301 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.0 t -81.38 -33.56 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.941 0.337 . . . . 0.0 110.984 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.3 -30.64 67.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.253 -0.28 . . . . 0.0 110.741 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.83 -33.03 46.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.33 71.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.027 0.531 . . . . 0.0 110.795 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.26 4.5 3.6 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.442 0.697 . . . . 0.0 112.151 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.63 -27.8 1.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -155.74 155.58 33.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -76.73 135.63 39.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.635 0.255 . . . . 0.0 110.357 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.11 135.16 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 11.2 m-85 -85.85 130.46 34.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.4 mm -128.82 126.3 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.43 34.45 6.68 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.96 0.504 . . . . 0.0 112.048 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.63 9.62 80.97 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.053 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -136.09 148.94 66.76 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 118.558 1.179 . . . . 0.0 111.809 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.06 149.43 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.594 2.863 . . . . 0.0 111.718 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 170.92 19.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.282 1.033 . . . . 0.0 109.914 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -114.17 158.2 21.63 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.61 142.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.583 0.753 . . . . 0.0 109.969 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -155.55 167.64 29.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.72 147.82 51.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.392 -0.817 . . . . 0.0 110.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -77.09 152.46 35.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.225 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -71.03 -2.77 16.55 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 72.8 m -127.85 155.18 44.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.183 0.993 . . . . 0.0 109.642 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -83.92 -4.99 59.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.84 156.79 25.65 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.624 0.647 . . . . 0.0 111.516 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.6 mt -90.4 141.16 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 46.7 t -67.88 116.8 8.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.401 ' H ' ' HB2' ' A' ' 179' ' ' ASP . 68.0 mmt-85 -76.5 164.09 61.86 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.56 -1.28 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.169 3.246 . . . . 0.0 113.602 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -154.96 21.85 0.59 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.461 0.553 . . . . 0.0 112.021 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.401 ' HB2' ' H ' ' A' ' 176' ' ' ARG . 11.1 t0 -60.51 -29.89 69.38 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.5 m 56.62 -177.18 0.05 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.415 1.086 . . . . 0.0 113.054 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -158.28 177.3 11.43 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.21 0.9 1.76 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 44.7 t -153.07 -16.69 0.15 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -72.12 141.71 49.16 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 118.377 0.535 . . . . 0.0 109.918 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.4 t -72.92 146.49 46.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.301 0.24 . . . . 0.0 111.047 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.56 -18.56 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -87.84 1.72 53.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.236 0.615 . . . . 0.0 111.468 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.505 -1.236 . . . . 0.0 110.991 179.873 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 C5'-C4'-C3' 109.632 -3.912 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.97 1 O4'-C1'-N19 112.909 4.709 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 1 C5'-C4'-C3' 108.649 -4.567 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.58 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 C5'-C4'-C3' 109.271 -4.153 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.633 0 O4'-C1'-N19 111.697 3.497 . 0.201 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.814 0 C5'-C4'-C3' 110.405 -3.396 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.091 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -71.9 -9.61 58.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.983 0.391 . . . . 0.0 111.041 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -138.95 164.62 29.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.687 1.195 . . . . 0.0 109.11 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.252 11.9 t80 -61.86 147.33 46.93 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -147.04 153.65 40.26 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -66.71 144.82 98.79 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.81 -9.97 22.86 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.772 2.981 . . . . 0.0 111.67 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -76.38 -12.5 60.07 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.878 0.471 . . . . 0.0 111.574 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.67 135.13 46.74 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.433 0.293 . . . . 0.0 110.581 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -85.08 148.15 49.7 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.42 158.47 48.04 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.722 2.948 . . . . 0.0 110.931 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.94 150.27 45.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.905 0.383 . . . . 0.0 111.331 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 t -161.59 148.47 11.48 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.296 0.638 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.87 -7.68 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.1 2.533 . . . . 0.0 110.037 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.0 t -106.08 141.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.121 0.969 . . . . 0.0 110.569 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.95 142.44 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 121.802 0.811 . . . . 0.0 112.242 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -99.68 137.67 37.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.857 1.663 . . . . 0.0 110.383 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.53 140.54 36.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.63 0.772 . . . . 0.0 109.782 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -143.26 153.03 42.38 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.734 0.414 . . . . 0.0 110.491 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.49 6.13 89.47 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.65 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.33 170.07 12.56 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.584 0.692 . . . . 0.0 110.854 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -93.39 153.93 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.996 0.518 . . . . 0.0 110.328 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.12 -22.29 65.81 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.57 -10.72 82.86 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.616 0.626 . . . . 0.0 112.486 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.3 147.83 10.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.53 168.14 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.974 0.91 . . . . 0.0 109.866 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.3 -32.74 68.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.169 -0.332 . . . . 0.0 111.369 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.41 72.13 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.152 0.181 . . . . 0.0 111.125 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.18 -31.46 62.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.24 -42.85 68.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.053 0.141 . . . . 0.0 110.776 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.93 -34.58 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -75.44 -22.89 56.97 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.137 -0.352 . . . . 0.0 111.256 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.66 -17.07 27.47 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -120.68 -8.45 9.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.11 -21.84 66.37 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.083 0.856 . . . . 0.0 110.979 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.48 -11.27 60.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.48 0.312 . . . . 0.0 111.584 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.72 -14.94 25.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.29 23.97 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.35 125.86 13.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.067 2.512 . . . . 0.0 110.678 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -93.31 142.67 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.875 0.47 . . . . 0.0 110.197 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.2 t -101.51 -34.2 9.64 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.06 0.544 . . . . 0.0 111.491 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -167.18 160.73 14.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.91 150.73 19.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.61 1.164 . . . . 0.0 111.929 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.09 155.8 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.108 0.563 . . . . 0.0 111.412 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.05 141.93 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.103 0.561 . . . . 0.0 112.363 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.77 79.32 72.08 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.837 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.61 -25.95 77.05 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.0 113.755 -175.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -12.0 61.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.408 0.549 . . . . 0.0 111.277 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -116.76 2.89 12.95 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.523 0.729 . . . . 0.0 112.327 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 58.77 38.97 24.68 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.259 0.624 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -140.81 167.28 22.55 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 112.114 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.18 40.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.286 0.634 . . . . 0.0 111.089 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.52 152.14 47.97 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -144.77 144.49 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -124.13 138.03 54.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.41 154.12 18.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.43 -15.41 62.34 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.125 -0.359 . . . . 0.0 110.148 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -139.24 142.94 37.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.487 1.515 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.53 -21.77 28.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 120.774 0.321 . . . . 0.0 111.583 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -69.94 -35.25 74.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.107 0.563 . . . . 0.0 110.79 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.9 -37.9 56.5 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 109.86 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.9 t -69.9 -34.82 74.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.168 0.587 . . . . 0.0 110.832 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.78 -34.54 78.05 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 117.973 0.351 . . . . 0.0 111.182 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.52 0.146 . . . . 0.0 111.38 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.32 -33.77 12.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 O-C-N 122.111 -0.368 . . . . 0.0 110.856 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -69.94 -33.12 71.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.955 -0.466 . . . . 0.0 110.528 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -77.34 -33.0 55.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.24 71.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.359 0.663 . . . . 0.0 111.188 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.01 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.545 0.338 . . . . 0.0 111.865 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.7 -23.58 10.98 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.99 155.34 25.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.28 0.632 . . . . 0.0 109.467 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -76.79 133.98 39.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.14 134.49 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.285 10.9 m-85 -84.7 129.83 34.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.3 mm -129.02 126.12 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.737 1.215 . . . . 0.0 107.898 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.31 34.42 6.33 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.058 0.543 . . . . 0.0 112.3 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.48 79.86 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.231 -0.76 . . . . 0.0 114.35 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.3 149.05 66.7 Favored Pre-proline 0 CA--C 1.528 0.125 0 CA-C-N 118.481 1.14 . . . . 0.0 111.767 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.64 151.05 85.74 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.491 2.794 . . . . 0.0 111.881 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 173.41 15.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.329 1.052 . . . . 0.0 109.889 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.32 156.98 27.95 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.3 144.89 25.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.582 0.753 . . . . 0.0 110.841 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -155.02 168.91 25.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.72 148.6 50.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.403 -0.811 . . . . 0.0 110.501 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.3 t -78.05 154.75 31.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 111.021 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.4 t -71.98 -2.62 18.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -130.68 149.25 52.42 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.01 0.924 . . . . 0.0 110.051 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -83.59 -2.73 56.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.981 0.512 . . . . 0.0 111.615 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -149.25 150.57 32.79 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.063 0.545 . . . . 0.0 112.008 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.465 HG23 ' H ' ' A' ' 176' ' ' ARG . 48.4 mt -100.51 155.29 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.6 t -63.58 -30.82 71.88 Favored 'General case' 0 C--O 1.23 0.048 0 O-C-N 121.711 -0.618 . . . . 0.0 112.177 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.465 ' H ' HG23 ' A' ' 174' ' ' ILE . 74.7 mtm-85 42.64 66.31 4.41 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 124.565 1.146 . . . . 0.0 112.358 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.26 -15.7 50.96 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.708 2.272 . . . . 0.0 111.38 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.49 -3.6 81.17 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.462 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.4 -8.67 58.07 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 32.9 t 51.87 52.23 14.93 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.12 0.968 . . . . 0.0 112.113 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -58.36 163.06 3.24 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -66.42 -7.9 22.39 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 97.9 p -102.84 -11.3 18.39 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.424 0.689 . . . . 0.0 111.235 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.7 -8.89 25.4 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.131 0.572 . . . . 0.0 111.39 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 37.0 t -156.67 164.06 38.58 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.918 0.487 . . . . 0.0 110.339 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.264 1.0 OUTLIER 59.29 5.25 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -178.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -145.9 7.56 1.08 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.621 0.769 . . . . 0.0 111.803 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.649 -1.167 . . . . 0.0 110.821 -178.833 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 C5'-C4'-C3' 109.812 -3.792 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . 0.401 H5'' ' C8 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.62 1 O4'-C1'-N19 112.622 4.422 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.06 0 C5'-C4'-C3' 111.79 -2.473 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.522 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.932 1 C5'-C4'-C3' 108.982 -4.345 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 1 C5'-C4'-C3' 108.275 -4.816 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 O4'-C1'-N19 111.587 3.387 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.189 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -151.27 158.33 43.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.904 0.481 . . . . 0.0 110.03 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -152.64 37.62 0.52 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.65 0.38 . . . . 0.0 109.988 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.261 10.7 t80 -138.65 141.21 39.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -120.58 144.43 48.11 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -137.81 168.28 16.95 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 174.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.74 -3.06 11.9 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.631 2.221 . . . . 0.0 113.273 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -102.26 -10.37 19.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.302 0.501 . . . . 0.0 111.429 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -72.23 152.88 41.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.723 0.809 . . . . 0.0 110.971 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -72.75 149.72 90.55 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.07 153.89 46.97 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.675 2.917 . . . . 0.0 110.26 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.18 146.01 52.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.0 m -153.53 152.43 27.36 Favored Pre-proline 0 CA--C 1.528 0.13 0 C-N-CA 123.234 0.614 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.47 3.59 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.928 3.085 . . . . 0.0 110.646 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.91 148.38 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.72 146.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 121.659 0.743 . . . . 0.0 110.672 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -101.37 137.48 39.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.093 1.757 . . . . 0.0 110.562 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.5 mt -114.75 140.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.174 0.99 . . . . 0.0 109.651 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -147.29 152.82 38.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.328 0.651 . . . . 0.0 110.233 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.28 78.65 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.932 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.27 176.79 6.34 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.081 0.94 . . . . 0.0 111.271 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.447 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -110.2 154.4 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 123.194 0.598 . . . . 0.0 109.522 177.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -69.43 -4.47 18.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.447 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -76.75 -10.86 85.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.02 148.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.57 168.42 24.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 123.984 0.914 . . . . 0.0 109.533 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.75 -32.67 69.47 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.158 -0.339 . . . . 0.0 111.496 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -31.42 72.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.329 0.252 . . . . 0.0 111.123 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.1 -30.59 60.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -72.27 -42.18 65.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.51 -34.61 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -75.19 -23.98 57.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.125 -0.359 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.35 -17.05 31.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.4 mt -123.77 -9.14 7.84 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.96 -21.79 66.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.258 0.936 . . . . 0.0 110.632 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -11.74 61.12 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.154 -0.342 . . . . 0.0 111.389 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -92.26 -15.08 27.94 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.13 173.47 24.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.42 127.18 15.27 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.426 2.75 . . . . 0.0 110.621 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.1 mt -93.56 140.96 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.843 0.457 . . . . 0.0 110.327 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.3 t -102.12 -34.09 9.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.729 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -163.48 161.48 24.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.5 t -145.66 145.27 20.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.009 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.63 153.42 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.168 0.587 . . . . 0.0 111.206 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.28 141.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.261 0.624 . . . . 0.0 111.495 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.11 89.55 23.55 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.736 0.414 . . . . 0.0 110.435 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -6.55 17.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.885 2.39 . . . . 0.0 110.809 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -64.03 -34.41 77.95 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.387 0.675 . . . . 0.0 110.313 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -117.0 7.25 13.09 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.884 0.874 . . . . 0.0 112.471 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 57.73 52.96 7.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.398 0.679 . . . . 0.0 110.76 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -144.69 169.59 17.72 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.471 0.709 . . . . 0.0 111.57 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.62 158.32 40.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.444 0.698 . . . . 0.0 110.324 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.0 152.29 51.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.015 0.435 . . . . 0.0 110.463 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.9 t -143.57 140.58 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -122.39 138.08 54.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -99.09 154.8 17.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -72.33 -14.2 61.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.872 0.305 . . . . 0.0 110.236 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -139.06 143.23 38.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.051 1.34 . . . . 0.0 113.142 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.21 -23.05 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.695 0.283 . . . . 0.0 111.282 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.6 tp -68.05 -35.53 78.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.766 0.427 . . . . 0.0 110.432 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.27 -37.36 59.36 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.55 88.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 96.7 m -70.96 -30.12 66.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -67.62 -35.63 79.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.174 0.443 . . . . 0.0 110.892 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.61 76.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 121.299 -0.16 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 -33.48 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.705 0.23 . . . . 0.0 111.492 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.8 -31.68 70.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.992 0.36 . . . . 0.0 110.651 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -75.05 -32.87 61.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.24 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.34 0.656 . . . . 0.0 111.025 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.44 5.5 1.76 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 112.333 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -135.93 -29.52 1.02 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -156.64 153.54 28.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.77 140.53 40.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.8 135.18 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.288 10.1 m-85 -84.87 129.5 34.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.4 mm -126.25 121.55 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.464 1.106 . . . . 0.0 108.359 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.33 33.96 2.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.67 0.788 . . . . 0.0 112.172 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 89.58 12.26 62.94 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.34 0.495 . . . . 0.0 112.738 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -136.22 139.4 29.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.552 0.741 . . . . 0.0 110.516 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.37 143.57 58.58 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.335 2.69 . . . . 0.0 112.183 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.74 174.41 12.21 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.521 0.729 . . . . 0.0 110.111 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -120.14 158.77 26.22 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.28 148.71 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.648 0.779 . . . . 0.0 111.03 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -155.2 170.07 22.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -68.6 145.2 54.16 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.544 -0.722 . . . . 0.0 109.489 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.4 t -74.67 154.29 38.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.34 -2.78 17.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.2 t -129.07 156.2 44.23 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.213 1.005 . . . . 0.0 110.018 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -84.91 -6.51 59.34 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -161.03 156.58 24.87 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.742 0.701 . . . . 0.0 111.734 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 45.6 mt -93.97 143.51 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.1 t -67.37 122.59 18.25 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 122.126 -0.359 . . . . 0.0 110.881 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -81.51 156.47 70.87 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 123.127 0.571 . . . . 0.0 110.244 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.3 -16.38 31.36 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.954 2.436 . . . . 0.0 110.716 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.42 135.04 1.84 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -106.57 -1.79 22.56 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 74.3 m -149.08 157.14 43.16 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.443 0.697 . . . . 0.0 110.968 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.14 101.9 2.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 51.52 24.01 2.09 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 69.0 m 53.34 33.09 14.93 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.82 0.448 . . . . 0.0 110.874 -174.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -78.22 154.13 31.32 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.115 0.966 . . . . 0.0 111.512 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.3 m 52.85 38.42 26.68 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.14 -14.65 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -151.37 24.28 0.71 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.823 0.449 . . . . 0.0 110.557 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.247 0.948 0 CA-C-O 117.347 -1.311 . . . . 0.0 110.656 -179.066 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C5'-C4'-C3' 109.672 -3.885 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.853 0 O4'-C1'-N19 111.657 3.457 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 1 C5'-C4'-C3' 108.825 -4.45 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.581 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.711 1 C5'-C4'-C3' 108.395 -4.737 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O4'-C1'-N19 111.006 2.806 . 0.19 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.912 0 C5'-C4'-C3' 110.436 -3.376 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 87' ' ' TYR . 42.7 tp10 -69.59 150.45 47.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.573 0.349 . . . . 0.0 110.337 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -74.81 4.67 6.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.13 0.572 . . . . 0.0 111.722 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 16.4 t80 -143.35 151.01 39.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -157.04 166.03 34.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -136.91 157.36 74.91 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -61.92 -13.54 31.66 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.725 2.95 . . . . 0.0 113.072 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.14 -9.37 59.14 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.081 0.552 . . . . 0.0 112.274 -177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -71.48 145.08 49.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.774 0.43 . . . . 0.0 110.835 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.82 148.05 36.29 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.57 145.49 42.13 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.3 2.667 . . . . 0.0 110.795 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.12 141.31 57.47 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.6 m -155.64 156.27 30.55 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.269 1.028 . . . . 0.0 109.799 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.68 0.14 8.59 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.828 3.019 . . . . 0.0 110.917 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.05 145.6 33.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.67 147.26 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.451 0.643 . . . . 0.0 111.647 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -105.86 137.52 43.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.316 1.846 . . . . 0.0 110.046 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.43 140.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 124.234 1.014 . . . . 0.0 109.749 -174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -142.75 153.68 43.53 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.193 0.597 . . . . 0.0 110.159 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.07 0.12 81.18 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.694 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -74.12 173.5 10.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 110.818 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.532 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -110.23 157.34 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-O 121.359 0.599 . . . . 0.0 109.599 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -68.87 -5.18 19.59 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.532 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.4 -10.76 86.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 176.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 p -65.31 146.72 13.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.67 169.39 22.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 124.383 1.073 . . . . 0.0 109.8 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.15 -32.71 70.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.176 -0.328 . . . . 0.0 111.516 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.57 -31.31 71.29 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.479 0.312 . . . . 0.0 111.045 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -74.1 -31.42 62.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.01 -43.6 71.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.47 -34.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.27 -22.98 57.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.972 0.351 . . . . 0.0 111.435 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.26 26.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.8 mt -122.44 -7.58 8.66 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.55 -21.83 66.15 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.278 0.944 . . . . 0.0 110.725 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.27 -10.6 59.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.507 0.323 . . . . 0.0 111.441 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.09 -14.34 27.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.21 175.05 24.19 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.53 125.2 12.47 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.498 2.799 . . . . 0.0 110.496 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -93.47 141.62 14.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.877 0.471 . . . . 0.0 110.391 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 t -101.18 -34.15 9.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.466 0.706 . . . . 0.0 111.76 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -167.21 160.46 13.72 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.15 150.31 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.165 0.986 . . . . 0.0 111.822 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.59 156.57 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.086 0.554 . . . . 0.0 111.683 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.6 141.84 38.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.99 78.42 65.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 122.863 0.465 . . . . 0.0 110.813 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.64 -16.31 42.42 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.437 2.758 . . . . 0.0 111.566 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -64.39 -28.22 69.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 111.319 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -116.88 5.03 12.93 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.124 0.57 . . . . 0.0 111.933 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 56.77 51.75 10.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.72 0.808 . . . . 0.0 110.743 -176.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -145.06 171.27 14.71 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.901 0.88 . . . . 0.0 110.671 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.56 158.12 40.76 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.992 0.517 . . . . 0.0 110.521 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -129.86 152.05 49.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.152 0.501 . . . . 0.0 110.056 176.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.38 142.03 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -122.29 139.1 54.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -102.32 155.98 17.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -71.58 -11.4 60.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.75 0.25 . . . . 0.0 110.622 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -143.52 145.59 32.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.646 1.578 . . . . 0.0 112.843 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.08 -24.99 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.0 tp -65.05 -36.31 83.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.204 -0.31 . . . . 0.0 110.896 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.61 -37.3 61.94 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.68 89.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 93.5 m -68.95 -32.35 71.87 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.491 0.316 . . . . 0.0 111.614 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.49 -32.98 74.18 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.901 0.318 . . . . 0.0 111.196 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.94 67.47 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.374 -0.204 . . . . 0.0 111.239 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.5 t -81.45 -37.78 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.968 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -74.43 -19.24 60.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.895 0.77 . . . . 0.0 111.396 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -81.08 -33.02 33.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.17 70.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.163 0.585 . . . . 0.0 110.969 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.95 -9.17 19.35 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -140.87 -0.31 1.51 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -159.02 149.06 19.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.76 138.39 39.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.8 mt -91.54 133.63 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.297 16.9 m-85 -84.84 130.87 34.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.3 mm -128.96 124.54 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.496 1.118 . . . . 0.0 108.228 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.12 34.55 5.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.237 0.615 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.75 74.3 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.86 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -135.76 148.95 67.46 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 118.38 1.09 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -67.47 150.68 80.52 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.54 2.827 . . . . 0.0 111.504 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 174.96 13.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.168 0.987 . . . . 0.0 109.925 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -128.02 157.15 41.42 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.6 t -141.94 139.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -148.21 167.84 24.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.517 1.527 . . . . 0.0 108.431 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -68.89 151.59 46.37 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.7 t -81.9 158.0 24.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.883 0.473 . . . . 0.0 110.842 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -9.29 55.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -108.14 161.67 14.76 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.756 0.822 . . . . 0.0 110.173 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -94.12 -5.5 47.11 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -163.1 156.49 19.56 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.376 0.534 . . . . 0.0 111.325 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 72.9 mt -88.32 140.37 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.6 m -75.56 89.76 2.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.49 0.316 . . . . 0.0 110.975 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -69.21 154.0 95.41 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.83 -18.64 52.94 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.934 2.423 . . . . 0.0 110.944 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.67 -8.43 62.24 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.462 178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -79.43 0.87 27.62 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 40.4 t -69.28 146.05 52.58 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.694 0.398 . . . . 0.0 111.23 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -73.32 -7.54 52.0 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -69.98 -9.91 56.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.2 t -72.69 -14.32 61.55 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.183 0.593 . . . . 0.0 111.09 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 40.0 ttm105 -59.12 128.25 36.26 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.147 0.579 . . . . 0.0 110.38 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.5 m 52.3 11.24 0.16 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.24 1.016 . . . . 0.0 113.369 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.269 0.9 OUTLIER 56.82 14.4 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -154.83 8.19 0.3 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.252 1.203 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.781 179.606 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 0 O4'-C1'-N19 110.736 2.536 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 1 O4'-C1'-N19 113.432 5.232 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.458 1 C5'-C4'-C3' 108.131 -4.913 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.589 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.631 1 C5'-C4'-C3' 108.658 -4.562 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.626 0 O4'-C1'-N19 111.165 2.965 . 0.156 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 C5'-C4'-C3' 110.755 -3.163 . 0.29 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.021 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.75 -11.35 60.77 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.889 0.476 . . . . 0.0 111.444 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -75.88 -4.54 41.43 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.132 0.573 . . . . 0.0 112.148 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -68.43 140.96 55.79 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -120.98 146.09 47.05 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -69.42 124.52 90.66 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.2 -16.64 40.05 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.945 2.43 . . . . 0.0 112.493 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -92.09 0.92 57.47 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.961 0.504 . . . . 0.0 111.546 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.39 135.95 49.21 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.231 -0.293 . . . . 0.0 111.224 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -132.49 154.66 81.62 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.487 1.115 . . . . 0.0 112.732 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.06 148.87 82.19 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.663 2.242 . . . . 0.0 110.44 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.68 146.39 53.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.893 0.378 . . . . 0.0 111.587 -176.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.6 m -153.59 153.16 28.65 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 124.146 0.978 . . . . 0.0 109.457 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.26 -0.28 9.86 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 110.727 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.9 p -123.16 145.09 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.48 147.32 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.71 0.767 . . . . 0.0 110.529 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -101.14 137.78 39.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.278 1.831 . . . . 0.0 110.697 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.1 mt -114.62 140.52 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 123.506 0.722 . . . . 0.0 109.741 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -145.9 152.7 39.87 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.458 0.703 . . . . 0.0 110.295 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.82 85.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.644 -0.531 . . . . 0.0 112.608 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.08 175.16 4.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.65 0.725 . . . . 0.0 110.687 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.571 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.44 160.93 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 CA-C-O 121.366 0.603 . . . . 0.0 110.089 -178.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -66.77 -9.58 38.35 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.571 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.33 -10.98 85.78 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.032 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.4 p -63.97 145.05 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 m -132.73 166.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.138 0.975 . . . . 0.0 109.557 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.96 -32.82 69.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.254 -0.279 . . . . 0.0 111.145 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.39 71.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.381 0.272 . . . . 0.0 111.172 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.18 -29.06 62.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.28 -44.26 68.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.5 -34.72 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.76 -22.37 58.82 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.035 -0.415 . . . . 0.0 111.454 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.45 -17.12 24.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.1 mt -121.68 -7.45 9.08 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.85 -21.79 66.49 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -70.24 -11.54 60.97 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.659 -0.21 . . . . 0.0 111.475 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -92.27 -14.48 28.83 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.73 173.37 22.78 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.29 129.06 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.612 2.874 . . . . 0.0 110.468 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.29 141.57 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.202 0.601 . . . . 0.0 110.712 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.2 t -101.14 -34.12 9.83 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.457 0.703 . . . . 0.0 112.205 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -166.53 158.27 13.3 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.52 148.97 20.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.046 0.938 . . . . 0.0 112.083 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.23 156.34 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.282 0.633 . . . . 0.0 111.181 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.14 141.74 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -131.05 82.02 64.92 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 123.215 0.606 . . . . 0.0 110.078 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.39 -8.67 21.36 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.223 2.615 . . . . 0.0 110.39 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.23 -29.73 69.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.882 0.873 . . . . 0.0 110.579 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -116.99 5.29 12.84 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.895 0.878 . . . . 0.0 113.09 176.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 58.17 48.64 12.53 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.449 0.7 . . . . 0.0 110.891 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -144.81 170.39 16.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.504 0.722 . . . . 0.0 111.488 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.34 40.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.287 0.635 . . . . 0.0 110.67 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.33 151.93 51.06 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.949 0.404 . . . . 0.0 110.166 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.94 144.01 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -126.02 137.7 53.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.557 0.343 . . . . 0.0 110.193 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.34 156.4 16.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -72.04 -14.05 61.77 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.221 -0.299 . . . . 0.0 110.224 175.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -139.79 143.12 36.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.251 1.42 . . . . 0.0 113.3 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.04 -21.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 111.565 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.4 tp -69.27 -36.29 76.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.941 0.496 . . . . 0.0 110.682 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -37.7 57.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.22 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.53 -33.03 70.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.445 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.84 -33.82 76.45 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.062 -0.399 . . . . 0.0 110.851 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.82 70.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.488 0.131 . . . . 0.0 111.2 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.43 -35.15 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 122.198 -0.314 . . . . 0.0 111.441 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -70.76 -28.42 64.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.054 0.388 . . . . 0.0 111.688 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -76.4 -33.1 58.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.52 71.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.07 0.548 . . . . 0.0 110.662 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.59 3.42 6.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.352 0.661 . . . . 0.0 112.117 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -132.26 -29.64 1.59 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -154.25 149.22 26.75 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.95 132.87 39.27 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.169 -0.332 . . . . 0.0 110.255 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.4 mt -81.18 145.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 C-N-CA 122.68 0.392 . . . . 0.0 110.079 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.252 19.9 m-85 -100.05 132.25 45.53 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 175.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.9 mm -128.97 126.99 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.57 34.39 6.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.176 0.59 . . . . 0.0 112.406 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.04 79.21 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.731 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -136.14 148.88 66.42 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 118.439 1.119 . . . . 0.0 111.529 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.5 143.56 69.64 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.717 2.945 . . . . 0.0 111.285 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.15 26.72 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.852 0.861 . . . . 0.0 110.456 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -112.2 159.21 18.79 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.6 t -141.11 142.5 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.688 0.795 . . . . 0.0 110.964 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -156.31 166.34 33.73 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -68.85 150.91 47.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.5 t -82.8 158.64 22.7 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.128 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.15 -2.68 10.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.3 t -124.04 160.42 27.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.085 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -89.39 -5.56 57.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -162.39 154.19 18.53 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.542 0.61 . . . . 0.0 111.188 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.56 143.83 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.2 t -67.29 -29.6 69.23 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 57.05 175.06 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.532 0.733 . . . . 0.0 111.745 -176.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -60.5 -21.38 68.06 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.917 1.744 . . . . 0.0 110.291 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.61 123.95 0.91 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 108.429 -1.869 . . . . 0.0 108.429 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -83.23 -6.28 59.42 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.9 m -64.37 117.22 6.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 53.61 19.83 1.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.6 t0 58.09 94.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 65.6 m 55.73 21.3 4.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.275 1.03 . . . . 0.0 113.629 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -78.71 -15.97 57.81 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.017 -0.427 . . . . 0.0 111.337 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 58.4 m -149.73 -179.96 7.53 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.731 0.812 . . . . 0.0 110.807 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.262 1.4 t 62.34 24.38 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.1 p30 -149.06 13.13 0.87 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.812 0.445 . . . . 0.0 111.656 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.325 -1.322 . . . . 0.0 111.08 -179.732 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.727 0 C5'-C4'-C3' 109.56 -3.96 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 O4'-C1'-N19 111.699 3.499 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.447 1 C5'-C4'-C3' 109.12 -4.253 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.574 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.96 1 C5'-C4'-C3' 108.618 -4.588 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 1 C5'-C4'-C3' 108.503 -4.664 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 110.912 2.712 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.155 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -153.46 148.0 26.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.517 0.727 . . . . 0.0 109.972 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 58.19 176.26 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.337 1.055 . . . . 0.0 112.572 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -146.32 154.14 41.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -153.94 158.05 40.09 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -63.52 147.42 95.45 Favored Pre-proline 0 CA--C 1.529 0.146 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.17 -13.59 28.49 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.279 2.653 . . . . 0.0 111.291 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -78.15 -7.34 56.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.166 0.586 . . . . 0.0 111.673 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -68.47 151.4 46.86 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.97 0.508 . . . . 0.0 110.351 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.83 148.32 61.99 Favored Pre-proline 0 C--O 1.232 0.154 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.83 158.87 46.09 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.583 2.855 . . . . 0.0 110.746 -178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.63 148.4 51.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.573 0.349 . . . . 0.0 111.366 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -152.83 152.32 28.17 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 109.657 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.97 -3.7 14.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.399 2.732 . . . . 0.0 110.458 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.63 149.48 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.991 0.916 . . . . 0.0 112.246 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 m -132.71 148.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.56 0.695 . . . . 0.0 112.043 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.068 1.747 . . . . 0.0 109.77 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.34 140.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.228 1.011 . . . . 0.0 109.575 -174.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -143.01 152.71 42.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.89 0.476 . . . . 0.0 111.063 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.02 5.01 71.22 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.659 -0.523 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -82.76 -175.78 5.96 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.964 0.882 . . . . 0.0 109.58 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.515 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -122.02 158.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.82 -3.52 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.515 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -79.42 -10.96 85.4 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.99 148.63 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.56 168.77 23.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.255 1.022 . . . . 0.0 110.258 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.8 -33.0 68.1 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.241 -0.287 . . . . 0.0 111.176 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.55 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 -33.83 66.62 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.54 -39.86 64.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.935 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.54 -34.35 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -75.39 -25.66 57.8 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.019 -0.426 . . . . 0.0 111.187 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.06 -17.13 33.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.76 -9.47 8.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.44 -21.91 66.21 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.208 0.913 . . . . 0.0 110.974 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.55 -11.49 60.96 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.422 -0.174 . . . . 0.0 111.372 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.47 -16.15 26.19 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.5 172.33 23.72 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.86 126.41 14.56 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.58 2.853 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.99 142.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.183 0.593 . . . . 0.0 110.331 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -106.24 -34.15 7.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.661 0.784 . . . . 0.0 111.764 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -162.75 161.42 26.25 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -146.75 144.04 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.918 0.887 . . . . 0.0 109.389 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.71 150.8 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.19 0.596 . . . . 0.0 111.774 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.45 141.74 45.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -131.65 76.48 74.69 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.544 0.737 . . . . 0.0 109.493 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.22 -12.5 35.08 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.217 2.611 . . . . 0.0 111.156 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -67.38 -23.11 65.54 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.487 0.715 . . . . 0.0 111.138 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.91 6.82 13.11 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.363 0.665 . . . . 0.0 112.756 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.45 43.46 28.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.364 0.529 . . . . 0.0 111.326 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -139.62 163.9 31.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.207 0.603 . . . . 0.0 111.096 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.65 158.22 40.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.103 0.561 . . . . 0.0 110.066 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.9 mp -124.33 149.26 46.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.6 t -141.88 143.47 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -121.76 135.03 54.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.296 0.638 . . . . 0.0 109.897 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -99.81 154.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -72.07 -13.42 61.58 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.199 -0.313 . . . . 0.0 110.17 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -142.24 143.1 32.71 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.341 1.456 . . . . 0.0 113.57 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.8 p -63.42 -21.9 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.15 -34.8 75.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.945 0.498 . . . . 0.0 110.733 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -38.99 55.83 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.22 -37.61 87.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.092 0.472 . . . . 0.0 109.857 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.08 -36.7 77.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.373 0.669 . . . . 0.0 110.613 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -65.05 -33.67 76.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.107 -0.371 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.01 -38.7 72.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.675 0.216 . . . . 0.0 110.977 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.2 t -75.81 -33.43 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 122.201 -0.312 . . . . 0.0 111.079 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.84 -26.6 64.3 Favored 'General case' 0 C--O 1.231 0.096 0 O-C-N 122.002 -0.436 . . . . 0.0 111.641 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -77.38 -33.06 55.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.2 71.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.036 0.535 . . . . 0.0 110.81 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.88 3.14 2.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.538 0.735 . . . . 0.0 112.244 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -133.8 -28.91 1.36 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -157.53 152.41 25.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.84 139.36 40.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.7 mt -83.31 135.08 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 20.4 m-85 -89.01 129.62 35.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.3 mm -129.14 123.57 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.528 1.131 . . . . 0.0 108.773 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.41 34.55 6.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.6 74.74 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.837 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -135.78 148.8 66.78 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 118.248 1.024 . . . . 0.0 111.192 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.92 150.35 78.17 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 0.0 111.189 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 175.09 13.26 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 110.115 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -130.12 162.21 29.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.04 148.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 123.388 0.675 . . . . 0.0 111.356 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -155.2 166.85 32.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -68.82 145.78 53.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.5 t -75.33 155.59 36.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.9 t -71.54 -2.59 17.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.494 0.717 . . . . 0.0 112.78 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 43.5 t -127.36 154.55 44.84 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.602 0.761 . . . . 0.0 110.332 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -87.1 -0.34 56.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.37 158.87 33.06 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.275 0.489 . . . . 0.0 111.288 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.5 mt -104.61 139.08 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.2 t -72.25 143.87 48.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.419 0.288 . . . . 0.0 111.293 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 14.1 ptt-85 -155.24 149.28 19.24 Favored Pre-proline 0 CA--C 1.529 0.149 0 C-N-CA 123.663 0.785 . . . . 0.0 109.849 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.77 -12.92 33.86 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.056 3.171 . . . . 0.0 111.84 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.37 135.83 2.65 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -106.44 4.32 28.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 35.5 t -156.34 156.69 34.38 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.93 0.892 . . . . 0.0 110.74 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -74.56 -3.14 29.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.281 80.3 m-20 58.7 7.56 0.77 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 39.8 t -163.03 -39.41 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -81.42 162.08 23.47 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 89.8 p -68.44 -2.29 8.32 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.188 0.995 . . . . 0.0 112.537 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.265 0.9 OUTLIER 57.94 23.58 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -177.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -140.95 17.95 2.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.966 0.506 . . . . 0.0 110.461 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.25 1.104 0 C-N-CA 124.308 1.043 . . . . 0.0 111.979 -179.045 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 111.838 3.638 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 1 O4'-C1'-N19 113.874 5.674 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.45 1 C5'-C4'-C3' 108.364 -4.757 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.581 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.527 1 C5'-C4'-C3' 108.839 -4.44 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.84 0 O4'-C1'-N19 111.211 3.011 . 0.196 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C5'-C4'-C3' 110.084 -3.611 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.047 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -154.03 149.52 27.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.169 0.588 . . . . 0.0 110.416 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -146.95 11.16 1.05 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.826 0.45 . . . . 0.0 112.159 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -63.49 146.36 53.79 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -163.39 179.49 7.29 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.86 153.97 15.32 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.35 -6.91 14.39 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.552 2.835 . . . . 0.0 112.642 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -75.79 -10.62 59.58 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 122.022 -0.424 . . . . 0.0 111.13 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -76.82 136.21 38.93 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.969 0.507 . . . . 0.0 111.141 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 94' ' ' PRO . 1.1 p -132.62 154.82 81.64 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 124.457 1.103 . . . . 0.0 113.256 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 67.6 Cg_endo -68.11 151.4 77.29 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.886 2.391 . . . . 0.0 111.247 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.14 148.45 51.81 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 111.778 -176.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.2 t -163.66 150.57 10.34 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.0 109.699 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.9 -10.47 27.72 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.755 2.304 . . . . 0.0 109.805 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.9 t -99.17 141.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.628 0.771 . . . . 0.0 111.36 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.11 141.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.952 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -99.23 137.5 37.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 110.43 -176.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -114.85 140.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.827 0.851 . . . . 0.0 109.73 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -144.57 148.98 35.06 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 123.11 0.564 . . . . 0.0 111.031 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.63 75.63 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.973 -0.349 . . . . 0.0 112.733 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 pp -76.19 178.17 6.63 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.565 0.682 . . . . 0.0 110.129 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.509 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -116.07 157.99 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.062 0.545 . . . . 0.0 109.929 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.87 -17.94 58.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.509 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -71.77 -10.9 72.78 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.681 -0.51 . . . . 0.0 112.606 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.02 146.63 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.9 m -132.67 168.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 C-N-CA 124.154 0.981 . . . . 0.0 110.071 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.42 -32.63 68.85 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.306 -0.246 . . . . 0.0 111.337 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.5 71.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.529 0.331 . . . . 0.0 111.232 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -73.6 -30.57 63.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.24 -42.51 68.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.76 -34.66 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -74.98 -23.11 58.22 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.141 -0.349 . . . . 0.0 111.443 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.1 -17.09 26.76 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.2 mt -121.83 -8.24 8.94 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.93 -21.89 66.46 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 119.367 0.985 . . . . 0.0 110.816 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -69.38 -10.44 57.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.262 -0.274 . . . . 0.0 111.523 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -95.07 -16.09 22.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.63 174.03 25.0 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.22 131.48 23.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.699 2.932 . . . . 0.0 110.779 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.94 142.19 15.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.968 0.507 . . . . 0.0 110.572 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.0 t -103.65 -34.08 8.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 112.094 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -165.84 156.27 13.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.9 149.24 17.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.331 1.053 . . . . 0.0 112.052 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 p -152.05 153.42 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.151 0.58 . . . . 0.0 111.186 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -126.61 141.76 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.043 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -136.12 79.12 44.81 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.247 0.619 . . . . 0.0 109.686 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.22 -4.94 12.6 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.288 2.659 . . . . 0.0 111.352 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.27 -27.62 68.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.268 0.627 . . . . 0.0 110.538 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -116.96 6.15 12.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.891 0.876 . . . . 0.0 112.591 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 55.47 51.38 12.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.405 0.548 . . . . 0.0 110.724 -171.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -142.21 163.88 31.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.71 158.1 40.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.062 0.545 . . . . 0.0 110.618 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.88 143.53 46.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.48 144.1 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -130.24 134.38 47.21 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.779 0.432 . . . . 0.0 110.158 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -93.97 155.1 17.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -71.5 -13.35 61.78 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.029 -0.419 . . . . 0.0 110.431 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -142.08 143.8 33.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.323 1.449 . . . . 0.0 113.216 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.26 -24.86 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 65.9 tp -67.08 -36.31 81.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.477 0.311 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.05 57.88 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.25 89.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.15 -34.95 75.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.382 0.673 . . . . 0.0 110.746 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.73 -34.51 78.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.037 -0.415 . . . . 0.0 110.999 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.1 73.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.642 0.201 . . . . 0.0 110.807 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.0 t -74.62 -33.68 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.193 -0.317 . . . . 0.0 110.791 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.31 -26.29 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.239 0.472 . . . . 0.0 111.606 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -76.24 -32.87 59.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.6 -30.23 69.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.299 0.64 . . . . 0.0 111.076 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.79 1.59 4.2 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.295 0.638 . . . . 0.0 112.17 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -130.11 -31.83 1.86 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -156.5 146.31 20.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.877 0.471 . . . . 0.0 109.735 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.78 134.66 39.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -75.01 145.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 122.878 0.471 . . . . 0.0 110.373 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.265 20.6 m-85 -96.95 131.71 43.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 175.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.6 mm -128.92 124.86 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.465 1.106 . . . . 0.0 108.385 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.77 34.64 5.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 8.28 76.92 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.992 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.1 148.29 64.07 Favored Pre-proline 0 CA--C 1.528 0.111 0 CA-C-N 118.49 1.145 . . . . 0.0 111.306 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.73 141.99 56.48 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.264 2.643 . . . . 0.0 110.964 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 159.04 43.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.31 0.644 . . . . 0.0 110.918 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -91.24 160.06 15.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.39 140.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -156.72 165.62 35.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -68.84 148.18 50.65 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.152 0.887 . . . . 0.0 109.706 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.5 t -83.99 159.95 21.13 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.946 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -71.33 -2.75 17.35 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.4 t -131.41 152.5 50.59 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.022 0.529 . . . . 0.0 110.961 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -83.26 -4.75 58.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.01 147.79 18.39 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.452 0.569 . . . . 0.0 111.472 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.8 mt -86.98 145.09 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.3 t -66.18 121.73 15.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.074 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -83.13 156.7 66.61 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 123.109 0.564 . . . . 0.0 110.379 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -70.25 -14.52 34.64 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.265 2.643 . . . . 0.0 110.122 173.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.39 131.79 1.34 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -106.47 7.97 31.23 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.0 t 56.95 33.91 24.03 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.872 0.869 . . . . 0.0 112.542 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.0 155.09 14.16 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -68.08 93.12 0.42 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.2 m 55.61 13.25 0.95 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -74.69 -25.1 58.93 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.575 0.625 . . . . 0.0 110.716 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.8 m -67.28 148.72 51.33 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.628 0.371 . . . . 0.0 110.451 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.3 t 56.78 12.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -137.01 7.97 2.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.654 0.782 . . . . 0.0 111.875 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.228 -1.367 . . . . 0.0 110.608 -178.343 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.665 0 O4'-C1'-N19 112.003 3.803 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.403 1 O4'-C1'-N19 113.739 5.539 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.726 1 C5'-C4'-C3' 108.822 -4.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' A' . . . . . 0.543 H5'' ' C8 ' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.826 1 C5'-C4'-C3' 109.041 -4.306 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 1 C5'-C4'-C3' 109.139 -4.24 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 0 C5'-C4'-C3' 110.472 -3.352 . 0.199 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.227 0.537 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 t -163.19 148.92 9.7 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.743 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.88 -7.4 21.03 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.802 2.335 . . . . 0.0 109.926 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.33 143.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.092 0.957 . . . . 0.0 110.439 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.46 139.83 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.628 0.728 . . . . 0.0 111.853 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.34 137.37 37.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.935 1.694 . . . . 0.0 109.843 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 63.3 mt -116.29 140.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.393 0.677 . . . . 0.0 109.772 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -145.84 150.9 37.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.051 0.54 . . . . 0.0 110.505 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.12 0.51 77.25 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.879 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.2 pp -70.53 174.69 5.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.13 0.965 . . . . 0.0 111.041 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.539 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.04 157.03 13.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.254 0.622 . . . . 0.0 109.7 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -67.47 -7.31 24.48 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.539 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.25 -11.04 85.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.23 149.47 11.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.66 169.68 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.393 1.077 . . . . 0.0 109.621 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -59.59 -32.84 70.76 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.302 -0.249 . . . . 0.0 111.074 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.43 72.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.611 0.365 . . . . 0.0 111.27 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -74.86 -31.63 61.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.28 -41.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.41 -34.66 58.9 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -74.97 -24.66 58.48 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 117.731 0.242 . . . . 0.0 111.2 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.12 35.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.14 -9.28 8.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.54 -21.99 66.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.328 0.967 . . . . 0.0 110.875 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.03 -12.23 61.41 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.222 -0.299 . . . . 0.0 111.209 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -92.06 -16.75 25.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.48 173.91 27.5 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.76 125.7 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.654 2.903 . . . . 0.0 110.8 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 142.92 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.786 0.434 . . . . 0.0 110.583 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -107.64 -32.35 7.7 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.523 0.729 . . . . 0.0 111.956 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -162.94 160.5 24.88 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.8 143.18 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.886 0.875 . . . . 0.0 109.239 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.11 154.91 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.215 0.606 . . . . 0.0 111.516 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.05 141.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.13 0.572 . . . . 0.0 112.179 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.76 88.76 45.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 123.153 0.581 . . . . 0.0 110.439 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.76 -6.5 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.888 2.392 . . . . 0.0 110.832 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.83 -31.76 71.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.439 0.696 . . . . 0.0 110.608 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -116.94 5.71 12.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.617 0.767 . . . . 0.0 112.584 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 57.95 49.82 11.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.345 0.658 . . . . 0.0 110.544 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -144.13 171.61 14.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.958 0.903 . . . . 0.0 111.283 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.16 40.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.195 0.598 . . . . 0.0 110.368 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.13 149.16 50.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.9 144.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -125.29 138.84 54.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.881 0.472 . . . . 0.0 109.797 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -102.48 155.73 18.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -72.8 -13.8 61.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.212 -0.305 . . . . 0.0 110.356 174.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -143.08 143.34 31.81 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.308 1.443 . . . . 0.0 113.451 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.5 p -62.9 -21.84 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 111.714 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.3 tp -69.81 -35.03 74.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.81 0.444 . . . . 0.0 110.761 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.07 -38.15 48.18 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.21 86.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -70.13 -35.52 74.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.24 -34.83 79.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.949 -0.469 . . . . 0.0 111.141 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.23 -37.43 69.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 121.325 -0.15 . . . . 0.0 111.214 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.31 -33.55 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 O-C-N 122.156 -0.34 . . . . 0.0 110.751 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -70.67 -28.39 64.74 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.17 0.441 . . . . 0.0 111.801 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.33 -33.05 61.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.76 -30.32 69.94 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.64 0.776 . . . . 0.0 111.675 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.12 -16.06 63.57 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -108.9 -27.17 9.85 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -160.06 154.8 24.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.003 0.521 . . . . 0.0 109.823 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.65 141.08 41.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.41 134.87 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.292 10.8 m-85 -84.77 129.08 34.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.9 mm -126.62 120.57 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.483 1.113 . . . . 0.0 108.254 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.17 34.31 2.93 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.811 0.844 . . . . 0.0 112.08 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 90.34 11.17 63.04 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.619 0.628 . . . . 0.0 112.993 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -136.3 139.53 30.07 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.358 0.663 . . . . 0.0 110.452 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.32 144.57 62.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.411 2.74 . . . . 0.0 112.156 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.49 171.86 16.39 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.458 0.703 . . . . 0.0 110.073 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.09 161.16 18.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.24 149.41 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.575 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -68.74 144.21 54.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.836 0.743 . . . . 0.0 109.544 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.3 t -76.39 153.86 35.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.4 -2.76 17.61 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.6 t -127.69 152.93 47.09 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.454 0.702 . . . . 0.0 110.496 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -88.46 -3.75 58.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.196 0.598 . . . . 0.0 112.525 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.38 150.87 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.353 0.524 . . . . 0.0 111.019 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mt . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.928 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -164.85 151.19 9.17 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.291 0.637 . . . . 0.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.46 -7.34 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.724 2.282 . . . . 0.0 110.446 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t -102.36 143.52 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.324 1.05 . . . . 0.0 110.657 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.35 140.92 46.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.713 0.768 . . . . 0.0 111.72 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.28 137.54 37.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.129 1.772 . . . . 0.0 110.058 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.7 mt -117.75 140.7 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.325 0.65 . . . . 0.0 109.554 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -144.49 151.49 39.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.074 0.55 . . . . 0.0 110.176 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.99 0.15 85.77 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.612 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.14 171.36 9.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.588 0.694 . . . . 0.0 110.881 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.21 154.33 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.221 0.608 . . . . 0.0 109.997 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -70.77 -10.98 60.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.76 -10.75 86.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.507 0.575 . . . . 0.0 111.705 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.1 148.72 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 169.85 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 124.273 1.029 . . . . 0.0 109.755 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.23 -32.75 70.25 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.175 -0.328 . . . . 0.0 111.085 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.67 -31.42 72.07 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.303 -0.248 . . . . 0.0 111.043 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.5 -32.09 60.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.13 -43.07 68.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.12 -34.65 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.61 -24.0 58.8 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.11 -0.369 . . . . 0.0 111.178 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.37 -17.11 31.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -123.74 -8.91 7.87 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.88 -21.93 66.49 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.448 1.022 . . . . 0.0 110.751 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.02 -10.43 58.63 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.09 -15.84 24.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.75 174.77 26.9 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.28 123.37 10.5 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.634 2.889 . . . . 0.0 110.92 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.44 141.93 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.021 0.528 . . . . 0.0 110.395 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -101.38 -34.24 9.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.21 0.604 . . . . 0.0 111.734 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -167.21 162.02 14.83 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 151.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 124.131 0.972 . . . . 0.0 111.945 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.6 p -151.13 155.94 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.179 0.592 . . . . 0.0 112.042 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.21 141.95 36.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.221 0.608 . . . . 0.0 112.287 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.91 81.75 57.15 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 123.63 0.772 . . . . 0.0 110.12 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -59.83 -12.48 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.389 2.726 . . . . 0.0 112.371 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -27.58 67.77 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.823 0.449 . . . . 0.0 111.136 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -116.81 5.74 13.09 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.685 0.794 . . . . 0.0 112.028 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 56.68 48.57 16.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.555 0.742 . . . . 0.0 110.285 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.58 168.84 18.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.882 0.873 . . . . 0.0 111.193 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.59 158.25 40.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.483 0.713 . . . . 0.0 110.441 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 mp -131.33 154.12 48.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.893 0.378 . . . . 0.0 110.131 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.2 t -143.33 143.07 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -118.41 130.76 56.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.13 154.5 17.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -72.64 -12.85 61.21 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.185 -0.322 . . . . 0.0 110.487 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -143.89 145.56 32.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 113.413 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.87 -23.37 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.4 tp -67.47 -36.69 81.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.393 0.277 . . . . 0.0 111.055 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.47 60.73 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.47 91.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.16 0.505 . . . . 0.0 109.893 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.7 t -69.34 -35.41 75.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.281 0.633 . . . . 0.0 110.827 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -65.54 -34.29 77.92 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.064 -0.398 . . . . 0.0 110.904 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.57 -33.39 69.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.472 0.124 . . . . 0.0 111.086 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -81.06 -33.7 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 122.12 -0.363 . . . . 0.0 111.158 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.142 0.428 . . . . 0.0 111.265 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -79.06 -33.04 45.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.247 0.619 . . . . 0.0 111.117 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.98 -17.4 63.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.47 0.308 . . . . 0.0 111.703 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -109.1 -24.1 11.33 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -159.94 155.65 25.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.294 0.638 . . . . 0.0 109.301 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.73 136.59 39.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.62 134.03 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.9 m-85 -85.61 131.27 34.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.08 125.31 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 0.0 108.357 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.81 34.58 5.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.3 0.64 . . . . 0.0 112.498 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.39 8.86 77.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.062 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -135.35 148.99 68.43 Favored Pre-proline 0 CA--C 1.527 0.083 0 CA-C-N 118.418 1.109 . . . . 0.0 111.75 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.54 151.68 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.53 2.82 . . . . 0.0 111.713 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.96 174.61 13.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -123.62 156.09 36.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.34 138.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.593 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -148.62 168.71 22.09 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 125.669 1.587 . . . . 0.0 108.621 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.65 149.89 48.59 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.7 t -84.83 156.27 21.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.344 0.658 . . . . 0.0 110.662 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.93 -16.03 62.64 Favored 'General case' 0 C--N 1.335 -0.045 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 84.1 p -92.06 152.77 19.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.255 0.622 . . . . 0.0 109.629 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -97.11 -5.51 37.17 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -161.91 149.02 14.1 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.12 0.568 . . . . 0.0 109.951 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.979 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.945 0.402 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.4 m -156.46 152.41 22.9 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.946 0.898 . . . . 0.0 109.445 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.25 -10.62 22.61 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.063 2.508 . . . . 0.0 109.756 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.96 146.37 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 124.473 1.109 . . . . 0.0 110.789 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.39 139.62 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 121.421 0.629 . . . . 0.0 111.566 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -100.04 137.4 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.762 1.625 . . . . 0.0 110.263 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.7 mt -117.4 140.49 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 110.151 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -144.21 155.51 43.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.287 0.635 . . . . 0.0 110.058 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.18 -1.09 87.62 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.77 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.64 173.44 8.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.679 0.739 . . . . 0.0 110.976 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.6 pt -98.89 153.92 4.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 C-N-CA 123.499 0.72 . . . . 0.0 109.52 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -72.89 -9.69 58.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.57 -10.75 86.04 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.5 149.62 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.69 169.3 22.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.117 0.967 . . . . 0.0 109.512 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.85 -32.73 69.71 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.239 -0.288 . . . . 0.0 111.119 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.62 -31.4 72.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.596 0.358 . . . . 0.0 111.041 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -74.38 -34.36 63.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -39.7 67.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.63 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -71.2 -34.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.9 -23.39 55.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.145 -0.347 . . . . 0.0 110.862 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.26 -17.14 31.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.97 -8.06 7.77 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.96 -21.81 65.95 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.407 1.003 . . . . 0.0 110.794 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.76 -10.49 59.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.515 0.326 . . . . 0.0 111.344 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -93.77 -14.96 25.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.37 173.59 24.25 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.54 125.66 13.08 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.744 2.963 . . . . 0.0 110.56 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.9 mt -93.35 141.37 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 122.898 0.479 . . . . 0.0 110.338 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.2 t -102.75 -33.68 9.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.518 0.727 . . . . 0.0 111.796 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -164.0 161.37 22.65 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -146.5 145.39 19.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.0 0.92 . . . . 0.0 109.187 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.62 156.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.254 0.622 . . . . 0.0 111.556 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.82 141.9 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 C-N-CA 123.291 0.636 . . . . 0.0 112.193 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -134.24 82.09 48.33 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.4 0.68 . . . . 0.0 110.263 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.941 2.427 . . . . 0.0 111.217 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.38 -26.41 67.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.851 0.86 . . . . 0.0 110.756 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -117.05 4.85 12.76 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.828 0.851 . . . . 0.0 112.371 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 55.64 51.73 12.12 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.726 0.811 . . . . 0.0 110.293 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -144.99 171.4 14.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.804 0.842 . . . . 0.0 111.1 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.58 158.26 40.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.146 0.579 . . . . 0.0 110.966 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -127.56 149.53 50.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.039 0.536 . . . . 0.0 109.637 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.9 t -143.42 144.53 23.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -126.37 137.98 53.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.686 0.394 . . . . 0.0 110.095 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -100.29 155.14 17.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -71.47 -12.69 61.52 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.782 0.264 . . . . 0.0 110.338 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -143.09 143.05 31.69 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 125.759 1.624 . . . . 0.0 112.93 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.06 -21.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 120.822 0.344 . . . . 0.0 111.509 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -69.8 -35.16 74.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 110.859 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.86 -37.96 60.66 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.15 85.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.76 -33.81 71.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.306 0.642 . . . . 0.0 111.129 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -66.17 -35.06 79.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.056 0.389 . . . . 0.0 111.124 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.27 71.15 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.655 0.207 . . . . 0.0 111.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.8 t -77.34 -33.49 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 O-C-N 122.311 -0.243 . . . . 0.0 111.088 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -68.03 -32.67 73.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 122.065 -0.397 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.75 -32.93 64.08 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.7 -30.34 69.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.344 0.658 . . . . 0.0 111.549 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.43 63.6 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.85 -28.2 8.89 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -159.95 154.34 23.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.962 0.505 . . . . 0.0 109.853 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.72 139.96 40.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.12 -0.362 . . . . 0.0 110.139 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.4 mt -83.39 136.13 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 14.2 m-85 -88.17 130.66 34.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.2 mm -129.04 124.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.743 1.217 . . . . 0.0 108.601 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.51 34.47 4.89 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.59 8.34 73.94 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.974 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -136.2 148.95 66.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.541 1.17 . . . . 0.0 111.402 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.84 152.4 80.55 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.38 2.72 . . . . 0.0 111.485 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 174.64 13.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.419 1.088 . . . . 0.0 109.569 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.37 156.4 42.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.28 144.34 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.082 0.553 . . . . 0.0 111.952 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -148.88 169.83 19.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.34 1.456 . . . . 0.0 108.639 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -68.64 146.94 52.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.9 t -79.27 154.21 29.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.456 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.8 t -71.2 -2.54 16.27 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.7 t -125.34 151.24 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.476 0.71 . . . . 0.0 110.568 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -86.22 -6.93 58.88 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -159.64 148.19 17.59 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.673 0.67 . . . . 0.0 110.875 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.221 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.84 0.352 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -153.17 152.72 28.42 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.822 0.849 . . . . 0.0 109.803 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.56 -3.91 14.33 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.697 2.931 . . . . 0.0 110.635 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.6 149.49 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 112.469 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.58 145.85 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -99.16 137.42 37.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.789 2.036 . . . . 0.0 110.282 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.6 mt -116.9 140.61 38.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.878 0.871 . . . . 0.0 109.749 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -143.77 152.03 40.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.423 0.689 . . . . 0.0 110.276 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.09 2.63 80.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.845 -0.419 . . . . 0.0 112.818 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 104' ' ' LEU . 2.8 pp -73.62 -173.96 1.6 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.543 0.671 . . . . 0.0 110.325 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.07 157.53 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.55 0.74 . . . . 0.0 110.6 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.97 -12.01 51.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 -10.83 85.25 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.19 148.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.69 168.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.153 0.981 . . . . 0.0 109.422 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -58.71 -32.67 69.39 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.141 -0.35 . . . . 0.0 110.95 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.39 71.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.46 0.304 . . . . 0.0 111.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -73.54 -31.67 63.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.97 -43.28 71.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -71.99 -34.54 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -75.21 -21.29 58.77 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.969 -0.457 . . . . 0.0 111.498 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.22 -17.24 25.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.18 -8.6 8.72 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.97 -21.77 66.43 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.346 0.975 . . . . 0.0 110.696 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -70.5 -10.8 60.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.152 -0.343 . . . . 0.0 111.486 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.96 -14.78 24.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.37 172.93 25.15 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.28 124.99 12.32 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.495 2.797 . . . . 0.0 110.666 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.67 142.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.025 0.53 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.6 t -105.25 -34.01 8.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.418 0.687 . . . . 0.0 111.566 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -165.91 159.33 15.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.89 151.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.071 0.948 . . . . 0.0 112.221 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.12 154.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.321 0.648 . . . . 0.0 111.382 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.93 141.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.048 0.539 . . . . 0.0 112.144 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.43 88.05 40.59 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 123.138 0.575 . . . . 0.0 110.223 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.44 -8.28 21.67 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.039 2.493 . . . . 0.0 110.473 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.59 -32.41 73.97 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.651 0.78 . . . . 0.0 110.1 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.98 4.96 12.81 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.673 0.789 . . . . 0.0 112.226 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 57.78 51.48 9.21 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.231 0.612 . . . . 0.0 110.262 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -146.21 170.16 17.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.795 0.838 . . . . 0.0 111.34 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.69 158.37 40.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.632 0.773 . . . . 0.0 110.692 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.98 152.91 48.92 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-O 121.155 0.502 . . . . 0.0 110.132 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.76 144.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -122.48 136.34 54.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.05 0.54 . . . . 0.0 110.106 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -101.65 156.64 17.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -73.24 -11.07 60.38 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.175 -0.328 . . . . 0.0 110.5 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -144.38 146.3 32.44 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.692 1.597 . . . . 0.0 113.481 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.6 -23.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.337 0.049 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.26 -37.38 83.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.252 0.221 . . . . 0.0 110.626 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 -38.44 65.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.97 89.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.059 0.457 . . . . 0.0 109.949 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.55 -33.46 71.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.09 0.556 . . . . 0.0 111.11 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.21 -34.62 78.44 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.112 0.415 . . . . 0.0 110.873 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -38.7 72.9 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.516 0.144 . . . . 0.0 110.85 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.27 -33.55 23.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 O-C-N 122.33 -0.231 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.16 -32.29 71.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.192 -0.317 . . . . 0.0 110.961 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.7 -32.94 64.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.22 70.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.528 0.731 . . . . 0.0 111.058 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.77 3.28 2.64 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.073 0.549 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.11 -28.67 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -156.72 152.57 27.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -76.75 141.35 40.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.12 136.15 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.304 16.2 m-85 -88.81 130.64 35.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -129.02 125.05 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.607 1.163 . . . . 0.0 108.453 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.95 34.52 5.57 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.322 0.649 . . . . 0.0 112.373 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.36 9.03 80.23 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.171 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -134.08 148.82 69.58 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 118.342 1.071 . . . . 0.0 111.726 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.92 149.96 83.01 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.295 2.663 . . . . 0.0 111.397 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 174.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 109.549 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -128.52 161.0 30.59 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -142.34 147.8 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 123.44 0.696 . . . . 0.0 111.294 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -155.73 166.48 33.37 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -68.84 151.04 47.12 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.142 0.883 . . . . 0.0 108.708 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -85.48 159.06 20.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.886 0.474 . . . . 0.0 111.281 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.6 -2.75 15.26 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.1 t -125.73 154.04 43.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.312 0.645 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -86.78 -0.44 56.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -158.46 158.88 34.96 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.782 0.719 . . . . 0.0 110.942 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.219 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.006 0.431 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -161.52 149.86 12.68 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 123.297 0.639 . . . . 0.0 109.697 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.35 -7.35 21.11 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.864 2.376 . . . . 0.0 109.897 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -104.06 141.59 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.058 0.943 . . . . 0.0 111.187 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.8 m -135.08 144.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.638 0.732 . . . . 0.0 111.412 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.427 ' HA ' HD23 ' A' ' 136' ' ' LEU . 22.1 t-80 -102.01 137.48 40.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.986 1.714 . . . . 0.0 110.578 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.38 140.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.736 0.814 . . . . 0.0 109.676 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -144.66 153.82 42.15 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.919 0.488 . . . . 0.0 110.603 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.64 4.59 88.94 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.801 -0.444 . . . . 0.0 112.614 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -72.36 173.77 8.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.737 0.768 . . . . 0.0 110.481 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.585 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.33 158.38 12.77 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.047 0 CA-C-O 121.363 0.602 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -68.93 -7.97 39.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -174.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.19 -11.04 85.75 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.94 146.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.64 166.46 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.239 1.016 . . . . 0.0 109.445 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.8 -32.7 69.58 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.182 -0.324 . . . . 0.0 111.281 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.08 -31.4 72.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.542 0.156 . . . . 0.0 110.955 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.89 -29.48 61.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.05 -44.24 69.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -71.95 -34.79 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -74.89 -20.4 59.74 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.212 0.46 . . . . 0.0 111.808 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.7 -16.98 22.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.48 -8.31 9.59 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.16 -21.83 66.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.111 0.869 . . . . 0.0 110.702 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.19 -12.85 61.89 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.861 -0.524 . . . . 0.0 111.284 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -90.77 -15.03 30.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.73 173.76 24.77 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.94 125.6 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.534 2.823 . . . . 0.0 110.364 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.32 142.74 12.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 122.722 0.409 . . . . 0.0 110.268 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.9 t -104.65 -34.03 8.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.347 0.659 . . . . 0.0 111.92 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -166.43 157.42 12.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -143.02 151.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 C-N-CA 124.088 0.955 . . . . 0.0 112.31 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.77 156.25 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.435 0.694 . . . . 0.0 110.53 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.99 141.96 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -133.32 81.84 54.52 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.446 0.699 . . . . 0.0 109.85 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.75 -13.62 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.054 2.503 . . . . 0.0 110.597 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -67.68 -22.22 65.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.182 0.593 . . . . 0.0 110.992 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -117.0 4.11 12.79 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.804 0.842 . . . . 0.0 112.097 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 59.13 40.23 22.11 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.375 0.67 . . . . 0.0 110.869 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.8 169.05 18.36 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.838 0.855 . . . . 0.0 111.088 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.18 40.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.153 0.581 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 100' ' ' HIS . 85.6 mt -125.24 150.33 47.14 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 123.013 0.525 . . . . 0.0 110.458 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.8 t -143.76 144.42 23.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -126.74 139.28 53.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.964 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.23 154.18 19.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.37 -16.34 62.96 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.854 0.297 . . . . 0.0 110.39 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -137.19 143.09 42.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.342 1.457 . . . . 0.0 113.044 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.77 -21.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.708 0.289 . . . . 0.0 111.561 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -70.62 -35.59 73.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.873 0.469 . . . . 0.0 110.727 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.31 -39.62 61.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.37 -36.84 83.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.166 0.508 . . . . 0.0 110.238 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.6 -36.27 78.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.218 0.607 . . . . 0.0 110.598 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.97 -35.35 80.89 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.191 -0.318 . . . . 0.0 110.991 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.61 -32.76 68.37 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.556 0.162 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 93.9 t -81.51 -33.48 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 122.12 -0.363 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.0 -31.65 68.23 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.999 0.363 . . . . 0.0 111.506 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -77.93 -33.17 51.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.28 71.35 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 110.649 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.18 3.54 5.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.37 0.668 . . . . 0.0 112.105 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.41 -27.29 1.57 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -155.27 155.83 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.256 0.622 . . . . 0.0 109.565 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -76.86 133.95 39.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.2 mt -83.86 134.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 16.5 m-85 -85.26 130.65 34.56 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.94 124.15 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.34 34.67 6.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.51 9.68 75.03 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.838 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -135.8 148.78 66.65 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.328 1.064 . . . . 0.0 111.537 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.8 149.77 78.52 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.32 2.68 . . . . 0.0 111.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.76 174.74 13.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.655 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -124.1 161.25 26.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.66 145.34 25.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 C-N-CA 123.458 0.703 . . . . 0.0 110.907 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -154.94 166.19 34.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -68.65 147.65 51.57 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.944 0.793 . . . . 0.0 111.299 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.2 t -82.92 156.89 23.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.695 0.398 . . . . 0.0 110.871 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -2.75 17.32 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -131.43 153.6 49.54 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.138 0.575 . . . . 0.0 110.868 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -85.48 -3.43 58.85 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -158.9 149.23 19.6 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.542 0.61 . . . . 0.0 111.777 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.709 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -156.41 153.05 24.21 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.513 1.125 . . . . 0.0 109.293 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.38 8.38 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.854 3.036 . . . . 0.0 111.073 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.95 146.22 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.56 144.38 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.576 0.703 . . . . 0.0 111.626 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -100.72 137.46 39.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.482 1.913 . . . . 0.0 110.059 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.4 mt -115.64 140.74 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.879 0.872 . . . . 0.0 109.612 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -144.29 153.81 42.41 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.89 0.476 . . . . 0.0 110.247 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.45 2.01 80.21 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.637 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.414 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.1 pp -73.79 174.63 8.17 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.727 0.763 . . . . 0.0 110.64 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.561 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.45 160.07 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-O 121.312 0.577 . . . . 0.0 109.946 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -67.34 -7.58 25.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.64 -11.05 85.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -65.77 146.87 12.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 m -132.54 168.27 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 124.24 1.016 . . . . 0.0 109.796 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.61 -32.77 70.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.085 -0.384 . . . . 0.0 110.999 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.51 72.09 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.42 0.288 . . . . 0.0 111.145 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -73.53 -30.09 62.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.69 -45.3 68.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.18 -34.66 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.63 -21.53 57.63 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.053 -0.405 . . . . 0.0 111.576 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.09 -17.14 25.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -121.51 -8.73 9.06 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.94 -21.97 66.92 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 119.023 0.829 . . . . 0.0 110.914 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -69.73 -12.65 61.8 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.301 -0.249 . . . . 0.0 111.455 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.66 -16.34 27.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.77 24.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.63 125.79 13.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.355 2.703 . . . . 0.0 110.7 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -93.51 142.77 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.837 0.455 . . . . 0.0 110.42 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 t -105.49 -32.99 8.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.385 0.674 . . . . 0.0 112.009 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -166.43 157.7 13.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.96 150.97 17.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 124.121 0.968 . . . . 0.0 112.084 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.77 157.27 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.483 0.713 . . . . 0.0 111.239 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.2 141.87 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.037 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -130.66 82.88 63.49 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 122.995 0.518 . . . . 0.0 110.212 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.19 -9.52 23.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.108 2.538 . . . . 0.0 110.413 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -65.02 -32.88 74.82 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.8 0.84 . . . . 0.0 110.284 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -116.94 7.18 13.15 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 56.65 48.06 17.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.808 0.843 . . . . 0.0 110.665 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -139.98 171.47 14.15 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.009 0.924 . . . . 0.0 110.847 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.8 158.3 42.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.168 0.587 . . . . 0.0 110.689 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.98 145.39 50.83 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -143.67 136.85 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -116.17 139.46 50.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.081 0.552 . . . . 0.0 110.384 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -101.64 154.95 18.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -71.26 -13.0 61.76 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.096 -0.378 . . . . 0.0 110.211 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -143.9 143.37 31.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.725 1.61 . . . . 0.0 113.361 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.32 -21.72 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.646 0.26 . . . . 0.0 111.394 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 66.8 tp -69.85 -34.05 73.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.854 0.461 . . . . 0.0 110.812 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.42 -39.42 56.91 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.48 83.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.172 0.51 . . . . 0.0 109.895 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.41 -33.75 73.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.619 0.768 . . . . 0.0 111.18 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -68.14 -34.31 76.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.056 -0.403 . . . . 0.0 110.855 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.77 68.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.74 -35.76 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 122.037 -0.415 . . . . 0.0 111.508 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -72.0 -24.62 61.59 Favored 'General case' 0 N--CA 1.458 -0.037 0 CA-C-N 118.511 0.596 . . . . 0.0 112.299 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.31 -33.78 49.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.69 -30.2 71.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.035 0.534 . . . . 0.0 110.667 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.89 4.79 3.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 112.265 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -136.11 -27.13 1.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -155.57 153.4 30.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -76.76 137.96 39.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.93 -0.482 . . . . 0.0 110.367 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -85.73 134.58 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 18.3 m-85 -87.31 130.89 34.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.4 mm -129.0 124.52 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.68 34.55 7.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.78 77.01 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.363 -0.687 . . . . 0.0 114.086 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -135.4 148.96 68.21 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 118.432 1.116 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.34 151.53 80.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.376 2.717 . . . . 0.0 111.606 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.7 174.82 13.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.104 0.961 . . . . 0.0 109.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.93 157.54 34.06 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.5 139.69 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.928 0.491 . . . . 0.0 111.867 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -147.42 167.33 24.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.705 1.602 . . . . 0.0 108.404 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.03 149.47 48.73 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.5 t -78.99 154.54 29.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.814 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -69.72 -12.92 62.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 46.4 t -100.43 158.3 16.0 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 110.116 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -94.86 -5.64 44.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -162.76 153.07 16.45 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.432 0.56 . . . . 0.0 110.928 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 CA--C 1.529 0.145 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.086 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -161.43 149.28 12.29 Favored Pre-proline 0 C--O 1.232 0.183 0 C-N-CA 123.374 0.67 . . . . 0.0 110.288 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.23 -6.56 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.93 2.42 . . . . 0.0 110.104 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.4 t -105.42 143.41 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.89 0.876 . . . . 0.0 110.86 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.32 141.75 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.709 0.766 . . . . 0.0 112.368 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -99.17 137.63 37.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.423 1.889 . . . . 0.0 109.702 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.5 mt -117.8 140.6 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 122.946 0.498 . . . . 0.0 109.806 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -146.28 154.39 41.65 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.69 0.796 . . . . 0.0 110.092 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.3 1.7 88.05 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 119.729 -0.484 . . . . 0.0 112.494 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -73.05 174.52 7.78 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.721 0.76 . . . . 0.0 110.318 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.556 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.18 159.45 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.067 0.461 . . . . 0.0 109.844 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.88 -17.39 63.14 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.556 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.06 -10.73 73.86 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.351 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -66.65 147.68 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.51 169.06 22.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.39 1.076 . . . . 0.0 109.488 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -60.04 -32.65 71.11 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.002 -0.436 . . . . 0.0 110.734 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.32 70.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.636 0.374 . . . . 0.0 111.503 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -73.99 -31.87 63.16 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.9 mt -73.26 -40.12 64.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.121 0.168 . . . . 0.0 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.78 -34.56 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.03 -23.9 58.22 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.06 -0.4 . . . . 0.0 111.44 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.29 -17.05 29.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.66 -10.05 9.26 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.1 -21.87 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.247 0.931 . . . . 0.0 111.017 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.96 -11.34 60.91 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.228 -0.295 . . . . 0.0 111.371 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -93.72 -16.79 23.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.16 173.38 26.5 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.66 126.17 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.663 2.908 . . . . 0.0 110.796 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.75 141.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 122.883 0.473 . . . . 0.0 110.716 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.6 t -101.63 -34.23 9.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.273 0.629 . . . . 0.0 111.891 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -164.48 163.04 22.22 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.86 0.3 . . . . 0.0 110.537 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -145.9 142.11 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 123.736 0.814 . . . . 0.0 109.568 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.3 155.02 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 110.85 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.19 141.82 40.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -130.59 84.02 60.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 123.304 0.642 . . . . 0.0 110.424 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.21 -7.59 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.683 2.256 . . . . 0.0 111.322 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -27.4 66.21 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.068 0.547 . . . . 0.0 111.03 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.78 2.99 12.95 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.476 0.71 . . . . 0.0 111.108 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 56.98 52.23 9.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.917 0.887 . . . . 0.0 110.657 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -145.05 172.02 13.65 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.171 0.989 . . . . 0.0 110.898 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.92 39.46 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.653 0.381 . . . . 0.0 110.836 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.63 144.78 48.9 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.729 0.811 . . . . 0.0 109.221 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.9 t -143.03 143.03 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -126.32 138.64 53.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.66 155.72 17.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -71.36 -13.36 61.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.241 -0.287 . . . . 0.0 110.401 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -143.19 144.04 32.02 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.409 1.484 . . . . 0.0 113.227 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.45 -21.68 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 120.928 0.394 . . . . 0.0 111.615 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.1 tp -69.37 -35.84 76.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.841 0.456 . . . . 0.0 110.699 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.8 -37.98 56.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -36.74 83.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 109.907 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.64 -35.81 75.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.23 0.612 . . . . 0.0 110.718 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -65.42 -35.01 79.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.139 -0.351 . . . . 0.0 111.187 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.46 68.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.345 -0.222 . . . . 0.0 111.241 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 98.2 t -80.8 -33.51 13.42 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 O-C-N 122.243 -0.286 . . . . 0.0 110.917 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -68.35 -32.08 71.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.107 -0.371 . . . . 0.0 110.573 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -78.09 -33.21 50.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.21 71.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.977 0.511 . . . . 0.0 110.582 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.3 3.87 4.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.291 0.636 . . . . 0.0 112.384 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -134.34 -25.84 1.5 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -156.94 155.24 31.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.153 0.581 . . . . 0.0 109.495 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.66 135.35 39.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 110.395 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.5 mt -84.75 133.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.6 m-85 -85.05 130.48 34.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mm -128.95 123.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.686 1.194 . . . . 0.0 108.603 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.18 34.55 6.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.56 10.1 74.05 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -136.16 148.89 66.4 Favored Pre-proline 0 C--N 1.339 0.115 0 CA-C-N 118.335 1.067 . . . . 0.0 111.005 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.35 150.07 81.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.363 2.709 . . . . 0.0 111.436 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.08 13.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.186 0.994 . . . . 0.0 109.978 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -124.58 157.73 34.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.5 t -139.48 138.22 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.327 0.651 . . . . 0.0 110.7 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -145.73 167.44 23.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.321 1.048 . . . . 0.0 108.535 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.86 149.07 49.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.588 -0.695 . . . . 0.0 110.47 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.3 t -78.68 155.99 29.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.224 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -72.1 -2.75 19.66 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.4 t -131.94 153.43 50.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.613 0.765 . . . . 0.0 110.723 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -84.86 -4.76 59.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -160.63 150.46 17.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.445 0.566 . . . . 0.0 111.127 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.445 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.043 0.449 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -159.84 150.76 15.83 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.5 0.72 . . . . 0.0 109.966 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.66 -8.32 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.463 2.108 . . . . 0.0 109.703 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.02 142.04 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.203 1.001 . . . . 0.0 111.837 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.65 143.13 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.459 0.647 . . . . 0.0 111.234 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -99.5 137.56 37.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.919 1.687 . . . . 0.0 110.099 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -115.65 140.52 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.22 0.608 . . . . 0.0 109.585 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -143.48 151.28 40.11 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 122.728 0.411 . . . . 0.0 110.591 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.31 86.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.798 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.07 170.07 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.634 0.717 . . . . 0.0 111.201 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.57 155.57 3.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.396 0.678 . . . . 0.0 109.976 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -70.71 -12.62 61.66 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.68 -10.81 85.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.505 0.574 . . . . 0.0 111.953 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.25 148.61 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 m -132.71 170.57 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 124.3 1.04 . . . . 0.0 109.331 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.17 -32.77 70.19 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 122.101 -0.374 . . . . 0.0 111.013 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.92 -31.55 72.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.582 0.353 . . . . 0.0 111.198 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -75.54 -32.87 60.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.761 -0.587 . . . . 0.0 112.538 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.71 -39.23 64.47 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.334 0.253 . . . . 0.0 110.564 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.03 -34.64 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -76.19 -24.45 54.73 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.94 -0.475 . . . . 0.0 111.119 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.74 -17.07 32.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.9 mt -122.01 -8.66 8.81 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.42 -21.7 66.22 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.449 1.022 . . . . 0.0 110.872 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.5 -11.34 60.86 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.142 -0.349 . . . . 0.0 111.202 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.93 -16.96 24.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.97 174.08 26.22 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -68.97 126.56 13.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.502 2.801 . . . . 0.0 110.703 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -94.0 142.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.981 0.512 . . . . 0.0 110.425 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 t -104.77 -34.21 8.18 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.696 0.798 . . . . 0.0 112.015 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -163.39 161.39 24.38 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -146.77 143.63 20.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 124.08 0.952 . . . . 0.0 109.541 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.77 154.25 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.62 141.91 39.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.061 0.544 . . . . 0.0 111.415 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -126.79 87.34 56.76 Favored Pre-proline 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.649 . . . . 0.0 109.984 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -12.93 36.94 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.002 2.468 . . . . 0.0 111.077 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -68.05 -25.87 65.57 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.626 0.37 . . . . 0.0 110.942 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.91 3.55 12.86 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 58.43 46.49 15.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.409 0.684 . . . . 0.0 110.828 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -140.47 170.08 16.46 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.866 0.866 . . . . 0.0 111.425 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.67 158.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.187 0.595 . . . . 0.0 110.984 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -128.35 148.64 50.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.959 0.504 . . . . 0.0 109.712 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -142.03 144.34 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -126.35 138.15 53.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.785 0.434 . . . . 0.0 110.096 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -100.91 155.02 18.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.8 -13.74 61.78 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.338 -0.226 . . . . 0.0 110.545 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -139.62 144.36 37.67 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.527 1.531 . . . . 0.0 112.964 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.18 -24.43 35.7 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -66.74 -35.98 81.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.431 0.292 . . . . 0.0 110.955 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -38.85 59.5 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.91 82.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.67 -35.96 73.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.183 0.593 . . . . 0.0 110.694 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.68 -35.08 79.73 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.007 0.367 . . . . 0.0 111.057 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.43 -32.55 66.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 71.1 t -81.36 -35.02 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.1 -0.375 . . . . 0.0 110.26 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -30.58 68.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.288 0.494 . . . . 0.0 111.714 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -77.72 -33.21 53.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.4 71.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.262 0.625 . . . . 0.0 110.714 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.4 4.47 3.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.591 0.756 . . . . 0.0 112.402 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.82 -26.12 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -156.3 154.54 30.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.86 137.25 39.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.231 -0.293 . . . . 0.0 110.251 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.8 mt -85.25 134.6 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 13.9 m-85 -85.51 130.27 34.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.7 mm -128.96 124.5 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.509 1.124 . . . . 0.0 108.507 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.05 34.53 5.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.016 0.526 . . . . 0.0 112.365 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.6 7.73 74.93 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.353 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -136.1 148.95 66.77 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 118.559 1.179 . . . . 0.0 111.846 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.32 153.02 79.63 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.72 2.946 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 172.84 16.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.185 0.994 . . . . 0.0 109.853 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -120.42 157.44 29.32 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.98 137.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.305 0.642 . . . . 0.0 111.272 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -148.99 171.17 16.81 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.644 1.178 . . . . 0.0 108.448 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -68.67 149.1 49.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.8 t -85.43 158.21 20.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.587 0.355 . . . . 0.0 111.259 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -2.78 18.98 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.8 t -131.57 152.35 50.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 111.0 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -83.36 -3.63 57.7 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.532 0.733 . . . . 0.0 112.675 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.06 148.3 20.32 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.249 0.477 . . . . 0.0 110.969 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 172.759 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.727 0.299 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.5 m -155.19 154.74 29.15 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 123.837 0.855 . . . . 0.0 109.717 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.72 -6.1 17.74 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.405 2.737 . . . . 0.0 110.66 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.81 145.86 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.32 144.39 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.475 0.655 . . . . 0.0 111.063 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.73 137.45 38.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.168 1.787 . . . . 0.0 110.341 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -116.47 140.7 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.204 1.002 . . . . 0.0 109.361 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -142.83 152.18 41.91 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.865 0.466 . . . . 0.0 111.188 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.58 7.55 66.75 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.546 -0.586 . . . . 0.0 112.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.419 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -82.58 177.69 8.59 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.911 0.856 . . . . 0.0 109.649 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.541 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.03 157.0 12.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 CA-C-O 121.347 0.594 . . . . 0.0 109.648 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -67.81 -4.71 13.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.99 -10.78 85.86 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.8 147.56 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.68 168.74 23.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 124.338 1.055 . . . . 0.0 109.984 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -60.32 -32.64 71.43 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.128 -0.357 . . . . 0.0 111.065 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.35 71.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.079 0.152 . . . . 0.0 111.072 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -71.99 -32.18 66.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.24 -44.71 71.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.66 -34.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -75.03 -23.45 58.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 122.074 -0.391 . . . . 0.0 111.435 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.02 -17.07 26.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.45 -9.15 9.04 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.35 -21.87 66.74 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.12 0.873 . . . . 0.0 110.91 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.28 -10.97 60.53 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -92.72 -13.79 28.87 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.5 173.02 22.25 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.24 126.13 14.57 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.465 2.776 . . . . 0.0 110.58 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.38 142.35 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.018 0.527 . . . . 0.0 110.294 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.33 -34.1 8.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.584 0.754 . . . . 0.0 111.857 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -167.14 160.4 13.83 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.29 151.47 17.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.169 0.988 . . . . 0.0 112.454 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.88 155.9 6.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 123.3 0.64 . . . . 0.0 111.186 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.14 141.88 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -136.09 81.11 39.57 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.811 0.444 . . . . 0.0 110.32 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.47 -6.63 15.61 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.18 2.586 . . . . 0.0 110.458 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.19 -32.1 73.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 110.215 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -117.12 7.22 12.98 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.891 0.876 . . . . 0.0 113.068 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 55.73 51.27 12.7 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.508 0.595 . . . . 0.0 111.362 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -143.24 164.72 29.42 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.394 0.678 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.27 40.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.415 0.686 . . . . 0.0 110.475 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -127.66 147.01 50.37 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.55 144.15 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -127.37 135.92 51.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -97.16 157.81 15.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.35 -13.35 61.84 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.857 0.299 . . . . 0.0 110.437 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -143.38 143.89 31.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.402 1.481 . . . . 0.0 113.113 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 p -61.49 -21.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.723 0.297 . . . . 0.0 111.496 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.4 tp -68.6 -35.82 77.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.806 0.442 . . . . 0.0 110.702 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 -38.14 58.37 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.66 87.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.01 -31.96 68.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 111.074 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.38 -35.7 80.99 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.997 -0.439 . . . . 0.0 111.007 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.16 70.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.414 -0.179 . . . . 0.0 110.917 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.15 -33.69 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 O-C-N 122.363 -0.211 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -70.18 -30.79 68.0 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.191 -0.318 . . . . 0.0 110.746 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -74.84 -32.96 62.07 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.31 70.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.56 1.9 3.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.393 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -132.1 -28.79 1.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -157.05 152.33 26.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.805 0.442 . . . . 0.0 109.86 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.81 138.37 39.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.6 mt -82.78 140.02 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.6 m-85 -92.27 131.21 37.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.02 124.68 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.624 1.17 . . . . 0.0 108.429 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.47 34.51 6.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.181 0.592 . . . . 0.0 112.464 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.08 10.16 78.9 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.787 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -134.99 148.81 68.41 Favored Pre-proline 0 C--N 1.339 0.11 0 CA-C-N 118.151 0.975 . . . . 0.0 111.311 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 150.46 82.76 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.36 2.706 . . . . 0.0 111.198 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.07 13.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.922 0.889 . . . . 0.0 109.709 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.72 158.63 39.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -142.34 145.52 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -152.4 168.9 23.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.716 1.606 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -68.93 150.5 47.66 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.8 t -81.08 162.34 23.77 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.205 0.602 . . . . 0.0 111.31 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -2.89 22.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.6 t -125.15 157.75 35.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.584 0.754 . . . . 0.0 110.082 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.41 -6.67 59.2 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -161.09 157.62 26.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.714 0.688 . . . . 0.0 111.67 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.405 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 t -162.05 148.8 11.1 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.527 0.731 . . . . 0.0 109.761 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.87 -9.72 26.27 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.663 2.242 . . . . 0.0 109.65 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.02 140.91 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.521 0.728 . . . . 0.0 110.924 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 m -134.97 141.71 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.997 0.903 . . . . 0.0 111.77 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.422 ' HA ' HD23 ' A' ' 136' ' ' LEU . 14.8 t60 -99.15 137.43 37.68 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.315 1.846 . . . . 0.0 110.412 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -116.02 140.8 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.829 0.851 . . . . 0.0 109.735 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -144.65 152.77 40.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.86 0.464 . . . . 0.0 110.582 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.15 86.66 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.75 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.405 HD12 ' C ' ' A' ' 104' ' ' LEU . 3.8 pp -71.45 173.94 7.26 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 117.86 0.83 . . . . 0.0 110.898 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 pt -104.03 153.4 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.04 0 C-N-CA 123.317 0.647 . . . . 0.0 109.296 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -71.46 -8.54 54.51 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.09 -10.85 85.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.79 150.02 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.66 166.88 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 C-N-CA 124.064 0.946 . . . . 0.0 109.522 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.85 -32.67 67.87 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 122.247 -0.283 . . . . 0.0 111.455 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.49 72.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.433 0.293 . . . . 0.0 111.48 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -74.33 -30.83 62.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.35 -44.24 68.54 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.8 -34.68 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.18 -21.57 58.65 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.091 0.405 . . . . 0.0 111.22 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.54 -17.09 26.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -121.97 -9.52 8.74 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.06 -21.95 66.9 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.185 0.902 . . . . 0.0 110.813 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -69.23 -12.72 61.91 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.201 0.2 . . . . 0.0 111.409 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.71 -17.65 25.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.07 172.26 25.02 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.24 128.84 19.17 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.253 2.635 . . . . 0.0 110.795 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.88 142.84 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.079 0.552 . . . . 0.0 110.781 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 t -103.73 -33.99 8.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.626 0.77 . . . . 0.0 111.914 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -167.0 159.68 13.46 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.77 152.7 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.314 1.046 . . . . 0.0 112.045 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.0 154.93 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.307 0.643 . . . . 0.0 111.052 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -138.02 141.88 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.141 0.577 . . . . 0.0 112.313 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -133.66 84.31 45.47 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 123.453 0.701 . . . . 0.0 109.741 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.55 -8.53 22.52 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.131 2.554 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -65.84 -30.56 71.19 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.416 0.686 . . . . 0.0 109.931 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.9 5.79 13.0 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.823 0.849 . . . . 0.0 111.897 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 57.13 48.59 15.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.889 0.875 . . . . 0.0 110.996 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -141.85 169.01 18.4 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.676 0.79 . . . . 0.0 110.841 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.5 157.71 40.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.163 0.585 . . . . 0.0 110.06 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 100' ' ' HIS . 26.4 mt -128.46 150.29 50.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.5 144.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -124.33 131.6 53.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.836 0.454 . . . . 0.0 109.787 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.02 155.34 17.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -71.93 -15.58 62.09 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -140.16 143.03 35.94 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.263 1.425 . . . . 0.0 113.688 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.72 -21.78 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.9 tp -68.99 -36.12 77.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.861 0.464 . . . . 0.0 110.638 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.57 -39.11 61.27 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.88 84.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.042 0.448 . . . . 0.0 109.985 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.8 t -70.95 -33.29 70.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 110.904 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.52 -35.02 78.29 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.211 -0.306 . . . . 0.0 110.961 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.86 -38.51 70.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.559 0.163 . . . . 0.0 111.433 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.73 -35.45 43.74 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 O-C-N 122.229 -0.294 . . . . 0.0 111.125 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -76.87 -21.36 55.08 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.468 0.576 . . . . 0.0 112.488 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -74.68 -32.96 62.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.07 -30.25 70.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.555 0.742 . . . . 0.0 111.7 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.55 -16.7 63.96 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.33 -28.6 9.78 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -159.97 152.4 20.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.23 0.612 . . . . 0.0 109.606 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.79 140.02 40.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -82.74 133.56 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.8 m-85 -86.51 129.38 34.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mm -128.88 124.49 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.572 1.149 . . . . 0.0 108.343 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.39 34.51 6.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.07 8.73 78.3 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.227 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -135.83 148.91 67.16 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.494 1.147 . . . . 0.0 111.849 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.25 150.89 81.64 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.349 2.699 . . . . 0.0 111.703 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.92 174.95 13.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.767 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.5 162.82 24.04 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.4 p -142.21 148.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.254 0.622 . . . . 0.0 111.956 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -156.02 166.79 32.42 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.84 148.48 50.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.222 0.919 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 t -85.05 160.61 19.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.974 0.51 . . . . 0.0 110.956 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -2.77 18.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.7 t -133.62 154.05 51.19 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.056 0.542 . . . . 0.0 111.043 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -85.11 -2.69 58.28 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.414 0.686 . . . . 0.0 112.243 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.76 151.85 20.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 111.479 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 73.5 mt . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.167 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -163.09 149.62 10.34 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 123.464 0.706 . . . . 0.0 110.011 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.39 -9.59 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 110.027 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.93 139.7 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.673 0.789 . . . . 0.0 110.621 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.38 139.02 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.625 0.726 . . . . 0.0 111.395 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.18 137.31 37.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.416 1.886 . . . . 0.0 110.296 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.3 mt -116.37 140.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.784 0.833 . . . . 0.0 109.911 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.138 0.575 . . . . 0.0 110.449 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.3 85.53 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.098 0.38 . . . . 0.0 112.705 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.96 173.99 7.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.448 0.624 . . . . 0.0 110.972 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.7 pt -100.71 154.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.599 0.76 . . . . 0.0 109.705 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -72.76 -10.48 59.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.71 -10.9 85.93 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.88 149.8 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.56 169.92 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 124.018 0.927 . . . . 0.0 109.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 60.3 mp0 -57.9 -32.84 68.13 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.407 0.283 . . . . 0.0 111.205 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.4 70.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.746 0.418 . . . . 0.0 111.722 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -72.97 -35.67 66.97 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.949 -0.469 . . . . 0.0 112.095 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.5 -38.48 65.35 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.488 0.315 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.93 -34.88 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.63 -25.0 56.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.148 -0.345 . . . . 0.0 111.007 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.0 35.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.6 mt -122.84 -9.62 8.31 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.62 -21.86 66.12 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.372 0.987 . . . . 0.0 110.915 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -68.96 -11.5 60.76 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.264 -0.273 . . . . 0.0 111.406 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.68 -16.09 23.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.68 172.43 23.97 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.17 129.26 17.9 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.499 2.799 . . . . 0.0 110.981 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.9 mt -97.81 142.78 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.604 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.8 t -104.71 -32.12 9.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.328 0.651 . . . . 0.0 111.641 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -163.0 161.88 25.71 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -147.26 143.96 19.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 109.319 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.5 p -151.03 153.3 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.335 0.654 . . . . 0.0 111.651 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.6 141.7 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.1 78.89 75.47 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 123.332 0.653 . . . . 0.0 109.811 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.22 -7.71 18.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.093 2.529 . . . . 0.0 111.201 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -65.35 -33.2 75.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.267 0.627 . . . . 0.0 110.097 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -117.1 7.5 13.07 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.743 0.817 . . . . 0.0 112.537 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 55.77 53.39 9.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.216 0.606 . . . . 0.0 110.58 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -144.76 172.87 12.41 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.923 0.889 . . . . 0.0 110.977 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.55 158.26 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.123 0.569 . . . . 0.0 110.82 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.4 mt -128.81 146.65 50.86 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.324 0.65 . . . . 0.0 109.657 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.7 t -141.56 144.22 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -126.76 126.81 44.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -87.19 156.94 19.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.66 -14.32 61.56 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 122.205 -0.309 . . . . 0.0 110.344 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -143.07 143.04 31.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.292 1.437 . . . . 0.0 113.382 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.51 -21.94 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.6 -36.72 79.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.866 0.466 . . . . 0.0 110.587 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -36.2 58.11 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.57 92.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 97.5 m -71.29 -28.71 64.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -68.04 -36.44 79.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.222 0.465 . . . . 0.0 110.932 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.461 0.119 . . . . 0.0 110.968 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.6 t -76.99 -33.43 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.358 -0.214 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -66.8 -34.48 77.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.176 0.443 . . . . 0.0 110.379 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.24 -32.99 63.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.28 -29.99 69.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.501 0.72 . . . . 0.0 111.862 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.61 -10.68 5.51 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.41 5.04 1.23 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -149.83 156.1 41.22 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -94.04 137.03 33.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.8 mt -90.04 135.1 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.299 24.7 m-85 -87.42 128.83 35.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.96 123.33 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.458 1.103 . . . . 0.0 108.578 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.05 34.41 4.2 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 112.562 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.47 8.8 70.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.459 -0.634 . . . . 0.0 114.105 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -136.05 148.91 66.7 Favored Pre-proline 0 N--CA 1.461 0.09 0 CA-C-N 118.355 1.078 . . . . 0.0 111.684 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.64 149.34 79.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.32 2.68 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.08 13.22 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.414 1.086 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -129.46 161.92 29.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.3 149.23 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.396 0.678 . . . . 0.0 110.894 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -154.2 167.66 29.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.97 150.79 47.31 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.39 -0.819 . . . . 0.0 109.103 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 40.9 t -84.21 160.02 20.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.941 0.496 . . . . 0.0 111.19 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.34 -2.66 17.08 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.2 t -133.91 152.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.248 0.619 . . . . 0.0 110.913 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -82.46 -2.7 54.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.47 0.708 . . . . 0.0 112.486 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -157.84 153.42 26.37 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.381 0.537 . . . . 0.0 111.608 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.6 mt . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.196 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.224 0 CA-C-O 121.014 0.435 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.8 t -164.05 149.86 9.34 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.531 0.732 . . . . 0.0 109.753 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.89 -9.22 25.3 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.887 2.392 . . . . 0.0 110.033 172.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.12 142.88 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.637 0.775 . . . . 0.0 110.68 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.31 141.17 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.495 0.664 . . . . 0.0 111.817 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -104.93 137.47 42.64 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.397 1.879 . . . . 0.0 109.996 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -115.19 140.7 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.232 1.013 . . . . 0.0 110.004 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -141.71 154.8 45.54 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.12 0.568 . . . . 0.0 110.11 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.24 83.13 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.713 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.8 pp -73.18 174.96 7.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.872 0.836 . . . . 0.0 110.584 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.546 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.8 160.86 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.104 0.561 . . . . 0.0 110.087 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.68 -19.04 64.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.546 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -70.41 -10.78 67.03 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.092 0.377 . . . . 0.0 112.561 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.73 146.61 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.57 166.79 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 C-N-CA 124.098 0.959 . . . . 0.0 109.827 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.45 -32.73 70.49 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.248 -0.282 . . . . 0.0 111.2 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.38 72.0 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.212 0.205 . . . . 0.0 111.09 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -74.01 -30.19 62.33 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.74 -45.02 72.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.38 -34.65 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -74.96 -21.57 59.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.998 -0.438 . . . . 0.0 111.754 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.74 -17.02 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.4 -8.74 9.58 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.5 -21.97 66.68 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.112 0.869 . . . . 0.0 110.993 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.0 -12.37 61.56 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.142 -0.349 . . . . 0.0 111.485 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -91.3 -16.09 28.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.21 23.45 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.01 130.67 22.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.496 2.798 . . . . 0.0 110.764 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.0 mt -98.52 142.79 14.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.211 0.604 . . . . 0.0 110.894 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.4 t -104.7 -33.7 8.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.615 0.766 . . . . 0.0 112.278 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -165.0 157.04 15.54 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.69 151.37 16.64 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 123.911 0.884 . . . . 0.0 111.941 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.07 157.97 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.317 0.647 . . . . 0.0 111.804 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.05 141.94 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -133.05 82.66 53.96 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 123.288 0.635 . . . . 0.0 110.328 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.02 -10.17 27.63 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.919 2.413 . . . . 0.0 111.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -69.98 -24.49 63.32 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 117.841 0.291 . . . . 0.0 111.065 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -116.8 3.34 12.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.503 0.721 . . . . 0.0 111.769 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 57.3 51.12 10.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.31 170.93 15.06 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.966 0.906 . . . . 0.0 110.873 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.23 40.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.13 0.572 . . . . 0.0 110.537 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.51 150.89 49.97 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.34 144.56 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -125.35 133.08 52.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.852 0.461 . . . . 0.0 109.968 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -95.37 155.3 16.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -71.42 -14.51 62.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -143.61 143.54 31.53 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.566 1.546 . . . . 0.0 113.415 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.17 -21.9 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 0.0 111.658 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.69 -35.31 77.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.687 0.395 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.06 -38.88 55.01 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.82 85.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.013 0.435 . . . . 0.0 109.852 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.96 -33.61 68.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.218 0.607 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.41 -34.75 79.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.118 0.417 . . . . 0.0 111.015 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.57 68.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.494 -0.128 . . . . 0.0 111.107 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.6 -33.6 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.046 0 O-C-N 122.069 -0.395 . . . . 0.0 110.876 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -71.68 -30.8 66.1 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.031 -0.418 . . . . 0.0 110.566 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.75 -32.93 64.07 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.35 69.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.635 0.774 . . . . 0.0 111.5 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.96 -14.91 63.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -109.99 -27.18 9.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -160.01 153.86 22.93 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.101 0.56 . . . . 0.0 109.587 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.72 137.04 39.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -81.37 137.61 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.286 13.9 m-85 -90.45 130.8 36.48 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.7 mm -128.79 124.43 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.62 1.168 . . . . 0.0 108.072 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.46 34.56 6.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.192 0.597 . . . . 0.0 112.528 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.19 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.871 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -135.65 148.8 67.05 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 118.54 1.17 . . . . 0.0 111.4 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.15 149.82 81.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.175 2.583 . . . . 0.0 111.791 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.78 175.1 13.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.162 0.985 . . . . 0.0 109.888 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -128.12 159.71 34.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 144.56 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -146.47 164.37 32.73 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.465 1.106 . . . . 0.0 108.257 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -68.88 150.7 47.48 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.4 t -85.12 159.12 20.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.883 0.473 . . . . 0.0 111.475 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.87 -2.66 15.74 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.9 t -131.05 152.03 50.79 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.199 0.6 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -82.54 -4.22 57.22 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -158.56 150.37 21.25 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.401 0.546 . . . . 0.0 111.228 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.117 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 m -152.81 151.17 26.06 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 110.418 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 -1.84 11.76 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.905 3.07 . . . . 0.0 110.599 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.9 149.73 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.803 0.841 . . . . 0.0 112.391 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.41 146.84 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.778 0.799 . . . . 0.0 111.932 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -100.94 137.59 39.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.216 2.206 . . . . 0.0 110.058 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.71 140.65 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.429 1.092 . . . . 0.0 110.25 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -144.32 154.3 42.9 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.203 0.601 . . . . 0.0 110.155 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.48 82.69 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.717 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.1 pp -73.28 173.27 9.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.758 0.779 . . . . 0.0 110.398 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.545 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.19 160.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.022 0.529 . . . . 0.0 109.831 -178.177 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.15 -18.88 63.94 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.35 -10.96 75.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.784 -0.454 . . . . 0.0 112.609 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.68 146.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -132.66 167.1 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.483 1.113 . . . . 0.0 109.376 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -58.83 -32.55 69.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.149 -0.344 . . . . 0.0 111.399 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.18 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.473 0.309 . . . . 0.0 111.178 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -74.89 -31.44 61.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.0 mt -71.85 -40.58 68.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.247 0.219 . . . . 0.0 110.648 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -71.86 -34.79 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.04 -22.7 58.24 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 122.267 -0.271 . . . . 0.0 111.421 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.7 -17.07 24.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.92 -9.02 10.17 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.63 -21.73 66.6 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.852 0.751 . . . . 0.0 110.834 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.59 -12.27 61.46 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.066 -0.396 . . . . 0.0 111.262 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -90.58 -17.87 26.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.87 173.86 26.84 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.11 127.75 16.46 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.667 2.912 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 77.4 mt -95.34 142.95 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.07 0.548 . . . . 0.0 110.542 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.5 t -108.5 -33.21 7.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.23 0.612 . . . . 0.0 112.07 -176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -161.86 159.75 27.24 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.64 145.82 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.102 0.961 . . . . 0.0 109.413 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.78 154.21 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.567 0.747 . . . . 0.0 110.921 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.05 141.74 39.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -131.22 84.19 57.75 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 123.293 0.637 . . . . 0.0 110.221 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.41 -9.85 25.51 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.758 2.306 . . . . 0.0 110.452 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.26 -30.73 71.77 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.15 0.98 . . . . 0.0 110.22 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -117.02 3.73 12.76 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.261 1.025 . . . . 0.0 112.706 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 56.5 44.8 23.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.341 0.656 . . . . 0.0 110.585 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -140.48 169.54 17.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 110.431 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.36 40.84 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.874 0.47 . . . . 0.0 111.192 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.4 149.64 50.46 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -142.34 144.42 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.32 134.53 53.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.179 0.592 . . . . 0.0 109.936 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -98.77 154.92 17.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.15 -13.72 61.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.101 0.409 . . . . 0.0 110.691 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -141.28 143.1 33.9 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.219 1.407 . . . . 0.0 113.624 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.76 -22.04 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 111.557 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.7 tp -69.01 -36.53 77.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.378 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.37 -38.35 58.39 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.02 86.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.4 t -71.59 -33.78 69.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.258 0.623 . . . . 0.0 111.075 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.25 -34.55 78.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.107 0.412 . . . . 0.0 111.029 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.54 -40.13 70.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.316 -0.24 . . . . 0.0 110.829 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -75.13 -33.8 29.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 122.329 -0.232 . . . . 0.0 110.524 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.42 -29.58 66.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.055 0.389 . . . . 0.0 110.887 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -75.46 -33.05 60.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.44 71.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.236 0.614 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.99 2.83 3.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 112.455 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.48 -27.8 1.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.94 153.95 27.03 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -76.71 142.14 40.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.657 0.265 . . . . 0.0 110.671 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.6 mt -83.88 138.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.31 19.2 m-85 -91.37 129.12 37.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.73 123.49 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.508 1.123 . . . . 0.0 108.333 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.44 34.56 6.84 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.219 0.608 . . . . 0.0 112.241 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 9.44 74.75 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.079 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.0 148.94 66.92 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 118.418 1.109 . . . . 0.0 111.394 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.9 148.35 76.35 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.333 2.688 . . . . 0.0 111.278 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.93 175.0 13.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.228 1.011 . . . . 0.0 109.822 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -128.15 163.4 24.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.1 148.12 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.321 0.649 . . . . 0.0 111.56 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -155.1 166.5 33.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -68.62 151.01 47.31 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.413 -0.804 . . . . 0.0 112.351 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.2 t -84.7 164.9 18.31 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.773 0.32 . . . . 0.0 111.096 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.99 -2.9 19.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.3 t -137.99 156.6 47.67 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.094 0.558 . . . . 0.0 111.312 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -82.46 -0.05 44.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -157.56 154.77 29.09 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 118.281 0.491 . . . . 0.0 110.942 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.077 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.965 0.412 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -153.63 151.99 26.35 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 123.748 0.819 . . . . 0.0 109.665 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.68 6.63 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.993 3.129 . . . . 0.0 110.908 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -137.62 147.47 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.23 148.12 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.934 0.873 . . . . 0.0 111.426 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -99.1 137.61 37.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.149 1.78 . . . . 0.0 109.866 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mt -114.6 140.47 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.487 0.715 . . . . 0.0 109.435 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -145.25 153.19 41.05 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.625 0.37 . . . . 0.0 110.613 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.16 90.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.684 -0.509 . . . . 0.0 112.766 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.23 172.46 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.91 157.29 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.331 0.653 . . . . 0.0 110.289 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.82 -22.42 66.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.83 -10.95 73.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.257 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.41 147.7 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -132.57 166.59 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.233 1.013 . . . . 0.0 109.804 174.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.42 -32.64 67.08 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 122.113 -0.367 . . . . 0.0 111.392 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -31.28 71.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.433 0.293 . . . . 0.0 111.184 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.04 -31.11 62.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.59 -43.06 73.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 121.937 0.095 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.03 -34.49 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.65 -22.08 57.1 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.949 0.34 . . . . 0.0 111.468 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.09 -17.38 26.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.79 -7.63 9.53 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -65.57 -21.71 66.62 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.17 0.895 . . . . 0.0 110.884 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.53 -12.26 61.45 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.214 -0.304 . . . . 0.0 111.488 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -92.05 -15.43 27.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.39 173.03 23.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.85 126.73 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.667 2.912 . . . . 0.0 110.804 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.3 mt -93.65 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.993 0.517 . . . . 0.0 110.616 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.6 -34.1 8.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.482 0.713 . . . . 0.0 111.761 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -166.36 159.0 14.35 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.41 151.19 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.23 1.012 . . . . 0.0 111.797 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.77 155.06 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.055 0.542 . . . . 0.0 111.355 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.16 141.76 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -133.87 87.41 35.49 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.457 0.703 . . . . 0.0 110.027 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.43 -12.71 36.73 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.944 2.429 . . . . 0.0 111.419 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.41 -23.85 65.6 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.894 0.478 . . . . 0.0 111.046 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.91 4.69 12.88 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.537 0.735 . . . . 0.0 112.258 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 tpp85 56.5 45.74 21.89 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.412 0.685 . . . . 0.0 110.473 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -140.5 165.59 27.03 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.892 0.877 . . . . 0.0 111.363 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.57 158.18 40.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.232 0.613 . . . . 0.0 110.647 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.06 149.88 50.19 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -143.41 139.82 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -121.74 140.91 51.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.83 0.452 . . . . 0.0 110.397 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -103.1 154.81 18.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -71.73 -13.54 61.75 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.665 0.211 . . . . 0.0 110.557 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -141.61 143.16 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.273 1.429 . . . . 0.0 113.553 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.07 -21.97 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.702 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -69.37 -35.34 75.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.748 0.419 . . . . 0.0 110.66 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.12 -38.92 59.16 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.43 83.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 109.996 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.9 t -70.39 -34.84 73.03 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.87 0.468 . . . . 0.0 110.867 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -66.3 -33.99 76.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.013 0.37 . . . . 0.0 110.928 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.32 69.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.545 0.157 . . . . 0.0 111.301 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.0 t -81.38 -33.56 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.941 0.337 . . . . 0.0 110.984 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.3 -30.64 67.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.253 -0.28 . . . . 0.0 110.741 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.83 -33.03 46.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.33 71.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.027 0.531 . . . . 0.0 110.795 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.26 4.5 3.6 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.442 0.697 . . . . 0.0 112.151 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.63 -27.8 1.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -155.74 155.58 33.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -76.73 135.63 39.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.635 0.255 . . . . 0.0 110.357 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.11 135.16 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 11.2 m-85 -85.85 130.46 34.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.4 mm -128.82 126.3 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.43 34.45 6.68 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.96 0.504 . . . . 0.0 112.048 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.63 9.62 80.97 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.053 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -136.09 148.94 66.76 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 118.558 1.179 . . . . 0.0 111.809 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.06 149.43 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.594 2.863 . . . . 0.0 111.718 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 170.92 19.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.282 1.033 . . . . 0.0 109.914 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -114.17 158.2 21.63 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.61 142.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.583 0.753 . . . . 0.0 109.969 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -155.55 167.64 29.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.72 147.82 51.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.392 -0.817 . . . . 0.0 110.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -77.09 152.46 35.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.225 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -71.03 -2.77 16.55 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 72.8 m -127.85 155.18 44.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.183 0.993 . . . . 0.0 109.642 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -83.92 -4.99 59.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.84 156.79 25.65 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.624 0.647 . . . . 0.0 111.516 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.439 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.905 0.383 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 t -161.59 148.47 11.48 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.296 0.638 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.87 -7.68 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.1 2.533 . . . . 0.0 110.037 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.0 t -106.08 141.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.121 0.969 . . . . 0.0 110.569 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.95 142.44 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 121.802 0.811 . . . . 0.0 112.242 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -99.68 137.67 37.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.857 1.663 . . . . 0.0 110.383 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.53 140.54 36.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.63 0.772 . . . . 0.0 109.782 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -143.26 153.03 42.38 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.734 0.414 . . . . 0.0 110.491 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.49 6.13 89.47 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.65 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.33 170.07 12.56 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.584 0.692 . . . . 0.0 110.854 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -93.39 153.93 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.996 0.518 . . . . 0.0 110.328 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.12 -22.29 65.81 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.57 -10.72 82.86 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.616 0.626 . . . . 0.0 112.486 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.3 147.83 10.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.53 168.14 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.974 0.91 . . . . 0.0 109.866 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.3 -32.74 68.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.169 -0.332 . . . . 0.0 111.369 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.41 72.13 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.152 0.181 . . . . 0.0 111.125 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.18 -31.46 62.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.24 -42.85 68.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.053 0.141 . . . . 0.0 110.776 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.93 -34.58 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -75.44 -22.89 56.97 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.137 -0.352 . . . . 0.0 111.256 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.66 -17.07 27.47 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -120.68 -8.45 9.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.11 -21.84 66.37 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.083 0.856 . . . . 0.0 110.979 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.48 -11.27 60.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.48 0.312 . . . . 0.0 111.584 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.72 -14.94 25.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.29 23.97 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.35 125.86 13.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.067 2.512 . . . . 0.0 110.678 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -93.31 142.67 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.875 0.47 . . . . 0.0 110.197 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.2 t -101.51 -34.2 9.64 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.06 0.544 . . . . 0.0 111.491 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -167.18 160.73 14.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.91 150.73 19.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.61 1.164 . . . . 0.0 111.929 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.09 155.8 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.108 0.563 . . . . 0.0 111.412 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.05 141.93 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.103 0.561 . . . . 0.0 112.363 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.77 79.32 72.08 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.837 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.61 -25.95 77.05 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.0 113.755 -175.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' H ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.41 -12.0 61.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.408 0.549 . . . . 0.0 111.277 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -116.76 2.89 12.95 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.523 0.729 . . . . 0.0 112.327 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 58.77 38.97 24.68 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.259 0.624 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -140.81 167.28 22.55 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 112.114 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.18 40.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.286 0.634 . . . . 0.0 111.089 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.52 152.14 47.97 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -144.77 144.49 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -124.13 138.03 54.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.41 154.12 18.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.43 -15.41 62.34 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.125 -0.359 . . . . 0.0 110.148 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -139.24 142.94 37.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.487 1.515 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.53 -21.77 28.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 120.774 0.321 . . . . 0.0 111.583 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -69.94 -35.25 74.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.107 0.563 . . . . 0.0 110.79 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.9 -37.9 56.5 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 109.86 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.9 t -69.9 -34.82 74.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.168 0.587 . . . . 0.0 110.832 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.78 -34.54 78.05 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 117.973 0.351 . . . . 0.0 111.182 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.52 0.146 . . . . 0.0 111.38 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.32 -33.77 12.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 O-C-N 122.111 -0.368 . . . . 0.0 110.856 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -69.94 -33.12 71.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.955 -0.466 . . . . 0.0 110.528 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -77.34 -33.0 55.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.24 71.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.359 0.663 . . . . 0.0 111.188 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.01 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.545 0.338 . . . . 0.0 111.865 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.7 -23.58 10.98 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.99 155.34 25.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.28 0.632 . . . . 0.0 109.467 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -76.79 133.98 39.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.14 134.49 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.285 10.9 m-85 -84.7 129.83 34.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.3 mm -129.02 126.12 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.737 1.215 . . . . 0.0 107.898 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.31 34.42 6.33 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.058 0.543 . . . . 0.0 112.3 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.48 79.86 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.231 -0.76 . . . . 0.0 114.35 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.3 149.05 66.7 Favored Pre-proline 0 CA--C 1.528 0.125 0 CA-C-N 118.481 1.14 . . . . 0.0 111.767 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.64 151.05 85.74 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.491 2.794 . . . . 0.0 111.881 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 173.41 15.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.329 1.052 . . . . 0.0 109.889 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.32 156.98 27.95 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.3 144.89 25.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.582 0.753 . . . . 0.0 110.841 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -155.02 168.91 25.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.72 148.6 50.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.403 -0.811 . . . . 0.0 110.501 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.3 t -78.05 154.75 31.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 111.021 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.4 t -71.98 -2.62 18.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -130.68 149.25 52.42 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.01 0.924 . . . . 0.0 110.051 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -83.59 -2.73 56.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.981 0.512 . . . . 0.0 111.615 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -149.25 150.57 32.79 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.063 0.545 . . . . 0.0 112.008 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.4 mt . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.475 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.0 m -153.53 152.43 27.36 Favored Pre-proline 0 CA--C 1.528 0.13 0 C-N-CA 123.234 0.614 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.47 3.59 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.928 3.085 . . . . 0.0 110.646 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.91 148.38 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.72 146.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 121.659 0.743 . . . . 0.0 110.672 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -101.37 137.48 39.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.093 1.757 . . . . 0.0 110.562 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.5 mt -114.75 140.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.174 0.99 . . . . 0.0 109.651 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -147.29 152.82 38.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.328 0.651 . . . . 0.0 110.233 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.28 78.65 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.932 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.27 176.79 6.34 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.081 0.94 . . . . 0.0 111.271 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.483 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -110.2 154.4 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 123.194 0.598 . . . . 0.0 109.522 177.462 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -69.43 -4.47 18.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -76.75 -10.86 85.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.02 148.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.57 168.42 24.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 123.984 0.914 . . . . 0.0 109.533 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.75 -32.67 69.47 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.158 -0.339 . . . . 0.0 111.496 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -31.42 72.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.329 0.252 . . . . 0.0 111.123 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.1 -30.59 60.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -72.27 -42.18 65.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.51 -34.61 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -75.19 -23.98 57.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.125 -0.359 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.35 -17.05 31.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.4 mt -123.77 -9.14 7.84 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.96 -21.79 66.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.258 0.936 . . . . 0.0 110.632 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -11.74 61.12 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.154 -0.342 . . . . 0.0 111.389 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -92.26 -15.08 27.94 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.13 173.47 24.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.42 127.18 15.27 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.426 2.75 . . . . 0.0 110.621 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.1 mt -93.56 140.96 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.843 0.457 . . . . 0.0 110.327 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.3 t -102.12 -34.09 9.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.729 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -163.48 161.48 24.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.5 t -145.66 145.27 20.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.009 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.63 153.42 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.168 0.587 . . . . 0.0 111.206 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.28 141.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.261 0.624 . . . . 0.0 111.495 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.11 89.55 23.55 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.736 0.414 . . . . 0.0 110.435 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -6.55 17.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.885 2.39 . . . . 0.0 110.809 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -64.03 -34.41 77.95 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.387 0.675 . . . . 0.0 110.313 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -117.0 7.25 13.09 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.884 0.874 . . . . 0.0 112.471 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 57.73 52.96 7.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.398 0.679 . . . . 0.0 110.76 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -144.69 169.59 17.72 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.471 0.709 . . . . 0.0 111.57 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.62 158.32 40.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.444 0.698 . . . . 0.0 110.324 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.0 152.29 51.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.015 0.435 . . . . 0.0 110.463 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.9 t -143.57 140.58 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -122.39 138.08 54.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -99.09 154.8 17.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -72.33 -14.2 61.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.872 0.305 . . . . 0.0 110.236 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -139.06 143.23 38.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.051 1.34 . . . . 0.0 113.142 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.21 -23.05 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.695 0.283 . . . . 0.0 111.282 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.6 tp -68.05 -35.53 78.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.766 0.427 . . . . 0.0 110.432 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.27 -37.36 59.36 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.55 88.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 96.7 m -70.96 -30.12 66.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -67.62 -35.63 79.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.174 0.443 . . . . 0.0 110.892 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.61 76.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 121.299 -0.16 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 -33.48 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.705 0.23 . . . . 0.0 111.492 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.8 -31.68 70.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.992 0.36 . . . . 0.0 110.651 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -75.05 -32.87 61.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.24 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.34 0.656 . . . . 0.0 111.025 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.44 5.5 1.76 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 112.333 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -135.93 -29.52 1.02 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -156.64 153.54 28.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.77 140.53 40.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.8 135.18 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.288 10.1 m-85 -84.87 129.5 34.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.4 mm -126.25 121.55 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.464 1.106 . . . . 0.0 108.359 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.33 33.96 2.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.67 0.788 . . . . 0.0 112.172 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 89.58 12.26 62.94 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.34 0.495 . . . . 0.0 112.738 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -136.22 139.4 29.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.552 0.741 . . . . 0.0 110.516 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.37 143.57 58.58 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.335 2.69 . . . . 0.0 112.183 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.74 174.41 12.21 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.521 0.729 . . . . 0.0 110.111 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -120.14 158.77 26.22 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.28 148.71 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.648 0.779 . . . . 0.0 111.03 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -155.2 170.07 22.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -68.6 145.2 54.16 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.544 -0.722 . . . . 0.0 109.489 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.4 t -74.67 154.29 38.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.34 -2.78 17.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.2 t -129.07 156.2 44.23 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.213 1.005 . . . . 0.0 110.018 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -84.91 -6.51 59.34 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -161.03 156.58 24.87 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.742 0.701 . . . . 0.0 111.734 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.376 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.6 m -155.64 156.27 30.55 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.269 1.028 . . . . 0.0 109.799 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.68 0.14 8.59 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.828 3.019 . . . . 0.0 110.917 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.05 145.6 33.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.67 147.26 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.451 0.643 . . . . 0.0 111.647 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -105.86 137.52 43.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.316 1.846 . . . . 0.0 110.046 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.43 140.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 124.234 1.014 . . . . 0.0 109.749 -174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -142.75 153.68 43.53 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.193 0.597 . . . . 0.0 110.159 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.07 0.12 81.18 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.694 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 104' ' ' LEU . 4.0 pp -74.12 173.5 10.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 110.818 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -110.23 157.34 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-O 121.359 0.599 . . . . 0.0 109.599 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -68.87 -5.18 19.59 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.4 -10.76 86.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 176.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 p -65.31 146.72 13.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.67 169.39 22.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 124.383 1.073 . . . . 0.0 109.8 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.15 -32.71 70.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.176 -0.328 . . . . 0.0 111.516 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.57 -31.31 71.29 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.479 0.312 . . . . 0.0 111.045 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -74.1 -31.42 62.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.01 -43.6 71.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.47 -34.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.27 -22.98 57.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.972 0.351 . . . . 0.0 111.435 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.26 26.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.8 mt -122.44 -7.58 8.66 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.55 -21.83 66.15 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.278 0.944 . . . . 0.0 110.725 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.27 -10.6 59.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.507 0.323 . . . . 0.0 111.441 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.09 -14.34 27.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.21 175.05 24.19 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.53 125.2 12.47 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.498 2.799 . . . . 0.0 110.496 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -93.47 141.62 14.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.877 0.471 . . . . 0.0 110.391 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 t -101.18 -34.15 9.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.466 0.706 . . . . 0.0 111.76 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -167.21 160.46 13.72 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.15 150.31 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.165 0.986 . . . . 0.0 111.822 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.59 156.57 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.086 0.554 . . . . 0.0 111.683 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.6 141.84 38.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.99 78.42 65.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 122.863 0.465 . . . . 0.0 110.813 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.64 -16.31 42.42 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.437 2.758 . . . . 0.0 111.566 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -64.39 -28.22 69.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 111.319 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -116.88 5.03 12.93 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.124 0.57 . . . . 0.0 111.933 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 56.77 51.75 10.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.72 0.808 . . . . 0.0 110.743 -176.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -145.06 171.27 14.71 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.901 0.88 . . . . 0.0 110.671 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.56 158.12 40.76 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.992 0.517 . . . . 0.0 110.521 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -129.86 152.05 49.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.152 0.501 . . . . 0.0 110.056 176.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.38 142.03 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -122.29 139.1 54.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -102.32 155.98 17.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -71.58 -11.4 60.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.75 0.25 . . . . 0.0 110.622 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -143.52 145.59 32.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.646 1.578 . . . . 0.0 112.843 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.08 -24.99 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.0 tp -65.05 -36.31 83.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.204 -0.31 . . . . 0.0 110.896 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.61 -37.3 61.94 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.68 89.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 93.5 m -68.95 -32.35 71.87 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.491 0.316 . . . . 0.0 111.614 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.49 -32.98 74.18 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.901 0.318 . . . . 0.0 111.196 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.94 67.47 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.374 -0.204 . . . . 0.0 111.239 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.5 t -81.45 -37.78 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.968 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -74.43 -19.24 60.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.895 0.77 . . . . 0.0 111.396 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -81.08 -33.02 33.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.17 70.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.163 0.585 . . . . 0.0 110.969 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.95 -9.17 19.35 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -140.87 -0.31 1.51 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -159.02 149.06 19.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.76 138.39 39.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.8 mt -91.54 133.63 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.297 16.9 m-85 -84.84 130.87 34.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.3 mm -128.96 124.54 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.496 1.118 . . . . 0.0 108.228 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.12 34.55 5.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.237 0.615 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.75 74.3 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.86 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -135.76 148.95 67.46 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 118.38 1.09 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -67.47 150.68 80.52 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.54 2.827 . . . . 0.0 111.504 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 174.96 13.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.168 0.987 . . . . 0.0 109.925 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -128.02 157.15 41.42 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.6 t -141.94 139.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -148.21 167.84 24.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.517 1.527 . . . . 0.0 108.431 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -68.89 151.59 46.37 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.7 t -81.9 158.0 24.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.883 0.473 . . . . 0.0 110.842 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -9.29 55.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -108.14 161.67 14.76 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.756 0.822 . . . . 0.0 110.173 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -94.12 -5.5 47.11 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -163.1 156.49 19.56 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.376 0.534 . . . . 0.0 111.325 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.782 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.893 0.378 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.6 m -153.59 153.16 28.65 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 124.146 0.978 . . . . 0.0 109.457 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.26 -0.28 9.86 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 110.727 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 1.9 p -123.16 145.09 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.48 147.32 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.71 0.767 . . . . 0.0 110.529 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -101.14 137.78 39.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.278 1.831 . . . . 0.0 110.697 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.1 mt -114.62 140.52 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 123.506 0.722 . . . . 0.0 109.741 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -145.9 152.7 39.87 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.458 0.703 . . . . 0.0 110.295 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.82 85.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.644 -0.531 . . . . 0.0 112.608 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.8 pp -70.08 175.16 4.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.65 0.725 . . . . 0.0 110.687 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.59 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.44 160.93 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 CA-C-O 121.366 0.603 . . . . 0.0 110.089 -178.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -66.77 -9.58 38.35 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.59 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.33 -10.98 85.78 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.032 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.4 p -63.97 145.05 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 m -132.73 166.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.138 0.975 . . . . 0.0 109.557 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.96 -32.82 69.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.254 -0.279 . . . . 0.0 111.145 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.39 71.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.381 0.272 . . . . 0.0 111.172 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.18 -29.06 62.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.28 -44.26 68.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.5 -34.72 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.76 -22.37 58.82 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.035 -0.415 . . . . 0.0 111.454 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.45 -17.12 24.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.1 mt -121.68 -7.45 9.08 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.85 -21.79 66.49 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -70.24 -11.54 60.97 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.659 -0.21 . . . . 0.0 111.475 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -92.27 -14.48 28.83 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.73 173.37 22.78 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.29 129.06 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.612 2.874 . . . . 0.0 110.468 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.29 141.57 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.202 0.601 . . . . 0.0 110.712 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.2 t -101.14 -34.12 9.83 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.457 0.703 . . . . 0.0 112.205 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -166.53 158.27 13.3 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.52 148.97 20.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.046 0.938 . . . . 0.0 112.083 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.23 156.34 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.282 0.633 . . . . 0.0 111.181 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.14 141.74 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -131.05 82.02 64.92 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 123.215 0.606 . . . . 0.0 110.078 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.39 -8.67 21.36 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.223 2.615 . . . . 0.0 110.39 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.23 -29.73 69.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.882 0.873 . . . . 0.0 110.579 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -116.99 5.29 12.84 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.895 0.878 . . . . 0.0 113.09 176.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 58.17 48.64 12.53 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.449 0.7 . . . . 0.0 110.891 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -144.81 170.39 16.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.504 0.722 . . . . 0.0 111.488 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.34 40.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.287 0.635 . . . . 0.0 110.67 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.33 151.93 51.06 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.949 0.404 . . . . 0.0 110.166 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.94 144.01 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 tt0 -126.02 137.7 53.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.557 0.343 . . . . 0.0 110.193 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.34 156.4 16.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -72.04 -14.05 61.77 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.221 -0.299 . . . . 0.0 110.224 175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -139.79 143.12 36.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.251 1.42 . . . . 0.0 113.3 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.04 -21.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 111.565 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.4 tp -69.27 -36.29 76.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.941 0.496 . . . . 0.0 110.682 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -37.7 57.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.22 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.53 -33.03 70.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.445 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.84 -33.82 76.45 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.062 -0.399 . . . . 0.0 110.851 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.82 70.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.488 0.131 . . . . 0.0 111.2 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.43 -35.15 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 122.198 -0.314 . . . . 0.0 111.441 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -70.76 -28.42 64.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.054 0.388 . . . . 0.0 111.688 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -76.4 -33.1 58.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.52 71.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.07 0.548 . . . . 0.0 110.662 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.59 3.42 6.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.352 0.661 . . . . 0.0 112.117 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -132.26 -29.64 1.59 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -154.25 149.22 26.75 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.95 132.87 39.27 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.169 -0.332 . . . . 0.0 110.255 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.4 mt -81.18 145.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 C-N-CA 122.68 0.392 . . . . 0.0 110.079 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.252 19.9 m-85 -100.05 132.25 45.53 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 175.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.9 mm -128.97 126.99 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.57 34.39 6.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.176 0.59 . . . . 0.0 112.406 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.04 79.21 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.731 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -136.14 148.88 66.42 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 118.439 1.119 . . . . 0.0 111.529 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.5 143.56 69.64 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.717 2.945 . . . . 0.0 111.285 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.15 26.72 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.852 0.861 . . . . 0.0 110.456 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -112.2 159.21 18.79 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.6 t -141.11 142.5 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.688 0.795 . . . . 0.0 110.964 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -156.31 166.34 33.73 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -68.85 150.91 47.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.5 t -82.8 158.64 22.7 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.128 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.15 -2.68 10.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.3 t -124.04 160.42 27.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.085 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -89.39 -5.56 57.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -162.39 154.19 18.53 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.542 0.61 . . . . 0.0 111.188 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.6 mt . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.303 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.815 0.34 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -152.83 152.32 28.17 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 109.657 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.97 -3.7 14.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.399 2.732 . . . . 0.0 110.458 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.63 149.48 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.991 0.916 . . . . 0.0 112.246 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 m -132.71 148.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.56 0.695 . . . . 0.0 112.043 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.068 1.747 . . . . 0.0 109.77 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.34 140.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.228 1.011 . . . . 0.0 109.575 -174.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -143.01 152.71 42.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.89 0.476 . . . . 0.0 111.063 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.02 5.01 71.22 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.659 -0.523 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -82.76 -175.78 5.96 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.964 0.882 . . . . 0.0 109.58 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.54 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -122.02 158.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.82 -3.52 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -79.42 -10.96 85.4 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.99 148.63 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.56 168.77 23.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.255 1.022 . . . . 0.0 110.258 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.8 -33.0 68.1 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.241 -0.287 . . . . 0.0 111.176 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.55 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 -33.83 66.62 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.54 -39.86 64.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.935 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.54 -34.35 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -75.39 -25.66 57.8 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.019 -0.426 . . . . 0.0 111.187 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.06 -17.13 33.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.76 -9.47 8.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.44 -21.91 66.21 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.208 0.913 . . . . 0.0 110.974 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.55 -11.49 60.96 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.422 -0.174 . . . . 0.0 111.372 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.47 -16.15 26.19 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.5 172.33 23.72 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.86 126.41 14.56 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.58 2.853 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.99 142.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.183 0.593 . . . . 0.0 110.331 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -106.24 -34.15 7.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.661 0.784 . . . . 0.0 111.764 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -162.75 161.42 26.25 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -146.75 144.04 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.918 0.887 . . . . 0.0 109.389 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.71 150.8 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.19 0.596 . . . . 0.0 111.774 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.45 141.74 45.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -131.65 76.48 74.69 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.544 0.737 . . . . 0.0 109.493 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.22 -12.5 35.08 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.217 2.611 . . . . 0.0 111.156 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -67.38 -23.11 65.54 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.487 0.715 . . . . 0.0 111.138 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.91 6.82 13.11 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.363 0.665 . . . . 0.0 112.756 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.45 43.46 28.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.364 0.529 . . . . 0.0 111.326 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -139.62 163.9 31.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.207 0.603 . . . . 0.0 111.096 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.65 158.22 40.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.103 0.561 . . . . 0.0 110.066 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.9 mp -124.33 149.26 46.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.6 t -141.88 143.47 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -121.76 135.03 54.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.296 0.638 . . . . 0.0 109.897 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -99.81 154.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -72.07 -13.42 61.58 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.199 -0.313 . . . . 0.0 110.17 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -142.24 143.1 32.71 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.341 1.456 . . . . 0.0 113.57 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.8 p -63.42 -21.9 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.15 -34.8 75.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.945 0.498 . . . . 0.0 110.733 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -38.99 55.83 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.22 -37.61 87.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.092 0.472 . . . . 0.0 109.857 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.08 -36.7 77.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.373 0.669 . . . . 0.0 110.613 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -65.05 -33.67 76.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.107 -0.371 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.01 -38.7 72.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.675 0.216 . . . . 0.0 110.977 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.2 t -75.81 -33.43 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 122.201 -0.312 . . . . 0.0 111.079 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.84 -26.6 64.3 Favored 'General case' 0 C--O 1.231 0.096 0 O-C-N 122.002 -0.436 . . . . 0.0 111.641 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -77.38 -33.06 55.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.2 71.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.036 0.535 . . . . 0.0 110.81 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.88 3.14 2.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.538 0.735 . . . . 0.0 112.244 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -133.8 -28.91 1.36 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -157.53 152.41 25.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.84 139.36 40.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.7 mt -83.31 135.08 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 20.4 m-85 -89.01 129.62 35.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.3 mm -129.14 123.57 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.528 1.131 . . . . 0.0 108.773 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.41 34.55 6.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.6 74.74 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.837 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -135.78 148.8 66.78 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 118.248 1.024 . . . . 0.0 111.192 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.92 150.35 78.17 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 0.0 111.189 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 175.09 13.26 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 110.115 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -130.12 162.21 29.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.04 148.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 123.388 0.675 . . . . 0.0 111.356 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -155.2 166.85 32.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -68.82 145.78 53.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.5 t -75.33 155.59 36.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.9 t -71.54 -2.59 17.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.494 0.717 . . . . 0.0 112.78 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 43.5 t -127.36 154.55 44.84 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.602 0.761 . . . . 0.0 110.332 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -87.1 -0.34 56.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.37 158.87 33.06 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.275 0.489 . . . . 0.0 111.288 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 175.786 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.2 t -163.66 150.57 10.34 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.0 109.699 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.9 -10.47 27.72 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.755 2.304 . . . . 0.0 109.805 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.9 t -99.17 141.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.628 0.771 . . . . 0.0 111.36 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.11 141.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.952 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -99.23 137.5 37.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 110.43 -176.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -114.85 140.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.827 0.851 . . . . 0.0 109.73 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -144.57 148.98 35.06 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 123.11 0.564 . . . . 0.0 111.031 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.63 75.63 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.973 -0.349 . . . . 0.0 112.733 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -76.19 178.17 6.63 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.565 0.682 . . . . 0.0 110.129 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.536 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -116.07 157.99 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.062 0.545 . . . . 0.0 109.929 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.87 -17.94 58.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.536 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -71.77 -10.9 72.78 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.681 -0.51 . . . . 0.0 112.606 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.02 146.63 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.9 m -132.67 168.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 C-N-CA 124.154 0.981 . . . . 0.0 110.071 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.42 -32.63 68.85 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.306 -0.246 . . . . 0.0 111.337 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.5 71.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.529 0.331 . . . . 0.0 111.232 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -73.6 -30.57 63.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.24 -42.51 68.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.76 -34.66 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -74.98 -23.11 58.22 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.141 -0.349 . . . . 0.0 111.443 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.1 -17.09 26.76 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.2 mt -121.83 -8.24 8.94 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.93 -21.89 66.46 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 119.367 0.985 . . . . 0.0 110.816 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -69.38 -10.44 57.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.262 -0.274 . . . . 0.0 111.523 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -95.07 -16.09 22.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.63 174.03 25.0 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.22 131.48 23.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.699 2.932 . . . . 0.0 110.779 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.94 142.19 15.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.968 0.507 . . . . 0.0 110.572 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.0 t -103.65 -34.08 8.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 112.094 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -165.84 156.27 13.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.9 149.24 17.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.331 1.053 . . . . 0.0 112.052 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 p -152.05 153.42 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.151 0.58 . . . . 0.0 111.186 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -126.61 141.76 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.043 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -136.12 79.12 44.81 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.247 0.619 . . . . 0.0 109.686 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.22 -4.94 12.6 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.288 2.659 . . . . 0.0 111.352 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.27 -27.62 68.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.268 0.627 . . . . 0.0 110.538 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -116.96 6.15 12.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.891 0.876 . . . . 0.0 112.591 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 55.47 51.38 12.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.405 0.548 . . . . 0.0 110.724 -171.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -142.21 163.88 31.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.71 158.1 40.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.062 0.545 . . . . 0.0 110.618 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.88 143.53 46.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.48 144.1 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -130.24 134.38 47.21 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.779 0.432 . . . . 0.0 110.158 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -93.97 155.1 17.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -71.5 -13.35 61.78 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.029 -0.419 . . . . 0.0 110.431 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -142.08 143.8 33.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.323 1.449 . . . . 0.0 113.216 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.26 -24.86 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 65.9 tp -67.08 -36.31 81.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.477 0.311 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.05 57.88 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.25 89.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.15 -34.95 75.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.382 0.673 . . . . 0.0 110.746 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.73 -34.51 78.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.037 -0.415 . . . . 0.0 110.999 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.1 73.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.642 0.201 . . . . 0.0 110.807 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.0 t -74.62 -33.68 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.193 -0.317 . . . . 0.0 110.791 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.31 -26.29 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.239 0.472 . . . . 0.0 111.606 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -76.24 -32.87 59.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.6 -30.23 69.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.299 0.64 . . . . 0.0 111.076 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.79 1.59 4.2 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.295 0.638 . . . . 0.0 112.17 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -130.11 -31.83 1.86 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -156.5 146.31 20.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.877 0.471 . . . . 0.0 109.735 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.78 134.66 39.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -75.01 145.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 122.878 0.471 . . . . 0.0 110.373 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.265 20.6 m-85 -96.95 131.71 43.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 175.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.6 mm -128.92 124.86 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.465 1.106 . . . . 0.0 108.385 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.77 34.64 5.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 8.28 76.92 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.992 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.1 148.29 64.07 Favored Pre-proline 0 CA--C 1.528 0.111 0 CA-C-N 118.49 1.145 . . . . 0.0 111.306 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.73 141.99 56.48 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.264 2.643 . . . . 0.0 110.964 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 159.04 43.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.31 0.644 . . . . 0.0 110.918 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -91.24 160.06 15.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.39 140.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -156.72 165.62 35.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -68.84 148.18 50.65 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.152 0.887 . . . . 0.0 109.706 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.5 t -83.99 159.95 21.13 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.946 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -71.33 -2.75 17.35 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.4 t -131.41 152.5 50.59 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.022 0.529 . . . . 0.0 110.961 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -83.26 -4.75 58.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.01 147.79 18.39 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.452 0.569 . . . . 0.0 111.472 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.22 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.229 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.84 -17.31 62.75 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.339 0.255 . . . . 0.0 111.033 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 59.2 176.39 0.08 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.492 1.117 . . . . 0.0 113.473 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -141.3 158.07 44.38 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 p30 -149.7 158.45 44.18 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -71.22 147.6 93.36 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.26 -9.23 25.03 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.817 3.011 . . . . 0.0 111.55 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -73.29 -18.31 61.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.389 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -86.25 135.68 33.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.621 0.368 . . . . 0.0 110.982 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 94' ' ' PRO . 1.2 p -132.46 154.22 81.48 Favored Pre-proline 0 C--O 1.231 0.117 0 C-N-CA 123.872 0.869 . . . . 0.0 113.259 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 64.1 Cg_endo -67.99 152.75 76.49 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.104 2.536 . . . . 0.0 111.064 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.08 152.18 45.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.227 0.537 . . . . 0.0 112.132 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 t -163.19 148.92 9.7 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.743 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.88 -7.4 21.03 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.802 2.335 . . . . 0.0 109.926 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.33 143.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.092 0.957 . . . . 0.0 110.439 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.46 139.83 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.628 0.728 . . . . 0.0 111.853 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.34 137.37 37.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.935 1.694 . . . . 0.0 109.843 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 63.3 mt -116.29 140.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.393 0.677 . . . . 0.0 109.772 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -145.84 150.9 37.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.051 0.54 . . . . 0.0 110.505 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.12 0.51 77.25 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.879 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.2 pp -70.53 174.69 5.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.13 0.965 . . . . 0.0 111.041 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.539 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.04 157.03 13.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.254 0.622 . . . . 0.0 109.7 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -67.47 -7.31 24.48 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.539 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.25 -11.04 85.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.23 149.47 11.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.66 169.68 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.393 1.077 . . . . 0.0 109.621 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -59.59 -32.84 70.76 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.302 -0.249 . . . . 0.0 111.074 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.43 72.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.611 0.365 . . . . 0.0 111.27 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -74.86 -31.63 61.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.28 -41.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.41 -34.66 58.9 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -74.97 -24.66 58.48 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 117.731 0.242 . . . . 0.0 111.2 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.12 35.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.14 -9.28 8.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.54 -21.99 66.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.328 0.967 . . . . 0.0 110.875 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.03 -12.23 61.41 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.222 -0.299 . . . . 0.0 111.209 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -92.06 -16.75 25.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.48 173.91 27.5 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.76 125.7 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.654 2.903 . . . . 0.0 110.8 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 142.92 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.786 0.434 . . . . 0.0 110.583 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -107.64 -32.35 7.7 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.523 0.729 . . . . 0.0 111.956 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -162.94 160.5 24.88 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.8 143.18 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.886 0.875 . . . . 0.0 109.239 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.11 154.91 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.215 0.606 . . . . 0.0 111.516 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.05 141.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.13 0.572 . . . . 0.0 112.179 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.76 88.76 45.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 123.153 0.581 . . . . 0.0 110.439 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.76 -6.5 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.888 2.392 . . . . 0.0 110.832 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.83 -31.76 71.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.439 0.696 . . . . 0.0 110.608 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -116.94 5.71 12.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.617 0.767 . . . . 0.0 112.584 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 57.95 49.82 11.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.345 0.658 . . . . 0.0 110.544 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -144.13 171.61 14.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.958 0.903 . . . . 0.0 111.283 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.16 40.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.195 0.598 . . . . 0.0 110.368 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.13 149.16 50.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.9 144.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -125.29 138.84 54.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.881 0.472 . . . . 0.0 109.797 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -102.48 155.73 18.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -72.8 -13.8 61.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.212 -0.305 . . . . 0.0 110.356 174.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -143.08 143.34 31.81 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.308 1.443 . . . . 0.0 113.451 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.5 p -62.9 -21.84 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 111.714 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.3 tp -69.81 -35.03 74.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.81 0.444 . . . . 0.0 110.761 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.07 -38.15 48.18 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.21 86.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -70.13 -35.52 74.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.24 -34.83 79.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.949 -0.469 . . . . 0.0 111.141 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.23 -37.43 69.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 121.325 -0.15 . . . . 0.0 111.214 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.31 -33.55 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 O-C-N 122.156 -0.34 . . . . 0.0 110.751 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -70.67 -28.39 64.74 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.17 0.441 . . . . 0.0 111.801 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.33 -33.05 61.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.76 -30.32 69.94 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.64 0.776 . . . . 0.0 111.675 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.12 -16.06 63.57 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -108.9 -27.17 9.85 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -160.06 154.8 24.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.003 0.521 . . . . 0.0 109.823 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.65 141.08 41.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.41 134.87 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.292 10.8 m-85 -84.77 129.08 34.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.9 mm -126.62 120.57 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.483 1.113 . . . . 0.0 108.254 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.17 34.31 2.93 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.811 0.844 . . . . 0.0 112.08 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 90.34 11.17 63.04 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.619 0.628 . . . . 0.0 112.993 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -136.3 139.53 30.07 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.358 0.663 . . . . 0.0 110.452 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.32 144.57 62.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.411 2.74 . . . . 0.0 112.156 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.49 171.86 16.39 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.458 0.703 . . . . 0.0 110.073 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.09 161.16 18.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.24 149.41 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.575 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -68.74 144.21 54.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.836 0.743 . . . . 0.0 109.544 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.3 t -76.39 153.86 35.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.4 -2.76 17.61 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.6 t -127.69 152.93 47.09 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.454 0.702 . . . . 0.0 110.496 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -88.46 -3.75 58.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.196 0.598 . . . . 0.0 112.525 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.38 150.87 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.353 0.524 . . . . 0.0 111.019 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mt -96.56 142.98 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.7 m -70.33 128.24 35.54 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.02 -0.425 . . . . 0.0 110.634 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -81.58 155.17 71.32 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.237 0.615 . . . . 0.0 109.947 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.45 -15.86 27.68 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.299 2.666 . . . . 0.0 110.075 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.04 141.81 3.83 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -106.68 8.01 30.83 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.8 t -152.38 148.32 27.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.273 0.629 . . . . 0.0 110.448 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -78.53 -4.59 49.39 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -67.93 -13.31 62.06 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 64.4 m -81.03 -8.77 59.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.879 0.472 . . . . 0.0 111.566 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -73.84 143.28 45.96 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.512 0.325 . . . . 0.0 110.321 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.8 m 61.5 159.53 0.05 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.482 1.513 . . . . 0.0 113.299 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.325 0.8 OUTLIER 54.97 1.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -154.49 -9.28 0.14 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.107 0.563 . . . . 0.0 111.89 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 117.85 -1.072 . . . . 0.0 111.369 179.47 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.727 1 C5'-C4'-C3' 109.483 -4.011 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.48 1 O4'-C1'-N19 113.981 5.781 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 1 C5'-C4'-C3' 108.528 -4.648 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.608 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.807 1 C5'-C4'-C3' 108.455 -4.697 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . 0.415 " H3'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.585 1 C5'-C4'-C3' 108.858 -4.428 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.415 H5'' " H3'" ' B' ' 5' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 O4'-C1'-N19 111.649 3.449 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.128 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -66.93 161.32 24.39 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.011 0.524 . . . . 0.0 111.291 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 56.13 23.78 7.28 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.812 0.845 . . . . 0.0 112.684 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -141.77 150.6 41.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -145.67 156.5 43.68 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -75.74 149.7 83.51 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.86 -9.95 27.31 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.56 2.84 . . . . 0.0 111.6 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -75.99 -8.82 57.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.59 0.356 . . . . 0.0 111.581 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -69.11 134.8 49.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.915 0.486 . . . . 0.0 110.467 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -81.57 148.22 61.56 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.71 148.47 46.91 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.562 2.842 . . . . 0.0 111.028 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.15 144.43 56.92 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 111.66 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -164.85 151.19 9.17 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.291 0.637 . . . . 0.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.46 -7.34 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.724 2.282 . . . . 0.0 110.446 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t -102.36 143.52 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.324 1.05 . . . . 0.0 110.657 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.35 140.92 46.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.713 0.768 . . . . 0.0 111.72 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.28 137.54 37.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.129 1.772 . . . . 0.0 110.058 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.7 mt -117.75 140.7 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.325 0.65 . . . . 0.0 109.554 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -144.49 151.49 39.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.074 0.55 . . . . 0.0 110.176 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.99 0.15 85.77 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.612 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.14 171.36 9.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.588 0.694 . . . . 0.0 110.881 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.21 154.33 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.221 0.608 . . . . 0.0 109.997 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -70.77 -10.98 60.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.76 -10.75 86.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.507 0.575 . . . . 0.0 111.705 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.1 148.72 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 169.85 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 124.273 1.029 . . . . 0.0 109.755 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.23 -32.75 70.25 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.175 -0.328 . . . . 0.0 111.085 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.67 -31.42 72.07 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.303 -0.248 . . . . 0.0 111.043 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.5 -32.09 60.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.13 -43.07 68.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.12 -34.65 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.61 -24.0 58.8 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.11 -0.369 . . . . 0.0 111.178 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.37 -17.11 31.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -123.74 -8.91 7.87 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.88 -21.93 66.49 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.448 1.022 . . . . 0.0 110.751 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.02 -10.43 58.63 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.09 -15.84 24.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.75 174.77 26.9 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.28 123.37 10.5 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.634 2.889 . . . . 0.0 110.92 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.44 141.93 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.021 0.528 . . . . 0.0 110.395 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -101.38 -34.24 9.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.21 0.604 . . . . 0.0 111.734 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -167.21 162.02 14.83 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 151.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 124.131 0.972 . . . . 0.0 111.945 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.6 p -151.13 155.94 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.179 0.592 . . . . 0.0 112.042 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.21 141.95 36.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.221 0.608 . . . . 0.0 112.287 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.91 81.75 57.15 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 123.63 0.772 . . . . 0.0 110.12 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -59.83 -12.48 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.389 2.726 . . . . 0.0 112.371 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -27.58 67.77 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.823 0.449 . . . . 0.0 111.136 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -116.81 5.74 13.09 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.685 0.794 . . . . 0.0 112.028 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 56.68 48.57 16.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.555 0.742 . . . . 0.0 110.285 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.58 168.84 18.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.882 0.873 . . . . 0.0 111.193 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.59 158.25 40.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.483 0.713 . . . . 0.0 110.441 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 mp -131.33 154.12 48.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.893 0.378 . . . . 0.0 110.131 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.2 t -143.33 143.07 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -118.41 130.76 56.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.13 154.5 17.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -72.64 -12.85 61.21 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.185 -0.322 . . . . 0.0 110.487 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -143.89 145.56 32.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 113.413 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.87 -23.37 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.4 tp -67.47 -36.69 81.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.393 0.277 . . . . 0.0 111.055 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.47 60.73 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.47 91.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.16 0.505 . . . . 0.0 109.893 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.7 t -69.34 -35.41 75.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.281 0.633 . . . . 0.0 110.827 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -65.54 -34.29 77.92 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.064 -0.398 . . . . 0.0 110.904 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.57 -33.39 69.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.472 0.124 . . . . 0.0 111.086 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -81.06 -33.7 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 122.12 -0.363 . . . . 0.0 111.158 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.142 0.428 . . . . 0.0 111.265 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -79.06 -33.04 45.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.247 0.619 . . . . 0.0 111.117 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.98 -17.4 63.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.47 0.308 . . . . 0.0 111.703 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -109.1 -24.1 11.33 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -159.94 155.65 25.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.294 0.638 . . . . 0.0 109.301 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.73 136.59 39.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.62 134.03 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.9 m-85 -85.61 131.27 34.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.08 125.31 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 0.0 108.357 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.81 34.58 5.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.3 0.64 . . . . 0.0 112.498 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.39 8.86 77.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.062 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -135.35 148.99 68.43 Favored Pre-proline 0 CA--C 1.527 0.083 0 CA-C-N 118.418 1.109 . . . . 0.0 111.75 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.54 151.68 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.53 2.82 . . . . 0.0 111.713 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.96 174.61 13.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -123.62 156.09 36.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.34 138.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.593 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -148.62 168.71 22.09 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 125.669 1.587 . . . . 0.0 108.621 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.65 149.89 48.59 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.7 t -84.83 156.27 21.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.344 0.658 . . . . 0.0 110.662 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.93 -16.03 62.64 Favored 'General case' 0 C--N 1.335 -0.045 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 84.1 p -92.06 152.77 19.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.255 0.622 . . . . 0.0 109.629 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -97.11 -5.51 37.17 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -161.91 149.02 14.1 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.12 0.568 . . . . 0.0 109.951 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.37 144.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.8 m -71.2 124.75 25.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 32.8 ptt85 -156.04 149.02 18.25 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.748 0.419 . . . . 0.0 110.565 -174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.58 -16.55 27.01 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.435 2.757 . . . . 0.0 110.684 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.68 16.51 59.05 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.589 0.614 . . . . 0.0 111.873 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -63.04 -5.3 2.88 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 97.6 p -76.94 -3.49 39.07 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.482 0.713 . . . . 0.0 110.7 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.273 81.6 m-20 55.52 29.18 12.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.268 71.6 m-20 58.43 18.06 5.33 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.0 t 55.69 25.19 7.93 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.163 0.585 . . . . 0.0 111.307 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -64.02 137.81 58.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.059 -0.401 . . . . 0.0 110.656 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.7 m 58.24 10.18 1.2 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -73.19 139.54 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 55.35 20.03 3.36 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.638 0.775 . . . . 0.0 113.073 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.754 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 109.905 -3.73 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 1 O4'-C1'-N19 113.694 5.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.603 1 C5'-C4'-C3' 108.616 -4.59 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.551 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.96 1 C5'-C4'-C3' 108.394 -4.737 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 1 C5'-C4'-C3' 109.19 -4.207 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.787 0 C5'-C4'-C3' 110.743 -3.171 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.246 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -153.05 152.33 31.23 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.976 0.511 . . . . 0.0 110.058 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.67 158.08 34.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.925 0.49 . . . . 0.0 111.446 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -146.71 151.84 37.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -155.18 160.57 40.99 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -58.04 124.59 70.64 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.16 -14.97 45.13 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.07 2.513 . . . . 0.0 112.578 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -90.55 6.29 44.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.774 0.43 . . . . 0.0 111.646 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -62.16 144.19 55.74 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.888 0.475 . . . . 0.0 110.374 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.63 149.28 97.51 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.53 145.39 64.26 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.423 2.749 . . . . 0.0 110.505 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.22 141.55 58.73 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.945 0.402 . . . . 0.0 111.738 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.4 m -156.46 152.41 22.9 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.946 0.898 . . . . 0.0 109.445 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.25 -10.62 22.61 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.063 2.508 . . . . 0.0 109.756 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.96 146.37 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 124.473 1.109 . . . . 0.0 110.789 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.39 139.62 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 121.421 0.629 . . . . 0.0 111.566 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -100.04 137.4 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.762 1.625 . . . . 0.0 110.263 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.7 mt -117.4 140.49 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 110.151 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -144.21 155.51 43.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.287 0.635 . . . . 0.0 110.058 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.18 -1.09 87.62 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.77 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.64 173.44 8.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.679 0.739 . . . . 0.0 110.976 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.6 pt -98.89 153.92 4.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 C-N-CA 123.499 0.72 . . . . 0.0 109.52 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -72.89 -9.69 58.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.57 -10.75 86.04 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.5 149.62 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.69 169.3 22.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.117 0.967 . . . . 0.0 109.512 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.85 -32.73 69.71 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.239 -0.288 . . . . 0.0 111.119 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.62 -31.4 72.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.596 0.358 . . . . 0.0 111.041 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -74.38 -34.36 63.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -39.7 67.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.63 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -71.2 -34.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.9 -23.39 55.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.145 -0.347 . . . . 0.0 110.862 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.26 -17.14 31.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.97 -8.06 7.77 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.96 -21.81 65.95 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.407 1.003 . . . . 0.0 110.794 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.76 -10.49 59.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.515 0.326 . . . . 0.0 111.344 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -93.77 -14.96 25.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.37 173.59 24.25 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.54 125.66 13.08 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.744 2.963 . . . . 0.0 110.56 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.9 mt -93.35 141.37 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 122.898 0.479 . . . . 0.0 110.338 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.2 t -102.75 -33.68 9.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.518 0.727 . . . . 0.0 111.796 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -164.0 161.37 22.65 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -146.5 145.39 19.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.0 0.92 . . . . 0.0 109.187 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.62 156.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.254 0.622 . . . . 0.0 111.556 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.82 141.9 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 C-N-CA 123.291 0.636 . . . . 0.0 112.193 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -134.24 82.09 48.33 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.4 0.68 . . . . 0.0 110.263 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.941 2.427 . . . . 0.0 111.217 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.38 -26.41 67.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.851 0.86 . . . . 0.0 110.756 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -117.05 4.85 12.76 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.828 0.851 . . . . 0.0 112.371 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 55.64 51.73 12.12 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.726 0.811 . . . . 0.0 110.293 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -144.99 171.4 14.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.804 0.842 . . . . 0.0 111.1 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.58 158.26 40.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.146 0.579 . . . . 0.0 110.966 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -127.56 149.53 50.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.039 0.536 . . . . 0.0 109.637 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.9 t -143.42 144.53 23.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -126.37 137.98 53.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.686 0.394 . . . . 0.0 110.095 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -100.29 155.14 17.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -71.47 -12.69 61.52 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.782 0.264 . . . . 0.0 110.338 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -143.09 143.05 31.69 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 125.759 1.624 . . . . 0.0 112.93 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.06 -21.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 120.822 0.344 . . . . 0.0 111.509 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -69.8 -35.16 74.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 110.859 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.86 -37.96 60.66 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.15 85.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.76 -33.81 71.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.306 0.642 . . . . 0.0 111.129 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -66.17 -35.06 79.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.056 0.389 . . . . 0.0 111.124 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.27 71.15 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.655 0.207 . . . . 0.0 111.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.8 t -77.34 -33.49 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 O-C-N 122.311 -0.243 . . . . 0.0 111.088 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -68.03 -32.67 73.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 122.065 -0.397 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.75 -32.93 64.08 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.7 -30.34 69.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.344 0.658 . . . . 0.0 111.549 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.43 63.6 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.85 -28.2 8.89 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -159.95 154.34 23.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.962 0.505 . . . . 0.0 109.853 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.72 139.96 40.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.12 -0.362 . . . . 0.0 110.139 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.4 mt -83.39 136.13 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 14.2 m-85 -88.17 130.66 34.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.2 mm -129.04 124.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.743 1.217 . . . . 0.0 108.601 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.51 34.47 4.89 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.59 8.34 73.94 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.974 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -136.2 148.95 66.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.541 1.17 . . . . 0.0 111.402 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.84 152.4 80.55 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.38 2.72 . . . . 0.0 111.485 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 174.64 13.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.419 1.088 . . . . 0.0 109.569 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.37 156.4 42.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -178.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.28 144.34 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.082 0.553 . . . . 0.0 111.952 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -148.88 169.83 19.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.34 1.456 . . . . 0.0 108.639 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -68.64 146.94 52.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.9 t -79.27 154.21 29.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.456 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.8 t -71.2 -2.54 16.27 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.7 t -125.34 151.24 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.476 0.71 . . . . 0.0 110.568 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -86.22 -6.93 58.88 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -159.64 148.19 17.59 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.673 0.67 . . . . 0.0 110.875 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 58.8 mt -89.39 142.51 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.8 t -65.54 119.54 11.26 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.111 -0.368 . . . . 0.0 110.592 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 63.7 mmt-85 -80.36 155.81 74.03 Favored Pre-proline 0 C--O 1.233 0.234 0 C-N-CA 123.194 0.598 . . . . 0.0 109.618 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.1 -7.1 18.87 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.355 2.704 . . . . 0.0 111.358 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.46 20.32 4.68 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.997 0.808 . . . . 0.0 111.228 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -54.42 -30.04 51.2 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.9 m 55.17 23.79 5.68 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.0 t0 64.85 165.56 0.16 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.92 0.888 . . . . 0.0 112.838 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.95 -6.28 8.11 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 34.6 t -80.06 -14.28 58.65 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.11 0.564 . . . . 0.0 110.07 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -68.03 -19.42 64.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.858 0.863 . . . . 0.0 112.501 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.3 t 61.71 160.66 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.502 1.121 . . . . 0.0 112.13 -174.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.3 t 56.02 16.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -151.63 14.66 0.66 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.34 0.656 . . . . 0.0 110.243 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.553 -1.213 . . . . 0.0 110.57 -179.451 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.676 0 C5'-C4'-C3' 109.91 -3.727 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 1 O4'-C1'-N19 113.779 5.579 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.561 1 C5'-C4'-C3' 108.43 -4.713 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.563 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.977 1 C5'-C4'-C3' 108.56 -4.627 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 1 C5'-C4'-C3' 108.936 -4.376 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.783 0 O4'-C1'-N19 111.693 3.493 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.196 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -146.22 -10.82 0.49 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.658 0.383 . . . . 0.0 111.292 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -153.87 168.1 27.49 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.082 0.553 . . . . 0.0 110.397 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -142.03 138.06 31.54 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -82.59 119.31 24.1 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -76.11 140.78 70.1 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.02 -15.89 16.19 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.635 2.89 . . . . 0.0 111.997 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -78.33 -12.82 60.03 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.705 0.402 . . . . 0.0 111.587 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -80.4 143.21 33.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.514 0.726 . . . . 0.0 110.333 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 p -79.25 154.74 77.09 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.34 159.83 52.2 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.703 2.935 . . . . 0.0 110.452 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.17 142.48 58.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.84 0.352 . . . . 0.0 111.421 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -153.17 152.72 28.42 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.822 0.849 . . . . 0.0 109.803 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.56 -3.91 14.33 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.697 2.931 . . . . 0.0 110.635 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.6 149.49 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 112.469 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.58 145.85 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -99.16 137.42 37.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.789 2.036 . . . . 0.0 110.282 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.6 mt -116.9 140.61 38.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.878 0.871 . . . . 0.0 109.749 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -143.77 152.03 40.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.423 0.689 . . . . 0.0 110.276 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.09 2.63 80.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.845 -0.419 . . . . 0.0 112.818 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 104' ' ' LEU . 2.8 pp -73.62 -173.96 1.6 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.543 0.671 . . . . 0.0 110.325 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.07 157.53 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.55 0.74 . . . . 0.0 110.6 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.97 -12.01 51.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 -10.83 85.25 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.19 148.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.69 168.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.153 0.981 . . . . 0.0 109.422 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -58.71 -32.67 69.39 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.141 -0.35 . . . . 0.0 110.95 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.39 71.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.46 0.304 . . . . 0.0 111.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -73.54 -31.67 63.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.97 -43.28 71.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -71.99 -34.54 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -75.21 -21.29 58.77 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.969 -0.457 . . . . 0.0 111.498 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.22 -17.24 25.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.18 -8.6 8.72 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.97 -21.77 66.43 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.346 0.975 . . . . 0.0 110.696 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -70.5 -10.8 60.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.152 -0.343 . . . . 0.0 111.486 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.96 -14.78 24.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.37 172.93 25.15 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.28 124.99 12.32 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.495 2.797 . . . . 0.0 110.666 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.67 142.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.025 0.53 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.6 t -105.25 -34.01 8.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.418 0.687 . . . . 0.0 111.566 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -165.91 159.33 15.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.89 151.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.071 0.948 . . . . 0.0 112.221 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.12 154.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.321 0.648 . . . . 0.0 111.382 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.93 141.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.048 0.539 . . . . 0.0 112.144 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.43 88.05 40.59 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 123.138 0.575 . . . . 0.0 110.223 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.44 -8.28 21.67 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.039 2.493 . . . . 0.0 110.473 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.59 -32.41 73.97 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.651 0.78 . . . . 0.0 110.1 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.98 4.96 12.81 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.673 0.789 . . . . 0.0 112.226 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 57.78 51.48 9.21 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.231 0.612 . . . . 0.0 110.262 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -146.21 170.16 17.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.795 0.838 . . . . 0.0 111.34 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.69 158.37 40.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.632 0.773 . . . . 0.0 110.692 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.98 152.91 48.92 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-O 121.155 0.502 . . . . 0.0 110.132 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.76 144.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -122.48 136.34 54.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.05 0.54 . . . . 0.0 110.106 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -101.65 156.64 17.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -73.24 -11.07 60.38 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.175 -0.328 . . . . 0.0 110.5 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -144.38 146.3 32.44 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.692 1.597 . . . . 0.0 113.481 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.6 -23.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.337 0.049 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.26 -37.38 83.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.252 0.221 . . . . 0.0 110.626 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 -38.44 65.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.97 89.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.059 0.457 . . . . 0.0 109.949 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.55 -33.46 71.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.09 0.556 . . . . 0.0 111.11 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.21 -34.62 78.44 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.112 0.415 . . . . 0.0 110.873 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -38.7 72.9 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.516 0.144 . . . . 0.0 110.85 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.27 -33.55 23.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 O-C-N 122.33 -0.231 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.16 -32.29 71.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.192 -0.317 . . . . 0.0 110.961 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.7 -32.94 64.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.22 70.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.528 0.731 . . . . 0.0 111.058 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.77 3.28 2.64 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.073 0.549 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.11 -28.67 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -156.72 152.57 27.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -76.75 141.35 40.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.12 136.15 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.304 16.2 m-85 -88.81 130.64 35.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -129.02 125.05 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.607 1.163 . . . . 0.0 108.453 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.95 34.52 5.57 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.322 0.649 . . . . 0.0 112.373 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.36 9.03 80.23 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.171 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -134.08 148.82 69.58 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 118.342 1.071 . . . . 0.0 111.726 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.92 149.96 83.01 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.295 2.663 . . . . 0.0 111.397 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 174.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 109.549 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -128.52 161.0 30.59 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -142.34 147.8 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 123.44 0.696 . . . . 0.0 111.294 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -155.73 166.48 33.37 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -68.84 151.04 47.12 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.142 0.883 . . . . 0.0 108.708 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -85.48 159.06 20.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.886 0.474 . . . . 0.0 111.281 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.6 -2.75 15.26 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.1 t -125.73 154.04 43.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.312 0.645 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -86.78 -0.44 56.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -158.46 158.88 34.96 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.782 0.719 . . . . 0.0 110.942 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt -98.34 136.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.3 t -67.83 130.8 44.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.62 0.247 . . . . 0.0 111.238 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -164.33 155.6 13.66 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 123.609 0.764 . . . . 0.0 109.099 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.81 22.55 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.536 3.491 . . . . 0.0 112.451 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -160.47 33.18 0.41 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 34.3 p30 -69.56 -9.44 53.99 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t 57.99 7.88 0.67 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.382 1.073 . . . . 0.0 113.151 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -68.48 128.06 35.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.683 -0.636 . . . . 0.0 111.236 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.254 89.7 m-20 53.96 36.84 25.39 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -175.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.5 m 61.58 19.9 10.8 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.295 1.038 . . . . 0.0 113.27 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -70.06 131.58 44.54 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.52 0.328 . . . . 0.0 110.672 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 24.4 t 54.77 -169.69 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.668 0.787 . . . . 0.0 111.959 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.274 1.2 t 60.41 17.17 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -152.11 10.96 0.54 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.08 0.552 . . . . 0.0 112.416 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.35 -1.31 . . . . 0.0 110.722 -179.611 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.592 0 C5'-C4'-C3' 109.656 -3.896 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 1 O4'-C1'-N19 113.616 5.416 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 1 C5'-C4'-C3' 108.221 -4.852 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.583 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.658 1 C5'-C4'-C3' 108.75 -4.5 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.741 0 O4'-C1'-N19 110.91 2.71 . 0.182 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.656 0 C5'-C4'-C3' 110.288 -3.474 . 0.311 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.095 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.62 163.42 27.04 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.703 0.401 . . . . 0.0 111.193 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -152.67 160.38 43.16 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.362 20.1 t80 62.82 -6.52 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -158.03 160.07 37.04 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.39 141.71 85.98 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.31 -11.65 20.93 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.52 2.813 . . . . 0.0 111.626 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -77.88 -10.14 59.42 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.016 0.526 . . . . 0.0 111.355 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -73.22 149.61 42.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.532 0.333 . . . . 0.0 110.737 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.87 151.78 79.14 Favored Pre-proline 0 C--O 1.231 0.112 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.51 154.68 60.24 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.353 2.702 . . . . 0.0 111.485 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.88 149.79 50.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.006 0.431 . . . . 0.0 111.578 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -161.52 149.86 12.68 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 123.297 0.639 . . . . 0.0 109.697 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.35 -7.35 21.11 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.864 2.376 . . . . 0.0 109.897 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -104.06 141.59 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.058 0.943 . . . . 0.0 111.187 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.8 m -135.08 144.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.638 0.732 . . . . 0.0 111.412 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.427 ' HA ' HD23 ' A' ' 136' ' ' LEU . 22.1 t-80 -102.01 137.48 40.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.986 1.714 . . . . 0.0 110.578 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.38 140.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.736 0.814 . . . . 0.0 109.676 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -144.66 153.82 42.15 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.919 0.488 . . . . 0.0 110.603 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.64 4.59 88.94 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.801 -0.444 . . . . 0.0 112.614 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -72.36 173.77 8.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.737 0.768 . . . . 0.0 110.481 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.585 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.33 158.38 12.77 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.047 0 CA-C-O 121.363 0.602 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -68.93 -7.97 39.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -174.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.19 -11.04 85.75 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.94 146.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.64 166.46 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.239 1.016 . . . . 0.0 109.445 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.8 -32.7 69.58 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.182 -0.324 . . . . 0.0 111.281 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.08 -31.4 72.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.542 0.156 . . . . 0.0 110.955 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.89 -29.48 61.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.05 -44.24 69.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -71.95 -34.79 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -74.89 -20.4 59.74 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.212 0.46 . . . . 0.0 111.808 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.7 -16.98 22.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.48 -8.31 9.59 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.16 -21.83 66.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.111 0.869 . . . . 0.0 110.702 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.19 -12.85 61.89 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.861 -0.524 . . . . 0.0 111.284 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -90.77 -15.03 30.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.73 173.76 24.77 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.94 125.6 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.534 2.823 . . . . 0.0 110.364 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.32 142.74 12.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 122.722 0.409 . . . . 0.0 110.268 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.9 t -104.65 -34.03 8.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.347 0.659 . . . . 0.0 111.92 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -166.43 157.42 12.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -143.02 151.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 C-N-CA 124.088 0.955 . . . . 0.0 112.31 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.77 156.25 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.435 0.694 . . . . 0.0 110.53 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.99 141.96 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -133.32 81.84 54.52 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.446 0.699 . . . . 0.0 109.85 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.75 -13.62 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.054 2.503 . . . . 0.0 110.597 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -67.68 -22.22 65.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.182 0.593 . . . . 0.0 110.992 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -117.0 4.11 12.79 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.804 0.842 . . . . 0.0 112.097 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 59.13 40.23 22.11 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.375 0.67 . . . . 0.0 110.869 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.8 169.05 18.36 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.838 0.855 . . . . 0.0 111.088 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.18 40.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.153 0.581 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 100' ' ' HIS . 85.6 mt -125.24 150.33 47.14 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 123.013 0.525 . . . . 0.0 110.458 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.8 t -143.76 144.42 23.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -126.74 139.28 53.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.964 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.23 154.18 19.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.37 -16.34 62.96 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.854 0.297 . . . . 0.0 110.39 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -137.19 143.09 42.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.342 1.457 . . . . 0.0 113.044 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.77 -21.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.708 0.289 . . . . 0.0 111.561 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -70.62 -35.59 73.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.873 0.469 . . . . 0.0 110.727 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.31 -39.62 61.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.37 -36.84 83.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.166 0.508 . . . . 0.0 110.238 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.6 -36.27 78.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.218 0.607 . . . . 0.0 110.598 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.97 -35.35 80.89 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.191 -0.318 . . . . 0.0 110.991 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.61 -32.76 68.37 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.556 0.162 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 93.9 t -81.51 -33.48 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 122.12 -0.363 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.0 -31.65 68.23 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.999 0.363 . . . . 0.0 111.506 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -77.93 -33.17 51.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.28 71.35 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 110.649 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.18 3.54 5.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.37 0.668 . . . . 0.0 112.105 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.41 -27.29 1.57 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -155.27 155.83 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.256 0.622 . . . . 0.0 109.565 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -76.86 133.95 39.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.2 mt -83.86 134.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 16.5 m-85 -85.26 130.65 34.56 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.94 124.15 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.34 34.67 6.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.51 9.68 75.03 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.838 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -135.8 148.78 66.65 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.328 1.064 . . . . 0.0 111.537 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.8 149.77 78.52 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.32 2.68 . . . . 0.0 111.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.76 174.74 13.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.655 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -124.1 161.25 26.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.66 145.34 25.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 C-N-CA 123.458 0.703 . . . . 0.0 110.907 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -154.94 166.19 34.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -68.65 147.65 51.57 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.944 0.793 . . . . 0.0 111.299 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.2 t -82.92 156.89 23.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.695 0.398 . . . . 0.0 110.871 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -2.75 17.32 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -131.43 153.6 49.54 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.138 0.575 . . . . 0.0 110.868 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -85.48 -3.43 58.85 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -158.9 149.23 19.6 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.542 0.61 . . . . 0.0 111.777 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.4 mt -92.98 147.77 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 70.0 m -73.66 131.95 42.21 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.725 -0.61 . . . . 0.0 111.642 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -85.64 159.34 55.56 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 123.323 0.649 . . . . 0.0 110.873 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.29 -10.92 26.32 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.408 2.739 . . . . 0.0 110.196 173.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.57 145.17 4.63 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -84.86 -2.26 57.55 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.9 t 61.34 161.07 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.015 1.326 . . . . 0.0 112.911 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 43.2 p30 -155.11 -177.93 6.89 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.167 0.587 . . . . 0.0 110.377 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -68.64 9.88 0.32 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 71.8 m -134.31 5.73 3.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.566 0.746 . . . . 0.0 111.469 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -71.63 -18.87 62.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.829 0.452 . . . . 0.0 111.951 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.3 m -62.71 147.18 50.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.722 0.409 . . . . 0.0 110.387 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.317 1.0 OUTLIER 52.94 13.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 66.0 t30 56.87 23.92 8.69 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.093 0.957 . . . . 0.0 111.457 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.854 1.262 . . . . 0.0 111.923 -179.294 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.482 0 C5'-C4'-C3' 109.711 -3.86 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.932 1 O4'-C1'-N19 113.462 5.262 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.633 2 C5'-C4'-C3' 109.35 -4.1 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.622 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.69 2 C5'-C4'-C3' 108.917 -4.389 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C5'-C4'-C3' 111.349 -2.767 . 0.144 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.407 ' N9 ' H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.883 0 C5'-C4'-C3' 111.233 -2.845 . 0.267 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.43 151.38 30.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.173 0.589 . . . . 0.0 109.832 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.51 149.95 46.64 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.78 0.324 . . . . 0.0 111.795 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -80.84 -4.75 55.82 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -79.15 156.68 28.13 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.48 155.81 92.83 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.28 -9.91 23.89 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.965 2.443 . . . . 0.0 111.647 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -77.23 -9.55 58.86 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 122.024 -0.422 . . . . 0.0 111.632 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -78.63 142.32 37.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.05 0.386 . . . . 0.0 110.533 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -132.3 151.56 78.54 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.57 148.92 67.36 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.372 2.715 . . . . 0.0 110.553 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.01 144.45 56.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -156.41 153.05 24.21 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.513 1.125 . . . . 0.0 109.293 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.38 8.38 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.854 3.036 . . . . 0.0 111.073 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.95 146.22 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.56 144.38 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.576 0.703 . . . . 0.0 111.626 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -100.72 137.46 39.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.482 1.913 . . . . 0.0 110.059 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.4 mt -115.64 140.74 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.879 0.872 . . . . 0.0 109.612 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -144.29 153.81 42.41 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.89 0.476 . . . . 0.0 110.247 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.45 2.01 80.21 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.637 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.414 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.1 pp -73.79 174.63 8.17 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.727 0.763 . . . . 0.0 110.64 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.561 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.45 160.07 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-O 121.312 0.577 . . . . 0.0 109.946 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -67.34 -7.58 25.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.64 -11.05 85.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -65.77 146.87 12.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 m -132.54 168.27 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 124.24 1.016 . . . . 0.0 109.796 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.61 -32.77 70.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.085 -0.384 . . . . 0.0 110.999 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.51 72.09 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.42 0.288 . . . . 0.0 111.145 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -73.53 -30.09 62.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.69 -45.3 68.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.18 -34.66 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.63 -21.53 57.63 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.053 -0.405 . . . . 0.0 111.576 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.09 -17.14 25.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -121.51 -8.73 9.06 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.94 -21.97 66.92 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 119.023 0.829 . . . . 0.0 110.914 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -69.73 -12.65 61.8 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.301 -0.249 . . . . 0.0 111.455 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.66 -16.34 27.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.77 24.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.63 125.79 13.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.355 2.703 . . . . 0.0 110.7 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -93.51 142.77 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.837 0.455 . . . . 0.0 110.42 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 t -105.49 -32.99 8.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.385 0.674 . . . . 0.0 112.009 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -166.43 157.7 13.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.96 150.97 17.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 124.121 0.968 . . . . 0.0 112.084 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.77 157.27 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.483 0.713 . . . . 0.0 111.239 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.2 141.87 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.037 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -130.66 82.88 63.49 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 122.995 0.518 . . . . 0.0 110.212 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.19 -9.52 23.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.108 2.538 . . . . 0.0 110.413 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -65.02 -32.88 74.82 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.8 0.84 . . . . 0.0 110.284 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -116.94 7.18 13.15 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 56.65 48.06 17.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.808 0.843 . . . . 0.0 110.665 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -139.98 171.47 14.15 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.009 0.924 . . . . 0.0 110.847 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.8 158.3 42.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.168 0.587 . . . . 0.0 110.689 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.98 145.39 50.83 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -143.67 136.85 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -116.17 139.46 50.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.081 0.552 . . . . 0.0 110.384 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -101.64 154.95 18.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -71.26 -13.0 61.76 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.096 -0.378 . . . . 0.0 110.211 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -143.9 143.37 31.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.725 1.61 . . . . 0.0 113.361 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.32 -21.72 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.646 0.26 . . . . 0.0 111.394 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 66.8 tp -69.85 -34.05 73.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.854 0.461 . . . . 0.0 110.812 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.42 -39.42 56.91 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.48 83.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.172 0.51 . . . . 0.0 109.895 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.41 -33.75 73.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.619 0.768 . . . . 0.0 111.18 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -68.14 -34.31 76.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.056 -0.403 . . . . 0.0 110.855 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.77 68.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.74 -35.76 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 122.037 -0.415 . . . . 0.0 111.508 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -72.0 -24.62 61.59 Favored 'General case' 0 N--CA 1.458 -0.037 0 CA-C-N 118.511 0.596 . . . . 0.0 112.299 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.31 -33.78 49.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.69 -30.2 71.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.035 0.534 . . . . 0.0 110.667 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.89 4.79 3.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 112.265 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -136.11 -27.13 1.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -155.57 153.4 30.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -76.76 137.96 39.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.93 -0.482 . . . . 0.0 110.367 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -85.73 134.58 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 18.3 m-85 -87.31 130.89 34.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.4 mm -129.0 124.52 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.68 34.55 7.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.78 77.01 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.363 -0.687 . . . . 0.0 114.086 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -135.4 148.96 68.21 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 118.432 1.116 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.34 151.53 80.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.376 2.717 . . . . 0.0 111.606 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.7 174.82 13.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.104 0.961 . . . . 0.0 109.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.93 157.54 34.06 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.5 139.69 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.928 0.491 . . . . 0.0 111.867 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -147.42 167.33 24.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.705 1.602 . . . . 0.0 108.404 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.03 149.47 48.73 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.5 t -78.99 154.54 29.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.814 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -69.72 -12.92 62.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 46.4 t -100.43 158.3 16.0 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 110.116 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -94.86 -5.64 44.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -162.76 153.07 16.45 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.432 0.56 . . . . 0.0 110.928 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -88.91 144.4 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.2 t -65.41 132.47 49.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -160.53 149.16 13.38 Favored Pre-proline 0 C--O 1.231 0.099 0 C-N-CA 122.712 0.405 . . . . 0.0 109.959 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.87 -20.59 34.14 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.205 2.603 . . . . 0.0 111.534 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -74.47 -13.04 82.05 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -96.68 -5.83 37.9 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 43.5 t -66.91 123.7 20.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.256 90.1 m-20 56.03 2.04 0.07 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -177.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -114.97 -4.09 12.6 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.6 t -150.54 15.33 0.78 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.187 0.595 . . . . 0.0 110.38 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -68.88 167.91 14.65 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 122.73 0.412 . . . . 0.0 110.366 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.7 t -148.22 164.53 33.68 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.818 0.447 . . . . 0.0 110.329 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.259 1.4 t 58.38 14.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -144.1 10.31 1.51 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.944 0.898 . . . . 0.0 111.746 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.252 1.212 0 C-N-CA 124.479 1.112 . . . . 0.0 111.138 -178.147 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.472 0 C5'-C4'-C3' 109.782 -3.812 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.646 1 O4'-C1'-N19 114.183 5.983 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.839 1 C5'-C4'-C3' 107.935 -5.043 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.619 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.841 1 C5'-C4'-C3' 108.281 -4.813 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 0 O4'-C1'-N19 111.168 2.968 . 0.152 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.706 0 C5'-C4'-C3' 110.177 -3.549 . 0.343 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -66.78 151.01 48.3 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.116 0.566 . . . . 0.0 110.898 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -64.83 157.38 27.94 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.949 0.5 . . . . 0.0 111.606 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.82 153.95 41.47 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -126.98 137.09 53.05 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.92 152.49 96.77 Favored Pre-proline 0 C--O 1.232 0.136 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.9 -10.03 27.99 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.091 2.527 . . . . 0.0 110.967 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -82.32 -1.07 48.48 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.428 0.691 . . . . 0.0 112.162 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -145.71 162.54 37.35 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.201 0.601 . . . . 0.0 110.642 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -76.29 154.79 84.23 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.75 150.54 68.39 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.766 2.977 . . . . 0.0 110.269 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.42 143.41 53.34 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -161.43 149.28 12.29 Favored Pre-proline 0 C--O 1.232 0.183 0 C-N-CA 123.374 0.67 . . . . 0.0 110.288 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.23 -6.56 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.93 2.42 . . . . 0.0 110.104 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.4 t -105.42 143.41 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.89 0.876 . . . . 0.0 110.86 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.32 141.75 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.709 0.766 . . . . 0.0 112.368 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -99.17 137.63 37.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.423 1.889 . . . . 0.0 109.702 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.5 mt -117.8 140.6 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 122.946 0.498 . . . . 0.0 109.806 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -146.28 154.39 41.65 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.69 0.796 . . . . 0.0 110.092 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.3 1.7 88.05 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 119.729 -0.484 . . . . 0.0 112.494 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -73.05 174.52 7.78 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.721 0.76 . . . . 0.0 110.318 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.556 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.18 159.45 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.067 0.461 . . . . 0.0 109.844 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.88 -17.39 63.14 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.556 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.06 -10.73 73.86 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.351 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -66.65 147.68 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.51 169.06 22.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.39 1.076 . . . . 0.0 109.488 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -60.04 -32.65 71.11 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.002 -0.436 . . . . 0.0 110.734 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.32 70.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.636 0.374 . . . . 0.0 111.503 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -73.99 -31.87 63.16 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.9 mt -73.26 -40.12 64.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.121 0.168 . . . . 0.0 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.78 -34.56 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.03 -23.9 58.22 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.06 -0.4 . . . . 0.0 111.44 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.29 -17.05 29.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.66 -10.05 9.26 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.1 -21.87 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.247 0.931 . . . . 0.0 111.017 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.96 -11.34 60.91 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.228 -0.295 . . . . 0.0 111.371 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -93.72 -16.79 23.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.16 173.38 26.5 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.66 126.17 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.663 2.908 . . . . 0.0 110.796 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.75 141.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 122.883 0.473 . . . . 0.0 110.716 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.6 t -101.63 -34.23 9.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.273 0.629 . . . . 0.0 111.891 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -164.48 163.04 22.22 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.86 0.3 . . . . 0.0 110.537 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -145.9 142.11 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 123.736 0.814 . . . . 0.0 109.568 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.3 155.02 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 110.85 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.19 141.82 40.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -130.59 84.02 60.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 123.304 0.642 . . . . 0.0 110.424 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.21 -7.59 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.683 2.256 . . . . 0.0 111.322 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -27.4 66.21 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.068 0.547 . . . . 0.0 111.03 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.78 2.99 12.95 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.476 0.71 . . . . 0.0 111.108 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 56.98 52.23 9.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.917 0.887 . . . . 0.0 110.657 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -145.05 172.02 13.65 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.171 0.989 . . . . 0.0 110.898 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.92 39.46 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.653 0.381 . . . . 0.0 110.836 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.63 144.78 48.9 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.729 0.811 . . . . 0.0 109.221 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.9 t -143.03 143.03 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -126.32 138.64 53.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.66 155.72 17.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -71.36 -13.36 61.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.241 -0.287 . . . . 0.0 110.401 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -143.19 144.04 32.02 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.409 1.484 . . . . 0.0 113.227 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.45 -21.68 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 120.928 0.394 . . . . 0.0 111.615 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.1 tp -69.37 -35.84 76.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.841 0.456 . . . . 0.0 110.699 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.8 -37.98 56.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -36.74 83.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 109.907 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.64 -35.81 75.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.23 0.612 . . . . 0.0 110.718 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -65.42 -35.01 79.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.139 -0.351 . . . . 0.0 111.187 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.46 68.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.345 -0.222 . . . . 0.0 111.241 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 98.2 t -80.8 -33.51 13.42 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 O-C-N 122.243 -0.286 . . . . 0.0 110.917 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -68.35 -32.08 71.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.107 -0.371 . . . . 0.0 110.573 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -78.09 -33.21 50.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.21 71.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.977 0.511 . . . . 0.0 110.582 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.3 3.87 4.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.291 0.636 . . . . 0.0 112.384 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -134.34 -25.84 1.5 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -156.94 155.24 31.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.153 0.581 . . . . 0.0 109.495 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.66 135.35 39.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 110.395 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.5 mt -84.75 133.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.6 m-85 -85.05 130.48 34.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mm -128.95 123.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.686 1.194 . . . . 0.0 108.603 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.18 34.55 6.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.56 10.1 74.05 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -136.16 148.89 66.4 Favored Pre-proline 0 C--N 1.339 0.115 0 CA-C-N 118.335 1.067 . . . . 0.0 111.005 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.35 150.07 81.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.363 2.709 . . . . 0.0 111.436 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.08 13.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.186 0.994 . . . . 0.0 109.978 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -124.58 157.73 34.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.5 t -139.48 138.22 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.327 0.651 . . . . 0.0 110.7 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -145.73 167.44 23.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.321 1.048 . . . . 0.0 108.535 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.86 149.07 49.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.588 -0.695 . . . . 0.0 110.47 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.3 t -78.68 155.99 29.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.224 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -72.1 -2.75 19.66 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.4 t -131.94 153.43 50.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.613 0.765 . . . . 0.0 110.723 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -84.86 -4.76 59.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -160.63 150.46 17.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.445 0.566 . . . . 0.0 111.127 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.9 mt -86.92 148.69 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 68.1 m -70.57 -33.11 70.73 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -173.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 58.06 160.0 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.452 1.101 . . . . 0.0 113.694 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.3 -9.21 24.95 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.56 2.84 . . . . 0.0 112.582 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.57 68.78 0.05 OUTLIER Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -70.98 -24.24 62.36 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 34.4 t -69.14 144.59 53.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.776 0.431 . . . . 0.0 111.056 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -65.67 -11.72 47.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -79.71 1.53 26.13 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 37.7 t -134.85 -12.59 2.24 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.746 0.418 . . . . 0.0 111.935 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -72.09 143.51 49.01 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 122.139 -0.351 . . . . 0.0 111.575 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 71.7 m 56.17 13.43 1.2 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.66 138.71 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 55.5 21.72 4.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.993 0.917 . . . . 0.0 112.814 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.253 1.251 0 CA-C-O 117.593 -1.194 . . . . 0.0 111.152 179.115 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 C5'-C4'-C3' 109.852 -3.765 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 1 O4'-C1'-N19 113.936 5.736 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.691 1 C5'-C4'-C3' 108.489 -4.674 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.602 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.656 1 C5'-C4'-C3' 107.854 -5.097 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.428 2 O4'-C1'-N19 112.348 4.148 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 O4'-C1'-N19 111.667 3.467 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -73.66 -23.78 59.9 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.644 0.377 . . . . 0.0 111.146 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -72.68 158.38 35.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.886 0.474 . . . . 0.0 110.916 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.96 -18.94 64.15 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -69.16 157.41 36.94 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -137.53 151.02 70.23 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.2 -9.27 25.16 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.236 2.624 . . . . 0.0 111.512 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -77.32 -8.12 57.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.73 0.412 . . . . 0.0 111.733 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -67.2 142.96 56.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.1 0.56 . . . . 0.0 111.082 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 p -80.66 149.43 67.87 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -67.42 150.85 80.81 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.626 2.884 . . . . 0.0 110.236 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.12 143.97 56.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.043 0.449 . . . . 0.0 111.721 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -159.84 150.76 15.83 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.5 0.72 . . . . 0.0 109.966 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.66 -8.32 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.463 2.108 . . . . 0.0 109.703 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.02 142.04 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.203 1.001 . . . . 0.0 111.837 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.65 143.13 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.459 0.647 . . . . 0.0 111.234 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -99.5 137.56 37.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.919 1.687 . . . . 0.0 110.099 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -115.65 140.52 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.22 0.608 . . . . 0.0 109.585 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -143.48 151.28 40.11 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 122.728 0.411 . . . . 0.0 110.591 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.31 86.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.798 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.07 170.07 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.634 0.717 . . . . 0.0 111.201 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.57 155.57 3.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.396 0.678 . . . . 0.0 109.976 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -70.71 -12.62 61.66 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.68 -10.81 85.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.505 0.574 . . . . 0.0 111.953 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.25 148.61 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 m -132.71 170.57 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 124.3 1.04 . . . . 0.0 109.331 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.17 -32.77 70.19 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 122.101 -0.374 . . . . 0.0 111.013 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.92 -31.55 72.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.582 0.353 . . . . 0.0 111.198 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -75.54 -32.87 60.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.761 -0.587 . . . . 0.0 112.538 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.71 -39.23 64.47 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.334 0.253 . . . . 0.0 110.564 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.03 -34.64 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -76.19 -24.45 54.73 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.94 -0.475 . . . . 0.0 111.119 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.74 -17.07 32.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.9 mt -122.01 -8.66 8.81 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.42 -21.7 66.22 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.449 1.022 . . . . 0.0 110.872 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.5 -11.34 60.86 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.142 -0.349 . . . . 0.0 111.202 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.93 -16.96 24.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.97 174.08 26.22 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -68.97 126.56 13.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.502 2.801 . . . . 0.0 110.703 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -94.0 142.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.981 0.512 . . . . 0.0 110.425 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 t -104.77 -34.21 8.18 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.696 0.798 . . . . 0.0 112.015 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -163.39 161.39 24.38 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -146.77 143.63 20.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 124.08 0.952 . . . . 0.0 109.541 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.77 154.25 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.62 141.91 39.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.061 0.544 . . . . 0.0 111.415 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -126.79 87.34 56.76 Favored Pre-proline 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.649 . . . . 0.0 109.984 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -12.93 36.94 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.002 2.468 . . . . 0.0 111.077 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -68.05 -25.87 65.57 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.626 0.37 . . . . 0.0 110.942 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.91 3.55 12.86 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 58.43 46.49 15.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.409 0.684 . . . . 0.0 110.828 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -140.47 170.08 16.46 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.866 0.866 . . . . 0.0 111.425 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.67 158.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.187 0.595 . . . . 0.0 110.984 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -128.35 148.64 50.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.959 0.504 . . . . 0.0 109.712 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -142.03 144.34 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -126.35 138.15 53.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.785 0.434 . . . . 0.0 110.096 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -100.91 155.02 18.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.8 -13.74 61.78 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.338 -0.226 . . . . 0.0 110.545 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -139.62 144.36 37.67 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.527 1.531 . . . . 0.0 112.964 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.18 -24.43 35.7 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -66.74 -35.98 81.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.431 0.292 . . . . 0.0 110.955 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -38.85 59.5 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.91 82.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.67 -35.96 73.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.183 0.593 . . . . 0.0 110.694 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.68 -35.08 79.73 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.007 0.367 . . . . 0.0 111.057 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.43 -32.55 66.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 71.1 t -81.36 -35.02 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.1 -0.375 . . . . 0.0 110.26 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -30.58 68.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.288 0.494 . . . . 0.0 111.714 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -77.72 -33.21 53.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.4 71.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.262 0.625 . . . . 0.0 110.714 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.4 4.47 3.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.591 0.756 . . . . 0.0 112.402 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.82 -26.12 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -156.3 154.54 30.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.86 137.25 39.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.231 -0.293 . . . . 0.0 110.251 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.8 mt -85.25 134.6 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 13.9 m-85 -85.51 130.27 34.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.7 mm -128.96 124.5 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.509 1.124 . . . . 0.0 108.507 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.05 34.53 5.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.016 0.526 . . . . 0.0 112.365 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.6 7.73 74.93 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.353 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -136.1 148.95 66.77 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 118.559 1.179 . . . . 0.0 111.846 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.32 153.02 79.63 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.72 2.946 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 172.84 16.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.185 0.994 . . . . 0.0 109.853 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -120.42 157.44 29.32 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.98 137.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.305 0.642 . . . . 0.0 111.272 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -148.99 171.17 16.81 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.644 1.178 . . . . 0.0 108.448 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -68.67 149.1 49.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.8 t -85.43 158.21 20.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.587 0.355 . . . . 0.0 111.259 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -2.78 18.98 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.8 t -131.57 152.35 50.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 111.0 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -83.36 -3.63 57.7 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.532 0.733 . . . . 0.0 112.675 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.06 148.3 20.32 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.249 0.477 . . . . 0.0 110.969 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.94 144.16 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.6 t -66.28 118.94 10.68 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.891 -0.506 . . . . 0.0 110.784 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 68.0 mmt-85 -81.43 159.04 68.12 Favored Pre-proline 0 CA--C 1.528 0.134 0 C-N-CA 123.494 0.717 . . . . 0.0 109.745 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.63 -14.37 41.82 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.654 2.236 . . . . 0.0 110.415 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.54 120.52 0.73 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -106.77 -3.34 20.56 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.8 m 52.61 28.92 6.59 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.77 0.428 . . . . 0.0 111.325 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.9 t0 54.51 62.72 2.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.097 0.559 . . . . 0.0 112.007 -175.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.259 62.2 m-20 55.92 26.8 10.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 70.9 m 58.39 19.08 6.08 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.388 1.075 . . . . 0.0 113.227 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 184' ' ' ARG . 24.8 ttt85 -67.91 -15.98 63.86 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.161 0.584 . . . . 0.0 110.839 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.4 t -151.7 166.06 32.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.705 0.802 . . . . 0.0 109.465 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.306 1.0 OUTLIER 55.71 5.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -153.26 14.51 0.51 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.175 0.59 . . . . 0.0 110.505 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 C--O 1.252 1.196 0 CA-C-O 117.368 -1.301 . . . . 0.0 110.168 -179.452 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.65 0 C5'-C4'-C3' 109.813 -3.791 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.663 1 O4'-C1'-N19 112.443 4.243 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 1 C5'-C4'-C3' 108.428 -4.714 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.543 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.053 0 C5'-C4'-C3' 109.949 -3.701 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-C3' 109.62 -3.92 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C5'-C4'-C3' 110.166 -3.556 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.261 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.61 -17.8 61.65 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.67 0.388 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -152.63 162.18 41.58 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.414 0.686 . . . . 0.0 109.203 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.261 37.7 t80 -144.39 147.59 33.59 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -70.92 161.91 30.24 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -63.06 124.58 84.35 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.68 -16.21 41.9 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.266 2.644 . . . . 0.0 112.972 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -89.23 -12.79 39.78 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.217 0.462 . . . . 0.0 111.221 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -91.32 149.4 21.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.253 0.621 . . . . 0.0 110.095 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.0 144.86 98.96 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.72 139.39 30.71 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.369 2.713 . . . . 0.0 110.926 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.22 138.44 58.54 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.727 0.299 . . . . 0.0 111.237 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.5 m -155.19 154.74 29.15 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 123.837 0.855 . . . . 0.0 109.717 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.72 -6.1 17.74 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.405 2.737 . . . . 0.0 110.66 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.81 145.86 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.32 144.39 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.475 0.655 . . . . 0.0 111.063 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.73 137.45 38.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.168 1.787 . . . . 0.0 110.341 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -116.47 140.7 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.204 1.002 . . . . 0.0 109.361 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -142.83 152.18 41.91 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.865 0.466 . . . . 0.0 111.188 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.58 7.55 66.75 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.546 -0.586 . . . . 0.0 112.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.419 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -82.58 177.69 8.59 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.911 0.856 . . . . 0.0 109.649 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.541 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.03 157.0 12.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 CA-C-O 121.347 0.594 . . . . 0.0 109.648 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -67.81 -4.71 13.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.99 -10.78 85.86 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.8 147.56 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.68 168.74 23.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 124.338 1.055 . . . . 0.0 109.984 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -60.32 -32.64 71.43 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.128 -0.357 . . . . 0.0 111.065 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.35 71.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.079 0.152 . . . . 0.0 111.072 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -71.99 -32.18 66.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.24 -44.71 71.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.66 -34.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -75.03 -23.45 58.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 122.074 -0.391 . . . . 0.0 111.435 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.02 -17.07 26.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.45 -9.15 9.04 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.35 -21.87 66.74 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.12 0.873 . . . . 0.0 110.91 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.28 -10.97 60.53 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -92.72 -13.79 28.87 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.5 173.02 22.25 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.24 126.13 14.57 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.465 2.776 . . . . 0.0 110.58 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.38 142.35 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.018 0.527 . . . . 0.0 110.294 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.33 -34.1 8.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.584 0.754 . . . . 0.0 111.857 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -167.14 160.4 13.83 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.29 151.47 17.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.169 0.988 . . . . 0.0 112.454 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.88 155.9 6.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 123.3 0.64 . . . . 0.0 111.186 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.14 141.88 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -136.09 81.11 39.57 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.811 0.444 . . . . 0.0 110.32 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.47 -6.63 15.61 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.18 2.586 . . . . 0.0 110.458 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.19 -32.1 73.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 110.215 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -117.12 7.22 12.98 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.891 0.876 . . . . 0.0 113.068 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 55.73 51.27 12.7 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.508 0.595 . . . . 0.0 111.362 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -143.24 164.72 29.42 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.394 0.678 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.27 40.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.415 0.686 . . . . 0.0 110.475 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -127.66 147.01 50.37 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.55 144.15 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -127.37 135.92 51.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -97.16 157.81 15.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.35 -13.35 61.84 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.857 0.299 . . . . 0.0 110.437 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -143.38 143.89 31.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.402 1.481 . . . . 0.0 113.113 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 p -61.49 -21.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.723 0.297 . . . . 0.0 111.496 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.4 tp -68.6 -35.82 77.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.806 0.442 . . . . 0.0 110.702 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 -38.14 58.37 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.66 87.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.01 -31.96 68.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 111.074 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.38 -35.7 80.99 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.997 -0.439 . . . . 0.0 111.007 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.16 70.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.414 -0.179 . . . . 0.0 110.917 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.15 -33.69 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 O-C-N 122.363 -0.211 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -70.18 -30.79 68.0 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.191 -0.318 . . . . 0.0 110.746 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -74.84 -32.96 62.07 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.31 70.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.56 1.9 3.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.393 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -132.1 -28.79 1.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -157.05 152.33 26.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.805 0.442 . . . . 0.0 109.86 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.81 138.37 39.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.6 mt -82.78 140.02 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.6 m-85 -92.27 131.21 37.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.02 124.68 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.624 1.17 . . . . 0.0 108.429 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.47 34.51 6.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.181 0.592 . . . . 0.0 112.464 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.08 10.16 78.9 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.787 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -134.99 148.81 68.41 Favored Pre-proline 0 C--N 1.339 0.11 0 CA-C-N 118.151 0.975 . . . . 0.0 111.311 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 150.46 82.76 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.36 2.706 . . . . 0.0 111.198 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.07 13.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.922 0.889 . . . . 0.0 109.709 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.72 158.63 39.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -142.34 145.52 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -152.4 168.9 23.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.716 1.606 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -68.93 150.5 47.66 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.8 t -81.08 162.34 23.77 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.205 0.602 . . . . 0.0 111.31 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -2.89 22.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.6 t -125.15 157.75 35.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.584 0.754 . . . . 0.0 110.082 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.41 -6.67 59.2 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -161.09 157.62 26.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.714 0.688 . . . . 0.0 111.67 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt -85.76 148.91 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.9 t -62.42 134.22 56.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.431 0.293 . . . . 0.0 111.274 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -148.56 149.54 31.48 Favored Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 123.782 0.833 . . . . 0.0 110.618 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.08 -21.77 15.36 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.629 2.886 . . . . 0.0 111.292 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.76 -13.93 64.0 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.7 -0.5 . . . . 0.0 112.542 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -85.9 -4.97 59.29 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.2 m 54.81 32.31 17.36 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.383 0.673 . . . . 0.0 112.602 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -56.73 152.68 11.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -55.24 112.01 0.99 Allowed 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 70.6 m 57.42 11.42 1.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.818 1.247 . . . . 0.0 114.017 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -86.53 153.1 22.08 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.225 0.61 . . . . 0.0 112.068 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.9 m 56.59 14.87 1.86 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.35 134.64 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.6 17.4 2.29 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.227 1.011 . . . . 0.0 113.722 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.8 m . . . . . 0 C--O 1.254 1.314 0 C-N-CA 123.975 0.91 . . . . 0.0 111.772 -179.449 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 C5'-C4'-C3' 109.57 -3.953 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.555 1 O4'-C1'-N19 113.744 5.544 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 1 C5'-C4'-C3' 108.505 -4.663 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.604 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.711 2 C5'-C4'-C3' 108.367 -4.756 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 O4'-C1'-N19 110.676 2.476 . 0.167 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.981 0 C5'-C4'-C3' 110.602 -3.266 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -73.33 -28.57 62.15 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 122.644 -0.327 . . . . 0.0 111.542 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -97.76 -19.41 18.21 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -153.65 146.43 24.32 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -67.4 158.07 32.59 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -137.7 152.52 72.77 Favored Pre-proline 0 C--O 1.232 0.171 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.7 -9.54 26.48 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.139 2.559 . . . . 0.0 111.734 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -77.44 -12.21 59.93 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.586 0.354 . . . . 0.0 111.32 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -70.73 152.19 44.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.584 0.754 . . . . 0.0 110.234 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -125.81 146.67 56.01 Favored Pre-proline 0 C--O 1.232 0.178 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.12 160.24 42.96 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.759 2.973 . . . . 0.0 111.102 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.77 147.24 53.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 111.047 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 t -162.05 148.8 11.1 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.527 0.731 . . . . 0.0 109.761 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.87 -9.72 26.27 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.663 2.242 . . . . 0.0 109.65 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.02 140.91 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.521 0.728 . . . . 0.0 110.924 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 m -134.97 141.71 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.997 0.903 . . . . 0.0 111.77 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.422 ' HA ' HD23 ' A' ' 136' ' ' LEU . 14.8 t60 -99.15 137.43 37.68 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.315 1.846 . . . . 0.0 110.412 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -116.02 140.8 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.829 0.851 . . . . 0.0 109.735 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -144.65 152.77 40.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.86 0.464 . . . . 0.0 110.582 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.15 86.66 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.75 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.405 HD12 ' C ' ' A' ' 104' ' ' LEU . 3.8 pp -71.45 173.94 7.26 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 117.86 0.83 . . . . 0.0 110.898 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 pt -104.03 153.4 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.04 0 C-N-CA 123.317 0.647 . . . . 0.0 109.296 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -71.46 -8.54 54.51 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.09 -10.85 85.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.79 150.02 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.66 166.88 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 C-N-CA 124.064 0.946 . . . . 0.0 109.522 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.85 -32.67 67.87 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 122.247 -0.283 . . . . 0.0 111.455 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.49 72.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.433 0.293 . . . . 0.0 111.48 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -74.33 -30.83 62.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.35 -44.24 68.54 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.8 -34.68 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.18 -21.57 58.65 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.091 0.405 . . . . 0.0 111.22 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.54 -17.09 26.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -121.97 -9.52 8.74 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.06 -21.95 66.9 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.185 0.902 . . . . 0.0 110.813 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -69.23 -12.72 61.91 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.201 0.2 . . . . 0.0 111.409 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.71 -17.65 25.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.07 172.26 25.02 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.24 128.84 19.17 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.253 2.635 . . . . 0.0 110.795 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.88 142.84 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.079 0.552 . . . . 0.0 110.781 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 t -103.73 -33.99 8.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.626 0.77 . . . . 0.0 111.914 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -167.0 159.68 13.46 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.77 152.7 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.314 1.046 . . . . 0.0 112.045 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.0 154.93 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.307 0.643 . . . . 0.0 111.052 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -138.02 141.88 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.141 0.577 . . . . 0.0 112.313 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -133.66 84.31 45.47 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 123.453 0.701 . . . . 0.0 109.741 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.55 -8.53 22.52 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.131 2.554 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -65.84 -30.56 71.19 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.416 0.686 . . . . 0.0 109.931 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.9 5.79 13.0 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.823 0.849 . . . . 0.0 111.897 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 57.13 48.59 15.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.889 0.875 . . . . 0.0 110.996 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -141.85 169.01 18.4 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.676 0.79 . . . . 0.0 110.841 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.5 157.71 40.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.163 0.585 . . . . 0.0 110.06 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 100' ' ' HIS . 26.4 mt -128.46 150.29 50.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.5 144.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -124.33 131.6 53.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.836 0.454 . . . . 0.0 109.787 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.02 155.34 17.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -71.93 -15.58 62.09 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -140.16 143.03 35.94 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.263 1.425 . . . . 0.0 113.688 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.72 -21.78 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.9 tp -68.99 -36.12 77.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.861 0.464 . . . . 0.0 110.638 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.57 -39.11 61.27 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.88 84.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.042 0.448 . . . . 0.0 109.985 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.8 t -70.95 -33.29 70.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 110.904 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.52 -35.02 78.29 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.211 -0.306 . . . . 0.0 110.961 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.86 -38.51 70.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.559 0.163 . . . . 0.0 111.433 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.73 -35.45 43.74 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 O-C-N 122.229 -0.294 . . . . 0.0 111.125 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -76.87 -21.36 55.08 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.468 0.576 . . . . 0.0 112.488 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -74.68 -32.96 62.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.07 -30.25 70.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.555 0.742 . . . . 0.0 111.7 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.55 -16.7 63.96 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.33 -28.6 9.78 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -159.97 152.4 20.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.23 0.612 . . . . 0.0 109.606 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.79 140.02 40.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -82.74 133.56 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.8 m-85 -86.51 129.38 34.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mm -128.88 124.49 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.572 1.149 . . . . 0.0 108.343 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.39 34.51 6.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.07 8.73 78.3 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.227 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -135.83 148.91 67.16 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.494 1.147 . . . . 0.0 111.849 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.25 150.89 81.64 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.349 2.699 . . . . 0.0 111.703 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.92 174.95 13.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.767 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.5 162.82 24.04 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.4 p -142.21 148.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.254 0.622 . . . . 0.0 111.956 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -156.02 166.79 32.42 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.84 148.48 50.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.222 0.919 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 t -85.05 160.61 19.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.974 0.51 . . . . 0.0 110.956 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -2.77 18.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.7 t -133.62 154.05 51.19 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.056 0.542 . . . . 0.0 111.043 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -85.11 -2.69 58.28 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.414 0.686 . . . . 0.0 112.243 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.76 151.85 20.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 111.479 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 73.5 mt -93.95 140.74 15.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 69.0 m -72.91 138.46 46.22 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 122.05 -0.406 . . . . 0.0 110.881 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 ptt-85 -160.56 142.47 9.31 Favored Pre-proline 0 N--CA 1.456 -0.135 0 C-N-CA 123.215 0.606 . . . . 0.0 109.897 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.39 -16.32 27.74 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.8 3.0 . . . . 0.0 111.846 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -74.67 -20.44 79.52 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -106.57 -3.03 21.21 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.2 m 60.57 161.52 0.05 Allowed 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.999 1.32 . . . . 0.0 113.824 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -112.85 11.23 19.2 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.277 70.8 m-20 59.51 2.57 0.34 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 116.89 2.182 . . . . 0.0 116.89 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.6 t -155.84 12.84 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.559 0.743 . . . . 0.0 110.33 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -64.92 145.96 55.6 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.123 0.569 . . . . 0.0 110.797 -174.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.3 t 54.2 19.08 2.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.793 0.837 . . . . 0.0 112.226 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.284 1.1 t 56.9 22.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -144.57 -5.43 0.74 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.166 -0.333 . . . . 0.0 111.792 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.626 -1.654 . . . . 0.0 111.487 -179.53 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.608 0 C5'-C4'-C3' 109.835 -3.776 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.611 1 O4'-C1'-N19 114.03 5.83 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.563 1 C5'-C4'-C3' 108.42 -4.72 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.598 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.01 1 C5'-C4'-C3' 108.628 -4.582 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . 0.457 " H4'" ' C2 ' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.553 1 C5'-C4'-C3' 108.09 -4.94 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.457 ' C2 ' " H4'" ' B' ' 5' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -2.975 0 C5'-C4'-C3' 110.435 -3.377 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -70.54 161.77 30.05 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.951 0.405 . . . . 0.0 111.063 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -69.04 156.84 37.96 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.62 0.368 . . . . 0.0 111.128 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -146.02 151.03 37.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -148.01 156.72 42.97 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -65.17 151.29 94.11 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.93 178.09 4.39 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.646 2.897 . . . . 0.0 111.034 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -79.14 2.07 22.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.121 1.368 . . . . 0.0 112.071 -175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -68.8 134.98 50.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.802 0.441 . . . . 0.0 110.595 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -85.92 151.46 54.86 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -71.36 157.18 57.38 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.502 2.801 . . . . 0.0 110.863 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.83 148.42 49.39 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 111.887 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -163.09 149.62 10.34 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 123.464 0.706 . . . . 0.0 110.011 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.39 -9.59 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 110.027 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.93 139.7 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.673 0.789 . . . . 0.0 110.621 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.38 139.02 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.625 0.726 . . . . 0.0 111.395 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.18 137.31 37.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.416 1.886 . . . . 0.0 110.296 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.3 mt -116.37 140.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.784 0.833 . . . . 0.0 109.911 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.138 0.575 . . . . 0.0 110.449 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.3 85.53 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.098 0.38 . . . . 0.0 112.705 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.96 173.99 7.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.448 0.624 . . . . 0.0 110.972 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.7 pt -100.71 154.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.599 0.76 . . . . 0.0 109.705 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -72.76 -10.48 59.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.71 -10.9 85.93 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.88 149.8 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.56 169.92 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 124.018 0.927 . . . . 0.0 109.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 60.3 mp0 -57.9 -32.84 68.13 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.407 0.283 . . . . 0.0 111.205 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.4 70.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.746 0.418 . . . . 0.0 111.722 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -72.97 -35.67 66.97 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.949 -0.469 . . . . 0.0 112.095 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.5 -38.48 65.35 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.488 0.315 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.93 -34.88 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.63 -25.0 56.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.148 -0.345 . . . . 0.0 111.007 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.0 35.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.6 mt -122.84 -9.62 8.31 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.62 -21.86 66.12 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.372 0.987 . . . . 0.0 110.915 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -68.96 -11.5 60.76 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.264 -0.273 . . . . 0.0 111.406 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.68 -16.09 23.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.68 172.43 23.97 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.17 129.26 17.9 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.499 2.799 . . . . 0.0 110.981 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.9 mt -97.81 142.78 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.604 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.8 t -104.71 -32.12 9.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.328 0.651 . . . . 0.0 111.641 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -163.0 161.88 25.71 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -147.26 143.96 19.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 109.319 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.5 p -151.03 153.3 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.335 0.654 . . . . 0.0 111.651 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.6 141.7 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.1 78.89 75.47 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 123.332 0.653 . . . . 0.0 109.811 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.22 -7.71 18.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.093 2.529 . . . . 0.0 111.201 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -65.35 -33.2 75.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.267 0.627 . . . . 0.0 110.097 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -117.1 7.5 13.07 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.743 0.817 . . . . 0.0 112.537 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 55.77 53.39 9.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.216 0.606 . . . . 0.0 110.58 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -144.76 172.87 12.41 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.923 0.889 . . . . 0.0 110.977 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.55 158.26 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.123 0.569 . . . . 0.0 110.82 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.4 mt -128.81 146.65 50.86 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.324 0.65 . . . . 0.0 109.657 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.7 t -141.56 144.22 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -126.76 126.81 44.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -87.19 156.94 19.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.66 -14.32 61.56 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 122.205 -0.309 . . . . 0.0 110.344 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -143.07 143.04 31.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.292 1.437 . . . . 0.0 113.382 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.51 -21.94 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.6 -36.72 79.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.866 0.466 . . . . 0.0 110.587 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -36.2 58.11 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.57 92.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 97.5 m -71.29 -28.71 64.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -68.04 -36.44 79.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.222 0.465 . . . . 0.0 110.932 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.461 0.119 . . . . 0.0 110.968 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.6 t -76.99 -33.43 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.358 -0.214 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -66.8 -34.48 77.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.176 0.443 . . . . 0.0 110.379 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.24 -32.99 63.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.28 -29.99 69.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.501 0.72 . . . . 0.0 111.862 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.61 -10.68 5.51 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.41 5.04 1.23 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -149.83 156.1 41.22 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -94.04 137.03 33.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.8 mt -90.04 135.1 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.299 24.7 m-85 -87.42 128.83 35.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.96 123.33 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.458 1.103 . . . . 0.0 108.578 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.05 34.41 4.2 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 112.562 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.47 8.8 70.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.459 -0.634 . . . . 0.0 114.105 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -136.05 148.91 66.7 Favored Pre-proline 0 N--CA 1.461 0.09 0 CA-C-N 118.355 1.078 . . . . 0.0 111.684 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.64 149.34 79.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.32 2.68 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.08 13.22 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.414 1.086 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -129.46 161.92 29.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.3 149.23 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.396 0.678 . . . . 0.0 110.894 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -154.2 167.66 29.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.97 150.79 47.31 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.39 -0.819 . . . . 0.0 109.103 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 40.9 t -84.21 160.02 20.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.941 0.496 . . . . 0.0 111.19 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.34 -2.66 17.08 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.2 t -133.91 152.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.248 0.619 . . . . 0.0 110.913 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -82.46 -2.7 54.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.47 0.708 . . . . 0.0 112.486 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -157.84 153.42 26.37 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.381 0.537 . . . . 0.0 111.608 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.6 mt -95.05 147.33 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.5 m -68.97 116.98 10.05 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -160.64 150.41 14.4 Favored Pre-proline 0 CA--C 1.528 0.117 0 C-N-CA 123.436 0.695 . . . . 0.0 109.976 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.63 -13.95 30.08 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.308 2.672 . . . . 0.0 111.722 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -73.78 -6.69 73.08 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.898 -0.39 . . . . 0.0 112.285 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -83.77 8.45 14.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.591 0.696 . . . . 0.0 110.307 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 41.3 t -149.99 151.41 33.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.539 -0.725 . . . . 0.0 111.228 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.319 0.8 OUTLIER 54.62 172.29 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.273 7.1 t0 61.78 -73.19 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.7 t -74.62 -27.29 60.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.236 -0.29 . . . . 0.0 111.227 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -77.87 157.4 29.87 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.868 0.467 . . . . 0.0 111.488 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 36.6 t 60.51 163.39 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.238 1.415 . . . . 0.0 113.374 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.78 9.14 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.93 0.892 . . . . 0.0 112.968 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -145.68 5.35 1.03 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.0 177.379 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 C5'-C4'-C3' 109.795 -3.803 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 1 O4'-C1'-N19 113.915 5.715 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 1 C5'-C4'-C3' 108.332 -4.779 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.53 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.413 -3.356 1 C5'-C4'-C3' 109.14 -4.24 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.254 1 C5'-C4'-C3' 108.624 -4.584 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . 0.401 ' C8 ' H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.901 0 C5'-C4'-C3' 109.644 -3.904 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 57.41 -179.14 0.06 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.297 1.039 . . . . 0.0 112.564 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -75.85 1.51 14.82 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.075 0.55 . . . . 0.0 112.147 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.264 38.9 t80 -62.72 148.54 46.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.76 156.09 36.39 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -66.36 124.38 87.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.15 -16.81 40.42 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.954 2.436 . . . . 0.0 112.502 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -98.3 4.34 48.71 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.113 0.565 . . . . 0.0 111.581 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -66.69 139.52 57.85 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.648 0.379 . . . . 0.0 110.731 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -91.77 148.48 37.24 Favored Pre-proline 0 CA--C 1.529 0.173 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.06 151.22 55.5 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.611 2.874 . . . . 0.0 110.86 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.46 144.39 57.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.014 0.435 . . . . 0.0 111.704 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.8 t -164.05 149.86 9.34 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.531 0.732 . . . . 0.0 109.753 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.89 -9.22 25.3 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.887 2.392 . . . . 0.0 110.033 172.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.12 142.88 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.637 0.775 . . . . 0.0 110.68 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.31 141.17 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.495 0.664 . . . . 0.0 111.817 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -104.93 137.47 42.64 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.397 1.879 . . . . 0.0 109.996 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -115.19 140.7 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.232 1.013 . . . . 0.0 110.004 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -141.71 154.8 45.54 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.12 0.568 . . . . 0.0 110.11 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.24 83.13 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.713 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.8 pp -73.18 174.96 7.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.872 0.836 . . . . 0.0 110.584 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.546 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.8 160.86 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.104 0.561 . . . . 0.0 110.087 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.68 -19.04 64.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.546 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -70.41 -10.78 67.03 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.092 0.377 . . . . 0.0 112.561 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.73 146.61 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.57 166.79 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 C-N-CA 124.098 0.959 . . . . 0.0 109.827 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.45 -32.73 70.49 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.248 -0.282 . . . . 0.0 111.2 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.38 72.0 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.212 0.205 . . . . 0.0 111.09 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -74.01 -30.19 62.33 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.74 -45.02 72.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.38 -34.65 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -74.96 -21.57 59.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.998 -0.438 . . . . 0.0 111.754 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.74 -17.02 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.4 -8.74 9.58 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.5 -21.97 66.68 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.112 0.869 . . . . 0.0 110.993 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.0 -12.37 61.56 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.142 -0.349 . . . . 0.0 111.485 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -91.3 -16.09 28.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.21 23.45 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.01 130.67 22.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.496 2.798 . . . . 0.0 110.764 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.0 mt -98.52 142.79 14.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.211 0.604 . . . . 0.0 110.894 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.4 t -104.7 -33.7 8.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.615 0.766 . . . . 0.0 112.278 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -165.0 157.04 15.54 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.69 151.37 16.64 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 123.911 0.884 . . . . 0.0 111.941 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.07 157.97 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.317 0.647 . . . . 0.0 111.804 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.05 141.94 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -133.05 82.66 53.96 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 123.288 0.635 . . . . 0.0 110.328 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.02 -10.17 27.63 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.919 2.413 . . . . 0.0 111.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -69.98 -24.49 63.32 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 117.841 0.291 . . . . 0.0 111.065 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -116.8 3.34 12.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.503 0.721 . . . . 0.0 111.769 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 57.3 51.12 10.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.31 170.93 15.06 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.966 0.906 . . . . 0.0 110.873 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.23 40.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.13 0.572 . . . . 0.0 110.537 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.51 150.89 49.97 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.34 144.56 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -125.35 133.08 52.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.852 0.461 . . . . 0.0 109.968 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -95.37 155.3 16.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -71.42 -14.51 62.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -143.61 143.54 31.53 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.566 1.546 . . . . 0.0 113.415 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.17 -21.9 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 0.0 111.658 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.69 -35.31 77.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.687 0.395 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.06 -38.88 55.01 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.82 85.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.013 0.435 . . . . 0.0 109.852 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.96 -33.61 68.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.218 0.607 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.41 -34.75 79.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.118 0.417 . . . . 0.0 111.015 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.57 68.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.494 -0.128 . . . . 0.0 111.107 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.6 -33.6 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.046 0 O-C-N 122.069 -0.395 . . . . 0.0 110.876 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -71.68 -30.8 66.1 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.031 -0.418 . . . . 0.0 110.566 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.75 -32.93 64.07 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.35 69.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.635 0.774 . . . . 0.0 111.5 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.96 -14.91 63.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -109.99 -27.18 9.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -160.01 153.86 22.93 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.101 0.56 . . . . 0.0 109.587 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.72 137.04 39.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -81.37 137.61 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.286 13.9 m-85 -90.45 130.8 36.48 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.7 mm -128.79 124.43 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.62 1.168 . . . . 0.0 108.072 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.46 34.56 6.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.192 0.597 . . . . 0.0 112.528 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.19 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.871 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -135.65 148.8 67.05 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 118.54 1.17 . . . . 0.0 111.4 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.15 149.82 81.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.175 2.583 . . . . 0.0 111.791 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.78 175.1 13.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.162 0.985 . . . . 0.0 109.888 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -128.12 159.71 34.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 144.56 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -146.47 164.37 32.73 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.465 1.106 . . . . 0.0 108.257 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -68.88 150.7 47.48 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.4 t -85.12 159.12 20.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.883 0.473 . . . . 0.0 111.475 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.87 -2.66 15.74 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.9 t -131.05 152.03 50.79 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.199 0.6 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -82.54 -4.22 57.22 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -158.56 150.37 21.25 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.401 0.546 . . . . 0.0 111.228 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.2 mt -90.36 146.9 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 41.6 t -65.69 136.17 55.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.92 -0.488 . . . . 0.0 110.517 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -91.29 162.95 30.76 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.093 0.557 . . . . 0.0 110.194 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.16 -13.73 41.15 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.718 2.945 . . . . 0.0 112.044 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.75 -3.35 0.08 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.358 -0.69 . . . . 0.0 112.916 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -65.45 -10.97 38.52 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t 55.19 13.54 0.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.251 1.02 . . . . 0.0 111.841 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.255 14.6 t70 61.3 -33.43 0.09 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.135 2.174 . . . . 0.0 116.293 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -68.17 -26.75 65.91 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.4 t -84.31 -24.45 29.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.325 0.25 . . . . 0.0 110.677 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -81.26 -25.43 36.58 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.961 0.505 . . . . 0.0 110.511 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.2 t 52.82 22.46 2.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.312 1.045 . . . . 0.0 112.593 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.315 0.4 OUTLIER 54.29 12.05 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -177.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -158.03 74.96 0.74 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.41 0.684 . . . . 0.0 109.368 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.58 -1.2 . . . . 0.0 111.789 179.695 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 C5'-C4'-C3' 110.071 -3.619 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 1 O4'-C1'-N19 114.25 6.05 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 1 C5'-C4'-C3' 108.453 -4.698 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.603 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.726 1 C5'-C4'-C3' 108.646 -4.569 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 O4'-C1'-N19 111.178 2.978 . 0.193 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 109.932 -3.712 . 0.318 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -69.15 158.95 33.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.885 0.474 . . . . 0.0 111.189 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -76.37 -2.8 33.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.057 0.543 . . . . 0.0 111.608 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -63.65 150.67 43.71 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -146.47 154.54 41.7 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -75.64 155.18 85.41 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.2 -16.36 45.88 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.168 2.579 . . . . 0.0 112.589 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -80.71 -5.84 57.6 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.769 0.828 . . . . 0.0 112.393 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -66.0 141.62 58.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.019 0.372 . . . . 0.0 110.442 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 p -74.24 141.28 77.22 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.68 159.11 35.43 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 124.144 3.23 . . . . 0.0 110.212 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.73 143.71 52.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 m -152.81 151.17 26.06 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 110.418 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 -1.84 11.76 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.905 3.07 . . . . 0.0 110.599 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.9 149.73 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.803 0.841 . . . . 0.0 112.391 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.41 146.84 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.778 0.799 . . . . 0.0 111.932 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -100.94 137.59 39.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.216 2.206 . . . . 0.0 110.058 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.71 140.65 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.429 1.092 . . . . 0.0 110.25 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -144.32 154.3 42.9 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.203 0.601 . . . . 0.0 110.155 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.48 82.69 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.717 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.1 pp -73.28 173.27 9.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.758 0.779 . . . . 0.0 110.398 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.545 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.19 160.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.022 0.529 . . . . 0.0 109.831 -178.177 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.15 -18.88 63.94 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.35 -10.96 75.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.784 -0.454 . . . . 0.0 112.609 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.68 146.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -132.66 167.1 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.483 1.113 . . . . 0.0 109.376 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -58.83 -32.55 69.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.149 -0.344 . . . . 0.0 111.399 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.18 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.473 0.309 . . . . 0.0 111.178 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -74.89 -31.44 61.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.0 mt -71.85 -40.58 68.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.247 0.219 . . . . 0.0 110.648 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -71.86 -34.79 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.04 -22.7 58.24 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 122.267 -0.271 . . . . 0.0 111.421 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.7 -17.07 24.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.92 -9.02 10.17 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.63 -21.73 66.6 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.852 0.751 . . . . 0.0 110.834 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.59 -12.27 61.46 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.066 -0.396 . . . . 0.0 111.262 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -90.58 -17.87 26.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.87 173.86 26.84 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.11 127.75 16.46 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.667 2.912 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 77.4 mt -95.34 142.95 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.07 0.548 . . . . 0.0 110.542 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.5 t -108.5 -33.21 7.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.23 0.612 . . . . 0.0 112.07 -176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -161.86 159.75 27.24 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.64 145.82 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.102 0.961 . . . . 0.0 109.413 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.78 154.21 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.567 0.747 . . . . 0.0 110.921 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.05 141.74 39.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -131.22 84.19 57.75 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 123.293 0.637 . . . . 0.0 110.221 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.41 -9.85 25.51 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.758 2.306 . . . . 0.0 110.452 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.26 -30.73 71.77 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.15 0.98 . . . . 0.0 110.22 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -117.02 3.73 12.76 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.261 1.025 . . . . 0.0 112.706 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 56.5 44.8 23.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.341 0.656 . . . . 0.0 110.585 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -140.48 169.54 17.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 110.431 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.36 40.84 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.874 0.47 . . . . 0.0 111.192 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.4 149.64 50.46 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -142.34 144.42 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.32 134.53 53.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.179 0.592 . . . . 0.0 109.936 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -98.77 154.92 17.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.15 -13.72 61.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.101 0.409 . . . . 0.0 110.691 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -141.28 143.1 33.9 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.219 1.407 . . . . 0.0 113.624 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.76 -22.04 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 111.557 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.7 tp -69.01 -36.53 77.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.378 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.37 -38.35 58.39 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.02 86.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.4 t -71.59 -33.78 69.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.258 0.623 . . . . 0.0 111.075 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.25 -34.55 78.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.107 0.412 . . . . 0.0 111.029 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.54 -40.13 70.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.316 -0.24 . . . . 0.0 110.829 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -75.13 -33.8 29.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 122.329 -0.232 . . . . 0.0 110.524 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.42 -29.58 66.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.055 0.389 . . . . 0.0 110.887 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -75.46 -33.05 60.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.44 71.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.236 0.614 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.99 2.83 3.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 112.455 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.48 -27.8 1.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.94 153.95 27.03 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -76.71 142.14 40.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.657 0.265 . . . . 0.0 110.671 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.6 mt -83.88 138.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.31 19.2 m-85 -91.37 129.12 37.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.73 123.49 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.508 1.123 . . . . 0.0 108.333 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.44 34.56 6.84 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.219 0.608 . . . . 0.0 112.241 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 9.44 74.75 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.079 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.0 148.94 66.92 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 118.418 1.109 . . . . 0.0 111.394 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.9 148.35 76.35 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.333 2.688 . . . . 0.0 111.278 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.93 175.0 13.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.228 1.011 . . . . 0.0 109.822 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -128.15 163.4 24.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.1 148.12 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.321 0.649 . . . . 0.0 111.56 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -155.1 166.5 33.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -68.62 151.01 47.31 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.413 -0.804 . . . . 0.0 112.351 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.2 t -84.7 164.9 18.31 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.773 0.32 . . . . 0.0 111.096 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.99 -2.9 19.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.3 t -137.99 156.6 47.67 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.094 0.558 . . . . 0.0 111.312 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -82.46 -0.05 44.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -157.56 154.77 29.09 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 118.281 0.491 . . . . 0.0 110.942 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -91.1 138.78 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.5 t -69.01 135.97 51.7 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.367 -0.208 . . . . 0.0 111.319 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 28.4 ptt-85 -164.43 149.34 8.51 Favored Pre-proline 0 C--O 1.231 0.099 0 C-N-CA 123.803 0.841 . . . . 0.0 109.473 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.98 -14.61 29.33 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.113 2.542 . . . . 0.0 111.309 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -75.48 -8.49 83.98 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.813 -0.437 . . . . 0.0 112.643 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -77.57 -4.73 47.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.976 0.888 . . . . 0.0 108.682 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.4 m 54.27 35.09 21.92 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.179 0.992 . . . . 0.0 112.637 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -55.04 160.03 2.19 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.285 6.2 t0 65.17 -58.33 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.7 m -77.56 9.84 3.05 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.747 0.819 . . . . 0.0 111.933 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -77.12 11.85 1.67 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.946 0.898 . . . . 0.0 113.043 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 73.7 m 52.47 28.54 6.02 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.862 0.465 . . . . 0.0 112.239 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.318 1.0 OUTLIER 55.47 14.19 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 178.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -148.86 -16.58 0.31 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.481 -1.247 . . . . 0.0 110.935 178.062 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.596 0 C5'-C4'-C3' 109.949 -3.701 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.89 1 O4'-C1'-N19 112.91 4.71 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 2 C5'-C4'-C3' 108.89 -4.407 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.573 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.104 1 C5'-C4'-C3' 108.39 -4.74 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 1 C5'-C4'-C3' 109.421 -4.052 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 C5'-C4'-C3' 110.589 -3.274 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.099 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 57.16 25.87 11.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.804 0.842 . . . . 0.0 111.715 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -66.85 157.2 33.65 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.918 -0.488 . . . . 0.0 111.125 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -68.77 158.57 34.07 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -70.98 160.28 33.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -63.89 124.7 85.92 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.9 -14.16 43.22 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.046 2.497 . . . . 0.0 112.952 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -86.62 -11.84 50.24 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.077 0.399 . . . . 0.0 111.939 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -79.51 132.27 36.27 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 117.892 0.314 . . . . 0.0 111.197 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 94' ' ' PRO . 1.1 p -132.33 153.11 81.12 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 124.296 1.039 . . . . 0.0 113.169 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 74.1 Cg_endo -69.93 154.39 67.13 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.119 2.546 . . . . 0.0 110.914 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.06 146.79 53.95 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.965 0.412 . . . . 0.0 111.87 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -153.63 151.99 26.35 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 123.748 0.819 . . . . 0.0 109.665 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.68 6.63 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.993 3.129 . . . . 0.0 110.908 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -137.62 147.47 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.23 148.12 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.934 0.873 . . . . 0.0 111.426 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -99.1 137.61 37.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.149 1.78 . . . . 0.0 109.866 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mt -114.6 140.47 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.487 0.715 . . . . 0.0 109.435 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -145.25 153.19 41.05 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.625 0.37 . . . . 0.0 110.613 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.16 90.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.684 -0.509 . . . . 0.0 112.766 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.23 172.46 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.91 157.29 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.331 0.653 . . . . 0.0 110.289 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.82 -22.42 66.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.83 -10.95 73.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.257 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.41 147.7 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -132.57 166.59 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.233 1.013 . . . . 0.0 109.804 174.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.42 -32.64 67.08 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 122.113 -0.367 . . . . 0.0 111.392 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -31.28 71.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.433 0.293 . . . . 0.0 111.184 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.04 -31.11 62.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.59 -43.06 73.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 121.937 0.095 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.03 -34.49 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.65 -22.08 57.1 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.949 0.34 . . . . 0.0 111.468 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.09 -17.38 26.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.79 -7.63 9.53 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -65.57 -21.71 66.62 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.17 0.895 . . . . 0.0 110.884 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.53 -12.26 61.45 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.214 -0.304 . . . . 0.0 111.488 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -92.05 -15.43 27.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.39 173.03 23.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.85 126.73 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.667 2.912 . . . . 0.0 110.804 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.3 mt -93.65 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.993 0.517 . . . . 0.0 110.616 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.6 -34.1 8.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.482 0.713 . . . . 0.0 111.761 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -166.36 159.0 14.35 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.41 151.19 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.23 1.012 . . . . 0.0 111.797 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.77 155.06 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.055 0.542 . . . . 0.0 111.355 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.16 141.76 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -133.87 87.41 35.49 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.457 0.703 . . . . 0.0 110.027 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.43 -12.71 36.73 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.944 2.429 . . . . 0.0 111.419 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.41 -23.85 65.6 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.894 0.478 . . . . 0.0 111.046 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.91 4.69 12.88 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.537 0.735 . . . . 0.0 112.258 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 tpp85 56.5 45.74 21.89 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.412 0.685 . . . . 0.0 110.473 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -140.5 165.59 27.03 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.892 0.877 . . . . 0.0 111.363 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.57 158.18 40.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.232 0.613 . . . . 0.0 110.647 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.06 149.88 50.19 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -143.41 139.82 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -121.74 140.91 51.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.83 0.452 . . . . 0.0 110.397 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -103.1 154.81 18.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -71.73 -13.54 61.75 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.665 0.211 . . . . 0.0 110.557 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -141.61 143.16 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.273 1.429 . . . . 0.0 113.553 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.07 -21.97 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.702 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -69.37 -35.34 75.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.748 0.419 . . . . 0.0 110.66 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.12 -38.92 59.16 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.43 83.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 109.996 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.9 t -70.39 -34.84 73.03 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.87 0.468 . . . . 0.0 110.867 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -66.3 -33.99 76.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.013 0.37 . . . . 0.0 110.928 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.32 69.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.545 0.157 . . . . 0.0 111.301 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.0 t -81.38 -33.56 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.941 0.337 . . . . 0.0 110.984 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.3 -30.64 67.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.253 -0.28 . . . . 0.0 110.741 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.83 -33.03 46.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.33 71.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.027 0.531 . . . . 0.0 110.795 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.26 4.5 3.6 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.442 0.697 . . . . 0.0 112.151 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.63 -27.8 1.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -155.74 155.58 33.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -76.73 135.63 39.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.635 0.255 . . . . 0.0 110.357 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.11 135.16 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 11.2 m-85 -85.85 130.46 34.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.4 mm -128.82 126.3 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.43 34.45 6.68 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.96 0.504 . . . . 0.0 112.048 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.63 9.62 80.97 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.053 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -136.09 148.94 66.76 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 118.558 1.179 . . . . 0.0 111.809 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.06 149.43 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.594 2.863 . . . . 0.0 111.718 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 170.92 19.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.282 1.033 . . . . 0.0 109.914 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -114.17 158.2 21.63 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.61 142.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.583 0.753 . . . . 0.0 109.969 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -155.55 167.64 29.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.72 147.82 51.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.392 -0.817 . . . . 0.0 110.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -77.09 152.46 35.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.225 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -71.03 -2.77 16.55 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 72.8 m -127.85 155.18 44.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.183 0.993 . . . . 0.0 109.642 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -83.92 -4.99 59.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.84 156.79 25.65 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.624 0.647 . . . . 0.0 111.516 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.6 mt -90.4 141.16 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 46.7 t -67.88 116.8 8.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.446 ' H ' ' HB2' ' A' ' 179' ' ' ASP . 68.0 mmt-85 -76.5 164.09 61.86 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.56 -1.28 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.169 3.246 . . . . 0.0 113.602 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -154.96 21.85 0.59 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.461 0.553 . . . . 0.0 112.021 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 176' ' ' ARG . 11.1 t0 -60.51 -29.89 69.38 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.5 m 56.62 -177.18 0.05 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.415 1.086 . . . . 0.0 113.054 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -158.28 177.3 11.43 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.21 0.9 1.76 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 44.7 t -153.07 -16.69 0.15 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -72.12 141.71 49.16 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 118.377 0.535 . . . . 0.0 109.918 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.4 t -72.92 146.49 46.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.301 0.24 . . . . 0.0 111.047 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.56 -18.56 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -87.84 1.72 53.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.236 0.615 . . . . 0.0 111.468 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.505 -1.236 . . . . 0.0 110.991 179.873 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 C5'-C4'-C3' 109.632 -3.912 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.97 1 O4'-C1'-N19 112.909 4.709 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 1 C5'-C4'-C3' 108.649 -4.567 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.606 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 C5'-C4'-C3' 109.271 -4.153 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.633 0 O4'-C1'-N19 111.697 3.497 . 0.201 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.814 0 C5'-C4'-C3' 110.405 -3.396 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.091 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -71.9 -9.61 58.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.983 0.391 . . . . 0.0 111.041 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -138.95 164.62 29.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.687 1.195 . . . . 0.0 109.11 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.252 11.9 t80 -61.86 147.33 46.93 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -147.04 153.65 40.26 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -66.71 144.82 98.79 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.81 -9.97 22.86 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.772 2.981 . . . . 0.0 111.67 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -76.38 -12.5 60.07 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.878 0.471 . . . . 0.0 111.574 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.67 135.13 46.74 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.433 0.293 . . . . 0.0 110.581 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -85.08 148.15 49.7 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.42 158.47 48.04 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.722 2.948 . . . . 0.0 110.931 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.94 150.27 45.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.905 0.383 . . . . 0.0 111.331 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 t -161.59 148.47 11.48 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.296 0.638 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.87 -7.68 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.1 2.533 . . . . 0.0 110.037 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.0 t -106.08 141.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.121 0.969 . . . . 0.0 110.569 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.95 142.44 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 121.802 0.811 . . . . 0.0 112.242 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -99.68 137.67 37.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.857 1.663 . . . . 0.0 110.383 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.53 140.54 36.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.63 0.772 . . . . 0.0 109.782 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -143.26 153.03 42.38 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.734 0.414 . . . . 0.0 110.491 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.49 6.13 89.47 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.65 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.33 170.07 12.56 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.584 0.692 . . . . 0.0 110.854 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -93.39 153.93 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.996 0.518 . . . . 0.0 110.328 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.12 -22.29 65.81 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.57 -10.72 82.86 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.616 0.626 . . . . 0.0 112.486 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.3 147.83 10.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.53 168.14 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.974 0.91 . . . . 0.0 109.866 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.3 -32.74 68.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.169 -0.332 . . . . 0.0 111.369 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.41 72.13 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.152 0.181 . . . . 0.0 111.125 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.18 -31.46 62.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.24 -42.85 68.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.053 0.141 . . . . 0.0 110.776 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.93 -34.58 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -75.44 -22.89 56.97 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.137 -0.352 . . . . 0.0 111.256 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.66 -17.07 27.47 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -120.68 -8.45 9.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.11 -21.84 66.37 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.083 0.856 . . . . 0.0 110.979 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.48 -11.27 60.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.48 0.312 . . . . 0.0 111.584 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.72 -14.94 25.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.29 23.97 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.35 125.86 13.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.067 2.512 . . . . 0.0 110.678 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -93.31 142.67 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.875 0.47 . . . . 0.0 110.197 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.2 t -101.51 -34.2 9.64 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.06 0.544 . . . . 0.0 111.491 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -167.18 160.73 14.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.91 150.73 19.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.61 1.164 . . . . 0.0 111.929 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.09 155.8 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.108 0.563 . . . . 0.0 111.412 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.05 141.93 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.103 0.561 . . . . 0.0 112.363 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.77 79.32 72.08 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.837 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.61 -25.95 77.05 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.0 113.755 -175.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.407 ' H ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.41 -12.0 61.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.408 0.549 . . . . 0.0 111.277 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -116.76 2.89 12.95 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.523 0.729 . . . . 0.0 112.327 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 58.77 38.97 24.68 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.259 0.624 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -140.81 167.28 22.55 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 112.114 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.18 40.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.286 0.634 . . . . 0.0 111.089 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.52 152.14 47.97 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -144.77 144.49 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -124.13 138.03 54.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.41 154.12 18.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.43 -15.41 62.34 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.125 -0.359 . . . . 0.0 110.148 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -139.24 142.94 37.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.487 1.515 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.53 -21.77 28.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 120.774 0.321 . . . . 0.0 111.583 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -69.94 -35.25 74.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.107 0.563 . . . . 0.0 110.79 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.9 -37.9 56.5 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 109.86 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.9 t -69.9 -34.82 74.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.168 0.587 . . . . 0.0 110.832 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.78 -34.54 78.05 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 117.973 0.351 . . . . 0.0 111.182 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.52 0.146 . . . . 0.0 111.38 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.32 -33.77 12.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 O-C-N 122.111 -0.368 . . . . 0.0 110.856 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -69.94 -33.12 71.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.955 -0.466 . . . . 0.0 110.528 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -77.34 -33.0 55.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.24 71.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.359 0.663 . . . . 0.0 111.188 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.01 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.545 0.338 . . . . 0.0 111.865 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.7 -23.58 10.98 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.99 155.34 25.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.28 0.632 . . . . 0.0 109.467 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -76.79 133.98 39.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.14 134.49 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.285 10.9 m-85 -84.7 129.83 34.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.3 mm -129.02 126.12 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.737 1.215 . . . . 0.0 107.898 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.31 34.42 6.33 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.058 0.543 . . . . 0.0 112.3 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.48 79.86 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.231 -0.76 . . . . 0.0 114.35 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.3 149.05 66.7 Favored Pre-proline 0 CA--C 1.528 0.125 0 CA-C-N 118.481 1.14 . . . . 0.0 111.767 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.64 151.05 85.74 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.491 2.794 . . . . 0.0 111.881 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 173.41 15.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.329 1.052 . . . . 0.0 109.889 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.32 156.98 27.95 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.3 144.89 25.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.582 0.753 . . . . 0.0 110.841 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -155.02 168.91 25.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.72 148.6 50.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.403 -0.811 . . . . 0.0 110.501 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.3 t -78.05 154.75 31.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 111.021 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.4 t -71.98 -2.62 18.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -130.68 149.25 52.42 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.01 0.924 . . . . 0.0 110.051 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -83.59 -2.73 56.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.981 0.512 . . . . 0.0 111.615 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -149.25 150.57 32.79 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.063 0.545 . . . . 0.0 112.008 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.479 HG22 ' H ' ' A' ' 176' ' ' ARG . 48.4 mt -100.51 155.29 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.6 t -63.58 -30.82 71.88 Favored 'General case' 0 C--O 1.23 0.048 0 O-C-N 121.711 -0.618 . . . . 0.0 112.177 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.479 ' H ' HG22 ' A' ' 174' ' ' ILE . 74.7 mtm-85 42.64 66.31 4.41 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 124.565 1.146 . . . . 0.0 112.358 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.26 -15.7 50.96 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.708 2.272 . . . . 0.0 111.38 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.49 -3.6 81.17 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.462 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.4 -8.67 58.07 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 32.9 t 51.87 52.23 14.93 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.12 0.968 . . . . 0.0 112.113 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -58.36 163.06 3.24 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -66.42 -7.9 22.39 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 97.9 p -102.84 -11.3 18.39 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.424 0.689 . . . . 0.0 111.235 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.7 -8.89 25.4 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.131 0.572 . . . . 0.0 111.39 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 37.0 t -156.67 164.06 38.58 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.918 0.487 . . . . 0.0 110.339 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.264 1.0 OUTLIER 59.29 5.25 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -178.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -145.9 7.56 1.08 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.621 0.769 . . . . 0.0 111.803 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.649 -1.167 . . . . 0.0 110.821 -178.833 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 C5'-C4'-C3' 109.812 -3.792 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . 0.401 H5'' ' C8 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.62 1 O4'-C1'-N19 112.622 4.422 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.06 0 C5'-C4'-C3' 111.79 -2.473 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.535 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.932 1 C5'-C4'-C3' 108.982 -4.345 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 1 C5'-C4'-C3' 108.275 -4.816 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 O4'-C1'-N19 111.587 3.387 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.189 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -151.27 158.33 43.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.904 0.481 . . . . 0.0 110.03 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -152.64 37.62 0.52 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.65 0.38 . . . . 0.0 109.988 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.261 10.7 t80 -138.65 141.21 39.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -120.58 144.43 48.11 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 35.4 p30 -137.81 168.28 16.95 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 89' ' ' ASP . 73.5 Cg_endo -70.74 -3.06 11.9 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.631 2.221 . . . . 0.0 113.273 -174.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -102.26 -10.37 19.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.302 0.501 . . . . 0.0 111.429 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -72.23 152.88 41.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.723 0.809 . . . . 0.0 110.971 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -72.75 149.72 90.55 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.07 153.89 46.97 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.675 2.917 . . . . 0.0 110.26 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.18 146.01 52.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.0 m -153.53 152.43 27.36 Favored Pre-proline 0 CA--C 1.528 0.13 0 C-N-CA 123.234 0.614 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.47 3.59 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.928 3.085 . . . . 0.0 110.646 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.91 148.38 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.72 146.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 121.659 0.743 . . . . 0.0 110.672 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -101.37 137.48 39.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.093 1.757 . . . . 0.0 110.562 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.5 mt -114.75 140.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.174 0.99 . . . . 0.0 109.651 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -147.29 152.82 38.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.328 0.651 . . . . 0.0 110.233 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.28 78.65 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.932 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.27 176.79 6.34 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.081 0.94 . . . . 0.0 111.271 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.483 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -110.2 154.4 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 123.194 0.598 . . . . 0.0 109.522 177.462 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -69.43 -4.47 18.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -76.75 -10.86 85.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.02 148.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.57 168.42 24.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 123.984 0.914 . . . . 0.0 109.533 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.75 -32.67 69.47 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.158 -0.339 . . . . 0.0 111.496 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -31.42 72.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.329 0.252 . . . . 0.0 111.123 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.1 -30.59 60.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -72.27 -42.18 65.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.51 -34.61 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -75.19 -23.98 57.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.125 -0.359 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.35 -17.05 31.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.4 mt -123.77 -9.14 7.84 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.96 -21.79 66.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.258 0.936 . . . . 0.0 110.632 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -11.74 61.12 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.154 -0.342 . . . . 0.0 111.389 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -92.26 -15.08 27.94 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.13 173.47 24.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.42 127.18 15.27 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.426 2.75 . . . . 0.0 110.621 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.1 mt -93.56 140.96 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.843 0.457 . . . . 0.0 110.327 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.3 t -102.12 -34.09 9.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.729 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -163.48 161.48 24.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.5 t -145.66 145.27 20.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.009 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.63 153.42 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.168 0.587 . . . . 0.0 111.206 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.28 141.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.261 0.624 . . . . 0.0 111.495 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.11 89.55 23.55 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.736 0.414 . . . . 0.0 110.435 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -6.55 17.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.885 2.39 . . . . 0.0 110.809 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -64.03 -34.41 77.95 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.387 0.675 . . . . 0.0 110.313 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -117.0 7.25 13.09 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.884 0.874 . . . . 0.0 112.471 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 57.73 52.96 7.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.398 0.679 . . . . 0.0 110.76 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -144.69 169.59 17.72 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.471 0.709 . . . . 0.0 111.57 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.62 158.32 40.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.444 0.698 . . . . 0.0 110.324 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.0 152.29 51.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.015 0.435 . . . . 0.0 110.463 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.9 t -143.57 140.58 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -122.39 138.08 54.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -99.09 154.8 17.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -72.33 -14.2 61.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.872 0.305 . . . . 0.0 110.236 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -139.06 143.23 38.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.051 1.34 . . . . 0.0 113.142 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.21 -23.05 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.695 0.283 . . . . 0.0 111.282 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.6 tp -68.05 -35.53 78.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.766 0.427 . . . . 0.0 110.432 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.27 -37.36 59.36 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.55 88.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 96.7 m -70.96 -30.12 66.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -67.62 -35.63 79.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.174 0.443 . . . . 0.0 110.892 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.61 76.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 121.299 -0.16 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 -33.48 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.705 0.23 . . . . 0.0 111.492 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.8 -31.68 70.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.992 0.36 . . . . 0.0 110.651 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -75.05 -32.87 61.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.24 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.34 0.656 . . . . 0.0 111.025 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.44 5.5 1.76 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 112.333 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -135.93 -29.52 1.02 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -156.64 153.54 28.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.77 140.53 40.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.8 135.18 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.288 10.1 m-85 -84.87 129.5 34.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.4 mm -126.25 121.55 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.464 1.106 . . . . 0.0 108.359 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.33 33.96 2.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.67 0.788 . . . . 0.0 112.172 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 89.58 12.26 62.94 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.34 0.495 . . . . 0.0 112.738 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -136.22 139.4 29.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.552 0.741 . . . . 0.0 110.516 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.37 143.57 58.58 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.335 2.69 . . . . 0.0 112.183 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.74 174.41 12.21 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.521 0.729 . . . . 0.0 110.111 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -120.14 158.77 26.22 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.28 148.71 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.648 0.779 . . . . 0.0 111.03 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -155.2 170.07 22.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -68.6 145.2 54.16 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.544 -0.722 . . . . 0.0 109.489 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.4 t -74.67 154.29 38.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.34 -2.78 17.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.2 t -129.07 156.2 44.23 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.213 1.005 . . . . 0.0 110.018 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -84.91 -6.51 59.34 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -161.03 156.58 24.87 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.742 0.701 . . . . 0.0 111.734 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 45.6 mt -93.97 143.51 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.1 t -67.37 122.59 18.25 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 122.126 -0.359 . . . . 0.0 110.881 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -81.51 156.47 70.87 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 123.127 0.571 . . . . 0.0 110.244 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.3 -16.38 31.36 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.954 2.436 . . . . 0.0 110.716 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.42 135.04 1.84 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -106.57 -1.79 22.56 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 74.3 m -149.08 157.14 43.16 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.443 0.697 . . . . 0.0 110.968 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.14 101.9 2.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 51.52 24.01 2.09 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 69.0 m 53.34 33.09 14.93 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.82 0.448 . . . . 0.0 110.874 -174.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -78.22 154.13 31.32 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.115 0.966 . . . . 0.0 111.512 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.3 m 52.85 38.42 26.68 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.14 -14.65 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -151.37 24.28 0.71 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.823 0.449 . . . . 0.0 110.557 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.247 0.948 0 CA-C-O 117.347 -1.311 . . . . 0.0 110.656 -179.066 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C5'-C4'-C3' 109.672 -3.885 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.853 0 O4'-C1'-N19 111.657 3.457 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 1 C5'-C4'-C3' 108.825 -4.45 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.609 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.711 1 C5'-C4'-C3' 108.395 -4.737 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O4'-C1'-N19 111.006 2.806 . 0.19 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.912 0 C5'-C4'-C3' 110.436 -3.376 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 87' ' ' TYR . 42.7 tp10 -69.59 150.45 47.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.573 0.349 . . . . 0.0 110.337 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -74.81 4.67 6.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.13 0.572 . . . . 0.0 111.722 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.444 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 16.4 t80 -143.35 151.01 39.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -157.04 166.03 34.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -136.91 157.36 74.91 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -61.92 -13.54 31.66 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.725 2.95 . . . . 0.0 113.072 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.14 -9.37 59.14 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.081 0.552 . . . . 0.0 112.274 -177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -71.48 145.08 49.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.774 0.43 . . . . 0.0 110.835 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.82 148.05 36.29 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.57 145.49 42.13 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.3 2.667 . . . . 0.0 110.795 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.12 141.31 57.47 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.6 m -155.64 156.27 30.55 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.269 1.028 . . . . 0.0 109.799 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.68 0.14 8.59 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.828 3.019 . . . . 0.0 110.917 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.05 145.6 33.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.67 147.26 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.451 0.643 . . . . 0.0 111.647 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -105.86 137.52 43.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.316 1.846 . . . . 0.0 110.046 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.43 140.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 124.234 1.014 . . . . 0.0 109.749 -174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -142.75 153.68 43.53 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.193 0.597 . . . . 0.0 110.159 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.07 0.12 81.18 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.694 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 104' ' ' LEU . 4.0 pp -74.12 173.5 10.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 110.818 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -110.23 157.34 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-O 121.359 0.599 . . . . 0.0 109.599 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -68.87 -5.18 19.59 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.4 -10.76 86.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 176.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 p -65.31 146.72 13.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.67 169.39 22.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 124.383 1.073 . . . . 0.0 109.8 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.15 -32.71 70.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.176 -0.328 . . . . 0.0 111.516 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.57 -31.31 71.29 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.479 0.312 . . . . 0.0 111.045 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -74.1 -31.42 62.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.01 -43.6 71.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.47 -34.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.27 -22.98 57.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.972 0.351 . . . . 0.0 111.435 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.26 26.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.8 mt -122.44 -7.58 8.66 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.55 -21.83 66.15 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.278 0.944 . . . . 0.0 110.725 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.27 -10.6 59.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.507 0.323 . . . . 0.0 111.441 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.09 -14.34 27.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.21 175.05 24.19 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.53 125.2 12.47 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.498 2.799 . . . . 0.0 110.496 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -93.47 141.62 14.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.877 0.471 . . . . 0.0 110.391 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 t -101.18 -34.15 9.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.466 0.706 . . . . 0.0 111.76 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -167.21 160.46 13.72 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.15 150.31 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.165 0.986 . . . . 0.0 111.822 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.59 156.57 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.086 0.554 . . . . 0.0 111.683 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.6 141.84 38.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.99 78.42 65.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 122.863 0.465 . . . . 0.0 110.813 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.64 -16.31 42.42 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.437 2.758 . . . . 0.0 111.566 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -64.39 -28.22 69.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 111.319 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -116.88 5.03 12.93 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.124 0.57 . . . . 0.0 111.933 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 56.77 51.75 10.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.72 0.808 . . . . 0.0 110.743 -176.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -145.06 171.27 14.71 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.901 0.88 . . . . 0.0 110.671 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.56 158.12 40.76 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.992 0.517 . . . . 0.0 110.521 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -129.86 152.05 49.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.152 0.501 . . . . 0.0 110.056 176.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.38 142.03 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -122.29 139.1 54.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -102.32 155.98 17.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -71.58 -11.4 60.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.75 0.25 . . . . 0.0 110.622 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -143.52 145.59 32.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.646 1.578 . . . . 0.0 112.843 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.08 -24.99 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.0 tp -65.05 -36.31 83.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.204 -0.31 . . . . 0.0 110.896 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.61 -37.3 61.94 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.68 89.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 93.5 m -68.95 -32.35 71.87 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.491 0.316 . . . . 0.0 111.614 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.49 -32.98 74.18 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.901 0.318 . . . . 0.0 111.196 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.94 67.47 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.374 -0.204 . . . . 0.0 111.239 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.5 t -81.45 -37.78 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.968 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -74.43 -19.24 60.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.895 0.77 . . . . 0.0 111.396 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -81.08 -33.02 33.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.17 70.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.163 0.585 . . . . 0.0 110.969 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.95 -9.17 19.35 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -140.87 -0.31 1.51 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -159.02 149.06 19.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.76 138.39 39.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.8 mt -91.54 133.63 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.297 16.9 m-85 -84.84 130.87 34.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.3 mm -128.96 124.54 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.496 1.118 . . . . 0.0 108.228 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.12 34.55 5.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.237 0.615 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.75 74.3 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.86 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -135.76 148.95 67.46 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 118.38 1.09 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -67.47 150.68 80.52 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.54 2.827 . . . . 0.0 111.504 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 174.96 13.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.168 0.987 . . . . 0.0 109.925 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -128.02 157.15 41.42 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.6 t -141.94 139.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -148.21 167.84 24.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.517 1.527 . . . . 0.0 108.431 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -68.89 151.59 46.37 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.7 t -81.9 158.0 24.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.883 0.473 . . . . 0.0 110.842 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -9.29 55.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -108.14 161.67 14.76 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.756 0.822 . . . . 0.0 110.173 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -94.12 -5.5 47.11 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -163.1 156.49 19.56 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.376 0.534 . . . . 0.0 111.325 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 72.9 mt -88.32 140.37 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.6 m -75.56 89.76 2.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.49 0.316 . . . . 0.0 110.975 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -69.21 154.0 95.41 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.83 -18.64 52.94 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.934 2.423 . . . . 0.0 110.944 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.67 -8.43 62.24 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.462 178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -79.43 0.87 27.62 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 40.4 t -69.28 146.05 52.58 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.694 0.398 . . . . 0.0 111.23 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -73.32 -7.54 52.0 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -69.98 -9.91 56.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.2 t -72.69 -14.32 61.55 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.183 0.593 . . . . 0.0 111.09 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 40.0 ttm105 -59.12 128.25 36.26 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.147 0.579 . . . . 0.0 110.38 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.5 m 52.3 11.24 0.16 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.24 1.016 . . . . 0.0 113.369 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.269 0.9 OUTLIER 56.82 14.4 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -154.83 8.19 0.3 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.252 1.203 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.781 179.606 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 0 O4'-C1'-N19 110.736 2.536 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 1 O4'-C1'-N19 113.432 5.232 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.458 1 C5'-C4'-C3' 108.131 -4.913 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.608 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.631 1 C5'-C4'-C3' 108.658 -4.562 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.626 0 O4'-C1'-N19 111.165 2.965 . 0.156 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 C5'-C4'-C3' 110.755 -3.163 . 0.29 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.021 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.75 -11.35 60.77 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.889 0.476 . . . . 0.0 111.444 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -75.88 -4.54 41.43 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.132 0.573 . . . . 0.0 112.148 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -68.43 140.96 55.79 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -120.98 146.09 47.05 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -69.42 124.52 90.66 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.2 -16.64 40.05 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.945 2.43 . . . . 0.0 112.493 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -92.09 0.92 57.47 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.961 0.504 . . . . 0.0 111.546 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.39 135.95 49.21 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.231 -0.293 . . . . 0.0 111.224 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 94' ' ' PRO . 1.2 p -132.49 154.66 81.62 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.487 1.115 . . . . 0.0 112.732 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 60.0 Cg_endo -67.06 148.87 82.19 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.663 2.242 . . . . 0.0 110.44 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.68 146.39 53.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.893 0.378 . . . . 0.0 111.587 -176.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.6 m -153.59 153.16 28.65 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 124.146 0.978 . . . . 0.0 109.457 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.26 -0.28 9.86 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 110.727 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 1.9 p -123.16 145.09 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.48 147.32 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.71 0.767 . . . . 0.0 110.529 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -101.14 137.78 39.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.278 1.831 . . . . 0.0 110.697 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.1 mt -114.62 140.52 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 123.506 0.722 . . . . 0.0 109.741 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -145.9 152.7 39.87 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.458 0.703 . . . . 0.0 110.295 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.82 85.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.644 -0.531 . . . . 0.0 112.608 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.8 pp -70.08 175.16 4.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.65 0.725 . . . . 0.0 110.687 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.59 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.44 160.93 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 CA-C-O 121.366 0.603 . . . . 0.0 110.089 -178.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -66.77 -9.58 38.35 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.59 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.33 -10.98 85.78 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.032 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.4 p -63.97 145.05 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 m -132.73 166.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.138 0.975 . . . . 0.0 109.557 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.96 -32.82 69.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.254 -0.279 . . . . 0.0 111.145 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.39 71.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.381 0.272 . . . . 0.0 111.172 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.18 -29.06 62.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.28 -44.26 68.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.5 -34.72 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.76 -22.37 58.82 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.035 -0.415 . . . . 0.0 111.454 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.45 -17.12 24.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.1 mt -121.68 -7.45 9.08 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.85 -21.79 66.49 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -70.24 -11.54 60.97 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.659 -0.21 . . . . 0.0 111.475 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -92.27 -14.48 28.83 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.73 173.37 22.78 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.29 129.06 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.612 2.874 . . . . 0.0 110.468 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.29 141.57 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.202 0.601 . . . . 0.0 110.712 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.2 t -101.14 -34.12 9.83 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.457 0.703 . . . . 0.0 112.205 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -166.53 158.27 13.3 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.52 148.97 20.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.046 0.938 . . . . 0.0 112.083 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.23 156.34 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.282 0.633 . . . . 0.0 111.181 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.14 141.74 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -131.05 82.02 64.92 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 123.215 0.606 . . . . 0.0 110.078 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.39 -8.67 21.36 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.223 2.615 . . . . 0.0 110.39 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.23 -29.73 69.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.882 0.873 . . . . 0.0 110.579 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -116.99 5.29 12.84 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.895 0.878 . . . . 0.0 113.09 176.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 58.17 48.64 12.53 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.449 0.7 . . . . 0.0 110.891 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -144.81 170.39 16.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.504 0.722 . . . . 0.0 111.488 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.34 40.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.287 0.635 . . . . 0.0 110.67 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.33 151.93 51.06 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.949 0.404 . . . . 0.0 110.166 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.94 144.01 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 tt0 -126.02 137.7 53.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.557 0.343 . . . . 0.0 110.193 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.34 156.4 16.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -72.04 -14.05 61.77 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.221 -0.299 . . . . 0.0 110.224 175.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -139.79 143.12 36.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.251 1.42 . . . . 0.0 113.3 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.04 -21.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 111.565 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.4 tp -69.27 -36.29 76.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.941 0.496 . . . . 0.0 110.682 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -37.7 57.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.22 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.53 -33.03 70.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.445 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.84 -33.82 76.45 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.062 -0.399 . . . . 0.0 110.851 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.82 70.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.488 0.131 . . . . 0.0 111.2 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.43 -35.15 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 122.198 -0.314 . . . . 0.0 111.441 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -70.76 -28.42 64.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.054 0.388 . . . . 0.0 111.688 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -76.4 -33.1 58.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.52 71.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.07 0.548 . . . . 0.0 110.662 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.59 3.42 6.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.352 0.661 . . . . 0.0 112.117 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -132.26 -29.64 1.59 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -154.25 149.22 26.75 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.95 132.87 39.27 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.169 -0.332 . . . . 0.0 110.255 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.4 mt -81.18 145.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 C-N-CA 122.68 0.392 . . . . 0.0 110.079 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.252 19.9 m-85 -100.05 132.25 45.53 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 175.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.9 mm -128.97 126.99 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.57 34.39 6.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.176 0.59 . . . . 0.0 112.406 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.04 79.21 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.731 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -136.14 148.88 66.42 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 118.439 1.119 . . . . 0.0 111.529 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.5 143.56 69.64 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.717 2.945 . . . . 0.0 111.285 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.15 26.72 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.852 0.861 . . . . 0.0 110.456 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -112.2 159.21 18.79 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.6 t -141.11 142.5 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.688 0.795 . . . . 0.0 110.964 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -156.31 166.34 33.73 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -68.85 150.91 47.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.5 t -82.8 158.64 22.7 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.128 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.15 -2.68 10.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.3 t -124.04 160.42 27.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.085 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -89.39 -5.56 57.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -162.39 154.19 18.53 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.542 0.61 . . . . 0.0 111.188 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.56 143.83 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.2 t -67.29 -29.6 69.23 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 57.05 175.06 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.532 0.733 . . . . 0.0 111.745 -176.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -60.5 -21.38 68.06 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.917 1.744 . . . . 0.0 110.291 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.61 123.95 0.91 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 108.429 -1.869 . . . . 0.0 108.429 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -83.23 -6.28 59.42 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.9 m -64.37 117.22 6.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 53.61 19.83 1.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.6 t0 58.09 94.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 65.6 m 55.73 21.3 4.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.275 1.03 . . . . 0.0 113.629 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -78.71 -15.97 57.81 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.017 -0.427 . . . . 0.0 111.337 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 58.4 m -149.73 -179.96 7.53 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.731 0.812 . . . . 0.0 110.807 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.262 1.4 t 62.34 24.38 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.1 p30 -149.06 13.13 0.87 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.812 0.445 . . . . 0.0 111.656 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.325 -1.322 . . . . 0.0 111.08 -179.732 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.727 0 C5'-C4'-C3' 109.56 -3.96 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 O4'-C1'-N19 111.699 3.499 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.447 1 C5'-C4'-C3' 109.12 -4.253 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.592 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.96 1 C5'-C4'-C3' 108.618 -4.588 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 1 C5'-C4'-C3' 108.503 -4.664 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 110.912 2.712 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.155 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -153.46 148.0 26.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.517 0.727 . . . . 0.0 109.972 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 58.19 176.26 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.337 1.055 . . . . 0.0 112.572 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -146.32 154.14 41.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -153.94 158.05 40.09 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -63.52 147.42 95.45 Favored Pre-proline 0 CA--C 1.529 0.146 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.17 -13.59 28.49 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.279 2.653 . . . . 0.0 111.291 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -78.15 -7.34 56.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.166 0.586 . . . . 0.0 111.673 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -68.47 151.4 46.86 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.97 0.508 . . . . 0.0 110.351 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.83 148.32 61.99 Favored Pre-proline 0 C--O 1.232 0.154 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.83 158.87 46.09 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.583 2.855 . . . . 0.0 110.746 -178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.63 148.4 51.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.573 0.349 . . . . 0.0 111.366 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -152.83 152.32 28.17 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 109.657 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.97 -3.7 14.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.399 2.732 . . . . 0.0 110.458 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.63 149.48 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.991 0.916 . . . . 0.0 112.246 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 m -132.71 148.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.56 0.695 . . . . 0.0 112.043 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.068 1.747 . . . . 0.0 109.77 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.34 140.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.228 1.011 . . . . 0.0 109.575 -174.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -143.01 152.71 42.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.89 0.476 . . . . 0.0 111.063 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.02 5.01 71.22 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.659 -0.523 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -82.76 -175.78 5.96 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.964 0.882 . . . . 0.0 109.58 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.54 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -122.02 158.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.82 -3.52 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -79.42 -10.96 85.4 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.99 148.63 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.56 168.77 23.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.255 1.022 . . . . 0.0 110.258 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.8 -33.0 68.1 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.241 -0.287 . . . . 0.0 111.176 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.55 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 -33.83 66.62 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.54 -39.86 64.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.935 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.54 -34.35 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -75.39 -25.66 57.8 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.019 -0.426 . . . . 0.0 111.187 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.06 -17.13 33.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.76 -9.47 8.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.44 -21.91 66.21 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.208 0.913 . . . . 0.0 110.974 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.55 -11.49 60.96 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.422 -0.174 . . . . 0.0 111.372 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.47 -16.15 26.19 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.5 172.33 23.72 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.86 126.41 14.56 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.58 2.853 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.99 142.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.183 0.593 . . . . 0.0 110.331 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -106.24 -34.15 7.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.661 0.784 . . . . 0.0 111.764 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -162.75 161.42 26.25 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -146.75 144.04 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.918 0.887 . . . . 0.0 109.389 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.71 150.8 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.19 0.596 . . . . 0.0 111.774 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.45 141.74 45.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -131.65 76.48 74.69 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.544 0.737 . . . . 0.0 109.493 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.22 -12.5 35.08 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.217 2.611 . . . . 0.0 111.156 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -67.38 -23.11 65.54 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.487 0.715 . . . . 0.0 111.138 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.91 6.82 13.11 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.363 0.665 . . . . 0.0 112.756 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.45 43.46 28.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.364 0.529 . . . . 0.0 111.326 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -139.62 163.9 31.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.207 0.603 . . . . 0.0 111.096 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.65 158.22 40.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.103 0.561 . . . . 0.0 110.066 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.9 mp -124.33 149.26 46.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.6 t -141.88 143.47 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -121.76 135.03 54.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.296 0.638 . . . . 0.0 109.897 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -99.81 154.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -72.07 -13.42 61.58 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.199 -0.313 . . . . 0.0 110.17 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -142.24 143.1 32.71 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.341 1.456 . . . . 0.0 113.57 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.8 p -63.42 -21.9 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.15 -34.8 75.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.945 0.498 . . . . 0.0 110.733 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -38.99 55.83 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.22 -37.61 87.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.092 0.472 . . . . 0.0 109.857 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.08 -36.7 77.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.373 0.669 . . . . 0.0 110.613 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -65.05 -33.67 76.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.107 -0.371 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.01 -38.7 72.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.675 0.216 . . . . 0.0 110.977 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.2 t -75.81 -33.43 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 122.201 -0.312 . . . . 0.0 111.079 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.84 -26.6 64.3 Favored 'General case' 0 C--O 1.231 0.096 0 O-C-N 122.002 -0.436 . . . . 0.0 111.641 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -77.38 -33.06 55.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.2 71.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.036 0.535 . . . . 0.0 110.81 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.88 3.14 2.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.538 0.735 . . . . 0.0 112.244 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -133.8 -28.91 1.36 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -157.53 152.41 25.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.84 139.36 40.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.7 mt -83.31 135.08 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 20.4 m-85 -89.01 129.62 35.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.3 mm -129.14 123.57 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.528 1.131 . . . . 0.0 108.773 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.41 34.55 6.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.6 74.74 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.837 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -135.78 148.8 66.78 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 118.248 1.024 . . . . 0.0 111.192 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.92 150.35 78.17 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 0.0 111.189 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 175.09 13.26 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 110.115 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -130.12 162.21 29.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.04 148.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 123.388 0.675 . . . . 0.0 111.356 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -155.2 166.85 32.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -68.82 145.78 53.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.5 t -75.33 155.59 36.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.9 t -71.54 -2.59 17.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.494 0.717 . . . . 0.0 112.78 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 43.5 t -127.36 154.55 44.84 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.602 0.761 . . . . 0.0 110.332 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -87.1 -0.34 56.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.37 158.87 33.06 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.275 0.489 . . . . 0.0 111.288 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.5 mt -104.61 139.08 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.2 t -72.25 143.87 48.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.419 0.288 . . . . 0.0 111.293 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 179' ' ' ASP . 14.1 ptt-85 -155.24 149.28 19.24 Favored Pre-proline 0 CA--C 1.529 0.149 0 C-N-CA 123.663 0.785 . . . . 0.0 109.849 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.77 -12.92 33.86 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.056 3.171 . . . . 0.0 111.84 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.37 135.83 2.65 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.423 ' HB3' ' HE ' ' A' ' 176' ' ' ARG . 27.5 p30 -106.44 4.32 28.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 35.5 t -156.34 156.69 34.38 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.93 0.892 . . . . 0.0 110.74 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -74.56 -3.14 29.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.281 80.3 m-20 58.7 7.56 0.77 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 39.8 t -163.03 -39.41 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -81.42 162.08 23.47 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 89.8 p -68.44 -2.29 8.32 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.188 0.995 . . . . 0.0 112.537 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.265 0.9 OUTLIER 57.94 23.58 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -177.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -140.95 17.95 2.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.966 0.506 . . . . 0.0 110.461 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.25 1.104 0 C-N-CA 124.308 1.043 . . . . 0.0 111.979 -179.045 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 111.838 3.638 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 1 O4'-C1'-N19 113.874 5.674 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.45 1 C5'-C4'-C3' 108.364 -4.757 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.601 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.527 1 C5'-C4'-C3' 108.839 -4.44 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.84 0 O4'-C1'-N19 111.211 3.011 . 0.196 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C5'-C4'-C3' 110.084 -3.611 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.047 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -154.03 149.52 27.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.169 0.588 . . . . 0.0 110.416 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -146.95 11.16 1.05 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.826 0.45 . . . . 0.0 112.159 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -63.49 146.36 53.79 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -163.39 179.49 7.29 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.86 153.97 15.32 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.35 -6.91 14.39 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.552 2.835 . . . . 0.0 112.642 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -75.79 -10.62 59.58 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 122.022 -0.424 . . . . 0.0 111.13 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -76.82 136.21 38.93 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.969 0.507 . . . . 0.0 111.141 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 94' ' ' PRO . 1.1 p -132.62 154.82 81.64 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 124.457 1.103 . . . . 0.0 113.256 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 67.6 Cg_endo -68.11 151.4 77.29 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.886 2.391 . . . . 0.0 111.247 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.14 148.45 51.81 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 111.778 -176.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.2 t -163.66 150.57 10.34 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.0 109.699 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.9 -10.47 27.72 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.755 2.304 . . . . 0.0 109.805 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.9 t -99.17 141.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.628 0.771 . . . . 0.0 111.36 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.11 141.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.952 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -99.23 137.5 37.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 110.43 -176.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -114.85 140.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.827 0.851 . . . . 0.0 109.73 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -144.57 148.98 35.06 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 123.11 0.564 . . . . 0.0 111.031 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.63 75.63 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.973 -0.349 . . . . 0.0 112.733 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -76.19 178.17 6.63 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.565 0.682 . . . . 0.0 110.129 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.536 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -116.07 157.99 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.062 0.545 . . . . 0.0 109.929 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.87 -17.94 58.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.536 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -71.77 -10.9 72.78 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.681 -0.51 . . . . 0.0 112.606 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.02 146.63 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.9 m -132.67 168.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 C-N-CA 124.154 0.981 . . . . 0.0 110.071 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.42 -32.63 68.85 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.306 -0.246 . . . . 0.0 111.337 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.5 71.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.529 0.331 . . . . 0.0 111.232 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -73.6 -30.57 63.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.24 -42.51 68.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.76 -34.66 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -74.98 -23.11 58.22 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.141 -0.349 . . . . 0.0 111.443 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.1 -17.09 26.76 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.2 mt -121.83 -8.24 8.94 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.93 -21.89 66.46 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 119.367 0.985 . . . . 0.0 110.816 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -69.38 -10.44 57.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.262 -0.274 . . . . 0.0 111.523 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -95.07 -16.09 22.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.63 174.03 25.0 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.22 131.48 23.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.699 2.932 . . . . 0.0 110.779 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.94 142.19 15.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.968 0.507 . . . . 0.0 110.572 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.0 t -103.65 -34.08 8.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 112.094 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -165.84 156.27 13.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.9 149.24 17.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.331 1.053 . . . . 0.0 112.052 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 p -152.05 153.42 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.151 0.58 . . . . 0.0 111.186 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -126.61 141.76 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.043 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -136.12 79.12 44.81 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.247 0.619 . . . . 0.0 109.686 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.22 -4.94 12.6 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.288 2.659 . . . . 0.0 111.352 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.27 -27.62 68.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.268 0.627 . . . . 0.0 110.538 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -116.96 6.15 12.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.891 0.876 . . . . 0.0 112.591 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 55.47 51.38 12.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.405 0.548 . . . . 0.0 110.724 -171.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -142.21 163.88 31.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.71 158.1 40.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.062 0.545 . . . . 0.0 110.618 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.88 143.53 46.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.48 144.1 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -130.24 134.38 47.21 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.779 0.432 . . . . 0.0 110.158 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -93.97 155.1 17.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -71.5 -13.35 61.78 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.029 -0.419 . . . . 0.0 110.431 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -142.08 143.8 33.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.323 1.449 . . . . 0.0 113.216 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.26 -24.86 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 65.9 tp -67.08 -36.31 81.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.477 0.311 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.05 57.88 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.25 89.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.15 -34.95 75.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.382 0.673 . . . . 0.0 110.746 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.73 -34.51 78.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.037 -0.415 . . . . 0.0 110.999 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.1 73.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.642 0.201 . . . . 0.0 110.807 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.0 t -74.62 -33.68 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.193 -0.317 . . . . 0.0 110.791 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.31 -26.29 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.239 0.472 . . . . 0.0 111.606 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -76.24 -32.87 59.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.6 -30.23 69.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.299 0.64 . . . . 0.0 111.076 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.79 1.59 4.2 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.295 0.638 . . . . 0.0 112.17 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -130.11 -31.83 1.86 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -156.5 146.31 20.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.877 0.471 . . . . 0.0 109.735 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.78 134.66 39.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -75.01 145.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 122.878 0.471 . . . . 0.0 110.373 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.265 20.6 m-85 -96.95 131.71 43.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 175.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.6 mm -128.92 124.86 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.465 1.106 . . . . 0.0 108.385 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.77 34.64 5.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 8.28 76.92 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.992 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.1 148.29 64.07 Favored Pre-proline 0 CA--C 1.528 0.111 0 CA-C-N 118.49 1.145 . . . . 0.0 111.306 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.73 141.99 56.48 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.264 2.643 . . . . 0.0 110.964 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 159.04 43.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.31 0.644 . . . . 0.0 110.918 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -91.24 160.06 15.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.39 140.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -156.72 165.62 35.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -68.84 148.18 50.65 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.152 0.887 . . . . 0.0 109.706 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.5 t -83.99 159.95 21.13 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.946 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -71.33 -2.75 17.35 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.4 t -131.41 152.5 50.59 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.022 0.529 . . . . 0.0 110.961 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -83.26 -4.75 58.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.01 147.79 18.39 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.452 0.569 . . . . 0.0 111.472 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.8 mt -86.98 145.09 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.3 t -66.18 121.73 15.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.074 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -83.13 156.7 66.61 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 123.109 0.564 . . . . 0.0 110.379 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -70.25 -14.52 34.64 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.265 2.643 . . . . 0.0 110.122 173.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.39 131.79 1.34 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -106.47 7.97 31.23 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.0 t 56.95 33.91 24.03 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.872 0.869 . . . . 0.0 112.542 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.0 155.09 14.16 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -68.08 93.12 0.42 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.2 m 55.61 13.25 0.95 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -74.69 -25.1 58.93 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.575 0.625 . . . . 0.0 110.716 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.8 m -67.28 148.72 51.33 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.628 0.371 . . . . 0.0 110.451 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.3 t 56.78 12.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -137.01 7.97 2.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.654 0.782 . . . . 0.0 111.875 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.228 -1.367 . . . . 0.0 110.608 -178.343 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.665 0 O4'-C1'-N19 112.003 3.803 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.403 1 O4'-C1'-N19 113.739 5.539 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.726 1 C5'-C4'-C3' 108.822 -4.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' A' . . . . . 0.557 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.826 1 C5'-C4'-C3' 109.041 -4.306 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 1 C5'-C4'-C3' 109.139 -4.24 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 0 C5'-C4'-C3' 110.472 -3.352 . 0.199 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.227 0.537 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 t -163.19 148.92 9.7 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.743 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.88 -7.4 21.03 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.802 2.335 . . . . 0.0 109.926 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.33 143.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.092 0.957 . . . . 0.0 110.439 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.46 139.83 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.628 0.728 . . . . 0.0 111.853 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.34 137.37 37.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.935 1.694 . . . . 0.0 109.843 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 63.3 mt -116.29 140.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.393 0.677 . . . . 0.0 109.772 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -145.84 150.9 37.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.051 0.54 . . . . 0.0 110.505 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.12 0.51 77.25 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.879 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.2 pp -70.53 174.69 5.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.13 0.965 . . . . 0.0 111.041 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.539 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.04 157.03 13.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.254 0.622 . . . . 0.0 109.7 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -67.47 -7.31 24.48 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.539 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.25 -11.04 85.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.23 149.47 11.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.66 169.68 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.393 1.077 . . . . 0.0 109.621 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -59.59 -32.84 70.76 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.302 -0.249 . . . . 0.0 111.074 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.43 72.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.611 0.365 . . . . 0.0 111.27 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -74.86 -31.63 61.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.28 -41.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.41 -34.66 58.9 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -74.97 -24.66 58.48 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 117.731 0.242 . . . . 0.0 111.2 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.12 35.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.14 -9.28 8.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.54 -21.99 66.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.328 0.967 . . . . 0.0 110.875 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.03 -12.23 61.41 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.222 -0.299 . . . . 0.0 111.209 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -92.06 -16.75 25.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.48 173.91 27.5 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.76 125.7 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.654 2.903 . . . . 0.0 110.8 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 142.92 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.786 0.434 . . . . 0.0 110.583 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -107.64 -32.35 7.7 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.523 0.729 . . . . 0.0 111.956 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -162.94 160.5 24.88 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.8 143.18 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.886 0.875 . . . . 0.0 109.239 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.11 154.91 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.215 0.606 . . . . 0.0 111.516 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.05 141.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.13 0.572 . . . . 0.0 112.179 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.76 88.76 45.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 123.153 0.581 . . . . 0.0 110.439 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.76 -6.5 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.888 2.392 . . . . 0.0 110.832 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.83 -31.76 71.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.439 0.696 . . . . 0.0 110.608 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -116.94 5.71 12.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.617 0.767 . . . . 0.0 112.584 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 57.95 49.82 11.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.345 0.658 . . . . 0.0 110.544 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -144.13 171.61 14.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.958 0.903 . . . . 0.0 111.283 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.16 40.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.195 0.598 . . . . 0.0 110.368 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.13 149.16 50.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.9 144.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -125.29 138.84 54.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.881 0.472 . . . . 0.0 109.797 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -102.48 155.73 18.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -72.8 -13.8 61.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.212 -0.305 . . . . 0.0 110.356 174.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -143.08 143.34 31.81 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.308 1.443 . . . . 0.0 113.451 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.5 p -62.9 -21.84 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 111.714 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.3 tp -69.81 -35.03 74.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.81 0.444 . . . . 0.0 110.761 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.07 -38.15 48.18 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.21 86.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -70.13 -35.52 74.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.24 -34.83 79.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.949 -0.469 . . . . 0.0 111.141 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.23 -37.43 69.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 121.325 -0.15 . . . . 0.0 111.214 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.31 -33.55 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 O-C-N 122.156 -0.34 . . . . 0.0 110.751 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -70.67 -28.39 64.74 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.17 0.441 . . . . 0.0 111.801 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.33 -33.05 61.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.76 -30.32 69.94 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.64 0.776 . . . . 0.0 111.675 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.12 -16.06 63.57 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -108.9 -27.17 9.85 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -160.06 154.8 24.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.003 0.521 . . . . 0.0 109.823 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.65 141.08 41.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.41 134.87 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.292 10.8 m-85 -84.77 129.08 34.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.9 mm -126.62 120.57 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.483 1.113 . . . . 0.0 108.254 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.17 34.31 2.93 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.811 0.844 . . . . 0.0 112.08 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 90.34 11.17 63.04 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.619 0.628 . . . . 0.0 112.993 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -136.3 139.53 30.07 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.358 0.663 . . . . 0.0 110.452 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.32 144.57 62.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.411 2.74 . . . . 0.0 112.156 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.49 171.86 16.39 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.458 0.703 . . . . 0.0 110.073 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.09 161.16 18.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.24 149.41 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.575 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -68.74 144.21 54.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.836 0.743 . . . . 0.0 109.544 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.3 t -76.39 153.86 35.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.4 -2.76 17.61 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.6 t -127.69 152.93 47.09 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.454 0.702 . . . . 0.0 110.496 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -88.46 -3.75 58.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.196 0.598 . . . . 0.0 112.525 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.38 150.87 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.353 0.524 . . . . 0.0 111.019 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mt . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.928 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -164.85 151.19 9.17 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.291 0.637 . . . . 0.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.46 -7.34 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.724 2.282 . . . . 0.0 110.446 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t -102.36 143.52 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.324 1.05 . . . . 0.0 110.657 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.35 140.92 46.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.713 0.768 . . . . 0.0 111.72 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.28 137.54 37.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.129 1.772 . . . . 0.0 110.058 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.7 mt -117.75 140.7 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.325 0.65 . . . . 0.0 109.554 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -144.49 151.49 39.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.074 0.55 . . . . 0.0 110.176 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.99 0.15 85.77 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.612 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.14 171.36 9.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.588 0.694 . . . . 0.0 110.881 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.21 154.33 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.221 0.608 . . . . 0.0 109.997 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -70.77 -10.98 60.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.76 -10.75 86.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.507 0.575 . . . . 0.0 111.705 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.1 148.72 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 169.85 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 124.273 1.029 . . . . 0.0 109.755 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.23 -32.75 70.25 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.175 -0.328 . . . . 0.0 111.085 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.67 -31.42 72.07 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.303 -0.248 . . . . 0.0 111.043 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.5 -32.09 60.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.13 -43.07 68.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.12 -34.65 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.61 -24.0 58.8 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.11 -0.369 . . . . 0.0 111.178 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.37 -17.11 31.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -123.74 -8.91 7.87 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.88 -21.93 66.49 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.448 1.022 . . . . 0.0 110.751 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.02 -10.43 58.63 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.09 -15.84 24.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.75 174.77 26.9 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.28 123.37 10.5 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.634 2.889 . . . . 0.0 110.92 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.44 141.93 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.021 0.528 . . . . 0.0 110.395 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -101.38 -34.24 9.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.21 0.604 . . . . 0.0 111.734 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -167.21 162.02 14.83 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 151.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 124.131 0.972 . . . . 0.0 111.945 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.6 p -151.13 155.94 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.179 0.592 . . . . 0.0 112.042 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.21 141.95 36.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.221 0.608 . . . . 0.0 112.287 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.91 81.75 57.15 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 123.63 0.772 . . . . 0.0 110.12 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -59.83 -12.48 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.389 2.726 . . . . 0.0 112.371 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -27.58 67.77 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.823 0.449 . . . . 0.0 111.136 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -116.81 5.74 13.09 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.685 0.794 . . . . 0.0 112.028 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 56.68 48.57 16.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.555 0.742 . . . . 0.0 110.285 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.58 168.84 18.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.882 0.873 . . . . 0.0 111.193 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.59 158.25 40.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.483 0.713 . . . . 0.0 110.441 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 mp -131.33 154.12 48.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.893 0.378 . . . . 0.0 110.131 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.2 t -143.33 143.07 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -118.41 130.76 56.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.13 154.5 17.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -72.64 -12.85 61.21 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.185 -0.322 . . . . 0.0 110.487 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -143.89 145.56 32.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 113.413 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.87 -23.37 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.4 tp -67.47 -36.69 81.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.393 0.277 . . . . 0.0 111.055 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.47 60.73 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.47 91.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.16 0.505 . . . . 0.0 109.893 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.7 t -69.34 -35.41 75.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.281 0.633 . . . . 0.0 110.827 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -65.54 -34.29 77.92 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.064 -0.398 . . . . 0.0 110.904 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.57 -33.39 69.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.472 0.124 . . . . 0.0 111.086 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -81.06 -33.7 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 122.12 -0.363 . . . . 0.0 111.158 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.142 0.428 . . . . 0.0 111.265 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -79.06 -33.04 45.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.247 0.619 . . . . 0.0 111.117 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.98 -17.4 63.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.47 0.308 . . . . 0.0 111.703 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -109.1 -24.1 11.33 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -159.94 155.65 25.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.294 0.638 . . . . 0.0 109.301 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.73 136.59 39.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.62 134.03 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.9 m-85 -85.61 131.27 34.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.08 125.31 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 0.0 108.357 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.81 34.58 5.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.3 0.64 . . . . 0.0 112.498 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.39 8.86 77.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.062 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -135.35 148.99 68.43 Favored Pre-proline 0 CA--C 1.527 0.083 0 CA-C-N 118.418 1.109 . . . . 0.0 111.75 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.54 151.68 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.53 2.82 . . . . 0.0 111.713 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.96 174.61 13.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -123.62 156.09 36.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.34 138.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.593 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -148.62 168.71 22.09 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 125.669 1.587 . . . . 0.0 108.621 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.65 149.89 48.59 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.7 t -84.83 156.27 21.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.344 0.658 . . . . 0.0 110.662 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.93 -16.03 62.64 Favored 'General case' 0 C--N 1.335 -0.045 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 84.1 p -92.06 152.77 19.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.255 0.622 . . . . 0.0 109.629 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -97.11 -5.51 37.17 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -161.91 149.02 14.1 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.12 0.568 . . . . 0.0 109.951 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.945 0.402 . . . . 0.0 111.738 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.4 m -156.46 152.41 22.9 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.946 0.898 . . . . 0.0 109.445 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.25 -10.62 22.61 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.063 2.508 . . . . 0.0 109.756 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.96 146.37 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 124.473 1.109 . . . . 0.0 110.789 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.39 139.62 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 121.421 0.629 . . . . 0.0 111.566 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -100.04 137.4 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.762 1.625 . . . . 0.0 110.263 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.7 mt -117.4 140.49 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 110.151 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -144.21 155.51 43.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.287 0.635 . . . . 0.0 110.058 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.18 -1.09 87.62 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.77 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.64 173.44 8.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.679 0.739 . . . . 0.0 110.976 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.6 pt -98.89 153.92 4.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 C-N-CA 123.499 0.72 . . . . 0.0 109.52 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -72.89 -9.69 58.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.57 -10.75 86.04 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.5 149.62 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.69 169.3 22.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.117 0.967 . . . . 0.0 109.512 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.85 -32.73 69.71 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.239 -0.288 . . . . 0.0 111.119 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.62 -31.4 72.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.596 0.358 . . . . 0.0 111.041 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -74.38 -34.36 63.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -39.7 67.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.63 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -71.2 -34.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.9 -23.39 55.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.145 -0.347 . . . . 0.0 110.862 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.26 -17.14 31.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.97 -8.06 7.77 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.96 -21.81 65.95 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.407 1.003 . . . . 0.0 110.794 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.76 -10.49 59.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.515 0.326 . . . . 0.0 111.344 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -93.77 -14.96 25.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.37 173.59 24.25 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.54 125.66 13.08 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.744 2.963 . . . . 0.0 110.56 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.9 mt -93.35 141.37 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 122.898 0.479 . . . . 0.0 110.338 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.2 t -102.75 -33.68 9.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.518 0.727 . . . . 0.0 111.796 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -164.0 161.37 22.65 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -146.5 145.39 19.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.0 0.92 . . . . 0.0 109.187 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.62 156.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.254 0.622 . . . . 0.0 111.556 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.82 141.9 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 C-N-CA 123.291 0.636 . . . . 0.0 112.193 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -134.24 82.09 48.33 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.4 0.68 . . . . 0.0 110.263 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.941 2.427 . . . . 0.0 111.217 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.38 -26.41 67.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.851 0.86 . . . . 0.0 110.756 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -117.05 4.85 12.76 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.828 0.851 . . . . 0.0 112.371 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 55.64 51.73 12.12 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.726 0.811 . . . . 0.0 110.293 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -144.99 171.4 14.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.804 0.842 . . . . 0.0 111.1 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.58 158.26 40.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.146 0.579 . . . . 0.0 110.966 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -127.56 149.53 50.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.039 0.536 . . . . 0.0 109.637 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.9 t -143.42 144.53 23.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -126.37 137.98 53.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.686 0.394 . . . . 0.0 110.095 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -100.29 155.14 17.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -71.47 -12.69 61.52 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.782 0.264 . . . . 0.0 110.338 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -143.09 143.05 31.69 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 125.759 1.624 . . . . 0.0 112.93 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.06 -21.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 120.822 0.344 . . . . 0.0 111.509 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -69.8 -35.16 74.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 110.859 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.86 -37.96 60.66 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.15 85.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.76 -33.81 71.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.306 0.642 . . . . 0.0 111.129 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -66.17 -35.06 79.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.056 0.389 . . . . 0.0 111.124 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.27 71.15 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.655 0.207 . . . . 0.0 111.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.8 t -77.34 -33.49 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 O-C-N 122.311 -0.243 . . . . 0.0 111.088 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -68.03 -32.67 73.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 122.065 -0.397 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.75 -32.93 64.08 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.7 -30.34 69.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.344 0.658 . . . . 0.0 111.549 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.43 63.6 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.85 -28.2 8.89 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -159.95 154.34 23.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.962 0.505 . . . . 0.0 109.853 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.72 139.96 40.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.12 -0.362 . . . . 0.0 110.139 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.4 mt -83.39 136.13 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 14.2 m-85 -88.17 130.66 34.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.2 mm -129.04 124.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.743 1.217 . . . . 0.0 108.601 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.51 34.47 4.89 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.59 8.34 73.94 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.974 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -136.2 148.95 66.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.541 1.17 . . . . 0.0 111.402 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.84 152.4 80.55 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.38 2.72 . . . . 0.0 111.485 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 174.64 13.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.419 1.088 . . . . 0.0 109.569 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.37 156.4 42.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.28 144.34 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.082 0.553 . . . . 0.0 111.952 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -148.88 169.83 19.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.34 1.456 . . . . 0.0 108.639 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -68.64 146.94 52.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.9 t -79.27 154.21 29.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.456 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.8 t -71.2 -2.54 16.27 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.7 t -125.34 151.24 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.476 0.71 . . . . 0.0 110.568 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -86.22 -6.93 58.88 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -159.64 148.19 17.59 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.673 0.67 . . . . 0.0 110.875 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.221 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.84 0.352 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -153.17 152.72 28.42 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.822 0.849 . . . . 0.0 109.803 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.56 -3.91 14.33 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.697 2.931 . . . . 0.0 110.635 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.6 149.49 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 112.469 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.58 145.85 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -99.16 137.42 37.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.789 2.036 . . . . 0.0 110.282 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.6 mt -116.9 140.61 38.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.878 0.871 . . . . 0.0 109.749 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -143.77 152.03 40.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.423 0.689 . . . . 0.0 110.276 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.09 2.63 80.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.845 -0.419 . . . . 0.0 112.818 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 104' ' ' LEU . 2.8 pp -73.62 -173.96 1.6 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.543 0.671 . . . . 0.0 110.325 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.07 157.53 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.55 0.74 . . . . 0.0 110.6 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.97 -12.01 51.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 -10.83 85.25 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.19 148.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.69 168.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.153 0.981 . . . . 0.0 109.422 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -58.71 -32.67 69.39 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.141 -0.35 . . . . 0.0 110.95 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.39 71.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.46 0.304 . . . . 0.0 111.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -73.54 -31.67 63.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.97 -43.28 71.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -71.99 -34.54 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -75.21 -21.29 58.77 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.969 -0.457 . . . . 0.0 111.498 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.22 -17.24 25.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.18 -8.6 8.72 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.97 -21.77 66.43 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.346 0.975 . . . . 0.0 110.696 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -70.5 -10.8 60.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.152 -0.343 . . . . 0.0 111.486 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.96 -14.78 24.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.37 172.93 25.15 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.28 124.99 12.32 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.495 2.797 . . . . 0.0 110.666 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.67 142.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.025 0.53 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.6 t -105.25 -34.01 8.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.418 0.687 . . . . 0.0 111.566 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -165.91 159.33 15.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.89 151.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.071 0.948 . . . . 0.0 112.221 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.12 154.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.321 0.648 . . . . 0.0 111.382 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.93 141.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.048 0.539 . . . . 0.0 112.144 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.43 88.05 40.59 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 123.138 0.575 . . . . 0.0 110.223 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.44 -8.28 21.67 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.039 2.493 . . . . 0.0 110.473 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.59 -32.41 73.97 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.651 0.78 . . . . 0.0 110.1 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.98 4.96 12.81 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.673 0.789 . . . . 0.0 112.226 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 57.78 51.48 9.21 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.231 0.612 . . . . 0.0 110.262 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -146.21 170.16 17.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.795 0.838 . . . . 0.0 111.34 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.69 158.37 40.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.632 0.773 . . . . 0.0 110.692 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.98 152.91 48.92 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-O 121.155 0.502 . . . . 0.0 110.132 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.76 144.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -122.48 136.34 54.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.05 0.54 . . . . 0.0 110.106 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -101.65 156.64 17.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -73.24 -11.07 60.38 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.175 -0.328 . . . . 0.0 110.5 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -144.38 146.3 32.44 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.692 1.597 . . . . 0.0 113.481 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.6 -23.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.337 0.049 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.26 -37.38 83.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.252 0.221 . . . . 0.0 110.626 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 -38.44 65.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.97 89.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.059 0.457 . . . . 0.0 109.949 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.55 -33.46 71.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.09 0.556 . . . . 0.0 111.11 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.21 -34.62 78.44 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.112 0.415 . . . . 0.0 110.873 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -38.7 72.9 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.516 0.144 . . . . 0.0 110.85 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.27 -33.55 23.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 O-C-N 122.33 -0.231 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.16 -32.29 71.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.192 -0.317 . . . . 0.0 110.961 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.7 -32.94 64.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.22 70.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.528 0.731 . . . . 0.0 111.058 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.77 3.28 2.64 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.073 0.549 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.11 -28.67 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -156.72 152.57 27.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -76.75 141.35 40.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.12 136.15 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.304 16.2 m-85 -88.81 130.64 35.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -129.02 125.05 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.607 1.163 . . . . 0.0 108.453 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.95 34.52 5.57 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.322 0.649 . . . . 0.0 112.373 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.36 9.03 80.23 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.171 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -134.08 148.82 69.58 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 118.342 1.071 . . . . 0.0 111.726 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.92 149.96 83.01 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.295 2.663 . . . . 0.0 111.397 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 174.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 109.549 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -128.52 161.0 30.59 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -142.34 147.8 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 123.44 0.696 . . . . 0.0 111.294 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -155.73 166.48 33.37 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -68.84 151.04 47.12 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.142 0.883 . . . . 0.0 108.708 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -85.48 159.06 20.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.886 0.474 . . . . 0.0 111.281 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.6 -2.75 15.26 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.1 t -125.73 154.04 43.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.312 0.645 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -86.78 -0.44 56.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -158.46 158.88 34.96 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.782 0.719 . . . . 0.0 110.942 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.219 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 121.006 0.431 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -161.52 149.86 12.68 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 123.297 0.639 . . . . 0.0 109.697 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.35 -7.35 21.11 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.864 2.376 . . . . 0.0 109.897 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -104.06 141.59 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.058 0.943 . . . . 0.0 111.187 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.8 m -135.08 144.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.638 0.732 . . . . 0.0 111.412 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.427 ' HA ' HD23 ' A' ' 136' ' ' LEU . 22.1 t-80 -102.01 137.48 40.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.986 1.714 . . . . 0.0 110.578 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.38 140.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.736 0.814 . . . . 0.0 109.676 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -144.66 153.82 42.15 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.919 0.488 . . . . 0.0 110.603 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.64 4.59 88.94 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.801 -0.444 . . . . 0.0 112.614 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -72.36 173.77 8.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.737 0.768 . . . . 0.0 110.481 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.585 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.33 158.38 12.77 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.047 0 CA-C-O 121.363 0.602 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -68.93 -7.97 39.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -174.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.19 -11.04 85.75 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.94 146.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.64 166.46 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.239 1.016 . . . . 0.0 109.445 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.8 -32.7 69.58 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.182 -0.324 . . . . 0.0 111.281 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.08 -31.4 72.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.542 0.156 . . . . 0.0 110.955 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.89 -29.48 61.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.05 -44.24 69.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -71.95 -34.79 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -74.89 -20.4 59.74 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.212 0.46 . . . . 0.0 111.808 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.7 -16.98 22.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.48 -8.31 9.59 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.16 -21.83 66.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.111 0.869 . . . . 0.0 110.702 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.19 -12.85 61.89 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.861 -0.524 . . . . 0.0 111.284 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -90.77 -15.03 30.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.73 173.76 24.77 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.94 125.6 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.534 2.823 . . . . 0.0 110.364 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.32 142.74 12.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 122.722 0.409 . . . . 0.0 110.268 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.9 t -104.65 -34.03 8.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.347 0.659 . . . . 0.0 111.92 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -166.43 157.42 12.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -143.02 151.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 C-N-CA 124.088 0.955 . . . . 0.0 112.31 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.77 156.25 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.435 0.694 . . . . 0.0 110.53 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.99 141.96 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -133.32 81.84 54.52 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.446 0.699 . . . . 0.0 109.85 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.75 -13.62 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.054 2.503 . . . . 0.0 110.597 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -67.68 -22.22 65.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.182 0.593 . . . . 0.0 110.992 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -117.0 4.11 12.79 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.804 0.842 . . . . 0.0 112.097 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 59.13 40.23 22.11 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.375 0.67 . . . . 0.0 110.869 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.8 169.05 18.36 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.838 0.855 . . . . 0.0 111.088 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.18 40.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.153 0.581 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 100' ' ' HIS . 85.6 mt -125.24 150.33 47.14 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 123.013 0.525 . . . . 0.0 110.458 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.8 t -143.76 144.42 23.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -126.74 139.28 53.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.964 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.23 154.18 19.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.37 -16.34 62.96 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.854 0.297 . . . . 0.0 110.39 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -137.19 143.09 42.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.342 1.457 . . . . 0.0 113.044 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.77 -21.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.708 0.289 . . . . 0.0 111.561 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -70.62 -35.59 73.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.873 0.469 . . . . 0.0 110.727 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.31 -39.62 61.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.37 -36.84 83.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.166 0.508 . . . . 0.0 110.238 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.6 -36.27 78.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.218 0.607 . . . . 0.0 110.598 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.97 -35.35 80.89 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.191 -0.318 . . . . 0.0 110.991 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.61 -32.76 68.37 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.556 0.162 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 93.9 t -81.51 -33.48 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 122.12 -0.363 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.0 -31.65 68.23 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.999 0.363 . . . . 0.0 111.506 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -77.93 -33.17 51.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.28 71.35 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 110.649 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.18 3.54 5.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.37 0.668 . . . . 0.0 112.105 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.41 -27.29 1.57 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -155.27 155.83 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.256 0.622 . . . . 0.0 109.565 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -76.86 133.95 39.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.2 mt -83.86 134.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 16.5 m-85 -85.26 130.65 34.56 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.94 124.15 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.34 34.67 6.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.51 9.68 75.03 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.838 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -135.8 148.78 66.65 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.328 1.064 . . . . 0.0 111.537 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.8 149.77 78.52 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.32 2.68 . . . . 0.0 111.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.76 174.74 13.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.655 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -124.1 161.25 26.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.66 145.34 25.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 C-N-CA 123.458 0.703 . . . . 0.0 110.907 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -154.94 166.19 34.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -68.65 147.65 51.57 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.944 0.793 . . . . 0.0 111.299 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.2 t -82.92 156.89 23.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.695 0.398 . . . . 0.0 110.871 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -2.75 17.32 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -131.43 153.6 49.54 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.138 0.575 . . . . 0.0 110.868 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -85.48 -3.43 58.85 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -158.9 149.23 19.6 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.542 0.61 . . . . 0.0 111.777 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -156.41 153.05 24.21 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.513 1.125 . . . . 0.0 109.293 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.38 8.38 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.854 3.036 . . . . 0.0 111.073 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.95 146.22 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.56 144.38 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.576 0.703 . . . . 0.0 111.626 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -100.72 137.46 39.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.482 1.913 . . . . 0.0 110.059 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.4 mt -115.64 140.74 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.879 0.872 . . . . 0.0 109.612 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -144.29 153.81 42.41 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.89 0.476 . . . . 0.0 110.247 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.45 2.01 80.21 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.637 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.414 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.1 pp -73.79 174.63 8.17 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.727 0.763 . . . . 0.0 110.64 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.561 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.45 160.07 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-O 121.312 0.577 . . . . 0.0 109.946 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -67.34 -7.58 25.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.64 -11.05 85.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -65.77 146.87 12.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 m -132.54 168.27 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 124.24 1.016 . . . . 0.0 109.796 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.61 -32.77 70.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.085 -0.384 . . . . 0.0 110.999 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.51 72.09 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.42 0.288 . . . . 0.0 111.145 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -73.53 -30.09 62.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.69 -45.3 68.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.18 -34.66 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.63 -21.53 57.63 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.053 -0.405 . . . . 0.0 111.576 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.09 -17.14 25.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -121.51 -8.73 9.06 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.94 -21.97 66.92 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 119.023 0.829 . . . . 0.0 110.914 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -69.73 -12.65 61.8 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.301 -0.249 . . . . 0.0 111.455 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.66 -16.34 27.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.77 24.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.63 125.79 13.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.355 2.703 . . . . 0.0 110.7 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -93.51 142.77 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.837 0.455 . . . . 0.0 110.42 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 t -105.49 -32.99 8.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.385 0.674 . . . . 0.0 112.009 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -166.43 157.7 13.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.96 150.97 17.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 124.121 0.968 . . . . 0.0 112.084 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.77 157.27 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.483 0.713 . . . . 0.0 111.239 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.2 141.87 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.037 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -130.66 82.88 63.49 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 122.995 0.518 . . . . 0.0 110.212 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.19 -9.52 23.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.108 2.538 . . . . 0.0 110.413 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -65.02 -32.88 74.82 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.8 0.84 . . . . 0.0 110.284 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -116.94 7.18 13.15 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 56.65 48.06 17.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.808 0.843 . . . . 0.0 110.665 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -139.98 171.47 14.15 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.009 0.924 . . . . 0.0 110.847 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.8 158.3 42.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.168 0.587 . . . . 0.0 110.689 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.98 145.39 50.83 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -143.67 136.85 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -116.17 139.46 50.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.081 0.552 . . . . 0.0 110.384 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -101.64 154.95 18.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -71.26 -13.0 61.76 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.096 -0.378 . . . . 0.0 110.211 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -143.9 143.37 31.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.725 1.61 . . . . 0.0 113.361 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.32 -21.72 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.646 0.26 . . . . 0.0 111.394 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 66.8 tp -69.85 -34.05 73.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.854 0.461 . . . . 0.0 110.812 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.42 -39.42 56.91 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.48 83.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.172 0.51 . . . . 0.0 109.895 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.41 -33.75 73.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.619 0.768 . . . . 0.0 111.18 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -68.14 -34.31 76.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.056 -0.403 . . . . 0.0 110.855 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.77 68.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.74 -35.76 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 122.037 -0.415 . . . . 0.0 111.508 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.0 -24.62 61.59 Favored 'General case' 0 N--CA 1.458 -0.037 0 CA-C-N 118.511 0.596 . . . . 0.0 112.299 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.31 -33.78 49.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.69 -30.2 71.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.035 0.534 . . . . 0.0 110.667 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.89 4.79 3.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 112.265 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -136.11 -27.13 1.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -155.57 153.4 30.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -76.76 137.96 39.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.93 -0.482 . . . . 0.0 110.367 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -85.73 134.58 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 18.3 m-85 -87.31 130.89 34.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.4 mm -129.0 124.52 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.68 34.55 7.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.78 77.01 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.363 -0.687 . . . . 0.0 114.086 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -135.4 148.96 68.21 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 118.432 1.116 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.34 151.53 80.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.376 2.717 . . . . 0.0 111.606 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.7 174.82 13.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.104 0.961 . . . . 0.0 109.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.93 157.54 34.06 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.5 139.69 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.928 0.491 . . . . 0.0 111.867 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -147.42 167.33 24.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.705 1.602 . . . . 0.0 108.404 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.03 149.47 48.73 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.5 t -78.99 154.54 29.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.814 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -69.72 -12.92 62.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 46.4 t -100.43 158.3 16.0 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 110.116 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -94.86 -5.64 44.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -162.76 153.07 16.45 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.432 0.56 . . . . 0.0 110.928 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 CA--C 1.529 0.145 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.086 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -161.43 149.28 12.29 Favored Pre-proline 0 C--O 1.232 0.183 0 C-N-CA 123.374 0.67 . . . . 0.0 110.288 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.23 -6.56 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.93 2.42 . . . . 0.0 110.104 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.4 t -105.42 143.41 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.89 0.876 . . . . 0.0 110.86 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.32 141.75 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.709 0.766 . . . . 0.0 112.368 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -99.17 137.63 37.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.423 1.889 . . . . 0.0 109.702 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.5 mt -117.8 140.6 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 122.946 0.498 . . . . 0.0 109.806 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -146.28 154.39 41.65 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.69 0.796 . . . . 0.0 110.092 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.3 1.7 88.05 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 119.729 -0.484 . . . . 0.0 112.494 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -73.05 174.52 7.78 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.721 0.76 . . . . 0.0 110.318 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.556 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.18 159.45 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.067 0.461 . . . . 0.0 109.844 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.88 -17.39 63.14 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.556 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.06 -10.73 73.86 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.351 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -66.65 147.68 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.51 169.06 22.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.39 1.076 . . . . 0.0 109.488 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -60.04 -32.65 71.11 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.002 -0.436 . . . . 0.0 110.734 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.32 70.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.636 0.374 . . . . 0.0 111.503 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -73.99 -31.87 63.16 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.9 mt -73.26 -40.12 64.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.121 0.168 . . . . 0.0 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.78 -34.56 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.03 -23.9 58.22 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.06 -0.4 . . . . 0.0 111.44 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.29 -17.05 29.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.66 -10.05 9.26 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.1 -21.87 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.247 0.931 . . . . 0.0 111.017 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.96 -11.34 60.91 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.228 -0.295 . . . . 0.0 111.371 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -93.72 -16.79 23.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.16 173.38 26.5 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.66 126.17 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.663 2.908 . . . . 0.0 110.796 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.75 141.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 122.883 0.473 . . . . 0.0 110.716 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.6 t -101.63 -34.23 9.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.273 0.629 . . . . 0.0 111.891 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -164.48 163.04 22.22 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.86 0.3 . . . . 0.0 110.537 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -145.9 142.11 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 123.736 0.814 . . . . 0.0 109.568 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.3 155.02 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 110.85 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.19 141.82 40.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -130.59 84.02 60.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 123.304 0.642 . . . . 0.0 110.424 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.21 -7.59 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.683 2.256 . . . . 0.0 111.322 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -27.4 66.21 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.068 0.547 . . . . 0.0 111.03 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.78 2.99 12.95 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.476 0.71 . . . . 0.0 111.108 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 56.98 52.23 9.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.917 0.887 . . . . 0.0 110.657 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -145.05 172.02 13.65 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.171 0.989 . . . . 0.0 110.898 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.92 39.46 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.653 0.381 . . . . 0.0 110.836 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.63 144.78 48.9 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.729 0.811 . . . . 0.0 109.221 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.9 t -143.03 143.03 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -126.32 138.64 53.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.66 155.72 17.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -71.36 -13.36 61.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.241 -0.287 . . . . 0.0 110.401 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -143.19 144.04 32.02 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.409 1.484 . . . . 0.0 113.227 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.45 -21.68 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 120.928 0.394 . . . . 0.0 111.615 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.1 tp -69.37 -35.84 76.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.841 0.456 . . . . 0.0 110.699 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.8 -37.98 56.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -36.74 83.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 109.907 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.64 -35.81 75.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.23 0.612 . . . . 0.0 110.718 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -65.42 -35.01 79.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.139 -0.351 . . . . 0.0 111.187 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.46 68.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.345 -0.222 . . . . 0.0 111.241 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 98.2 t -80.8 -33.51 13.42 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 O-C-N 122.243 -0.286 . . . . 0.0 110.917 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -68.35 -32.08 71.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.107 -0.371 . . . . 0.0 110.573 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -78.09 -33.21 50.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.21 71.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.977 0.511 . . . . 0.0 110.582 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.3 3.87 4.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.291 0.636 . . . . 0.0 112.384 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -134.34 -25.84 1.5 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -156.94 155.24 31.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.153 0.581 . . . . 0.0 109.495 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.66 135.35 39.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 110.395 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.5 mt -84.75 133.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.6 m-85 -85.05 130.48 34.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mm -128.95 123.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.686 1.194 . . . . 0.0 108.603 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.18 34.55 6.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.56 10.1 74.05 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -136.16 148.89 66.4 Favored Pre-proline 0 C--N 1.339 0.115 0 CA-C-N 118.335 1.067 . . . . 0.0 111.005 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.35 150.07 81.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.363 2.709 . . . . 0.0 111.436 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.08 13.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.186 0.994 . . . . 0.0 109.978 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -124.58 157.73 34.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.5 t -139.48 138.22 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.327 0.651 . . . . 0.0 110.7 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -145.73 167.44 23.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.321 1.048 . . . . 0.0 108.535 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.86 149.07 49.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.588 -0.695 . . . . 0.0 110.47 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.3 t -78.68 155.99 29.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.224 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -72.1 -2.75 19.66 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.4 t -131.94 153.43 50.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.613 0.765 . . . . 0.0 110.723 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -84.86 -4.76 59.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -160.63 150.46 17.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.445 0.566 . . . . 0.0 111.127 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.445 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.043 0.449 . . . . 0.0 111.721 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -159.84 150.76 15.83 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.5 0.72 . . . . 0.0 109.966 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.66 -8.32 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.463 2.108 . . . . 0.0 109.703 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.02 142.04 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.203 1.001 . . . . 0.0 111.837 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.65 143.13 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.459 0.647 . . . . 0.0 111.234 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -99.5 137.56 37.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.919 1.687 . . . . 0.0 110.099 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -115.65 140.52 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.22 0.608 . . . . 0.0 109.585 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -143.48 151.28 40.11 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 122.728 0.411 . . . . 0.0 110.591 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.31 86.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.798 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.07 170.07 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.634 0.717 . . . . 0.0 111.201 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.57 155.57 3.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.396 0.678 . . . . 0.0 109.976 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -70.71 -12.62 61.66 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.68 -10.81 85.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.505 0.574 . . . . 0.0 111.953 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.25 148.61 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 m -132.71 170.57 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 124.3 1.04 . . . . 0.0 109.331 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.17 -32.77 70.19 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 122.101 -0.374 . . . . 0.0 111.013 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.92 -31.55 72.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.582 0.353 . . . . 0.0 111.198 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -75.54 -32.87 60.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.761 -0.587 . . . . 0.0 112.538 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.71 -39.23 64.47 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.334 0.253 . . . . 0.0 110.564 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.03 -34.64 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -76.19 -24.45 54.73 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.94 -0.475 . . . . 0.0 111.119 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.74 -17.07 32.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.9 mt -122.01 -8.66 8.81 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.42 -21.7 66.22 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.449 1.022 . . . . 0.0 110.872 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.5 -11.34 60.86 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.142 -0.349 . . . . 0.0 111.202 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.93 -16.96 24.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.97 174.08 26.22 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -68.97 126.56 13.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.502 2.801 . . . . 0.0 110.703 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -94.0 142.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.981 0.512 . . . . 0.0 110.425 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 t -104.77 -34.21 8.18 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.696 0.798 . . . . 0.0 112.015 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -163.39 161.39 24.38 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -146.77 143.63 20.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 124.08 0.952 . . . . 0.0 109.541 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.77 154.25 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.62 141.91 39.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.061 0.544 . . . . 0.0 111.415 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -126.79 87.34 56.76 Favored Pre-proline 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.649 . . . . 0.0 109.984 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -12.93 36.94 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.002 2.468 . . . . 0.0 111.077 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -68.05 -25.87 65.57 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.626 0.37 . . . . 0.0 110.942 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.91 3.55 12.86 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 58.43 46.49 15.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.409 0.684 . . . . 0.0 110.828 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -140.47 170.08 16.46 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.866 0.866 . . . . 0.0 111.425 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.67 158.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.187 0.595 . . . . 0.0 110.984 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -128.35 148.64 50.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.959 0.504 . . . . 0.0 109.712 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -142.03 144.34 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -126.35 138.15 53.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.785 0.434 . . . . 0.0 110.096 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -100.91 155.02 18.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.8 -13.74 61.78 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.338 -0.226 . . . . 0.0 110.545 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -139.62 144.36 37.67 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.527 1.531 . . . . 0.0 112.964 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.18 -24.43 35.7 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -66.74 -35.98 81.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.431 0.292 . . . . 0.0 110.955 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -38.85 59.5 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.91 82.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.67 -35.96 73.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.183 0.593 . . . . 0.0 110.694 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.68 -35.08 79.73 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.007 0.367 . . . . 0.0 111.057 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.43 -32.55 66.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 71.1 t -81.36 -35.02 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.1 -0.375 . . . . 0.0 110.26 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -30.58 68.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.288 0.494 . . . . 0.0 111.714 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -77.72 -33.21 53.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.4 71.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.262 0.625 . . . . 0.0 110.714 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.4 4.47 3.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.591 0.756 . . . . 0.0 112.402 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.82 -26.12 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -156.3 154.54 30.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.86 137.25 39.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.231 -0.293 . . . . 0.0 110.251 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.8 mt -85.25 134.6 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 13.9 m-85 -85.51 130.27 34.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.7 mm -128.96 124.5 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.509 1.124 . . . . 0.0 108.507 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.05 34.53 5.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.016 0.526 . . . . 0.0 112.365 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.6 7.73 74.93 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.353 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -136.1 148.95 66.77 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 118.559 1.179 . . . . 0.0 111.846 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.32 153.02 79.63 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.72 2.946 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 172.84 16.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.185 0.994 . . . . 0.0 109.853 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -120.42 157.44 29.32 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.98 137.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.305 0.642 . . . . 0.0 111.272 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -148.99 171.17 16.81 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.644 1.178 . . . . 0.0 108.448 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -68.67 149.1 49.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.8 t -85.43 158.21 20.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.587 0.355 . . . . 0.0 111.259 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -2.78 18.98 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.8 t -131.57 152.35 50.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 111.0 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -83.36 -3.63 57.7 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.532 0.733 . . . . 0.0 112.675 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.06 148.3 20.32 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.249 0.477 . . . . 0.0 110.969 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 172.759 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.727 0.299 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.5 m -155.19 154.74 29.15 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 123.837 0.855 . . . . 0.0 109.717 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.72 -6.1 17.74 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.405 2.737 . . . . 0.0 110.66 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.81 145.86 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.32 144.39 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.475 0.655 . . . . 0.0 111.063 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.73 137.45 38.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.168 1.787 . . . . 0.0 110.341 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -116.47 140.7 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.204 1.002 . . . . 0.0 109.361 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -142.83 152.18 41.91 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.865 0.466 . . . . 0.0 111.188 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.58 7.55 66.75 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.546 -0.586 . . . . 0.0 112.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.419 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -82.58 177.69 8.59 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.911 0.856 . . . . 0.0 109.649 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.541 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.03 157.0 12.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 CA-C-O 121.347 0.594 . . . . 0.0 109.648 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -67.81 -4.71 13.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.99 -10.78 85.86 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.8 147.56 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.68 168.74 23.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 124.338 1.055 . . . . 0.0 109.984 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -60.32 -32.64 71.43 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.128 -0.357 . . . . 0.0 111.065 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.35 71.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.079 0.152 . . . . 0.0 111.072 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -71.99 -32.18 66.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.24 -44.71 71.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.66 -34.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -75.03 -23.45 58.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 122.074 -0.391 . . . . 0.0 111.435 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.02 -17.07 26.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.45 -9.15 9.04 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.35 -21.87 66.74 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.12 0.873 . . . . 0.0 110.91 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.28 -10.97 60.53 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -92.72 -13.79 28.87 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.5 173.02 22.25 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.24 126.13 14.57 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.465 2.776 . . . . 0.0 110.58 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.38 142.35 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.018 0.527 . . . . 0.0 110.294 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.33 -34.1 8.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.584 0.754 . . . . 0.0 111.857 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -167.14 160.4 13.83 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.29 151.47 17.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.169 0.988 . . . . 0.0 112.454 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.88 155.9 6.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 123.3 0.64 . . . . 0.0 111.186 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.14 141.88 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -136.09 81.11 39.57 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.811 0.444 . . . . 0.0 110.32 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.47 -6.63 15.61 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.18 2.586 . . . . 0.0 110.458 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.19 -32.1 73.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 110.215 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -117.12 7.22 12.98 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.891 0.876 . . . . 0.0 113.068 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 55.73 51.27 12.7 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.508 0.595 . . . . 0.0 111.362 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -143.24 164.72 29.42 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.394 0.678 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.27 40.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.415 0.686 . . . . 0.0 110.475 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -127.66 147.01 50.37 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.55 144.15 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -127.37 135.92 51.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -97.16 157.81 15.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.35 -13.35 61.84 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.857 0.299 . . . . 0.0 110.437 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -143.38 143.89 31.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.402 1.481 . . . . 0.0 113.113 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 p -61.49 -21.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.723 0.297 . . . . 0.0 111.496 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.4 tp -68.6 -35.82 77.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.806 0.442 . . . . 0.0 110.702 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 -38.14 58.37 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.66 87.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.01 -31.96 68.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 111.074 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.38 -35.7 80.99 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.997 -0.439 . . . . 0.0 111.007 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.16 70.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.414 -0.179 . . . . 0.0 110.917 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.15 -33.69 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 O-C-N 122.363 -0.211 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -70.18 -30.79 68.0 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.191 -0.318 . . . . 0.0 110.746 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -74.84 -32.96 62.07 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.31 70.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.56 1.9 3.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.393 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -132.1 -28.79 1.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -157.05 152.33 26.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.805 0.442 . . . . 0.0 109.86 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.81 138.37 39.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.6 mt -82.78 140.02 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.6 m-85 -92.27 131.21 37.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.02 124.68 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.624 1.17 . . . . 0.0 108.429 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.47 34.51 6.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.181 0.592 . . . . 0.0 112.464 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.08 10.16 78.9 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.787 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -134.99 148.81 68.41 Favored Pre-proline 0 C--N 1.339 0.11 0 CA-C-N 118.151 0.975 . . . . 0.0 111.311 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 150.46 82.76 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.36 2.706 . . . . 0.0 111.198 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.07 13.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.922 0.889 . . . . 0.0 109.709 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.72 158.63 39.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -142.34 145.52 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -152.4 168.9 23.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.716 1.606 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -68.93 150.5 47.66 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.8 t -81.08 162.34 23.77 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.205 0.602 . . . . 0.0 111.31 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -2.89 22.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.6 t -125.15 157.75 35.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.584 0.754 . . . . 0.0 110.082 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.41 -6.67 59.2 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -161.09 157.62 26.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.714 0.688 . . . . 0.0 111.67 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.405 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 111.047 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 t -162.05 148.8 11.1 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.527 0.731 . . . . 0.0 109.761 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.87 -9.72 26.27 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.663 2.242 . . . . 0.0 109.65 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.02 140.91 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.521 0.728 . . . . 0.0 110.924 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 m -134.97 141.71 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.997 0.903 . . . . 0.0 111.77 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.422 ' HA ' HD23 ' A' ' 136' ' ' LEU . 14.8 t60 -99.15 137.43 37.68 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.315 1.846 . . . . 0.0 110.412 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -116.02 140.8 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.829 0.851 . . . . 0.0 109.735 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -144.65 152.77 40.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.86 0.464 . . . . 0.0 110.582 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.15 86.66 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.75 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.405 HD12 ' C ' ' A' ' 104' ' ' LEU . 3.8 pp -71.45 173.94 7.26 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 117.86 0.83 . . . . 0.0 110.898 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 pt -104.03 153.4 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.04 0 C-N-CA 123.317 0.647 . . . . 0.0 109.296 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -71.46 -8.54 54.51 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.09 -10.85 85.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.79 150.02 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.66 166.88 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 C-N-CA 124.064 0.946 . . . . 0.0 109.522 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.85 -32.67 67.87 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 122.247 -0.283 . . . . 0.0 111.455 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.49 72.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.433 0.293 . . . . 0.0 111.48 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -74.33 -30.83 62.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.35 -44.24 68.54 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.8 -34.68 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.18 -21.57 58.65 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.091 0.405 . . . . 0.0 111.22 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.54 -17.09 26.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -121.97 -9.52 8.74 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.06 -21.95 66.9 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.185 0.902 . . . . 0.0 110.813 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -69.23 -12.72 61.91 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.201 0.2 . . . . 0.0 111.409 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.71 -17.65 25.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.07 172.26 25.02 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.24 128.84 19.17 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.253 2.635 . . . . 0.0 110.795 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.88 142.84 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.079 0.552 . . . . 0.0 110.781 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 t -103.73 -33.99 8.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.626 0.77 . . . . 0.0 111.914 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -167.0 159.68 13.46 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.77 152.7 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.314 1.046 . . . . 0.0 112.045 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.0 154.93 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.307 0.643 . . . . 0.0 111.052 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -138.02 141.88 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.141 0.577 . . . . 0.0 112.313 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -133.66 84.31 45.47 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 123.453 0.701 . . . . 0.0 109.741 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.55 -8.53 22.52 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.131 2.554 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -65.84 -30.56 71.19 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.416 0.686 . . . . 0.0 109.931 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.9 5.79 13.0 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.823 0.849 . . . . 0.0 111.897 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 57.13 48.59 15.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.889 0.875 . . . . 0.0 110.996 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -141.85 169.01 18.4 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.676 0.79 . . . . 0.0 110.841 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.5 157.71 40.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.163 0.585 . . . . 0.0 110.06 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 100' ' ' HIS . 26.4 mt -128.46 150.29 50.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.5 144.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -124.33 131.6 53.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.836 0.454 . . . . 0.0 109.787 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.02 155.34 17.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -71.93 -15.58 62.09 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -140.16 143.03 35.94 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.263 1.425 . . . . 0.0 113.688 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.72 -21.78 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.9 tp -68.99 -36.12 77.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.861 0.464 . . . . 0.0 110.638 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.57 -39.11 61.27 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.88 84.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.042 0.448 . . . . 0.0 109.985 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.8 t -70.95 -33.29 70.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 110.904 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.52 -35.02 78.29 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.211 -0.306 . . . . 0.0 110.961 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.86 -38.51 70.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.559 0.163 . . . . 0.0 111.433 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.73 -35.45 43.74 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 O-C-N 122.229 -0.294 . . . . 0.0 111.125 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -76.87 -21.36 55.08 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.468 0.576 . . . . 0.0 112.488 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -74.68 -32.96 62.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.07 -30.25 70.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.555 0.742 . . . . 0.0 111.7 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.55 -16.7 63.96 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.33 -28.6 9.78 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -159.97 152.4 20.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.23 0.612 . . . . 0.0 109.606 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.79 140.02 40.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -82.74 133.56 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.8 m-85 -86.51 129.38 34.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mm -128.88 124.49 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.572 1.149 . . . . 0.0 108.343 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.39 34.51 6.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.07 8.73 78.3 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.227 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -135.83 148.91 67.16 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.494 1.147 . . . . 0.0 111.849 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.25 150.89 81.64 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.349 2.699 . . . . 0.0 111.703 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.92 174.95 13.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.767 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.5 162.82 24.04 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.4 p -142.21 148.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.254 0.622 . . . . 0.0 111.956 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -156.02 166.79 32.42 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.84 148.48 50.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.222 0.919 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 t -85.05 160.61 19.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.974 0.51 . . . . 0.0 110.956 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -2.77 18.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.7 t -133.62 154.05 51.19 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.056 0.542 . . . . 0.0 111.043 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -85.11 -2.69 58.28 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.414 0.686 . . . . 0.0 112.243 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.76 151.85 20.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 111.479 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 73.5 mt . . . . . 0 C--O 1.231 0.131 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.167 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 111.887 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -163.09 149.62 10.34 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 123.464 0.706 . . . . 0.0 110.011 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.39 -9.59 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 110.027 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.93 139.7 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.673 0.789 . . . . 0.0 110.621 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.38 139.02 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.625 0.726 . . . . 0.0 111.395 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.18 137.31 37.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.416 1.886 . . . . 0.0 110.296 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.3 mt -116.37 140.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.784 0.833 . . . . 0.0 109.911 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.138 0.575 . . . . 0.0 110.449 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.3 85.53 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.098 0.38 . . . . 0.0 112.705 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.96 173.99 7.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.448 0.624 . . . . 0.0 110.972 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.7 pt -100.71 154.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.599 0.76 . . . . 0.0 109.705 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -72.76 -10.48 59.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.71 -10.9 85.93 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.88 149.8 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.56 169.92 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 124.018 0.927 . . . . 0.0 109.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 60.3 mp0 -57.9 -32.84 68.13 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.407 0.283 . . . . 0.0 111.205 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.4 70.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.746 0.418 . . . . 0.0 111.722 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -72.97 -35.67 66.97 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.949 -0.469 . . . . 0.0 112.095 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.5 -38.48 65.35 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.488 0.315 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.93 -34.88 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.63 -25.0 56.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.148 -0.345 . . . . 0.0 111.007 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.0 35.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.6 mt -122.84 -9.62 8.31 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.62 -21.86 66.12 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.372 0.987 . . . . 0.0 110.915 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -68.96 -11.5 60.76 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.264 -0.273 . . . . 0.0 111.406 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.68 -16.09 23.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.68 172.43 23.97 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.17 129.26 17.9 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.499 2.799 . . . . 0.0 110.981 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.9 mt -97.81 142.78 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.604 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.8 t -104.71 -32.12 9.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.328 0.651 . . . . 0.0 111.641 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -163.0 161.88 25.71 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -147.26 143.96 19.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 109.319 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.5 p -151.03 153.3 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.335 0.654 . . . . 0.0 111.651 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.6 141.7 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.1 78.89 75.47 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 123.332 0.653 . . . . 0.0 109.811 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.22 -7.71 18.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.093 2.529 . . . . 0.0 111.201 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -65.35 -33.2 75.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.267 0.627 . . . . 0.0 110.097 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -117.1 7.5 13.07 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.743 0.817 . . . . 0.0 112.537 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 55.77 53.39 9.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.216 0.606 . . . . 0.0 110.58 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -144.76 172.87 12.41 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.923 0.889 . . . . 0.0 110.977 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.55 158.26 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.123 0.569 . . . . 0.0 110.82 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.4 mt -128.81 146.65 50.86 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.324 0.65 . . . . 0.0 109.657 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.7 t -141.56 144.22 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -126.76 126.81 44.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -87.19 156.94 19.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.66 -14.32 61.56 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 122.205 -0.309 . . . . 0.0 110.344 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -143.07 143.04 31.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.292 1.437 . . . . 0.0 113.382 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.51 -21.94 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.6 -36.72 79.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.866 0.466 . . . . 0.0 110.587 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -36.2 58.11 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.57 92.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 97.5 m -71.29 -28.71 64.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -68.04 -36.44 79.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.222 0.465 . . . . 0.0 110.932 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.461 0.119 . . . . 0.0 110.968 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.6 t -76.99 -33.43 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.358 -0.214 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -66.8 -34.48 77.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.176 0.443 . . . . 0.0 110.379 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.24 -32.99 63.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.28 -29.99 69.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.501 0.72 . . . . 0.0 111.862 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.61 -10.68 5.51 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.41 5.04 1.23 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -149.83 156.1 41.22 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -94.04 137.03 33.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.8 mt -90.04 135.1 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.299 24.7 m-85 -87.42 128.83 35.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.96 123.33 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.458 1.103 . . . . 0.0 108.578 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.05 34.41 4.2 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 112.562 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.47 8.8 70.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.459 -0.634 . . . . 0.0 114.105 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -136.05 148.91 66.7 Favored Pre-proline 0 N--CA 1.461 0.09 0 CA-C-N 118.355 1.078 . . . . 0.0 111.684 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.64 149.34 79.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.32 2.68 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.08 13.22 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.414 1.086 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -129.46 161.92 29.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.3 149.23 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.396 0.678 . . . . 0.0 110.894 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -154.2 167.66 29.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.97 150.79 47.31 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.39 -0.819 . . . . 0.0 109.103 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 40.9 t -84.21 160.02 20.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.941 0.496 . . . . 0.0 111.19 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.34 -2.66 17.08 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.2 t -133.91 152.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.248 0.619 . . . . 0.0 110.913 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -82.46 -2.7 54.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.47 0.708 . . . . 0.0 112.486 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -157.84 153.42 26.37 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.381 0.537 . . . . 0.0 111.608 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.6 mt . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.196 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.224 0 CA-C-O 121.014 0.435 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.8 t -164.05 149.86 9.34 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.531 0.732 . . . . 0.0 109.753 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.89 -9.22 25.3 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.887 2.392 . . . . 0.0 110.033 172.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.12 142.88 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.637 0.775 . . . . 0.0 110.68 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.31 141.17 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.495 0.664 . . . . 0.0 111.817 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -104.93 137.47 42.64 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.397 1.879 . . . . 0.0 109.996 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -115.19 140.7 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.232 1.013 . . . . 0.0 110.004 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -141.71 154.8 45.54 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.12 0.568 . . . . 0.0 110.11 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.24 83.13 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.713 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.8 pp -73.18 174.96 7.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.872 0.836 . . . . 0.0 110.584 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.546 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.8 160.86 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.104 0.561 . . . . 0.0 110.087 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.68 -19.04 64.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.546 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -70.41 -10.78 67.03 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.092 0.377 . . . . 0.0 112.561 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.73 146.61 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.57 166.79 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 C-N-CA 124.098 0.959 . . . . 0.0 109.827 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.45 -32.73 70.49 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.248 -0.282 . . . . 0.0 111.2 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.38 72.0 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.212 0.205 . . . . 0.0 111.09 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -74.01 -30.19 62.33 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.74 -45.02 72.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.38 -34.65 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -74.96 -21.57 59.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.998 -0.438 . . . . 0.0 111.754 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.74 -17.02 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.4 -8.74 9.58 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.5 -21.97 66.68 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.112 0.869 . . . . 0.0 110.993 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.0 -12.37 61.56 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.142 -0.349 . . . . 0.0 111.485 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -91.3 -16.09 28.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.21 23.45 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.01 130.67 22.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.496 2.798 . . . . 0.0 110.764 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.0 mt -98.52 142.79 14.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.211 0.604 . . . . 0.0 110.894 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.4 t -104.7 -33.7 8.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.615 0.766 . . . . 0.0 112.278 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -165.0 157.04 15.54 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.69 151.37 16.64 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 123.911 0.884 . . . . 0.0 111.941 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.07 157.97 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.317 0.647 . . . . 0.0 111.804 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.05 141.94 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -133.05 82.66 53.96 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 123.288 0.635 . . . . 0.0 110.328 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.02 -10.17 27.63 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.919 2.413 . . . . 0.0 111.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -69.98 -24.49 63.32 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 117.841 0.291 . . . . 0.0 111.065 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -116.8 3.34 12.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.503 0.721 . . . . 0.0 111.769 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 57.3 51.12 10.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.31 170.93 15.06 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.966 0.906 . . . . 0.0 110.873 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.23 40.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.13 0.572 . . . . 0.0 110.537 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.51 150.89 49.97 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.34 144.56 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -125.35 133.08 52.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.852 0.461 . . . . 0.0 109.968 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -95.37 155.3 16.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -71.42 -14.51 62.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -143.61 143.54 31.53 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.566 1.546 . . . . 0.0 113.415 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.17 -21.9 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 0.0 111.658 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.69 -35.31 77.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.687 0.395 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.06 -38.88 55.01 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.82 85.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.013 0.435 . . . . 0.0 109.852 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.96 -33.61 68.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.218 0.607 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.41 -34.75 79.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.118 0.417 . . . . 0.0 111.015 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.57 68.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.494 -0.128 . . . . 0.0 111.107 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.6 -33.6 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.046 0 O-C-N 122.069 -0.395 . . . . 0.0 110.876 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -71.68 -30.8 66.1 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.031 -0.418 . . . . 0.0 110.566 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.75 -32.93 64.07 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.35 69.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.635 0.774 . . . . 0.0 111.5 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.96 -14.91 63.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -109.99 -27.18 9.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -160.01 153.86 22.93 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.101 0.56 . . . . 0.0 109.587 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.72 137.04 39.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -81.37 137.61 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.286 13.9 m-85 -90.45 130.8 36.48 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.7 mm -128.79 124.43 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.62 1.168 . . . . 0.0 108.072 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.46 34.56 6.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.192 0.597 . . . . 0.0 112.528 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.19 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.871 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -135.65 148.8 67.05 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 118.54 1.17 . . . . 0.0 111.4 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.15 149.82 81.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.175 2.583 . . . . 0.0 111.791 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.78 175.1 13.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.162 0.985 . . . . 0.0 109.888 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -128.12 159.71 34.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 144.56 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -146.47 164.37 32.73 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.465 1.106 . . . . 0.0 108.257 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -68.88 150.7 47.48 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.4 t -85.12 159.12 20.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.883 0.473 . . . . 0.0 111.475 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.87 -2.66 15.74 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.9 t -131.05 152.03 50.79 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.199 0.6 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -82.54 -4.22 57.22 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -158.56 150.37 21.25 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.401 0.546 . . . . 0.0 111.228 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.2 mt . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.117 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 m -152.81 151.17 26.06 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 110.418 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 -1.84 11.76 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.905 3.07 . . . . 0.0 110.599 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.9 149.73 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.803 0.841 . . . . 0.0 112.391 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.41 146.84 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.778 0.799 . . . . 0.0 111.932 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -100.94 137.59 39.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.216 2.206 . . . . 0.0 110.058 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.71 140.65 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.429 1.092 . . . . 0.0 110.25 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -144.32 154.3 42.9 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.203 0.601 . . . . 0.0 110.155 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.48 82.69 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.717 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.1 pp -73.28 173.27 9.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.758 0.779 . . . . 0.0 110.398 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.545 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.19 160.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.022 0.529 . . . . 0.0 109.831 -178.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.15 -18.88 63.94 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.35 -10.96 75.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.784 -0.454 . . . . 0.0 112.609 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.68 146.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -132.66 167.1 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.483 1.113 . . . . 0.0 109.376 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -58.83 -32.55 69.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.149 -0.344 . . . . 0.0 111.399 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.18 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.473 0.309 . . . . 0.0 111.178 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -74.89 -31.44 61.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.0 mt -71.85 -40.58 68.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.247 0.219 . . . . 0.0 110.648 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -71.86 -34.79 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.04 -22.7 58.24 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 122.267 -0.271 . . . . 0.0 111.421 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.7 -17.07 24.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.92 -9.02 10.17 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.63 -21.73 66.6 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.852 0.751 . . . . 0.0 110.834 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.59 -12.27 61.46 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.066 -0.396 . . . . 0.0 111.262 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -90.58 -17.87 26.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.87 173.86 26.84 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.11 127.75 16.46 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.667 2.912 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 77.4 mt -95.34 142.95 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.07 0.548 . . . . 0.0 110.542 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.5 t -108.5 -33.21 7.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.23 0.612 . . . . 0.0 112.07 -176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -161.86 159.75 27.24 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.64 145.82 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.102 0.961 . . . . 0.0 109.413 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.78 154.21 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.567 0.747 . . . . 0.0 110.921 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.05 141.74 39.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -131.22 84.19 57.75 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 123.293 0.637 . . . . 0.0 110.221 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.41 -9.85 25.51 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.758 2.306 . . . . 0.0 110.452 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.26 -30.73 71.77 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.15 0.98 . . . . 0.0 110.22 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -117.02 3.73 12.76 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.261 1.025 . . . . 0.0 112.706 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 56.5 44.8 23.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.341 0.656 . . . . 0.0 110.585 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -140.48 169.54 17.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 110.431 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.36 40.84 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.874 0.47 . . . . 0.0 111.192 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.4 149.64 50.46 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -142.34 144.42 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.32 134.53 53.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.179 0.592 . . . . 0.0 109.936 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -98.77 154.92 17.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.15 -13.72 61.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.101 0.409 . . . . 0.0 110.691 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -141.28 143.1 33.9 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.219 1.407 . . . . 0.0 113.624 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.76 -22.04 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 111.557 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.7 tp -69.01 -36.53 77.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.378 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.37 -38.35 58.39 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.02 86.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.4 t -71.59 -33.78 69.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.258 0.623 . . . . 0.0 111.075 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.25 -34.55 78.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.107 0.412 . . . . 0.0 111.029 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.54 -40.13 70.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.316 -0.24 . . . . 0.0 110.829 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -75.13 -33.8 29.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 122.329 -0.232 . . . . 0.0 110.524 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.42 -29.58 66.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.055 0.389 . . . . 0.0 110.887 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -75.46 -33.05 60.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.44 71.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.236 0.614 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.99 2.83 3.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 112.455 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.48 -27.8 1.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.94 153.95 27.03 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -76.71 142.14 40.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.657 0.265 . . . . 0.0 110.671 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.6 mt -83.88 138.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.31 19.2 m-85 -91.37 129.12 37.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.73 123.49 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.508 1.123 . . . . 0.0 108.333 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.44 34.56 6.84 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.219 0.608 . . . . 0.0 112.241 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 9.44 74.75 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.079 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.0 148.94 66.92 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 118.418 1.109 . . . . 0.0 111.394 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.9 148.35 76.35 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.333 2.688 . . . . 0.0 111.278 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.93 175.0 13.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.228 1.011 . . . . 0.0 109.822 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -128.15 163.4 24.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.1 148.12 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.321 0.649 . . . . 0.0 111.56 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -155.1 166.5 33.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -68.62 151.01 47.31 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.413 -0.804 . . . . 0.0 112.351 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.2 t -84.7 164.9 18.31 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.773 0.32 . . . . 0.0 111.096 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.99 -2.9 19.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.3 t -137.99 156.6 47.67 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.094 0.558 . . . . 0.0 111.312 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -82.46 -0.05 44.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -157.56 154.77 29.09 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 118.281 0.491 . . . . 0.0 110.942 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 N--CA 1.456 -0.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.077 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.965 0.412 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -153.63 151.99 26.35 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 123.748 0.819 . . . . 0.0 109.665 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.68 6.63 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.993 3.129 . . . . 0.0 110.908 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -137.62 147.47 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.23 148.12 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.934 0.873 . . . . 0.0 111.426 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -99.1 137.61 37.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.149 1.78 . . . . 0.0 109.866 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mt -114.6 140.47 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.487 0.715 . . . . 0.0 109.435 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -145.25 153.19 41.05 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.625 0.37 . . . . 0.0 110.613 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.16 90.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.684 -0.509 . . . . 0.0 112.766 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.23 172.46 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.91 157.29 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.331 0.653 . . . . 0.0 110.289 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.82 -22.42 66.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.83 -10.95 73.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.257 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.41 147.7 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -132.57 166.59 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.233 1.013 . . . . 0.0 109.804 174.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.42 -32.64 67.08 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 122.113 -0.367 . . . . 0.0 111.392 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -31.28 71.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.433 0.293 . . . . 0.0 111.184 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.04 -31.11 62.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.59 -43.06 73.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 121.937 0.095 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.03 -34.49 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.65 -22.08 57.1 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.949 0.34 . . . . 0.0 111.468 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.09 -17.38 26.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.79 -7.63 9.53 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -65.57 -21.71 66.62 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.17 0.895 . . . . 0.0 110.884 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.53 -12.26 61.45 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.214 -0.304 . . . . 0.0 111.488 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -92.05 -15.43 27.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.39 173.03 23.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.85 126.73 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.667 2.912 . . . . 0.0 110.804 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.3 mt -93.65 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.993 0.517 . . . . 0.0 110.616 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.6 -34.1 8.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.482 0.713 . . . . 0.0 111.761 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -166.36 159.0 14.35 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.41 151.19 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.23 1.012 . . . . 0.0 111.797 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.77 155.06 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.055 0.542 . . . . 0.0 111.355 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.16 141.76 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -133.87 87.41 35.49 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.457 0.703 . . . . 0.0 110.027 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.43 -12.71 36.73 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.944 2.429 . . . . 0.0 111.419 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.41 -23.85 65.6 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.894 0.478 . . . . 0.0 111.046 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.91 4.69 12.88 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.537 0.735 . . . . 0.0 112.258 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 tpp85 56.5 45.74 21.89 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.412 0.685 . . . . 0.0 110.473 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -140.5 165.59 27.03 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.892 0.877 . . . . 0.0 111.363 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.57 158.18 40.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.232 0.613 . . . . 0.0 110.647 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.06 149.88 50.19 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -143.41 139.82 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -121.74 140.91 51.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.83 0.452 . . . . 0.0 110.397 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -103.1 154.81 18.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -71.73 -13.54 61.75 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.665 0.211 . . . . 0.0 110.557 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -141.61 143.16 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.273 1.429 . . . . 0.0 113.553 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.07 -21.97 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.702 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -69.37 -35.34 75.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.748 0.419 . . . . 0.0 110.66 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.12 -38.92 59.16 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.43 83.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 109.996 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.9 t -70.39 -34.84 73.03 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.87 0.468 . . . . 0.0 110.867 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -66.3 -33.99 76.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.013 0.37 . . . . 0.0 110.928 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.32 69.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.545 0.157 . . . . 0.0 111.301 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.0 t -81.38 -33.56 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.941 0.337 . . . . 0.0 110.984 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.3 -30.64 67.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.253 -0.28 . . . . 0.0 110.741 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.83 -33.03 46.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.33 71.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.027 0.531 . . . . 0.0 110.795 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.26 4.5 3.6 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.442 0.697 . . . . 0.0 112.151 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.63 -27.8 1.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -155.74 155.58 33.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -76.73 135.63 39.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.635 0.255 . . . . 0.0 110.357 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.11 135.16 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 11.2 m-85 -85.85 130.46 34.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.4 mm -128.82 126.3 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.43 34.45 6.68 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.96 0.504 . . . . 0.0 112.048 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.63 9.62 80.97 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.053 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -136.09 148.94 66.76 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 118.558 1.179 . . . . 0.0 111.809 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.06 149.43 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.594 2.863 . . . . 0.0 111.718 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 170.92 19.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.282 1.033 . . . . 0.0 109.914 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -114.17 158.2 21.63 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.61 142.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.583 0.753 . . . . 0.0 109.969 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -155.55 167.64 29.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.72 147.82 51.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.392 -0.817 . . . . 0.0 110.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -77.09 152.46 35.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.225 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -71.03 -2.77 16.55 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 72.8 m -127.85 155.18 44.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.183 0.993 . . . . 0.0 109.642 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -83.92 -4.99 59.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.84 156.79 25.65 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.624 0.647 . . . . 0.0 111.516 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.439 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.905 0.383 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 t -161.59 148.47 11.48 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.296 0.638 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.87 -7.68 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.1 2.533 . . . . 0.0 110.037 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.0 t -106.08 141.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.121 0.969 . . . . 0.0 110.569 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.95 142.44 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 121.802 0.811 . . . . 0.0 112.242 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -99.68 137.67 37.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.857 1.663 . . . . 0.0 110.383 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.53 140.54 36.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.63 0.772 . . . . 0.0 109.782 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -143.26 153.03 42.38 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.734 0.414 . . . . 0.0 110.491 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.49 6.13 89.47 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.65 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.33 170.07 12.56 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.584 0.692 . . . . 0.0 110.854 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -93.39 153.93 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.996 0.518 . . . . 0.0 110.328 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.12 -22.29 65.81 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.57 -10.72 82.86 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.616 0.626 . . . . 0.0 112.486 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.3 147.83 10.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.53 168.14 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.974 0.91 . . . . 0.0 109.866 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.3 -32.74 68.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.169 -0.332 . . . . 0.0 111.369 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.41 72.13 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.152 0.181 . . . . 0.0 111.125 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.18 -31.46 62.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.24 -42.85 68.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.053 0.141 . . . . 0.0 110.776 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.93 -34.58 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -75.44 -22.89 56.97 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.137 -0.352 . . . . 0.0 111.256 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.66 -17.07 27.47 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -120.68 -8.45 9.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.11 -21.84 66.37 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.083 0.856 . . . . 0.0 110.979 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.48 -11.27 60.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.48 0.312 . . . . 0.0 111.584 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.72 -14.94 25.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.29 23.97 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.35 125.86 13.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.067 2.512 . . . . 0.0 110.678 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -93.31 142.67 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.875 0.47 . . . . 0.0 110.197 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.2 t -101.51 -34.2 9.64 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.06 0.544 . . . . 0.0 111.491 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -167.18 160.73 14.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.91 150.73 19.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.61 1.164 . . . . 0.0 111.929 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.09 155.8 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.108 0.563 . . . . 0.0 111.412 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.05 141.93 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.103 0.561 . . . . 0.0 112.363 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.77 79.32 72.08 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.837 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.61 -25.95 77.05 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.0 113.755 -175.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.407 ' H ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.41 -12.0 61.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.408 0.549 . . . . 0.0 111.277 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -116.76 2.89 12.95 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.523 0.729 . . . . 0.0 112.327 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 58.77 38.97 24.68 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.259 0.624 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -140.81 167.28 22.55 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 112.114 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.18 40.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.286 0.634 . . . . 0.0 111.089 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.52 152.14 47.97 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -144.77 144.49 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -124.13 138.03 54.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.41 154.12 18.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.43 -15.41 62.34 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.125 -0.359 . . . . 0.0 110.148 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -139.24 142.94 37.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.487 1.515 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.53 -21.77 28.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 120.774 0.321 . . . . 0.0 111.583 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -69.94 -35.25 74.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.107 0.563 . . . . 0.0 110.79 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.9 -37.9 56.5 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 109.86 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.9 t -69.9 -34.82 74.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.168 0.587 . . . . 0.0 110.832 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.78 -34.54 78.05 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 117.973 0.351 . . . . 0.0 111.182 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.52 0.146 . . . . 0.0 111.38 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.32 -33.77 12.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 O-C-N 122.111 -0.368 . . . . 0.0 110.856 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -69.94 -33.12 71.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.955 -0.466 . . . . 0.0 110.528 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -77.34 -33.0 55.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.24 71.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.359 0.663 . . . . 0.0 111.188 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.01 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.545 0.338 . . . . 0.0 111.865 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.7 -23.58 10.98 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.99 155.34 25.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.28 0.632 . . . . 0.0 109.467 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -76.79 133.98 39.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.14 134.49 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.285 10.9 m-85 -84.7 129.83 34.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.3 mm -129.02 126.12 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.737 1.215 . . . . 0.0 107.898 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.31 34.42 6.33 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.058 0.543 . . . . 0.0 112.3 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.48 79.86 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.231 -0.76 . . . . 0.0 114.35 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.3 149.05 66.7 Favored Pre-proline 0 CA--C 1.528 0.125 0 CA-C-N 118.481 1.14 . . . . 0.0 111.767 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.64 151.05 85.74 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.491 2.794 . . . . 0.0 111.881 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 173.41 15.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.329 1.052 . . . . 0.0 109.889 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.32 156.98 27.95 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.3 144.89 25.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.582 0.753 . . . . 0.0 110.841 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -155.02 168.91 25.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.72 148.6 50.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.403 -0.811 . . . . 0.0 110.501 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.3 t -78.05 154.75 31.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 111.021 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.4 t -71.98 -2.62 18.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -130.68 149.25 52.42 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.01 0.924 . . . . 0.0 110.051 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -83.59 -2.73 56.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.981 0.512 . . . . 0.0 111.615 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -149.25 150.57 32.79 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.063 0.545 . . . . 0.0 112.008 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.4 mt . . . . . 0 CA--C 1.532 0.283 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.475 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.288 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.0 m -153.53 152.43 27.36 Favored Pre-proline 0 CA--C 1.528 0.13 0 C-N-CA 123.234 0.614 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.47 3.59 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.928 3.085 . . . . 0.0 110.646 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.91 148.38 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.72 146.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 121.659 0.743 . . . . 0.0 110.672 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -101.37 137.48 39.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.093 1.757 . . . . 0.0 110.562 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.5 mt -114.75 140.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.174 0.99 . . . . 0.0 109.651 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -147.29 152.82 38.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.328 0.651 . . . . 0.0 110.233 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.28 78.65 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.932 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.27 176.79 6.34 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.081 0.94 . . . . 0.0 111.271 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.483 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -110.2 154.4 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 123.194 0.598 . . . . 0.0 109.522 177.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -69.43 -4.47 18.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -76.75 -10.86 85.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.02 148.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.57 168.42 24.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 123.984 0.914 . . . . 0.0 109.533 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.75 -32.67 69.47 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.158 -0.339 . . . . 0.0 111.496 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -31.42 72.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.329 0.252 . . . . 0.0 111.123 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.1 -30.59 60.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -72.27 -42.18 65.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.51 -34.61 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -75.19 -23.98 57.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.125 -0.359 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.35 -17.05 31.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.4 mt -123.77 -9.14 7.84 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.96 -21.79 66.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.258 0.936 . . . . 0.0 110.632 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -11.74 61.12 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.154 -0.342 . . . . 0.0 111.389 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -92.26 -15.08 27.94 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.13 173.47 24.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.42 127.18 15.27 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.426 2.75 . . . . 0.0 110.621 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.1 mt -93.56 140.96 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.843 0.457 . . . . 0.0 110.327 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.3 t -102.12 -34.09 9.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.729 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -163.48 161.48 24.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.5 t -145.66 145.27 20.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.009 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.63 153.42 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.168 0.587 . . . . 0.0 111.206 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.28 141.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.261 0.624 . . . . 0.0 111.495 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.11 89.55 23.55 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.736 0.414 . . . . 0.0 110.435 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -6.55 17.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.885 2.39 . . . . 0.0 110.809 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -64.03 -34.41 77.95 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.387 0.675 . . . . 0.0 110.313 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -117.0 7.25 13.09 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.884 0.874 . . . . 0.0 112.471 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 57.73 52.96 7.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.398 0.679 . . . . 0.0 110.76 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -144.69 169.59 17.72 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.471 0.709 . . . . 0.0 111.57 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.62 158.32 40.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.444 0.698 . . . . 0.0 110.324 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.0 152.29 51.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.015 0.435 . . . . 0.0 110.463 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.9 t -143.57 140.58 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -122.39 138.08 54.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -99.09 154.8 17.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -72.33 -14.2 61.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.872 0.305 . . . . 0.0 110.236 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -139.06 143.23 38.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.051 1.34 . . . . 0.0 113.142 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.21 -23.05 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.695 0.283 . . . . 0.0 111.282 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.6 tp -68.05 -35.53 78.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.766 0.427 . . . . 0.0 110.432 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.27 -37.36 59.36 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.55 88.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 96.7 m -70.96 -30.12 66.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -67.62 -35.63 79.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.174 0.443 . . . . 0.0 110.892 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.61 76.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 121.299 -0.16 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 -33.48 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.705 0.23 . . . . 0.0 111.492 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.8 -31.68 70.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.992 0.36 . . . . 0.0 110.651 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -75.05 -32.87 61.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.24 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.34 0.656 . . . . 0.0 111.025 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.44 5.5 1.76 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 112.333 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -135.93 -29.52 1.02 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -156.64 153.54 28.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.77 140.53 40.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.8 135.18 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.288 10.1 m-85 -84.87 129.5 34.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.4 mm -126.25 121.55 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.464 1.106 . . . . 0.0 108.359 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.33 33.96 2.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.67 0.788 . . . . 0.0 112.172 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 89.58 12.26 62.94 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.34 0.495 . . . . 0.0 112.738 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -136.22 139.4 29.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.552 0.741 . . . . 0.0 110.516 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.37 143.57 58.58 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.335 2.69 . . . . 0.0 112.183 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.74 174.41 12.21 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.521 0.729 . . . . 0.0 110.111 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -120.14 158.77 26.22 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.28 148.71 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.648 0.779 . . . . 0.0 111.03 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -155.2 170.07 22.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -68.6 145.2 54.16 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.544 -0.722 . . . . 0.0 109.489 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.4 t -74.67 154.29 38.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.34 -2.78 17.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.2 t -129.07 156.2 44.23 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.213 1.005 . . . . 0.0 110.018 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -84.91 -6.51 59.34 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -161.03 156.58 24.87 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.742 0.701 . . . . 0.0 111.734 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 45.6 mt . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.376 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.216 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.6 m -155.64 156.27 30.55 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.269 1.028 . . . . 0.0 109.799 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.68 0.14 8.59 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.828 3.019 . . . . 0.0 110.917 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.05 145.6 33.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.67 147.26 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.451 0.643 . . . . 0.0 111.647 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -105.86 137.52 43.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.316 1.846 . . . . 0.0 110.046 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.43 140.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 124.234 1.014 . . . . 0.0 109.749 -174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -142.75 153.68 43.53 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.193 0.597 . . . . 0.0 110.159 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.07 0.12 81.18 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.694 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 104' ' ' LEU . 4.0 pp -74.12 173.5 10.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 110.818 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -110.23 157.34 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-O 121.359 0.599 . . . . 0.0 109.599 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -68.87 -5.18 19.59 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.4 -10.76 86.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 176.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 p -65.31 146.72 13.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.67 169.39 22.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 124.383 1.073 . . . . 0.0 109.8 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.15 -32.71 70.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.176 -0.328 . . . . 0.0 111.516 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.57 -31.31 71.29 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.479 0.312 . . . . 0.0 111.045 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -74.1 -31.42 62.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.01 -43.6 71.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.47 -34.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.27 -22.98 57.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.972 0.351 . . . . 0.0 111.435 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.26 26.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.8 mt -122.44 -7.58 8.66 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.55 -21.83 66.15 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.278 0.944 . . . . 0.0 110.725 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.27 -10.6 59.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.507 0.323 . . . . 0.0 111.441 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.09 -14.34 27.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.21 175.05 24.19 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.53 125.2 12.47 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.498 2.799 . . . . 0.0 110.496 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -93.47 141.62 14.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.877 0.471 . . . . 0.0 110.391 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 t -101.18 -34.15 9.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.466 0.706 . . . . 0.0 111.76 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -167.21 160.46 13.72 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.15 150.31 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.165 0.986 . . . . 0.0 111.822 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.59 156.57 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.086 0.554 . . . . 0.0 111.683 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.6 141.84 38.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.99 78.42 65.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 122.863 0.465 . . . . 0.0 110.813 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.64 -16.31 42.42 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.437 2.758 . . . . 0.0 111.566 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -64.39 -28.22 69.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 111.319 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -116.88 5.03 12.93 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.124 0.57 . . . . 0.0 111.933 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 56.77 51.75 10.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.72 0.808 . . . . 0.0 110.743 -176.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -145.06 171.27 14.71 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.901 0.88 . . . . 0.0 110.671 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.56 158.12 40.76 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.992 0.517 . . . . 0.0 110.521 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -129.86 152.05 49.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.152 0.501 . . . . 0.0 110.056 176.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.38 142.03 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -122.29 139.1 54.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -102.32 155.98 17.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -71.58 -11.4 60.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.75 0.25 . . . . 0.0 110.622 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -143.52 145.59 32.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.646 1.578 . . . . 0.0 112.843 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.08 -24.99 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.0 tp -65.05 -36.31 83.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.204 -0.31 . . . . 0.0 110.896 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.61 -37.3 61.94 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.68 89.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 93.5 m -68.95 -32.35 71.87 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.491 0.316 . . . . 0.0 111.614 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.49 -32.98 74.18 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.901 0.318 . . . . 0.0 111.196 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.94 67.47 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.374 -0.204 . . . . 0.0 111.239 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.5 t -81.45 -37.78 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.968 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -74.43 -19.24 60.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.895 0.77 . . . . 0.0 111.396 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -81.08 -33.02 33.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.17 70.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.163 0.585 . . . . 0.0 110.969 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.95 -9.17 19.35 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -140.87 -0.31 1.51 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -159.02 149.06 19.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.76 138.39 39.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.8 mt -91.54 133.63 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.297 16.9 m-85 -84.84 130.87 34.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.3 mm -128.96 124.54 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.496 1.118 . . . . 0.0 108.228 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.12 34.55 5.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.237 0.615 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.75 74.3 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.86 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -135.76 148.95 67.46 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 118.38 1.09 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -67.47 150.68 80.52 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.54 2.827 . . . . 0.0 111.504 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 174.96 13.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.168 0.987 . . . . 0.0 109.925 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -128.02 157.15 41.42 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.6 t -141.94 139.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -148.21 167.84 24.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.517 1.527 . . . . 0.0 108.431 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -68.89 151.59 46.37 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.7 t -81.9 158.0 24.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.883 0.473 . . . . 0.0 110.842 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -9.29 55.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -108.14 161.67 14.76 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.756 0.822 . . . . 0.0 110.173 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -94.12 -5.5 47.11 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -163.1 156.49 19.56 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.376 0.534 . . . . 0.0 111.325 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 72.9 mt . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.782 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.893 0.378 . . . . 0.0 111.587 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.6 m -153.59 153.16 28.65 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 124.146 0.978 . . . . 0.0 109.457 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.26 -0.28 9.86 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 110.727 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 1.9 p -123.16 145.09 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.48 147.32 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.71 0.767 . . . . 0.0 110.529 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -101.14 137.78 39.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.278 1.831 . . . . 0.0 110.697 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.1 mt -114.62 140.52 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 123.506 0.722 . . . . 0.0 109.741 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -145.9 152.7 39.87 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.458 0.703 . . . . 0.0 110.295 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.82 85.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.644 -0.531 . . . . 0.0 112.608 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.8 pp -70.08 175.16 4.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.65 0.725 . . . . 0.0 110.687 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.59 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.44 160.93 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 CA-C-O 121.366 0.603 . . . . 0.0 110.089 -178.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -66.77 -9.58 38.35 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.59 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.33 -10.98 85.78 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.032 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.4 p -63.97 145.05 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 m -132.73 166.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.138 0.975 . . . . 0.0 109.557 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.96 -32.82 69.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.254 -0.279 . . . . 0.0 111.145 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.39 71.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.381 0.272 . . . . 0.0 111.172 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.18 -29.06 62.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.28 -44.26 68.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.5 -34.72 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.76 -22.37 58.82 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.035 -0.415 . . . . 0.0 111.454 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.45 -17.12 24.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.1 mt -121.68 -7.45 9.08 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.85 -21.79 66.49 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -70.24 -11.54 60.97 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.659 -0.21 . . . . 0.0 111.475 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -92.27 -14.48 28.83 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.73 173.37 22.78 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.29 129.06 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.612 2.874 . . . . 0.0 110.468 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.29 141.57 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.202 0.601 . . . . 0.0 110.712 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.2 t -101.14 -34.12 9.83 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.457 0.703 . . . . 0.0 112.205 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -166.53 158.27 13.3 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.52 148.97 20.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.046 0.938 . . . . 0.0 112.083 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.23 156.34 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.282 0.633 . . . . 0.0 111.181 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.14 141.74 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -131.05 82.02 64.92 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 123.215 0.606 . . . . 0.0 110.078 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.39 -8.67 21.36 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.223 2.615 . . . . 0.0 110.39 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.23 -29.73 69.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.882 0.873 . . . . 0.0 110.579 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -116.99 5.29 12.84 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.895 0.878 . . . . 0.0 113.09 176.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 58.17 48.64 12.53 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.449 0.7 . . . . 0.0 110.891 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -144.81 170.39 16.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.504 0.722 . . . . 0.0 111.488 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.34 40.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.287 0.635 . . . . 0.0 110.67 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.33 151.93 51.06 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.949 0.404 . . . . 0.0 110.166 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.94 144.01 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 tt0 -126.02 137.7 53.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.557 0.343 . . . . 0.0 110.193 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.34 156.4 16.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -72.04 -14.05 61.77 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.221 -0.299 . . . . 0.0 110.224 175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -139.79 143.12 36.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.251 1.42 . . . . 0.0 113.3 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.04 -21.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 111.565 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.4 tp -69.27 -36.29 76.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.941 0.496 . . . . 0.0 110.682 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -37.7 57.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.22 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.53 -33.03 70.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.445 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.84 -33.82 76.45 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.062 -0.399 . . . . 0.0 110.851 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.82 70.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.488 0.131 . . . . 0.0 111.2 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.43 -35.15 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 122.198 -0.314 . . . . 0.0 111.441 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -70.76 -28.42 64.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.054 0.388 . . . . 0.0 111.688 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -76.4 -33.1 58.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.52 71.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.07 0.548 . . . . 0.0 110.662 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.59 3.42 6.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.352 0.661 . . . . 0.0 112.117 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -132.26 -29.64 1.59 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -154.25 149.22 26.75 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.95 132.87 39.27 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.169 -0.332 . . . . 0.0 110.255 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.4 mt -81.18 145.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 C-N-CA 122.68 0.392 . . . . 0.0 110.079 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.252 19.9 m-85 -100.05 132.25 45.53 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 175.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.9 mm -128.97 126.99 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.57 34.39 6.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.176 0.59 . . . . 0.0 112.406 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.04 79.21 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.731 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -136.14 148.88 66.42 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 118.439 1.119 . . . . 0.0 111.529 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.5 143.56 69.64 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.717 2.945 . . . . 0.0 111.285 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.15 26.72 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.852 0.861 . . . . 0.0 110.456 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -112.2 159.21 18.79 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.6 t -141.11 142.5 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.688 0.795 . . . . 0.0 110.964 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -156.31 166.34 33.73 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -68.85 150.91 47.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.5 t -82.8 158.64 22.7 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.128 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.15 -2.68 10.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.3 t -124.04 160.42 27.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.085 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -89.39 -5.56 57.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -162.39 154.19 18.53 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.542 0.61 . . . . 0.0 111.188 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.6 mt . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.303 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 120.815 0.34 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -152.83 152.32 28.17 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 109.657 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.97 -3.7 14.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.399 2.732 . . . . 0.0 110.458 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.63 149.48 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.991 0.916 . . . . 0.0 112.246 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 m -132.71 148.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.56 0.695 . . . . 0.0 112.043 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.068 1.747 . . . . 0.0 109.77 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.34 140.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.228 1.011 . . . . 0.0 109.575 -174.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -143.01 152.71 42.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.89 0.476 . . . . 0.0 111.063 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.02 5.01 71.22 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.659 -0.523 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -82.76 -175.78 5.96 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.964 0.882 . . . . 0.0 109.58 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.54 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -122.02 158.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.82 -3.52 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -79.42 -10.96 85.4 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.99 148.63 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.56 168.77 23.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.255 1.022 . . . . 0.0 110.258 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.8 -33.0 68.1 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.241 -0.287 . . . . 0.0 111.176 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.55 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 -33.83 66.62 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.54 -39.86 64.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.935 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.54 -34.35 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -75.39 -25.66 57.8 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.019 -0.426 . . . . 0.0 111.187 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.06 -17.13 33.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.76 -9.47 8.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.44 -21.91 66.21 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.208 0.913 . . . . 0.0 110.974 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.55 -11.49 60.96 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.422 -0.174 . . . . 0.0 111.372 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.47 -16.15 26.19 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.5 172.33 23.72 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.86 126.41 14.56 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.58 2.853 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.99 142.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.183 0.593 . . . . 0.0 110.331 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -106.24 -34.15 7.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.661 0.784 . . . . 0.0 111.764 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -162.75 161.42 26.25 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -146.75 144.04 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.918 0.887 . . . . 0.0 109.389 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.71 150.8 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.19 0.596 . . . . 0.0 111.774 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.45 141.74 45.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -131.65 76.48 74.69 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.544 0.737 . . . . 0.0 109.493 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.22 -12.5 35.08 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.217 2.611 . . . . 0.0 111.156 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -67.38 -23.11 65.54 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.487 0.715 . . . . 0.0 111.138 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.91 6.82 13.11 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.363 0.665 . . . . 0.0 112.756 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.45 43.46 28.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.364 0.529 . . . . 0.0 111.326 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -139.62 163.9 31.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.207 0.603 . . . . 0.0 111.096 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.65 158.22 40.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.103 0.561 . . . . 0.0 110.066 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.9 mp -124.33 149.26 46.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.6 t -141.88 143.47 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -121.76 135.03 54.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.296 0.638 . . . . 0.0 109.897 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -99.81 154.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -72.07 -13.42 61.58 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.199 -0.313 . . . . 0.0 110.17 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -142.24 143.1 32.71 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.341 1.456 . . . . 0.0 113.57 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.8 p -63.42 -21.9 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.15 -34.8 75.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.945 0.498 . . . . 0.0 110.733 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -38.99 55.83 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.22 -37.61 87.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.092 0.472 . . . . 0.0 109.857 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.08 -36.7 77.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.373 0.669 . . . . 0.0 110.613 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -65.05 -33.67 76.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.107 -0.371 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.01 -38.7 72.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.675 0.216 . . . . 0.0 110.977 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.2 t -75.81 -33.43 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 122.201 -0.312 . . . . 0.0 111.079 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.84 -26.6 64.3 Favored 'General case' 0 C--O 1.231 0.096 0 O-C-N 122.002 -0.436 . . . . 0.0 111.641 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -77.38 -33.06 55.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.2 71.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.036 0.535 . . . . 0.0 110.81 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.88 3.14 2.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.538 0.735 . . . . 0.0 112.244 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -133.8 -28.91 1.36 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -157.53 152.41 25.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.84 139.36 40.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.7 mt -83.31 135.08 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 20.4 m-85 -89.01 129.62 35.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.3 mm -129.14 123.57 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.528 1.131 . . . . 0.0 108.773 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.41 34.55 6.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.6 74.74 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.837 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -135.78 148.8 66.78 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 118.248 1.024 . . . . 0.0 111.192 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.92 150.35 78.17 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 0.0 111.189 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 175.09 13.26 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 110.115 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -130.12 162.21 29.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.04 148.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 123.388 0.675 . . . . 0.0 111.356 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -155.2 166.85 32.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -68.82 145.78 53.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.5 t -75.33 155.59 36.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.9 t -71.54 -2.59 17.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.494 0.717 . . . . 0.0 112.78 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 43.5 t -127.36 154.55 44.84 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.602 0.761 . . . . 0.0 110.332 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -87.1 -0.34 56.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.37 158.87 33.06 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.275 0.489 . . . . 0.0 111.288 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 N--CA 1.456 -0.126 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 175.786 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 111.778 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.2 t -163.66 150.57 10.34 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.0 109.699 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.9 -10.47 27.72 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.755 2.304 . . . . 0.0 109.805 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.9 t -99.17 141.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.628 0.771 . . . . 0.0 111.36 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.11 141.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.952 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -99.23 137.5 37.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 110.43 -176.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -114.85 140.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.827 0.851 . . . . 0.0 109.73 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -144.57 148.98 35.06 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 123.11 0.564 . . . . 0.0 111.031 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.63 75.63 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.973 -0.349 . . . . 0.0 112.733 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -76.19 178.17 6.63 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.565 0.682 . . . . 0.0 110.129 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.536 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -116.07 157.99 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.062 0.545 . . . . 0.0 109.929 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.87 -17.94 58.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.536 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -71.77 -10.9 72.78 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.681 -0.51 . . . . 0.0 112.606 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.02 146.63 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.9 m -132.67 168.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 C-N-CA 124.154 0.981 . . . . 0.0 110.071 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.42 -32.63 68.85 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.306 -0.246 . . . . 0.0 111.337 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.5 71.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.529 0.331 . . . . 0.0 111.232 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -73.6 -30.57 63.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.24 -42.51 68.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.76 -34.66 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -74.98 -23.11 58.22 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.141 -0.349 . . . . 0.0 111.443 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.1 -17.09 26.76 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.2 mt -121.83 -8.24 8.94 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.93 -21.89 66.46 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 119.367 0.985 . . . . 0.0 110.816 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -69.38 -10.44 57.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.262 -0.274 . . . . 0.0 111.523 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -95.07 -16.09 22.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.63 174.03 25.0 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.22 131.48 23.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.699 2.932 . . . . 0.0 110.779 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.94 142.19 15.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.968 0.507 . . . . 0.0 110.572 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.0 t -103.65 -34.08 8.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 112.094 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -165.84 156.27 13.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.9 149.24 17.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.331 1.053 . . . . 0.0 112.052 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 p -152.05 153.42 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.151 0.58 . . . . 0.0 111.186 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -126.61 141.76 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.043 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -136.12 79.12 44.81 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.247 0.619 . . . . 0.0 109.686 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.22 -4.94 12.6 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.288 2.659 . . . . 0.0 111.352 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.27 -27.62 68.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.268 0.627 . . . . 0.0 110.538 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -116.96 6.15 12.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.891 0.876 . . . . 0.0 112.591 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 55.47 51.38 12.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.405 0.548 . . . . 0.0 110.724 -171.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -142.21 163.88 31.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.71 158.1 40.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.062 0.545 . . . . 0.0 110.618 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.88 143.53 46.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.48 144.1 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -130.24 134.38 47.21 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.779 0.432 . . . . 0.0 110.158 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -93.97 155.1 17.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -71.5 -13.35 61.78 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.029 -0.419 . . . . 0.0 110.431 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -142.08 143.8 33.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.323 1.449 . . . . 0.0 113.216 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.26 -24.86 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 65.9 tp -67.08 -36.31 81.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.477 0.311 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.05 57.88 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.25 89.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.15 -34.95 75.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.382 0.673 . . . . 0.0 110.746 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.73 -34.51 78.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.037 -0.415 . . . . 0.0 110.999 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.1 73.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.642 0.201 . . . . 0.0 110.807 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.0 t -74.62 -33.68 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.193 -0.317 . . . . 0.0 110.791 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.31 -26.29 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.239 0.472 . . . . 0.0 111.606 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -76.24 -32.87 59.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.6 -30.23 69.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.299 0.64 . . . . 0.0 111.076 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.79 1.59 4.2 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.295 0.638 . . . . 0.0 112.17 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -130.11 -31.83 1.86 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -156.5 146.31 20.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.877 0.471 . . . . 0.0 109.735 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.78 134.66 39.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -75.01 145.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 122.878 0.471 . . . . 0.0 110.373 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.265 20.6 m-85 -96.95 131.71 43.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 175.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.6 mm -128.92 124.86 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.465 1.106 . . . . 0.0 108.385 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.77 34.64 5.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 8.28 76.92 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.992 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.1 148.29 64.07 Favored Pre-proline 0 CA--C 1.528 0.111 0 CA-C-N 118.49 1.145 . . . . 0.0 111.306 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.73 141.99 56.48 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.264 2.643 . . . . 0.0 110.964 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 159.04 43.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.31 0.644 . . . . 0.0 110.918 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -91.24 160.06 15.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.39 140.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -156.72 165.62 35.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -68.84 148.18 50.65 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.152 0.887 . . . . 0.0 109.706 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.5 t -83.99 159.95 21.13 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.946 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -71.33 -2.75 17.35 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.4 t -131.41 152.5 50.59 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.022 0.529 . . . . 0.0 110.961 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -83.26 -4.75 58.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.01 147.79 18.39 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.452 0.569 . . . . 0.0 111.472 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.457 -0.078 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.22 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.229 0 N-CA-C 111.282 -0.727 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.84 -17.31 62.75 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 122.339 0.255 . . . . 0.0 111.033 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 59.2 176.39 0.08 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.492 1.117 . . . . 0.0 113.473 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -141.3 158.07 44.38 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 115.706 1.743 . . . . 0.0 115.706 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 p30 -149.7 158.45 44.18 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -71.22 147.6 93.36 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.26 -9.23 25.03 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.817 3.011 . . . . 0.0 111.55 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -73.29 -18.31 61.22 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 119.623 -0.227 . . . . 0.0 111.389 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -86.25 135.68 33.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.621 0.368 . . . . 0.0 110.982 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 94' ' ' PRO . 1.2 p -132.46 154.22 81.48 Favored Pre-proline 0 C--O 1.231 0.117 0 C-N-CA 123.872 0.869 . . . . 0.0 113.259 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 64.1 Cg_endo -67.99 152.75 76.49 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.104 2.536 . . . . 0.0 111.064 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.08 152.18 45.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.227 0.537 . . . . 0.0 112.132 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.9 t -163.19 148.92 9.7 Favored Pre-proline 0 C--O 1.232 0.169 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.743 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.88 -7.4 21.03 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.802 2.335 . . . . 0.0 109.926 172.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.33 143.85 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.092 0.957 . . . . 0.0 110.439 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.3 m -133.46 139.83 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.628 0.728 . . . . 0.0 111.853 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.34 137.37 37.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.935 1.694 . . . . 0.0 109.843 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 63.3 mt -116.29 140.57 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 123.393 0.677 . . . . 0.0 109.772 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 -145.84 150.9 37.02 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.051 0.54 . . . . 0.0 110.505 -175.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.12 0.51 77.25 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.58 -0.566 . . . . 0.0 112.879 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.2 pp -70.53 174.69 5.52 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.13 0.965 . . . . 0.0 111.041 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.539 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.04 157.03 13.87 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.254 0.622 . . . . 0.0 109.7 177.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -67.47 -7.31 24.48 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.539 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.25 -11.04 85.91 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -67.23 149.47 11.56 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -132.66 169.68 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.082 0 C-N-CA 124.393 1.077 . . . . 0.0 109.621 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -59.59 -32.84 70.76 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.302 -0.249 . . . . 0.0 111.074 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.43 72.02 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.611 0.365 . . . . 0.0 111.27 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -74.86 -31.63 61.68 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.28 -41.4 63.65 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.41 -34.66 58.9 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -74.97 -24.66 58.48 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 117.731 0.242 . . . . 0.0 111.2 177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.47 -17.12 35.04 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -123.14 -9.28 8.18 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -174.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.54 -21.99 66.16 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 119.328 0.967 . . . . 0.0 110.875 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -71.03 -12.23 61.41 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.222 -0.299 . . . . 0.0 111.209 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -92.06 -16.75 25.98 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.48 173.91 27.5 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -68.76 125.7 13.01 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.654 2.903 . . . . 0.0 110.8 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 142.92 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.786 0.434 . . . . 0.0 110.583 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.6 t -107.64 -32.35 7.7 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.523 0.729 . . . . 0.0 111.956 -176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -162.94 160.5 24.88 Favored 'General case' 0 C--N 1.34 0.166 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 76.0 t -146.8 143.18 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.886 0.875 . . . . 0.0 109.239 -178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.11 154.91 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 123.215 0.606 . . . . 0.0 111.516 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.6 p -138.05 141.81 37.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.13 0.572 . . . . 0.0 112.179 -177.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.76 88.76 45.32 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 123.153 0.581 . . . . 0.0 110.439 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.76 -6.5 16.98 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.888 2.392 . . . . 0.0 110.832 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -67.83 -31.76 71.82 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 123.439 0.696 . . . . 0.0 110.608 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -116.94 5.71 12.94 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.617 0.767 . . . . 0.0 112.584 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 57.95 49.82 11.25 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.345 0.658 . . . . 0.0 110.544 -176.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -144.13 171.61 14.05 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.958 0.903 . . . . 0.0 111.283 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.16 40.7 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.195 0.598 . . . . 0.0 110.368 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.13 149.16 50.54 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 76.4 t -141.9 144.57 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -125.29 138.84 54.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 122.881 0.472 . . . . 0.0 109.797 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -102.48 155.73 18.07 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -72.8 -13.8 61.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.212 -0.305 . . . . 0.0 110.356 174.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -143.08 143.34 31.81 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 125.308 1.443 . . . . 0.0 113.451 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.5 p -62.9 -21.84 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.821 0.343 . . . . 0.0 111.714 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.3 tp -69.81 -35.03 74.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 122.81 0.444 . . . . 0.0 110.761 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.07 -38.15 48.18 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.09 -37.21 86.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -70.13 -35.52 74.13 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.521 0.728 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -65.24 -34.83 79.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 O-C-N 121.949 -0.469 . . . . 0.0 111.141 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.23 -37.43 69.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 121.325 -0.15 . . . . 0.0 111.214 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.6 t -77.31 -33.55 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 O-C-N 122.156 -0.34 . . . . 0.0 110.751 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -70.67 -28.39 64.74 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.17 0.441 . . . . 0.0 111.801 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -75.33 -33.05 61.1 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.76 -30.32 69.94 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.64 0.776 . . . . 0.0 111.675 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.12 -16.06 63.57 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -108.9 -27.17 9.85 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -160.06 154.8 24.25 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.003 0.521 . . . . 0.0 109.823 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.65 141.08 41.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.7 mt -84.41 134.87 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.292 10.8 m-85 -84.77 129.08 34.87 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.9 mm -126.62 120.57 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 124.483 1.113 . . . . 0.0 108.254 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.17 34.31 2.93 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.811 0.844 . . . . 0.0 112.08 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 90.34 11.17 63.04 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.619 0.628 . . . . 0.0 112.993 172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -136.3 139.53 30.07 Favored Pre-proline 0 CA--C 1.534 0.356 0 C-N-CA 123.358 0.663 . . . . 0.0 110.452 -177.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.32 144.57 62.63 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.411 2.74 . . . . 0.0 112.156 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -150.49 171.86 16.39 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.458 0.703 . . . . 0.0 110.073 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -115.09 161.16 18.76 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.0 p -142.24 149.41 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.575 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -153.71 168.62 25.66 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -68.74 144.21 54.45 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.836 0.743 . . . . 0.0 109.544 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 36.3 t -76.39 153.86 35.37 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.317 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.4 -2.76 17.61 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.6 t -127.69 152.93 47.09 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 123.454 0.702 . . . . 0.0 110.496 177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.0 mm-40 -88.46 -3.75 58.76 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.196 0.598 . . . . 0.0 112.525 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.38 150.87 20.17 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.353 0.524 . . . . 0.0 111.019 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mt -96.56 142.98 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.7 m -70.33 128.24 35.54 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.02 -0.425 . . . . 0.0 110.634 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 85.4 mmt-85 -81.58 155.17 71.32 Favored Pre-proline 0 CA--C 1.53 0.196 0 C-N-CA 123.237 0.615 . . . . 0.0 109.947 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -72.45 -15.86 27.68 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.299 2.666 . . . . 0.0 110.075 174.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.04 141.81 3.83 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -106.68 8.01 30.83 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.8 t -152.38 148.32 27.34 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.273 0.629 . . . . 0.0 110.448 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -78.53 -4.59 49.39 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -67.93 -13.31 62.06 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 64.4 m -81.03 -8.77 59.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.879 0.472 . . . . 0.0 111.566 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -73.84 143.28 45.96 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.512 0.325 . . . . 0.0 110.321 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.8 m 61.5 159.53 0.05 Allowed 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.482 1.513 . . . . 0.0 113.299 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.325 0.8 OUTLIER 54.97 1.82 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 115.975 1.842 . . . . 0.0 115.975 -178.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -154.49 -9.28 0.14 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.107 0.563 . . . . 0.0 111.89 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--O 1.252 1.195 0 CA-C-O 117.85 -1.072 . . . . 0.0 111.369 179.47 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.727 1 C5'-C4'-C3' 109.483 -4.011 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.48 1 O4'-C1'-N19 113.981 5.781 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.606 1 C5'-C4'-C3' 108.528 -4.648 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.608 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.807 1 C5'-C4'-C3' 108.455 -4.697 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . 0.415 " H3'" H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.585 1 C5'-C4'-C3' 108.858 -4.428 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.415 H5'' " H3'" ' B' ' 5' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.419 -2.816 0 O4'-C1'-N19 111.649 3.449 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.128 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -66.93 161.32 24.39 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.011 0.524 . . . . 0.0 111.291 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 56.13 23.78 7.28 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.812 0.845 . . . . 0.0 112.684 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -141.77 150.6 41.94 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -145.67 156.5 43.68 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -75.74 149.7 83.51 Favored Pre-proline 0 N--CA 1.454 -0.252 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.86 -9.95 27.31 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.56 2.84 . . . . 0.0 111.6 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -75.99 -8.82 57.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.59 0.356 . . . . 0.0 111.581 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -69.11 134.8 49.82 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.915 0.486 . . . . 0.0 110.467 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -81.57 148.22 61.56 Favored Pre-proline 0 CA--C 1.531 0.244 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.71 148.47 46.91 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.562 2.842 . . . . 0.0 111.028 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.15 144.43 56.92 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.851 0.358 . . . . 0.0 111.66 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -164.85 151.19 9.17 Favored Pre-proline 0 N--CA 1.454 -0.23 0 C-N-CA 123.291 0.637 . . . . 0.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.46 -7.34 20.71 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.724 2.282 . . . . 0.0 110.446 172.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.7 t -102.36 143.52 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.324 1.05 . . . . 0.0 110.657 175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.5 m -132.35 140.92 46.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-O 121.713 0.768 . . . . 0.0 111.72 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -99.28 137.54 37.65 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.129 1.772 . . . . 0.0 110.058 -176.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.7 mt -117.75 140.7 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.325 0.65 . . . . 0.0 109.554 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -144.49 151.49 39.24 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.074 0.55 . . . . 0.0 110.176 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.99 0.15 85.77 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.826 -0.43 . . . . 0.0 112.612 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.14 171.36 9.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.588 0.694 . . . . 0.0 110.881 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.21 154.33 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 C-N-CA 123.221 0.608 . . . . 0.0 109.997 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -70.77 -10.98 60.64 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.76 -10.75 86.02 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.507 0.575 . . . . 0.0 111.705 177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.1 148.72 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.51 169.85 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 C-N-CA 124.273 1.029 . . . . 0.0 109.755 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -59.23 -32.75 70.25 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.175 -0.328 . . . . 0.0 111.085 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.67 -31.42 72.07 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 122.303 -0.248 . . . . 0.0 111.043 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.5 -32.09 60.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.9 mt -71.13 -43.07 68.34 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.12 -34.65 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -74.61 -24.0 58.8 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 122.11 -0.369 . . . . 0.0 111.178 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.37 -17.11 31.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.9 mt -123.74 -8.91 7.87 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.88 -21.93 66.49 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.448 1.022 . . . . 0.0 110.751 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -70.02 -10.43 58.63 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.567 0.21 . . . . 0.0 111.567 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -94.09 -15.84 24.36 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.75 174.77 26.9 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.28 123.37 10.5 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.634 2.889 . . . . 0.0 110.92 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.44 141.93 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.021 0.528 . . . . 0.0 110.395 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.8 t -101.38 -34.24 9.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.21 0.604 . . . . 0.0 111.734 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -167.21 162.02 14.83 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.07 151.81 20.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 124.131 0.972 . . . . 0.0 111.945 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.6 p -151.13 155.94 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 123.179 0.592 . . . . 0.0 112.042 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.21 141.95 36.71 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 123.221 0.608 . . . . 0.0 112.287 -175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -132.91 81.75 57.15 Favored Pre-proline 0 C--O 1.233 0.189 0 C-N-CA 123.63 0.772 . . . . 0.0 110.12 177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -59.83 -12.48 18.52 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.389 2.726 . . . . 0.0 112.371 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -27.58 67.77 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 122.823 0.449 . . . . 0.0 111.136 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -116.81 5.74 13.09 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.685 0.794 . . . . 0.0 112.028 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 56.68 48.57 16.11 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.555 0.742 . . . . 0.0 110.285 -177.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.58 168.84 18.8 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.882 0.873 . . . . 0.0 111.193 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.59 158.25 40.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.483 0.713 . . . . 0.0 110.441 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 mp -131.33 154.12 48.89 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 120.893 0.378 . . . . 0.0 110.131 177.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.2 t -143.33 143.07 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -118.41 130.76 56.16 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -95.13 154.5 17.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -72.64 -12.85 61.21 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 122.185 -0.322 . . . . 0.0 110.487 175.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -143.89 145.56 32.38 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 125.595 1.558 . . . . 0.0 113.413 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 89.4 t -63.87 -23.37 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.4 tp -67.47 -36.69 81.64 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 122.393 0.277 . . . . 0.0 111.055 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.47 60.73 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.47 91.02 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.16 0.505 . . . . 0.0 109.893 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.7 t -69.34 -35.41 75.88 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.281 0.633 . . . . 0.0 110.827 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -65.54 -34.29 77.92 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 122.064 -0.398 . . . . 0.0 110.904 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.57 -33.39 69.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 117.472 0.124 . . . . 0.0 111.086 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -81.06 -33.7 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 122.12 -0.363 . . . . 0.0 111.158 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.47 -30.3 69.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 118.142 0.428 . . . . 0.0 111.265 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -79.06 -33.04 45.0 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.54 -30.41 71.28 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.247 0.619 . . . . 0.0 111.117 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.98 -17.4 63.29 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 122.47 0.308 . . . . 0.0 111.703 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -109.1 -24.1 11.33 Favored 'General case' 0 C--N 1.339 0.109 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -159.94 155.65 25.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.294 0.638 . . . . 0.0 109.301 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.73 136.59 39.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.62 134.03 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.9 m-85 -85.61 131.27 34.38 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 116.17 1.915 . . . . 0.0 116.17 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.9 mm -129.08 125.31 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 C-N-CA 124.554 1.142 . . . . 0.0 108.357 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.81 34.58 5.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.3 0.64 . . . . 0.0 112.498 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.39 8.86 77.02 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.062 175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -135.35 148.99 68.43 Favored Pre-proline 0 CA--C 1.527 0.083 0 CA-C-N 118.418 1.109 . . . . 0.0 111.75 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.54 151.68 79.39 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 123.53 2.82 . . . . 0.0 111.713 -176.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.96 174.61 13.91 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 109.577 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -123.62 156.09 36.48 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 105.758 -1.941 . . . . 0.0 105.758 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.6 t -141.34 138.77 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.131 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.593 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -148.62 168.71 22.09 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 125.669 1.587 . . . . 0.0 108.621 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.65 149.89 48.59 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.7 t -84.83 156.27 21.4 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.344 0.658 . . . . 0.0 110.662 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.93 -16.03 62.64 Favored 'General case' 0 C--N 1.335 -0.045 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 174.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 84.1 p -92.06 152.77 19.8 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.255 0.622 . . . . 0.0 109.629 176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -97.11 -5.51 37.17 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -161.91 149.02 14.1 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.12 0.568 . . . . 0.0 109.951 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt -92.37 144.13 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.8 m -71.2 124.75 25.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 32.8 ptt85 -156.04 149.02 18.25 Favored Pre-proline 0 N--CA 1.456 -0.163 0 C-N-CA 122.748 0.419 . . . . 0.0 110.565 -174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -72.58 -16.55 27.01 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.435 2.757 . . . . 0.0 110.684 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -91.68 16.51 59.05 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 123.589 0.614 . . . . 0.0 111.873 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.9 p30 -63.04 -5.3 2.88 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 97.6 p -76.94 -3.49 39.07 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.482 0.713 . . . . 0.0 110.7 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.273 81.6 m-20 55.52 29.18 12.92 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.268 71.6 m-20 58.43 18.06 5.33 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.41 1.633 . . . . 0.0 115.41 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.0 t 55.69 25.19 7.93 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.163 0.585 . . . . 0.0 111.307 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -64.02 137.81 58.17 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 122.059 -0.401 . . . . 0.0 110.656 -175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.7 m 58.24 10.18 1.2 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 85.4 t -73.19 139.54 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 55.35 20.03 3.36 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.638 0.775 . . . . 0.0 113.073 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.754 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 109.905 -3.73 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.614 1 O4'-C1'-N19 113.694 5.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.603 1 C5'-C4'-C3' 108.616 -4.59 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.551 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.96 1 C5'-C4'-C3' 108.394 -4.737 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.562 1 C5'-C4'-C3' 109.19 -4.207 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.787 0 C5'-C4'-C3' 110.743 -3.171 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.246 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -153.05 152.33 31.23 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.976 0.511 . . . . 0.0 110.058 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -68.67 158.08 34.88 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.925 0.49 . . . . 0.0 111.446 -178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -146.71 151.84 37.86 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -155.18 160.57 40.99 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -58.04 124.59 70.64 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.16 -14.97 45.13 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.07 2.513 . . . . 0.0 112.578 -176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -90.55 6.29 44.26 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.774 0.43 . . . . 0.0 111.646 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -62.16 144.19 55.74 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 122.888 0.475 . . . . 0.0 110.374 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.63 149.28 97.51 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -68.53 145.39 64.26 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.423 2.749 . . . . 0.0 110.505 -177.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.22 141.55 58.73 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.945 0.402 . . . . 0.0 111.738 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 57.4 m -156.46 152.41 22.9 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.946 0.898 . . . . 0.0 109.445 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.25 -10.62 22.61 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.063 2.508 . . . . 0.0 109.756 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -100.96 146.37 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 124.473 1.109 . . . . 0.0 110.789 174.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -133.39 139.62 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-O 121.421 0.629 . . . . 0.0 111.566 177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -100.04 137.4 38.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.762 1.625 . . . . 0.0 110.263 -176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 32.7 mt -117.4 140.49 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 110.151 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -144.21 155.51 43.91 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.287 0.635 . . . . 0.0 110.058 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.18 -1.09 87.62 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 119.858 -0.412 . . . . 0.0 112.77 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.64 173.44 8.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 117.679 0.739 . . . . 0.0 110.976 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.6 pt -98.89 153.92 4.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.072 0 C-N-CA 123.499 0.72 . . . . 0.0 109.52 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p30 -72.89 -9.69 58.97 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.223 1.564 . . . . 0.0 115.223 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.57 -10.75 86.04 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 176.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -63.5 149.62 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.4 m -132.69 169.3 22.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.117 0.967 . . . . 0.0 109.512 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -58.85 -32.73 69.71 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.239 -0.288 . . . . 0.0 111.119 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.62 -31.4 72.06 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.596 0.358 . . . . 0.0 111.041 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -74.38 -34.36 63.3 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -72.41 -39.7 67.73 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.63 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.6 p -71.2 -34.52 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.9 -23.39 55.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.145 -0.347 . . . . 0.0 110.862 177.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.26 -17.14 31.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.4 mt -123.97 -8.06 7.77 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.96 -21.81 65.95 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.407 1.003 . . . . 0.0 110.794 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.76 -10.49 59.6 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.515 0.326 . . . . 0.0 111.344 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -93.77 -14.96 25.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.37 173.59 24.25 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.54 125.66 13.08 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 123.744 2.963 . . . . 0.0 110.56 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 68.9 mt -93.35 141.37 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 122.898 0.479 . . . . 0.0 110.338 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.2 t -102.75 -33.68 9.3 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.518 0.727 . . . . 0.0 111.796 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -164.0 161.37 22.65 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.4 t -146.5 145.39 19.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 C-N-CA 124.0 0.92 . . . . 0.0 109.187 -178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.62 156.77 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.254 0.622 . . . . 0.0 111.556 176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.82 141.9 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.052 0 C-N-CA 123.291 0.636 . . . . 0.0 112.193 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -134.24 82.09 48.33 Favored Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 123.4 0.68 . . . . 0.0 110.263 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.87 -11.96 34.14 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.941 2.427 . . . . 0.0 111.217 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -65.38 -26.41 67.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.851 0.86 . . . . 0.0 110.756 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -117.05 4.85 12.76 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 123.828 0.851 . . . . 0.0 112.371 173.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 15.8 tpp85 55.64 51.73 12.12 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.726 0.811 . . . . 0.0 110.293 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -144.99 171.4 14.51 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.804 0.842 . . . . 0.0 111.1 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.58 158.26 40.94 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.146 0.579 . . . . 0.0 110.966 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 mp -127.56 149.53 50.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.039 0.536 . . . . 0.0 109.637 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 67.9 t -143.42 144.53 23.42 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -126.37 137.98 53.51 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.686 0.394 . . . . 0.0 110.095 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -100.29 155.14 17.95 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -71.47 -12.69 61.52 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.782 0.264 . . . . 0.0 110.338 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -143.09 143.05 31.69 Favored 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 125.759 1.624 . . . . 0.0 112.93 177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.4 p -62.06 -21.69 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-O 120.822 0.344 . . . . 0.0 111.509 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -69.8 -35.16 74.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.88 0.472 . . . . 0.0 110.859 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.86 -37.96 60.66 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.251 -1.139 . . . . 0.0 110.251 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.71 -37.15 85.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.76 -33.81 71.16 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.306 0.642 . . . . 0.0 111.129 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -66.17 -35.06 79.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.056 0.389 . . . . 0.0 111.124 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.51 -38.27 71.15 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 117.655 0.207 . . . . 0.0 111.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.8 t -77.34 -33.49 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 O-C-N 122.311 -0.243 . . . . 0.0 111.088 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -68.03 -32.67 73.2 Favored 'General case' 0 N--CA 1.456 -0.135 0 O-C-N 122.065 -0.397 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -73.75 -32.93 64.08 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.7 -30.34 69.89 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.344 0.658 . . . . 0.0 111.549 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -67.96 -15.43 63.6 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -109.85 -28.2 8.89 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -159.95 154.34 23.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.962 0.505 . . . . 0.0 109.853 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -76.72 139.96 40.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.12 -0.362 . . . . 0.0 110.139 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.4 mt -83.39 136.13 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 14.2 m-85 -88.17 130.66 34.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.2 mm -129.04 124.33 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.743 1.217 . . . . 0.0 108.601 -178.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.51 34.47 4.89 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.59 8.34 73.94 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-O 119.247 -0.752 . . . . 0.0 113.974 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -136.2 148.95 66.56 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 118.541 1.17 . . . . 0.0 111.402 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -66.84 152.4 80.55 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.38 2.72 . . . . 0.0 111.485 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 174.64 13.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.419 1.088 . . . . 0.0 109.569 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -127.37 156.4 42.08 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -178.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 10.0 p -142.28 144.34 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.082 0.553 . . . . 0.0 111.952 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.3 m-20 -148.88 169.83 19.65 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.34 1.456 . . . . 0.0 108.639 177.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -68.64 146.94 52.58 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.9 t -79.27 154.21 29.32 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.456 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.8 t -71.2 -2.54 16.27 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.7 t -125.34 151.24 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.476 0.71 . . . . 0.0 110.568 178.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -86.22 -6.93 58.88 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -159.64 148.19 17.59 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.673 0.67 . . . . 0.0 110.875 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 58.8 mt -89.39 142.51 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.8 t -65.54 119.54 11.26 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.111 -0.368 . . . . 0.0 110.592 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 63.7 mmt-85 -80.36 155.81 74.03 Favored Pre-proline 0 C--O 1.233 0.234 0 C-N-CA 123.194 0.598 . . . . 0.0 109.618 175.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.1 -7.1 18.87 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.355 2.704 . . . . 0.0 111.358 177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.46 20.32 4.68 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 123.997 0.808 . . . . 0.0 111.228 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -54.42 -30.04 51.2 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -176.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.9 m 55.17 23.79 5.68 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 24.0 t0 64.85 165.56 0.16 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.92 0.888 . . . . 0.0 112.838 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -64.95 -6.28 8.11 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 34.6 t -80.06 -14.28 58.65 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 123.11 0.564 . . . . 0.0 110.07 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -68.03 -19.42 64.9 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.858 0.863 . . . . 0.0 112.501 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 33.3 t 61.71 160.66 0.07 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.502 1.121 . . . . 0.0 112.13 -174.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.3 t 56.02 16.53 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -151.63 14.66 0.66 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.34 0.656 . . . . 0.0 110.243 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.251 1.144 0 CA-C-O 117.553 -1.213 . . . . 0.0 110.57 -179.451 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.676 0 C5'-C4'-C3' 109.91 -3.727 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.72 1 O4'-C1'-N19 113.779 5.579 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.561 1 C5'-C4'-C3' 108.43 -4.713 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.563 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.977 1 C5'-C4'-C3' 108.56 -4.627 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.492 1 C5'-C4'-C3' 108.936 -4.376 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.783 0 O4'-C1'-N19 111.693 3.493 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.196 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -146.22 -10.82 0.49 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 122.658 0.383 . . . . 0.0 111.292 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -153.87 168.1 27.49 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.082 0.553 . . . . 0.0 110.397 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -142.03 138.06 31.54 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -82.59 119.31 24.1 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.7 p30 -76.11 140.78 70.1 Favored Pre-proline 0 CA--C 1.535 0.378 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -77.02 -15.89 16.19 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.635 2.89 . . . . 0.0 111.997 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -78.33 -12.82 60.03 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 122.705 0.402 . . . . 0.0 111.587 -177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -80.4 143.21 33.66 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.514 0.726 . . . . 0.0 110.333 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 p -79.25 154.74 77.09 Favored Pre-proline 0 CA--C 1.531 0.249 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.34 159.83 52.2 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.703 2.935 . . . . 0.0 110.452 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.17 142.48 58.32 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.84 0.352 . . . . 0.0 111.421 -178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.0 m -153.17 152.72 28.42 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.822 0.849 . . . . 0.0 109.803 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.56 -3.91 14.33 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.697 2.931 . . . . 0.0 110.635 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.6 149.49 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 123.42 0.688 . . . . 0.0 112.469 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.3 m -134.58 145.85 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-O 121.826 0.822 . . . . 0.0 111.953 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -99.16 137.42 37.71 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.789 2.036 . . . . 0.0 110.282 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 58.6 mt -116.9 140.61 38.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 123.878 0.871 . . . . 0.0 109.749 -175.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -143.77 152.03 40.72 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.423 0.689 . . . . 0.0 110.276 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.09 2.63 80.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.845 -0.419 . . . . 0.0 112.818 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 104' ' ' LEU . 2.8 pp -73.62 -173.96 1.6 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.543 0.671 . . . . 0.0 110.325 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.0 pt -124.07 157.53 31.04 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 123.55 0.74 . . . . 0.0 110.6 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -65.97 -12.01 51.89 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.15 -10.83 85.25 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.489 -0.644 . . . . 0.0 111.489 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.19 148.66 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.8 m -132.69 168.68 23.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.153 0.981 . . . . 0.0 109.422 175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -58.71 -32.67 69.39 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.141 -0.35 . . . . 0.0 110.95 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.05 -31.39 71.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.46 0.304 . . . . 0.0 111.168 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -73.54 -31.67 63.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.3 mt -69.97 -43.28 71.84 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.7 p -71.99 -34.54 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -75.21 -21.29 58.77 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.969 -0.457 . . . . 0.0 111.498 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.22 -17.24 25.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -122.18 -8.6 8.72 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.97 -21.77 66.43 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 119.346 0.975 . . . . 0.0 110.696 178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -70.5 -10.8 60.13 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.152 -0.343 . . . . 0.0 111.486 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.96 -14.78 24.1 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.37 172.93 25.15 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -68.28 124.99 12.32 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.495 2.797 . . . . 0.0 110.666 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.5 mt -93.67 142.83 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 C-N-CA 123.025 0.53 . . . . 0.0 110.495 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.6 t -105.25 -34.01 8.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.418 0.687 . . . . 0.0 111.566 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -165.91 159.33 15.71 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -141.89 151.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.071 0.948 . . . . 0.0 112.221 176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.7 p -149.12 154.52 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.321 0.648 . . . . 0.0 111.382 177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -136.93 141.81 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 123.048 0.539 . . . . 0.0 112.144 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.43 88.05 40.59 Favored Pre-proline 0 CA--C 1.53 0.186 0 C-N-CA 123.138 0.575 . . . . 0.0 110.223 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -67.44 -8.28 21.67 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.039 2.493 . . . . 0.0 110.473 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -65.59 -32.41 73.97 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.651 0.78 . . . . 0.0 110.1 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -116.98 4.96 12.81 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.673 0.789 . . . . 0.0 112.226 177.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 57.78 51.48 9.21 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.231 0.612 . . . . 0.0 110.262 -176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -146.21 170.16 17.29 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.795 0.838 . . . . 0.0 111.34 -178.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.69 158.37 40.93 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 123.632 0.773 . . . . 0.0 110.692 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.3 mp -129.98 152.91 48.92 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-O 121.155 0.502 . . . . 0.0 110.132 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 51.4 t -142.76 144.57 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -122.48 136.34 54.87 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.05 0.54 . . . . 0.0 110.106 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -101.65 156.64 17.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -73.24 -11.07 60.38 Favored 'General case' 0 CA--C 1.53 0.186 0 O-C-N 122.175 -0.328 . . . . 0.0 110.5 176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -144.38 146.3 32.44 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.692 1.597 . . . . 0.0 113.481 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.6 -23.82 34.25 Favored 'Isoleucine or valine' 0 C--N 1.337 0.049 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -67.26 -37.38 83.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 122.252 0.221 . . . . 0.0 110.626 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -70.9 -38.44 65.02 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.18 -37.97 89.02 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.059 0.457 . . . . 0.0 109.949 176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.55 -33.46 71.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.09 0.556 . . . . 0.0 111.11 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -66.21 -34.62 78.44 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 118.112 0.415 . . . . 0.0 110.873 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.93 -38.7 72.9 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.516 0.144 . . . . 0.0 110.85 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 61.5 t -76.27 -33.55 23.99 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 O-C-N 122.33 -0.231 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.16 -32.29 71.52 Favored 'General case' 0 N--CA 1.455 -0.175 0 O-C-N 122.192 -0.317 . . . . 0.0 110.961 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.7 -32.94 64.17 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.22 70.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.528 0.731 . . . . 0.0 111.058 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.77 3.28 2.64 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.073 0.549 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.11 -28.67 1.33 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -156.72 152.57 27.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 122.7 0.4 . . . . 0.0 109.966 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -76.75 141.35 40.84 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.55 0.214 . . . . 0.0 110.477 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -85.12 136.15 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.304 16.2 m-85 -88.81 130.64 35.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.8 mm -129.02 125.05 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.607 1.163 . . . . 0.0 108.453 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.95 34.52 5.57 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.322 0.649 . . . . 0.0 112.373 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.36 9.03 80.23 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.412 -0.66 . . . . 0.0 114.171 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -134.08 148.82 69.58 Favored Pre-proline 0 CA--C 1.528 0.119 0 CA-C-N 118.342 1.071 . . . . 0.0 111.726 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.92 149.96 83.01 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 123.295 2.663 . . . . 0.0 111.397 -177.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 174.89 13.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.937 0.895 . . . . 0.0 109.549 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -128.52 161.0 30.59 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -142.34 147.8 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 123.44 0.696 . . . . 0.0 111.294 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -155.73 166.48 33.37 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -68.84 151.04 47.12 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.142 0.883 . . . . 0.0 108.708 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.4 t -85.48 159.06 20.02 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.886 0.474 . . . . 0.0 111.281 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -70.6 -2.75 15.26 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.1 t -125.73 154.04 43.06 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.312 0.645 . . . . 0.0 110.744 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -86.78 -0.44 56.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -158.46 158.88 34.96 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.782 0.719 . . . . 0.0 110.942 177.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt -98.34 136.74 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 171.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 47.3 t -67.83 130.8 44.11 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 120.62 0.247 . . . . 0.0 111.238 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 32.0 ptt-85 -164.33 155.6 13.66 Favored Pre-proline 0 CA--C 1.531 0.214 0 C-N-CA 123.609 0.764 . . . . 0.0 109.099 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.81 22.55 0.25 Allowed 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.536 3.491 . . . . 0.0 112.451 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -160.47 33.18 0.41 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 34.3 p30 -69.56 -9.44 53.99 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 114.306 1.225 . . . . 0.0 114.306 -176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.3 t 57.99 7.88 0.67 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.382 1.073 . . . . 0.0 113.151 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -68.48 128.06 35.23 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 121.683 -0.636 . . . . 0.0 111.236 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.254 89.7 m-20 53.96 36.84 25.39 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -175.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.5 m 61.58 19.9 10.8 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.295 1.038 . . . . 0.0 113.27 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 67.4 ttt-85 -70.06 131.58 44.54 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 122.52 0.328 . . . . 0.0 110.672 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 24.4 t 54.77 -169.69 0.07 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.668 0.787 . . . . 0.0 111.959 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.274 1.2 t 60.41 17.17 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -178.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -152.11 10.96 0.54 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.08 0.552 . . . . 0.0 112.416 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.251 1.162 0 CA-C-O 117.35 -1.31 . . . . 0.0 110.722 -179.611 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.592 0 C5'-C4'-C3' 109.656 -3.896 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.615 1 O4'-C1'-N19 113.616 5.416 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.621 1 C5'-C4'-C3' 108.221 -4.852 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.583 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.658 1 C5'-C4'-C3' 108.75 -4.5 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.741 0 O4'-C1'-N19 110.91 2.71 . 0.182 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.656 0 C5'-C4'-C3' 110.288 -3.474 . 0.311 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.095 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -70.62 163.42 27.04 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.703 0.401 . . . . 0.0 111.193 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -152.67 160.38 43.16 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.362 20.1 t80 62.82 -6.52 0.16 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 117.45 2.389 . . . . 0.0 117.45 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -158.03 160.07 37.04 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -71.39 141.71 85.98 Favored Pre-proline 0 CA--C 1.532 0.271 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.31 -11.65 20.93 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.52 2.813 . . . . 0.0 111.626 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -77.88 -10.14 59.42 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.016 0.526 . . . . 0.0 111.355 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -73.22 149.61 42.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.532 0.333 . . . . 0.0 110.737 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.87 151.78 79.14 Favored Pre-proline 0 C--O 1.231 0.112 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.51 154.68 60.24 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.353 2.702 . . . . 0.0 111.485 -175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.88 149.79 50.09 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 121.006 0.431 . . . . 0.0 111.578 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.4 t -161.52 149.86 12.68 Favored Pre-proline 0 N--CA 1.455 -0.187 0 C-N-CA 123.297 0.639 . . . . 0.0 109.697 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.35 -7.35 21.11 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.864 2.376 . . . . 0.0 109.897 172.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 12.7 t -104.06 141.59 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.058 0.943 . . . . 0.0 111.187 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.8 m -135.08 144.18 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.638 0.732 . . . . 0.0 111.412 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.427 ' HA ' HD23 ' A' ' 136' ' ' LEU . 22.1 t-80 -102.01 137.48 40.24 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.986 1.714 . . . . 0.0 110.578 -176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -114.38 140.56 34.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 123.736 0.814 . . . . 0.0 109.676 -175.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.6 tpt180 -144.66 153.82 42.15 Favored 'General case' 0 CA--C 1.527 0.087 0 C-N-CA 122.919 0.488 . . . . 0.0 110.603 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.64 4.59 88.94 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 119.801 -0.444 . . . . 0.0 112.614 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -72.36 173.77 8.26 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 117.737 0.768 . . . . 0.0 110.481 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.585 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.33 158.38 12.77 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.047 0 CA-C-O 121.363 0.602 . . . . 0.0 109.978 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.3 p30 -68.93 -7.97 39.95 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -174.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.19 -11.04 85.75 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 176.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -65.94 146.51 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.6 m -132.64 166.46 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.239 1.016 . . . . 0.0 109.445 174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.8 -32.7 69.58 Favored 'General case' 0 CA--C 1.53 0.176 0 O-C-N 122.182 -0.324 . . . . 0.0 111.281 -178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.08 -31.4 72.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.542 0.156 . . . . 0.0 110.955 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -74.89 -29.48 61.01 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.05 -44.24 69.57 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -71.95 -34.79 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -74.89 -20.4 59.74 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.212 0.46 . . . . 0.0 111.808 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.7 -16.98 22.65 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 78.5 mt -120.48 -8.31 9.59 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 113.52 0.934 . . . . 0.0 113.52 -174.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.16 -21.83 66.83 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.111 0.869 . . . . 0.0 110.702 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.19 -12.85 61.89 Favored 'General case' 0 CA--C 1.53 0.181 0 O-C-N 121.861 -0.524 . . . . 0.0 111.284 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -90.77 -15.03 30.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.73 173.76 24.77 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.67 -0.972 . . . . 0.0 110.67 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.94 125.6 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 123.534 2.823 . . . . 0.0 110.364 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.0 mt -93.32 142.74 12.78 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 122.722 0.409 . . . . 0.0 110.268 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.9 t -104.65 -34.03 8.29 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.347 0.659 . . . . 0.0 111.92 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -166.43 157.42 12.77 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 1.8 m -143.02 151.34 17.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 C-N-CA 124.088 0.955 . . . . 0.0 112.31 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.77 156.25 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 C-N-CA 123.435 0.694 . . . . 0.0 110.53 176.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.9 p -137.99 141.96 37.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.112 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.1 ptt? -133.32 81.84 54.52 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 123.446 0.699 . . . . 0.0 109.85 177.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.75 -13.62 40.63 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.054 2.503 . . . . 0.0 110.597 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -67.68 -22.22 65.3 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.182 0.593 . . . . 0.0 110.992 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -117.0 4.11 12.79 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.804 0.842 . . . . 0.0 112.097 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 59.13 40.23 22.11 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.375 0.67 . . . . 0.0 110.869 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -140.8 169.05 18.36 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.838 0.855 . . . . 0.0 111.088 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.61 158.18 40.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.153 0.581 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 100' ' ' HIS . 85.6 mt -125.24 150.33 47.14 Favored 'General case' 0 N--CA 1.458 -0.064 0 C-N-CA 123.013 0.525 . . . . 0.0 110.458 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.8 t -143.76 144.42 23.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 53.0 tt0 -126.74 139.28 53.25 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.027 0.531 . . . . 0.0 109.964 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.23 154.18 19.27 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.37 -16.34 62.96 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.854 0.297 . . . . 0.0 110.39 176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -137.19 143.09 42.17 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 125.342 1.457 . . . . 0.0 113.044 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.77 -21.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 CA-C-O 120.708 0.289 . . . . 0.0 111.561 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -70.62 -35.59 73.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 122.873 0.469 . . . . 0.0 110.727 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.31 -39.62 61.75 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.37 -36.84 83.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.166 0.508 . . . . 0.0 110.238 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.3 t -68.6 -36.27 78.47 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.218 0.607 . . . . 0.0 110.598 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.97 -35.35 80.89 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 122.191 -0.318 . . . . 0.0 110.991 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.61 -32.76 68.37 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 117.556 0.162 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 93.9 t -81.51 -33.48 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 O-C-N 122.12 -0.363 . . . . 0.0 110.775 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -71.0 -31.65 68.23 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.999 0.363 . . . . 0.0 111.506 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -77.93 -33.17 51.82 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 178.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.15 -30.28 71.35 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.33 0.652 . . . . 0.0 110.649 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.18 3.54 5.53 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.37 0.668 . . . . 0.0 112.105 178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -133.41 -27.29 1.57 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -155.27 155.83 34.48 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.256 0.622 . . . . 0.0 109.565 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -76.86 133.95 39.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.2 mt -83.86 134.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 176.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.303 16.5 m-85 -85.26 130.65 34.56 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.94 124.15 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.34 34.67 6.67 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.51 9.68 75.03 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.838 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -135.8 148.78 66.65 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.328 1.064 . . . . 0.0 111.537 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -67.8 149.77 78.52 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.32 2.68 . . . . 0.0 111.804 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.76 174.74 13.66 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.003 0.921 . . . . 0.0 109.655 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -124.1 161.25 26.0 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.9 t -140.66 145.34 25.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.084 0 C-N-CA 123.458 0.703 . . . . 0.0 110.907 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -154.94 166.19 34.34 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -68.65 147.65 51.57 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 118.944 0.793 . . . . 0.0 111.299 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 34.2 t -82.92 156.89 23.28 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.695 0.398 . . . . 0.0 110.871 178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.31 -2.75 17.32 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -131.43 153.6 49.54 Favored 'General case' 0 CA--C 1.527 0.062 0 C-N-CA 123.138 0.575 . . . . 0.0 110.868 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -85.48 -3.43 58.85 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -158.9 149.23 19.6 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.542 0.61 . . . . 0.0 111.777 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 59.4 mt -92.98 147.77 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 70.0 m -73.66 131.95 42.21 Favored 'General case' 0 N--CA 1.457 -0.093 0 O-C-N 121.725 -0.61 . . . . 0.0 111.642 177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 12.6 mpt_? -85.64 159.34 55.56 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 123.323 0.649 . . . . 0.0 110.873 175.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.29 -10.92 26.32 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.408 2.739 . . . . 0.0 110.196 173.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.57 145.17 4.63 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 109.756 -1.337 . . . . 0.0 109.756 177.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -84.86 -2.26 57.55 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.9 t 61.34 161.07 0.06 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.015 1.326 . . . . 0.0 112.911 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 43.2 p30 -155.11 -177.93 6.89 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.167 0.587 . . . . 0.0 110.377 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -68.64 9.88 0.32 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 71.8 m -134.31 5.73 3.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.566 0.746 . . . . 0.0 111.469 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -71.63 -18.87 62.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.829 0.452 . . . . 0.0 111.951 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.3 m -62.71 147.18 50.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.722 0.409 . . . . 0.0 110.387 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.317 1.0 OUTLIER 52.94 13.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 66.0 t30 56.87 23.92 8.69 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.093 0.957 . . . . 0.0 111.457 -176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.6 t . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.854 1.262 . . . . 0.0 111.923 -179.294 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.482 0 C5'-C4'-C3' 109.711 -3.86 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.932 1 O4'-C1'-N19 113.462 5.262 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.633 2 C5'-C4'-C3' 109.35 -4.1 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.622 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.69 2 C5'-C4'-C3' 108.917 -4.389 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.582 0 C5'-C4'-C3' 111.349 -2.767 . 0.144 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.407 ' N9 ' H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.883 0 C5'-C4'-C3' 111.233 -2.845 . 0.267 2u . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.414 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.43 151.38 30.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.173 0.589 . . . . 0.0 109.832 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.51 149.95 46.64 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.78 0.324 . . . . 0.0 111.795 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -80.84 -4.75 55.82 Favored 'General case' 0 N--CA 1.457 -0.089 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -79.15 156.68 28.13 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.48 155.81 92.83 Favored Pre-proline 0 N--CA 1.455 -0.201 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 175.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -65.28 -9.91 23.89 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.965 2.443 . . . . 0.0 111.647 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -77.23 -9.55 58.86 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 122.024 -0.422 . . . . 0.0 111.632 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -78.63 142.32 37.32 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.05 0.386 . . . . 0.0 110.533 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.1 p -132.3 151.56 78.54 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.57 148.92 67.36 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.372 2.715 . . . . 0.0 110.553 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.01 144.45 56.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -174.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.7 m -156.41 153.05 24.21 Favored Pre-proline 0 CA--C 1.529 0.16 0 C-N-CA 124.513 1.125 . . . . 0.0 109.293 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -75.38 8.38 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.854 3.036 . . . . 0.0 111.073 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -136.95 146.22 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.56 144.38 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 CA-C-O 121.576 0.703 . . . . 0.0 111.626 -174.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -100.72 137.46 39.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.482 1.913 . . . . 0.0 110.059 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 42.4 mt -115.64 140.74 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 123.879 0.872 . . . . 0.0 109.612 -175.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -144.29 153.81 42.41 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.89 0.476 . . . . 0.0 110.247 -176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.45 2.01 80.21 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 119.882 -0.399 . . . . 0.0 112.637 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.414 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.1 pp -73.79 174.63 8.17 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 117.727 0.763 . . . . 0.0 110.64 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.561 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.45 160.07 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.08 0 CA-C-O 121.312 0.577 . . . . 0.0 109.946 -179.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -67.34 -7.58 25.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -173.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.561 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.64 -11.05 85.83 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.994 -0.442 . . . . 0.0 111.994 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -65.77 146.87 12.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.2 m -132.54 168.27 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.08 0 C-N-CA 124.24 1.016 . . . . 0.0 109.796 174.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.61 -32.77 70.71 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 122.085 -0.384 . . . . 0.0 110.999 -177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.04 -31.51 72.09 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.42 0.288 . . . . 0.0 111.145 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -73.53 -30.09 62.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.69 -45.3 68.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.316 -0.253 . . . . 0.0 110.316 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 p -71.18 -34.66 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.63 -21.53 57.63 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.053 -0.405 . . . . 0.0 111.576 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.09 -17.14 25.41 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.1 mt -121.51 -8.73 9.06 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -64.94 -21.97 66.92 Favored 'General case' 0 CA--C 1.527 0.061 0 CA-C-N 119.023 0.829 . . . . 0.0 110.914 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -69.73 -12.65 61.8 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.301 -0.249 . . . . 0.0 111.455 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -91.66 -16.34 27.16 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.77 24.06 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -67.63 125.79 13.81 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 123.355 2.703 . . . . 0.0 110.7 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -93.51 142.77 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.089 0 C-N-CA 122.837 0.455 . . . . 0.0 110.42 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.9 t -105.49 -32.99 8.27 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.385 0.674 . . . . 0.0 112.009 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -166.43 157.7 13.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.3 m -142.96 150.97 17.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 C-N-CA 124.121 0.968 . . . . 0.0 112.084 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.2 p -151.77 157.27 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 C-N-CA 123.483 0.713 . . . . 0.0 111.239 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.0 p -138.2 141.87 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.037 0 N-CA-C 112.74 0.645 . . . . 0.0 112.74 -175.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -130.66 82.88 63.49 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 122.995 0.518 . . . . 0.0 110.212 177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.19 -9.52 23.92 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.108 2.538 . . . . 0.0 110.413 177.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -65.02 -32.88 74.82 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 123.8 0.84 . . . . 0.0 110.284 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -116.94 7.18 13.15 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.075 0.95 . . . . 0.0 112.026 176.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 56.65 48.06 17.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.808 0.843 . . . . 0.0 110.665 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -139.98 171.47 14.15 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 124.009 0.924 . . . . 0.0 110.847 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -152.8 158.3 42.04 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.168 0.587 . . . . 0.0 110.689 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 17.3 mt -132.98 145.39 50.83 Favored 'General case' 0 C--N 1.334 -0.078 0 C-N-CA 123.564 0.746 . . . . 0.0 109.678 179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -143.67 136.85 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.152 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -116.17 139.46 50.31 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.081 0.552 . . . . 0.0 110.384 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -101.64 154.95 18.41 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -71.26 -13.0 61.76 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 122.096 -0.378 . . . . 0.0 110.211 175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -143.9 143.37 31.25 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.725 1.61 . . . . 0.0 113.361 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.32 -21.72 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-O 120.646 0.26 . . . . 0.0 111.394 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 66.8 tp -69.85 -34.05 73.08 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 122.854 0.461 . . . . 0.0 110.812 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.42 -39.42 56.91 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.48 83.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.172 0.51 . . . . 0.0 109.895 175.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.3 t -69.41 -33.75 73.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.619 0.768 . . . . 0.0 111.18 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -68.14 -34.31 76.11 Favored 'General case' 0 N--CA 1.454 -0.244 0 O-C-N 122.056 -0.403 . . . . 0.0 110.855 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.77 -33.77 68.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.74 -35.76 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 O-C-N 122.037 -0.415 . . . . 0.0 111.508 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.0 -24.62 61.59 Favored 'General case' 0 N--CA 1.458 -0.037 0 CA-C-N 118.511 0.596 . . . . 0.0 112.299 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -78.31 -33.78 49.12 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.69 -30.2 71.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.035 0.534 . . . . 0.0 110.667 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.89 4.79 3.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.475 0.71 . . . . 0.0 112.265 178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -136.11 -27.13 1.12 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -155.57 153.4 30.1 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -76.76 137.96 39.62 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.93 -0.482 . . . . 0.0 110.367 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -85.73 134.58 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 18.3 m-85 -87.31 130.89 34.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 116.161 1.911 . . . . 0.0 116.161 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 26.4 mm -129.0 124.52 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.68 34.55 7.43 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.86 9.78 77.01 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.363 -0.687 . . . . 0.0 114.086 176.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -135.4 148.96 68.21 Favored Pre-proline 0 CA--C 1.529 0.144 0 CA-C-N 118.432 1.116 . . . . 0.0 111.224 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.34 151.53 80.44 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.376 2.717 . . . . 0.0 111.606 -177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.7 174.82 13.52 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.104 0.961 . . . . 0.0 109.78 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -123.93 157.54 34.06 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.5 139.69 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 C-N-CA 122.928 0.491 . . . . 0.0 111.867 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -147.42 167.33 24.66 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.705 1.602 . . . . 0.0 108.404 175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.03 149.47 48.73 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.5 t -78.99 154.54 29.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.814 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -69.72 -12.92 62.01 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 46.4 t -100.43 158.3 16.0 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.595 0.758 . . . . 0.0 110.116 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -94.86 -5.64 44.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -162.76 153.07 16.45 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.432 0.56 . . . . 0.0 110.928 177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -88.91 144.4 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.2 t -65.41 132.47 49.06 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -160.53 149.16 13.38 Favored Pre-proline 0 C--O 1.231 0.099 0 C-N-CA 122.712 0.405 . . . . 0.0 109.959 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.87 -20.59 34.14 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.205 2.603 . . . . 0.0 111.534 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -74.47 -13.04 82.05 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -96.68 -5.83 37.9 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 43.5 t -66.91 123.7 20.91 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.256 90.1 m-20 56.03 2.04 0.07 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -177.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -114.97 -4.09 12.6 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.6 t -150.54 15.33 0.78 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.187 0.595 . . . . 0.0 110.38 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -68.88 167.91 14.65 Favored 'General case' 0 C--O 1.23 0.064 0 C-N-CA 122.73 0.412 . . . . 0.0 110.366 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.7 t -148.22 164.53 33.68 Favored 'General case' 0 C--O 1.231 0.129 0 C-N-CA 122.818 0.447 . . . . 0.0 110.329 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.259 1.4 t 58.38 14.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -144.1 10.31 1.51 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.944 0.898 . . . . 0.0 111.746 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.252 1.212 0 C-N-CA 124.479 1.112 . . . . 0.0 111.138 -178.147 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.472 0 C5'-C4'-C3' 109.782 -3.812 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.646 1 O4'-C1'-N19 114.183 5.983 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.839 1 C5'-C4'-C3' 107.935 -5.043 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.619 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.841 1 C5'-C4'-C3' 108.281 -4.813 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.635 0 O4'-C1'-N19 111.168 2.968 . 0.152 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.706 0 C5'-C4'-C3' 110.177 -3.549 . 0.343 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -66.78 151.01 48.3 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.116 0.566 . . . . 0.0 110.898 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -64.83 157.38 27.94 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.949 0.5 . . . . 0.0 111.606 -178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -145.82 153.95 41.47 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -126.98 137.09 53.05 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -68.92 152.49 96.77 Favored Pre-proline 0 C--O 1.232 0.136 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.9 -10.03 27.99 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.091 2.527 . . . . 0.0 110.967 176.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -82.32 -1.07 48.48 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.428 0.691 . . . . 0.0 112.162 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -145.71 162.54 37.35 Favored 'General case' 0 C--N 1.34 0.188 0 C-N-CA 123.201 0.601 . . . . 0.0 110.642 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -76.29 154.79 84.23 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.75 150.54 68.39 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.766 2.977 . . . . 0.0 110.269 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.42 143.41 53.34 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.771 0.319 . . . . 0.0 111.028 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -161.43 149.28 12.29 Favored Pre-proline 0 C--O 1.232 0.183 0 C-N-CA 123.374 0.67 . . . . 0.0 110.288 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.23 -6.56 19.32 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.93 2.42 . . . . 0.0 110.104 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 9.4 t -105.42 143.41 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 123.89 0.876 . . . . 0.0 110.86 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.1 m -133.32 141.75 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.709 0.766 . . . . 0.0 112.368 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -99.17 137.63 37.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 126.423 1.889 . . . . 0.0 109.702 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.5 mt -117.8 140.6 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 C-N-CA 122.946 0.498 . . . . 0.0 109.806 -176.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.6 tpt180 -146.28 154.39 41.65 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.69 0.796 . . . . 0.0 110.092 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.3 1.7 88.05 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 119.729 -0.484 . . . . 0.0 112.494 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.9 pp -73.05 174.52 7.78 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.721 0.76 . . . . 0.0 110.318 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.556 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -114.18 159.45 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-O 121.067 0.461 . . . . 0.0 109.844 -178.652 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.88 -17.39 63.14 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.556 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.06 -10.73 73.86 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 119.831 -0.427 . . . . 0.0 112.351 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.0 p -66.65 147.68 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.5 m -132.51 169.06 22.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 124.39 1.076 . . . . 0.0 109.488 174.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 -60.04 -32.65 71.11 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.002 -0.436 . . . . 0.0 110.734 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.32 70.86 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.636 0.374 . . . . 0.0 111.503 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -73.99 -31.87 63.16 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 91.9 mt -73.26 -40.12 64.87 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.121 0.168 . . . . 0.0 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.78 -34.56 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -75.03 -23.9 58.22 Favored 'General case' 0 CA--C 1.528 0.115 0 O-C-N 122.06 -0.4 . . . . 0.0 111.44 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -89.29 -17.05 29.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.3 mt -120.66 -10.05 9.26 Favored 'General case' 0 C--N 1.339 0.116 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -174.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.1 -21.87 66.37 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.247 0.931 . . . . 0.0 111.017 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.96 -11.34 60.91 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 122.228 -0.295 . . . . 0.0 111.371 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -93.72 -16.79 23.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.16 173.38 26.5 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.66 126.17 13.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.663 2.908 . . . . 0.0 110.796 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.75 141.88 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.079 0 C-N-CA 122.883 0.473 . . . . 0.0 110.716 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.6 t -101.63 -34.23 9.58 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.273 0.629 . . . . 0.0 111.891 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -164.48 163.04 22.22 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 117.86 0.3 . . . . 0.0 110.537 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -145.9 142.11 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 C-N-CA 123.736 0.814 . . . . 0.0 109.568 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.9 p -150.3 155.02 8.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 C-N-CA 123.533 0.733 . . . . 0.0 110.85 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.19 141.82 40.42 Favored 'Isoleucine or valine' 0 C--O 1.23 0.076 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -130.59 84.02 60.29 Favored Pre-proline 0 N--CA 1.455 -0.188 0 C-N-CA 123.304 0.642 . . . . 0.0 110.424 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.21 -7.59 17.81 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.683 2.256 . . . . 0.0 111.322 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -27.4 66.21 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.068 0.547 . . . . 0.0 111.03 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.0 mtpm? -116.78 2.99 12.95 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 123.476 0.71 . . . . 0.0 111.108 175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 56.98 52.23 9.52 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.917 0.887 . . . . 0.0 110.657 -175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -145.05 172.02 13.65 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.171 0.989 . . . . 0.0 110.898 -178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.2 156.92 39.46 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 122.653 0.381 . . . . 0.0 110.836 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -122.63 144.78 48.9 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.729 0.811 . . . . 0.0 109.221 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.9 t -143.03 143.03 25.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -126.32 138.64 53.6 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -99.66 155.72 17.46 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -71.36 -13.36 61.83 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 122.241 -0.287 . . . . 0.0 110.401 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -143.19 144.04 32.02 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 125.409 1.484 . . . . 0.0 113.227 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.45 -21.68 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.104 0 CA-C-O 120.928 0.394 . . . . 0.0 111.615 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 70.1 tp -69.37 -35.84 76.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.841 0.456 . . . . 0.0 110.699 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.8 -37.98 56.87 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.15 -36.74 83.93 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 109.907 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.5 t -69.64 -35.81 75.56 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.23 0.612 . . . . 0.0 110.718 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -65.42 -35.01 79.65 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.139 -0.351 . . . . 0.0 111.187 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.32 -35.46 68.63 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 122.345 -0.222 . . . . 0.0 111.241 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 98.2 t -80.8 -33.51 13.42 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 O-C-N 122.243 -0.286 . . . . 0.0 110.917 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -68.35 -32.08 71.92 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 122.107 -0.371 . . . . 0.0 110.573 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -78.09 -33.21 50.83 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.21 71.34 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 122.977 0.511 . . . . 0.0 110.582 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.3 3.87 4.25 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.291 0.636 . . . . 0.0 112.384 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -134.34 -25.84 1.5 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -156.94 155.24 31.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.153 0.581 . . . . 0.0 109.495 178.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -76.66 135.35 39.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 122.183 -0.323 . . . . 0.0 110.395 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.5 mt -84.75 133.7 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.6 m-85 -85.05 130.48 34.61 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.911 1.819 . . . . 0.0 115.911 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.7 mm -128.95 123.4 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.686 1.194 . . . . 0.0 108.603 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.18 34.55 6.13 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.56 10.1 74.05 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.399 -0.667 . . . . 0.0 113.948 175.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -136.16 148.89 66.4 Favored Pre-proline 0 C--N 1.339 0.115 0 CA-C-N 118.335 1.067 . . . . 0.0 111.005 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -67.35 150.07 81.0 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.363 2.709 . . . . 0.0 111.436 -177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.81 175.08 13.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.186 0.994 . . . . 0.0 109.978 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -124.58 157.73 34.72 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.5 t -139.48 138.22 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.327 0.651 . . . . 0.0 110.7 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -145.73 167.44 23.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.321 1.048 . . . . 0.0 108.535 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -68.86 149.07 49.34 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.588 -0.695 . . . . 0.0 110.47 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.3 t -78.68 155.99 29.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.224 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -72.1 -2.75 19.66 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.4 t -131.94 153.43 50.3 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.613 0.765 . . . . 0.0 110.723 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -84.86 -4.76 59.23 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 15.2 ptmm? -160.63 150.46 17.62 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.445 0.566 . . . . 0.0 111.127 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.9 mt -86.92 148.69 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 68.1 m -70.57 -33.11 70.73 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -173.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.9 mtm-85 58.06 160.0 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 124.452 1.101 . . . . 0.0 113.694 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -71.3 -9.21 24.95 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.56 2.84 . . . . 0.0 112.582 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.57 68.78 0.05 OUTLIER Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -70.98 -24.24 62.36 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 34.4 t -69.14 144.59 53.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.776 0.431 . . . . 0.0 111.056 -178.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -65.67 -11.72 47.4 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -79.71 1.53 26.13 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 37.7 t -134.85 -12.59 2.24 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 122.746 0.418 . . . . 0.0 111.935 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -72.09 143.51 49.01 Favored 'General case' 0 C--O 1.232 0.168 0 O-C-N 122.139 -0.351 . . . . 0.0 111.575 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 71.7 m 56.17 13.43 1.2 Allowed 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.66 138.71 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 55.5 21.72 4.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.993 0.917 . . . . 0.0 112.814 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.253 1.251 0 CA-C-O 117.593 -1.194 . . . . 0.0 111.152 179.115 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.738 0 C5'-C4'-C3' 109.852 -3.765 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.644 1 O4'-C1'-N19 113.936 5.736 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.691 1 C5'-C4'-C3' 108.489 -4.674 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.602 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.656 1 C5'-C4'-C3' 107.854 -5.097 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.428 2 O4'-C1'-N19 112.348 4.148 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.578 0 O4'-C1'-N19 111.667 3.467 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.206 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -73.66 -23.78 59.9 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.644 0.377 . . . . 0.0 111.146 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -72.68 158.38 35.74 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.886 0.474 . . . . 0.0 110.916 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -68.96 -18.94 64.15 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -69.16 157.41 36.94 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -137.53 151.02 70.23 Favored Pre-proline 0 CA--C 1.529 0.15 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.2 -9.27 25.16 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.236 2.624 . . . . 0.0 111.512 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -77.32 -8.12 57.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.73 0.412 . . . . 0.0 111.733 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -67.2 142.96 56.8 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.1 0.56 . . . . 0.0 111.082 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 p -80.66 149.43 67.87 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -67.42 150.85 80.81 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.626 2.884 . . . . 0.0 110.236 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.12 143.97 56.34 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-O 121.043 0.449 . . . . 0.0 111.721 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.3 t -159.84 150.76 15.83 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.5 0.72 . . . . 0.0 109.966 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.66 -8.32 23.35 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.463 2.108 . . . . 0.0 109.703 171.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 10.5 t -103.02 142.04 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.203 1.001 . . . . 0.0 111.837 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 m -134.65 143.13 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-O 121.459 0.647 . . . . 0.0 111.234 178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -99.5 137.56 37.82 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.919 1.687 . . . . 0.0 110.099 -176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -115.65 140.52 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 123.22 0.608 . . . . 0.0 109.585 -176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -143.48 151.28 40.11 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 122.728 0.411 . . . . 0.0 110.591 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.31 86.55 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.949 -0.362 . . . . 0.0 112.798 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.07 170.07 12.16 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 117.634 0.717 . . . . 0.0 111.201 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 pt -98.57 155.57 3.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.098 0 C-N-CA 123.396 0.678 . . . . 0.0 109.976 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -70.71 -12.62 61.66 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.68 -10.81 85.87 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 123.505 0.574 . . . . 0.0 111.953 177.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.25 148.61 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 19.8 m -132.71 170.57 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 C-N-CA 124.3 1.04 . . . . 0.0 109.331 175.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -59.17 -32.77 70.19 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 122.101 -0.374 . . . . 0.0 111.013 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.92 -31.55 72.54 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.582 0.353 . . . . 0.0 111.198 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -75.54 -32.87 60.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.761 -0.587 . . . . 0.0 112.538 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.71 -39.23 64.47 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.334 0.253 . . . . 0.0 110.564 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.0 p -71.03 -34.64 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -76.19 -24.45 54.73 Favored 'General case' 0 N--CA 1.456 -0.174 0 O-C-N 121.94 -0.475 . . . . 0.0 111.119 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.74 -17.07 32.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.9 mt -122.01 -8.66 8.81 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.42 -21.7 66.22 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.449 1.022 . . . . 0.0 110.872 178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -70.5 -11.34 60.86 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 122.142 -0.349 . . . . 0.0 111.202 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -92.93 -16.96 24.57 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.97 174.08 26.22 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -68.97 126.56 13.99 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 123.502 2.801 . . . . 0.0 110.703 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 84.9 mt -94.0 142.84 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 122.981 0.512 . . . . 0.0 110.425 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 t -104.77 -34.21 8.18 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.696 0.798 . . . . 0.0 112.015 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -163.39 161.39 24.38 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 82.6 t -146.77 143.63 20.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 C-N-CA 124.08 0.952 . . . . 0.0 109.541 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.1 p -150.77 154.25 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 122.958 0.503 . . . . 0.0 111.592 175.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.4 p -136.62 141.91 39.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 C-N-CA 123.061 0.544 . . . . 0.0 111.415 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -126.79 87.34 56.76 Favored Pre-proline 0 N--CA 1.454 -0.263 0 C-N-CA 123.321 0.649 . . . . 0.0 109.984 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.89 -12.93 36.94 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.002 2.468 . . . . 0.0 111.077 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -68.05 -25.87 65.57 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.626 0.37 . . . . 0.0 110.942 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -116.91 3.55 12.86 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 58.43 46.49 15.1 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.409 0.684 . . . . 0.0 110.828 -176.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -140.47 170.08 16.46 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.866 0.866 . . . . 0.0 111.425 -177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.67 158.08 40.53 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.187 0.595 . . . . 0.0 110.984 178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -128.35 148.64 50.69 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.959 0.504 . . . . 0.0 109.712 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.9 t -142.03 144.34 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 65.8 tt0 -126.35 138.15 53.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.785 0.434 . . . . 0.0 110.096 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -100.91 155.02 18.19 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -71.8 -13.74 61.78 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.338 -0.226 . . . . 0.0 110.545 175.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -139.62 144.36 37.67 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.527 1.531 . . . . 0.0 112.964 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.18 -24.43 35.7 Favored 'Isoleucine or valine' 0 C--O 1.23 0.072 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.0 tp -66.74 -35.98 81.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.431 0.292 . . . . 0.0 110.955 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.04 -38.85 59.5 Favored Glycine 0 C--N 1.338 0.673 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.8 -35.91 82.04 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 175.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 45.8 t -70.67 -35.96 73.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.183 0.593 . . . . 0.0 110.694 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -65.68 -35.08 79.73 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.007 0.367 . . . . 0.0 111.057 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.43 -32.55 66.41 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 71.1 t -81.36 -35.02 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 O-C-N 122.1 -0.375 . . . . 0.0 110.26 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -30.58 68.07 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 118.288 0.494 . . . . 0.0 111.714 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -77.72 -33.21 53.11 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.24 -30.4 71.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.262 0.625 . . . . 0.0 110.714 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.4 4.47 3.74 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.591 0.756 . . . . 0.0 112.402 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -135.82 -26.12 1.22 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -156.3 154.54 30.8 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -76.86 137.25 39.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 122.231 -0.293 . . . . 0.0 110.251 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.8 mt -85.25 134.6 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 13.9 m-85 -85.51 130.27 34.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 -178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.7 mm -128.96 124.5 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 124.509 1.124 . . . . 0.0 108.507 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.05 34.53 5.78 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.016 0.526 . . . . 0.0 112.365 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.6 7.73 74.93 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.353 176.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -136.1 148.95 66.77 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 118.559 1.179 . . . . 0.0 111.846 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.32 153.02 79.63 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.72 2.946 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 172.84 16.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.185 0.994 . . . . 0.0 109.853 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -120.42 157.44 29.32 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 105.48 -2.045 . . . . 0.0 105.48 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.98 137.99 30.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.11 0 C-N-CA 123.305 0.642 . . . . 0.0 111.272 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -148.99 171.17 16.81 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.644 1.178 . . . . 0.0 108.448 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -68.67 149.1 49.5 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.8 t -85.43 158.21 20.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.587 0.355 . . . . 0.0 111.259 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.83 -2.78 18.98 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.8 t -131.57 152.35 50.86 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.192 0.597 . . . . 0.0 111.0 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -83.36 -3.63 57.7 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.532 0.733 . . . . 0.0 112.675 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -158.06 148.3 20.32 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.249 0.477 . . . . 0.0 110.969 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.94 144.16 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 172.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.6 t -66.28 118.94 10.68 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.891 -0.506 . . . . 0.0 110.784 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 68.0 mmt-85 -81.43 159.04 68.12 Favored Pre-proline 0 CA--C 1.528 0.134 0 C-N-CA 123.494 0.717 . . . . 0.0 109.745 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -67.63 -14.37 41.82 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.654 2.236 . . . . 0.0 110.415 172.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.54 120.52 0.73 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -106.77 -3.34 20.56 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.8 m 52.61 28.92 6.59 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.77 0.428 . . . . 0.0 111.325 -174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.9 t0 54.51 62.72 2.43 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.097 0.559 . . . . 0.0 112.007 -175.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.259 62.2 m-20 55.92 26.8 10.22 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 70.9 m 58.39 19.08 6.08 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.388 1.075 . . . . 0.0 113.227 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 184' ' ' ARG . 24.8 ttt85 -67.91 -15.98 63.86 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.161 0.584 . . . . 0.0 110.839 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.4 t -151.7 166.06 32.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.705 0.802 . . . . 0.0 109.465 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.306 1.0 OUTLIER 55.71 5.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -153.26 14.51 0.51 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.175 0.59 . . . . 0.0 110.505 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 C--O 1.252 1.196 0 CA-C-O 117.368 -1.301 . . . . 0.0 110.168 -179.452 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.65 0 C5'-C4'-C3' 109.813 -3.791 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.663 1 O4'-C1'-N19 112.443 4.243 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 1 C5'-C4'-C3' 108.428 -4.714 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.543 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.053 0 C5'-C4'-C3' 109.949 -3.701 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.524 0 C5'-C4'-C3' 109.62 -3.92 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.628 0 C5'-C4'-C3' 110.166 -3.556 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.261 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -72.61 -17.8 61.65 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.67 0.388 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -152.63 162.18 41.58 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.414 0.686 . . . . 0.0 109.203 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.261 37.7 t80 -144.39 147.59 33.59 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -70.92 161.91 30.24 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -63.06 124.58 84.35 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.68 -16.21 41.9 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.266 2.644 . . . . 0.0 112.972 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -89.23 -12.79 39.78 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.217 0.462 . . . . 0.0 111.221 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -91.32 149.4 21.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.253 0.621 . . . . 0.0 110.095 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.0 144.86 98.96 Favored Pre-proline 0 CA--C 1.532 0.251 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.72 139.39 30.71 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.369 2.713 . . . . 0.0 110.926 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.22 138.44 58.54 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.727 0.299 . . . . 0.0 111.237 -176.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 72.5 m -155.19 154.74 29.15 Favored Pre-proline 0 N--CA 1.456 -0.153 0 C-N-CA 123.837 0.855 . . . . 0.0 109.717 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -74.72 -6.1 17.74 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.405 2.737 . . . . 0.0 110.66 175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.1 p -114.81 145.86 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.8 m -133.32 144.39 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.475 0.655 . . . . 0.0 111.063 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.73 137.45 38.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.168 1.787 . . . . 0.0 110.341 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 62.8 mt -116.47 140.7 37.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 124.204 1.002 . . . . 0.0 109.361 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.5 tpt180 -142.83 152.18 41.91 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.865 0.466 . . . . 0.0 111.188 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.58 7.55 66.75 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 119.546 -0.586 . . . . 0.0 112.925 176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.419 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -82.58 177.69 8.59 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 117.911 0.856 . . . . 0.0 109.649 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.541 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -112.03 157.0 12.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.073 0 CA-C-O 121.347 0.594 . . . . 0.0 109.648 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -67.81 -4.71 13.4 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -174.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.541 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.99 -10.78 85.86 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.0 p -63.8 147.56 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.68 168.74 23.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 124.338 1.055 . . . . 0.0 109.984 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -60.32 -32.64 71.43 Favored 'General case' 0 CA--C 1.528 0.119 0 O-C-N 122.128 -0.357 . . . . 0.0 111.065 -177.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.47 -31.35 71.44 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.079 0.152 . . . . 0.0 111.072 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -71.99 -32.18 66.98 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -69.24 -44.71 71.43 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 116.827 -0.169 . . . . 0.0 110.845 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.66 -34.64 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -176.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -75.03 -23.45 58.15 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 122.074 -0.391 . . . . 0.0 111.435 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.02 -17.07 26.87 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.5 mt -121.45 -9.15 9.04 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.35 -21.87 66.74 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.12 0.873 . . . . 0.0 110.91 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.28 -10.97 60.53 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -92.72 -13.79 28.87 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.5 173.02 22.25 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.24 126.13 14.57 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 123.465 2.776 . . . . 0.0 110.58 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 62.2 mt -93.38 142.35 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 123.018 0.527 . . . . 0.0 110.294 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.33 -34.1 8.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.584 0.754 . . . . 0.0 111.857 -176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -167.14 160.4 13.83 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.29 151.47 17.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.169 0.988 . . . . 0.0 112.454 177.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.7 p -150.88 155.9 6.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 C-N-CA 123.3 0.64 . . . . 0.0 111.186 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 p -138.14 141.88 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -172.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -136.09 81.11 39.57 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 122.811 0.444 . . . . 0.0 110.32 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -66.47 -6.63 15.61 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.18 2.586 . . . . 0.0 110.458 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -64.19 -32.1 73.55 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 110.215 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -117.12 7.22 12.98 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 123.891 0.876 . . . . 0.0 113.068 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? 55.73 51.27 12.7 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.508 0.595 . . . . 0.0 111.362 -172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -143.24 164.72 29.42 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.394 0.678 . . . . 0.0 110.843 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.8 158.27 40.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.415 0.686 . . . . 0.0 110.475 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -127.66 147.01 50.37 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 176.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.7 t -143.55 144.15 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.114 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -127.37 135.92 51.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -97.16 157.81 15.75 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -71.35 -13.35 61.84 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 117.857 0.299 . . . . 0.0 110.437 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -143.38 143.89 31.83 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 125.402 1.481 . . . . 0.0 113.113 177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.8 p -61.49 -21.75 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.723 0.297 . . . . 0.0 111.496 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.4 tp -68.6 -35.82 77.87 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.806 0.442 . . . . 0.0 110.702 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.41 -38.14 58.37 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.34 -37.66 87.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.01 -31.96 68.62 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.091 0.557 . . . . 0.0 111.074 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -66.38 -35.7 80.99 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.997 -0.439 . . . . 0.0 111.007 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.16 70.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 122.414 -0.179 . . . . 0.0 110.917 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.5 t -77.15 -33.69 20.56 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 O-C-N 122.363 -0.211 . . . . 0.0 110.581 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -70.18 -30.79 68.0 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 122.191 -0.318 . . . . 0.0 110.746 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -74.84 -32.96 62.07 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.76 -30.31 70.7 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.518 0.727 . . . . 0.0 111.098 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.56 1.9 3.65 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.166 0.586 . . . . 0.0 112.393 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -132.1 -28.79 1.7 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -157.05 152.33 26.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 122.805 0.442 . . . . 0.0 109.86 177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.81 138.37 39.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.6 mt -82.78 140.02 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.3 16.6 m-85 -92.27 131.21 37.66 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.1 mm -129.02 124.68 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 124.624 1.17 . . . . 0.0 108.429 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.47 34.51 6.84 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.181 0.592 . . . . 0.0 112.464 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.08 10.16 78.9 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 119.647 -0.529 . . . . 0.0 113.787 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -134.99 148.81 68.41 Favored Pre-proline 0 C--N 1.339 0.11 0 CA-C-N 118.151 0.975 . . . . 0.0 111.311 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.01 150.46 82.76 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 123.36 2.706 . . . . 0.0 111.198 -178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.07 13.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.922 0.889 . . . . 0.0 109.709 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.72 158.63 39.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -142.34 145.52 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -152.4 168.9 23.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.716 1.606 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -68.93 150.5 47.66 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 38.8 t -81.08 162.34 23.77 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.205 0.602 . . . . 0.0 111.31 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.9 -2.89 22.6 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 175.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.6 t -125.15 157.75 35.63 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.584 0.754 . . . . 0.0 110.082 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -85.41 -6.67 59.2 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -161.09 157.62 26.33 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 118.714 0.688 . . . . 0.0 111.67 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.6 mt -85.76 148.91 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.9 t -62.42 134.22 56.14 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.431 0.293 . . . . 0.0 111.274 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 84.7 mtm-85 -148.56 149.54 31.48 Favored Pre-proline 0 C--O 1.232 0.143 0 C-N-CA 123.782 0.833 . . . . 0.0 110.618 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.08 -21.77 15.36 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.629 2.886 . . . . 0.0 111.292 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.76 -13.93 64.0 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.7 -0.5 . . . . 0.0 112.542 -178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -85.9 -4.97 59.29 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.2 m 54.81 32.31 17.36 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.383 0.673 . . . . 0.0 112.602 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -56.73 152.68 11.89 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -55.24 112.01 0.99 Allowed 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 70.6 m 57.42 11.42 1.17 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.818 1.247 . . . . 0.0 114.017 178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -86.53 153.1 22.08 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.225 0.61 . . . . 0.0 112.068 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 66.9 m 56.59 14.87 1.86 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.35 134.64 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.6 17.4 2.29 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.227 1.011 . . . . 0.0 113.722 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.8 m . . . . . 0 C--O 1.254 1.314 0 C-N-CA 123.975 0.91 . . . . 0.0 111.772 -179.449 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.512 0 C5'-C4'-C3' 109.57 -3.953 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.555 1 O4'-C1'-N19 113.744 5.544 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.692 1 C5'-C4'-C3' 108.505 -4.663 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.604 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.711 2 C5'-C4'-C3' 108.367 -4.756 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.78 0 O4'-C1'-N19 110.676 2.476 . 0.167 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.981 0 C5'-C4'-C3' 110.602 -3.266 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.056 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -73.33 -28.57 62.15 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 122.644 -0.327 . . . . 0.0 111.542 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -97.76 -19.41 18.21 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -153.65 146.43 24.32 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -67.4 158.07 32.59 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -176.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -137.7 152.52 72.77 Favored Pre-proline 0 C--O 1.232 0.171 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.7 -9.54 26.48 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.139 2.559 . . . . 0.0 111.734 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -77.44 -12.21 59.93 Favored 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.586 0.354 . . . . 0.0 111.32 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -70.73 152.19 44.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.584 0.754 . . . . 0.0 110.234 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -125.81 146.67 56.01 Favored Pre-proline 0 C--O 1.232 0.178 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.12 160.24 42.96 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.759 2.973 . . . . 0.0 111.102 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.77 147.24 53.54 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 120.99 0.424 . . . . 0.0 111.047 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.8 t -162.05 148.8 11.1 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.527 0.731 . . . . 0.0 109.761 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -70.87 -9.72 26.27 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.663 2.242 . . . . 0.0 109.65 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.4 t -100.02 140.91 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 123.521 0.728 . . . . 0.0 110.924 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.1 m -134.97 141.71 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-O 121.997 0.903 . . . . 0.0 111.77 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.422 ' HA ' HD23 ' A' ' 136' ' ' LEU . 14.8 t60 -99.15 137.43 37.68 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.315 1.846 . . . . 0.0 110.412 -177.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.8 mt -116.02 140.8 36.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 C-N-CA 123.829 0.851 . . . . 0.0 109.735 -175.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -144.65 152.77 40.95 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.86 0.464 . . . . 0.0 110.582 -175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.15 86.66 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.75 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.405 HD12 ' C ' ' A' ' 104' ' ' LEU . 3.8 pp -71.45 173.94 7.26 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 117.86 0.83 . . . . 0.0 110.898 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 7.6 pt -104.03 153.4 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.04 0 C-N-CA 123.317 0.647 . . . . 0.0 109.296 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -71.46 -8.54 54.51 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.09 -10.85 85.18 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.79 150.02 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.66 166.88 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 C-N-CA 124.064 0.946 . . . . 0.0 109.522 175.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.85 -32.67 67.87 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 122.247 -0.283 . . . . 0.0 111.455 -177.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.49 72.08 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.433 0.293 . . . . 0.0 111.48 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -74.33 -30.83 62.21 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.8 mt -70.35 -44.24 68.54 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.8 -34.68 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -75.18 -21.57 58.65 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.091 0.405 . . . . 0.0 111.22 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.54 -17.09 26.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.3 mt -121.97 -9.52 8.74 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.06 -21.95 66.9 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 119.185 0.902 . . . . 0.0 110.813 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -69.23 -12.72 61.91 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.201 0.2 . . . . 0.0 111.409 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -91.71 -17.65 25.12 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.07 172.26 25.02 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.24 128.84 19.17 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.253 2.635 . . . . 0.0 110.795 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 65.8 mt -96.88 142.84 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 C-N-CA 123.079 0.552 . . . . 0.0 110.781 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.9 t -103.73 -33.99 8.74 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 123.626 0.77 . . . . 0.0 111.914 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -167.0 159.68 13.46 Favored 'General case' 0 C--N 1.339 0.143 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -142.77 152.7 17.37 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 124.314 1.046 . . . . 0.0 112.045 176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.0 154.93 7.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.307 0.643 . . . . 0.0 111.052 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.4 p -138.02 141.88 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 123.141 0.577 . . . . 0.0 112.313 -176.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -133.66 84.31 45.47 Favored Pre-proline 0 CA--C 1.531 0.223 0 C-N-CA 123.453 0.701 . . . . 0.0 109.741 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.55 -8.53 22.52 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.131 2.554 . . . . 0.0 110.858 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -65.84 -30.56 71.19 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.416 0.686 . . . . 0.0 109.931 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -116.9 5.79 13.0 Favored 'General case' 0 C--N 1.338 0.079 0 C-N-CA 123.823 0.849 . . . . 0.0 111.897 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 57.13 48.59 15.09 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.889 0.875 . . . . 0.0 110.996 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -141.85 169.01 18.4 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 123.676 0.79 . . . . 0.0 110.841 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.5 157.71 40.22 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.163 0.585 . . . . 0.0 110.06 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 100' ' ' HIS . 26.4 mt -128.46 150.29 50.21 Favored 'General case' 0 N--CA 1.456 -0.131 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.5 144.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -124.33 131.6 53.52 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.836 0.454 . . . . 0.0 109.787 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -94.02 155.34 17.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -71.93 -15.58 62.09 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -140.16 143.03 35.94 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.263 1.425 . . . . 0.0 113.688 177.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.72 -21.78 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 CA-C-O 120.851 0.358 . . . . 0.0 111.452 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.9 tp -68.99 -36.12 77.47 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 122.861 0.464 . . . . 0.0 110.638 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.57 -39.11 61.27 Favored Glycine 0 C--N 1.338 0.654 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -36.88 84.95 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.042 0.448 . . . . 0.0 109.985 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 41.8 t -70.95 -33.29 70.33 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.551 0.74 . . . . 0.0 110.904 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.52 -35.02 78.29 Favored 'General case' 0 N--CA 1.456 -0.16 0 O-C-N 122.211 -0.306 . . . . 0.0 110.961 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.86 -38.51 70.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.559 0.163 . . . . 0.0 111.433 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.5 t -73.73 -35.45 43.74 Favored 'Isoleucine or valine' 0 C--N 1.338 0.087 0 O-C-N 122.229 -0.294 . . . . 0.0 111.125 -176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -76.87 -21.36 55.08 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.468 0.576 . . . . 0.0 112.488 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -74.68 -32.96 62.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.07 -30.25 70.22 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.555 0.742 . . . . 0.0 111.7 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.55 -16.7 63.96 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -107.33 -28.6 9.78 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -159.97 152.4 20.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.23 0.612 . . . . 0.0 109.606 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.79 140.02 40.58 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -82.74 133.56 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 16.8 m-85 -86.51 129.38 34.88 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 29.4 mm -128.88 124.49 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.572 1.149 . . . . 0.0 108.343 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.39 34.51 6.64 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.07 8.73 78.3 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-O 119.387 -0.674 . . . . 0.0 114.227 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -135.83 148.91 67.16 Favored Pre-proline 0 CA--C 1.528 0.108 0 CA-C-N 118.494 1.147 . . . . 0.0 111.849 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.25 150.89 81.64 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 123.349 2.699 . . . . 0.0 111.703 -176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.92 174.95 13.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.451 1.1 . . . . 0.0 109.767 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -125.5 162.82 24.04 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 4.4 p -142.21 148.87 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 123.254 0.622 . . . . 0.0 111.956 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -156.02 166.79 32.42 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -68.84 148.48 50.2 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 119.222 0.919 . . . . 0.0 110.598 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 41.1 t -85.05 160.61 19.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.974 0.51 . . . . 0.0 110.956 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.73 -2.77 18.64 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 115.621 1.711 . . . . 0.0 115.621 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.7 t -133.62 154.05 51.19 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.056 0.542 . . . . 0.0 111.043 -179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -85.11 -2.69 58.28 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.414 0.686 . . . . 0.0 112.243 -176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -159.76 151.85 20.66 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.814 0.34 . . . . 0.0 111.479 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 73.5 mt -93.95 140.74 15.98 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 69.0 m -72.91 138.46 46.22 Favored 'General case' 0 N--CA 1.456 -0.159 0 O-C-N 122.05 -0.406 . . . . 0.0 110.881 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 ptt-85 -160.56 142.47 9.31 Favored Pre-proline 0 N--CA 1.456 -0.135 0 C-N-CA 123.215 0.606 . . . . 0.0 109.897 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.39 -16.32 27.74 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.8 3.0 . . . . 0.0 111.846 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -74.67 -20.44 79.52 Favored Glycine 0 C--N 1.339 0.74 0 N-CA-C 111.774 -0.531 . . . . 0.0 111.774 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -106.57 -3.03 21.21 Favored 'General case' 0 C--N 1.339 0.136 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.2 m 60.57 161.52 0.05 Allowed 'General case' 0 C--O 1.231 0.08 0 C-N-CA 124.999 1.32 . . . . 0.0 113.824 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -112.85 11.23 19.2 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.277 70.8 m-20 59.51 2.57 0.34 Allowed 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 116.89 2.182 . . . . 0.0 116.89 -175.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.6 t -155.84 12.84 0.32 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.559 0.743 . . . . 0.0 110.33 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -64.92 145.96 55.6 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.123 0.569 . . . . 0.0 110.797 -174.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.3 t 54.2 19.08 2.01 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.793 0.837 . . . . 0.0 112.226 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.284 1.1 t 56.9 22.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -144.57 -5.43 0.74 Allowed 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.166 -0.333 . . . . 0.0 111.792 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.0 t . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.626 -1.654 . . . . 0.0 111.487 -179.53 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.608 0 C5'-C4'-C3' 109.835 -3.776 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.611 1 O4'-C1'-N19 114.03 5.83 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.563 1 C5'-C4'-C3' 108.42 -4.72 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.598 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.01 1 C5'-C4'-C3' 108.628 -4.582 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . 0.457 " H4'" ' C2 ' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.553 1 C5'-C4'-C3' 108.09 -4.94 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.457 ' C2 ' " H4'" ' B' ' 5' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.417 -2.975 0 C5'-C4'-C3' 110.435 -3.377 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -70.54 161.77 30.05 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.951 0.405 . . . . 0.0 111.063 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -69.04 156.84 37.96 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.62 0.368 . . . . 0.0 111.128 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -146.02 151.03 37.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -148.01 156.72 42.97 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -65.17 151.29 94.11 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -68.93 178.09 4.39 Favored 'Trans proline' 0 N--CA 1.448 -1.193 0 C-N-CA 123.646 2.897 . . . . 0.0 111.034 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.408 ' CD2' ' N ' ' A' ' 91' ' ' HIS . 18.7 m-70 -79.14 2.07 22.16 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.121 1.368 . . . . 0.0 112.071 -175.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -68.8 134.98 50.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.802 0.441 . . . . 0.0 110.595 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -85.92 151.46 54.86 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -71.36 157.18 57.38 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.502 2.801 . . . . 0.0 110.863 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.83 148.42 49.39 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.221 0.534 . . . . 0.0 111.887 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 28.6 t -163.09 149.62 10.34 Favored Pre-proline 0 N--CA 1.455 -0.195 0 C-N-CA 123.464 0.706 . . . . 0.0 110.011 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.39 -9.59 26.21 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.926 2.417 . . . . 0.0 110.027 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.7 t -99.93 139.7 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 123.673 0.789 . . . . 0.0 110.621 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.1 m -134.38 139.02 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-O 121.625 0.726 . . . . 0.0 111.395 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -99.18 137.31 37.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.416 1.886 . . . . 0.0 110.296 -175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 38.3 mt -116.37 140.69 37.42 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 123.784 0.833 . . . . 0.0 109.911 -174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -143.43 151.87 40.88 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 123.138 0.575 . . . . 0.0 110.449 -174.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.05 0.3 85.53 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.098 0.38 . . . . 0.0 112.705 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -71.96 173.99 7.62 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.448 0.624 . . . . 0.0 110.972 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.7 pt -100.71 154.53 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.074 0 C-N-CA 123.599 0.76 . . . . 0.0 109.705 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -72.76 -10.48 59.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -178.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -77.71 -10.9 85.93 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -63.88 149.8 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.1 m -132.56 169.92 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 C-N-CA 124.018 0.927 . . . . 0.0 109.895 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 60.3 mp0 -57.9 -32.84 68.13 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 122.407 0.283 . . . . 0.0 111.205 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.72 -31.4 70.44 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.746 0.418 . . . . 0.0 111.722 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -72.97 -35.67 66.97 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.949 -0.469 . . . . 0.0 112.095 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.5 -38.48 65.35 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.488 0.315 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 1.8 p -69.93 -34.88 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -75.63 -25.0 56.51 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 122.148 -0.345 . . . . 0.0 111.007 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -86.46 -17.0 35.38 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 98.6 mt -122.84 -9.62 8.31 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -174.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.62 -21.86 66.12 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 119.372 0.987 . . . . 0.0 110.915 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -68.96 -11.5 60.76 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.264 -0.273 . . . . 0.0 111.406 177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -94.68 -16.09 23.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 176.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.68 172.43 23.97 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.17 129.26 17.9 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.499 2.799 . . . . 0.0 110.981 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 93.9 mt -97.81 142.78 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 123.043 0.537 . . . . 0.0 110.604 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.8 t -104.71 -32.12 9.03 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.328 0.651 . . . . 0.0 111.641 -177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -163.0 161.88 25.71 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -178.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 98.5 t -147.26 143.96 19.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 C-N-CA 124.143 0.977 . . . . 0.0 109.319 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.5 p -151.03 153.3 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 123.335 0.654 . . . . 0.0 111.651 176.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.1 t -127.6 141.7 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.053 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -176.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -129.1 78.89 75.47 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 123.332 0.653 . . . . 0.0 109.811 178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.22 -7.71 18.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 123.093 2.529 . . . . 0.0 111.201 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -65.35 -33.2 75.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.267 0.627 . . . . 0.0 110.097 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -117.1 7.5 13.07 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 123.743 0.817 . . . . 0.0 112.537 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.2 tpp85 55.77 53.39 9.49 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.216 0.606 . . . . 0.0 110.58 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -144.76 172.87 12.41 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.923 0.889 . . . . 0.0 110.977 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.55 158.26 40.96 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.123 0.569 . . . . 0.0 110.82 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 19.4 mt -128.81 146.65 50.86 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.324 0.65 . . . . 0.0 109.657 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 75.7 t -141.56 144.22 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -126.76 126.81 44.06 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -87.19 156.94 19.47 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -72.66 -14.32 61.56 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 122.205 -0.309 . . . . 0.0 110.344 174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -143.07 143.04 31.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.292 1.437 . . . . 0.0 113.382 177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.51 -21.94 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.6 -36.72 79.06 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.866 0.466 . . . . 0.0 110.587 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -36.2 58.11 Favored Glycine 0 C--N 1.338 0.643 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.42 -39.57 92.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 97.5 m -71.29 -28.71 64.32 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -68.04 -36.44 79.91 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.222 0.465 . . . . 0.0 110.932 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.461 0.119 . . . . 0.0 110.968 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 92.6 t -76.99 -33.43 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.358 -0.214 . . . . 0.0 110.978 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -66.8 -34.48 77.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 118.176 0.443 . . . . 0.0 110.379 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -74.24 -32.99 63.19 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 175.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.28 -29.99 69.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.501 0.72 . . . . 0.0 111.862 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -60.61 -10.68 5.51 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -144.41 5.04 1.23 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 176.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -149.83 156.1 41.22 Favored 'General case' 0 C--N 1.339 0.121 0 C-N-CA 123.593 0.757 . . . . 0.0 110.716 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -94.04 137.03 33.69 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 77.8 mt -90.04 135.1 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.043 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.299 24.7 m-85 -87.42 128.83 35.21 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.96 123.33 58.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 C-N-CA 124.458 1.103 . . . . 0.0 108.578 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.05 34.41 4.2 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.293 0.637 . . . . 0.0 112.562 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.47 8.8 70.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.459 -0.634 . . . . 0.0 114.105 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -136.05 148.91 66.7 Favored Pre-proline 0 N--CA 1.461 0.09 0 CA-C-N 118.355 1.078 . . . . 0.0 111.684 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.64 149.34 79.22 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.32 2.68 . . . . 0.0 111.426 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.71 175.08 13.22 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.414 1.086 . . . . 0.0 109.516 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -129.46 161.92 29.29 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 105.858 -1.905 . . . . 0.0 105.858 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.6 p -142.3 149.23 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.396 0.678 . . . . 0.0 110.894 177.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -154.2 167.66 29.16 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -68.97 150.79 47.31 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 121.39 -0.819 . . . . 0.0 109.103 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 40.9 t -84.21 160.02 20.89 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.941 0.496 . . . . 0.0 111.19 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.34 -2.66 17.08 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 115.3 1.593 . . . . 0.0 115.3 176.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.2 t -133.91 152.48 51.87 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.248 0.619 . . . . 0.0 110.913 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -82.46 -2.7 54.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.47 0.708 . . . . 0.0 112.486 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -157.84 153.42 26.37 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.381 0.537 . . . . 0.0 111.608 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.6 mt -95.05 147.33 5.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 173.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 72.5 m -68.97 116.98 10.05 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -160.64 150.41 14.4 Favored Pre-proline 0 CA--C 1.528 0.117 0 C-N-CA 123.436 0.695 . . . . 0.0 109.976 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.63 -13.95 30.08 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.308 2.672 . . . . 0.0 111.722 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -73.78 -6.69 73.08 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-O 119.898 -0.39 . . . . 0.0 112.285 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -83.77 8.45 14.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 117.591 0.696 . . . . 0.0 110.307 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 41.3 t -149.99 151.41 33.27 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 121.539 -0.725 . . . . 0.0 111.228 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.319 0.8 OUTLIER 54.62 172.29 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.273 7.1 t0 61.78 -73.19 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 115.781 1.771 . . . . 0.0 115.781 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.7 t -74.62 -27.29 60.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 122.236 -0.29 . . . . 0.0 111.227 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -77.87 157.4 29.87 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 122.868 0.467 . . . . 0.0 111.488 178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 36.6 t 60.51 163.39 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.238 1.415 . . . . 0.0 113.374 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.8 t -135.78 9.14 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.93 0.892 . . . . 0.0 112.968 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 42.3 p30 -145.68 5.35 1.03 Allowed 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.0 177.379 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.731 0 C5'-C4'-C3' 109.795 -3.803 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 1 O4'-C1'-N19 113.915 5.715 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.526 1 C5'-C4'-C3' 108.332 -4.779 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.53 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.413 -3.356 1 C5'-C4'-C3' 109.14 -4.24 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.426 -2.254 1 C5'-C4'-C3' 108.624 -4.584 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . 0.401 ' C8 ' H5'' ' B' ' 6' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.901 0 C5'-C4'-C3' 109.644 -3.904 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.037 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 57.41 -179.14 0.06 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.297 1.039 . . . . 0.0 112.564 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -75.85 1.51 14.82 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.075 0.55 . . . . 0.0 112.147 -179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.264 38.9 t80 -62.72 148.54 46.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.76 156.09 36.39 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -66.36 124.38 87.96 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.15 -16.81 40.42 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.954 2.436 . . . . 0.0 112.502 -176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -98.3 4.34 48.71 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.113 0.565 . . . . 0.0 111.581 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -66.69 139.52 57.85 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.648 0.379 . . . . 0.0 110.731 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -91.77 148.48 37.24 Favored Pre-proline 0 CA--C 1.529 0.173 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -72.06 151.22 55.5 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.611 2.874 . . . . 0.0 110.86 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.46 144.39 57.02 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.014 0.435 . . . . 0.0 111.704 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.8 t -164.05 149.86 9.34 Favored Pre-proline 0 CA--C 1.529 0.151 0 C-N-CA 123.531 0.732 . . . . 0.0 109.753 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.89 -9.22 25.3 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.887 2.392 . . . . 0.0 110.033 172.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.12 142.88 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.637 0.775 . . . . 0.0 110.68 174.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 m -135.31 141.17 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-O 121.495 0.664 . . . . 0.0 111.817 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -104.93 137.47 42.64 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.397 1.879 . . . . 0.0 109.996 -176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -115.19 140.7 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 124.232 1.013 . . . . 0.0 110.004 -173.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 -141.71 154.8 45.54 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.12 0.568 . . . . 0.0 110.11 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.15 0.24 83.13 Favored Glycine 0 CA--C 1.531 1.061 0 CA-C-O 119.542 -0.588 . . . . 0.0 112.713 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.8 pp -73.18 174.96 7.25 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.872 0.836 . . . . 0.0 110.584 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.546 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.8 160.86 13.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.104 0.561 . . . . 0.0 110.087 -178.178 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.68 -19.04 64.59 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.546 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -70.41 -10.78 67.03 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.092 0.377 . . . . 0.0 112.561 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.73 146.61 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.9 m -132.57 166.79 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.065 0 C-N-CA 124.098 0.959 . . . . 0.0 109.827 174.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.45 -32.73 70.49 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 122.248 -0.282 . . . . 0.0 111.2 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.69 -31.38 72.0 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.212 0.205 . . . . 0.0 111.09 177.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -74.01 -30.19 62.33 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.6 mt -68.74 -45.02 72.56 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -71.38 -34.65 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -74.96 -21.57 59.09 Favored 'General case' 0 CA--C 1.529 0.163 0 O-C-N 121.998 -0.438 . . . . 0.0 111.754 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.74 -17.02 23.62 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.4 mt -120.4 -8.74 9.58 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -174.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.5 -21.97 66.68 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 119.112 0.869 . . . . 0.0 110.993 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.0 -12.37 61.56 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.142 -0.349 . . . . 0.0 111.485 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -91.3 -16.09 28.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.32 172.21 23.45 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -68.01 130.67 22.09 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.496 2.798 . . . . 0.0 110.764 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.0 mt -98.52 142.79 14.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 C-N-CA 123.211 0.604 . . . . 0.0 110.894 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 33.4 t -104.7 -33.7 8.38 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.615 0.766 . . . . 0.0 112.278 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -165.0 157.04 15.54 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.7 m -143.69 151.37 16.64 Favored 'Isoleucine or valine' 0 C--O 1.23 0.074 0 C-N-CA 123.911 0.884 . . . . 0.0 111.941 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.07 157.97 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 123.317 0.647 . . . . 0.0 111.804 177.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.1 p -138.05 141.94 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.113 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -133.05 82.66 53.96 Favored Pre-proline 0 N--CA 1.455 -0.183 0 C-N-CA 123.288 0.635 . . . . 0.0 110.328 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -67.02 -10.17 27.63 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.919 2.413 . . . . 0.0 111.513 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -69.98 -24.49 63.32 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 117.841 0.291 . . . . 0.0 111.065 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -116.8 3.34 12.94 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.503 0.721 . . . . 0.0 111.769 175.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 57.3 51.12 10.46 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.878 0.871 . . . . 0.0 110.507 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -144.31 170.93 15.06 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.966 0.906 . . . . 0.0 110.873 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.23 40.64 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 123.13 0.572 . . . . 0.0 110.537 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.51 150.89 49.97 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.6 t -143.34 144.56 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -125.35 133.08 52.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.852 0.461 . . . . 0.0 109.968 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -95.37 155.3 16.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -71.42 -14.51 62.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -143.61 143.54 31.53 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.566 1.546 . . . . 0.0 113.415 177.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -62.17 -21.9 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 CA-C-O 120.793 0.33 . . . . 0.0 111.658 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.69 -35.31 77.03 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 122.687 0.395 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.06 -38.88 55.01 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.74 -36.82 85.54 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.013 0.435 . . . . 0.0 109.852 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.96 -33.61 68.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.218 0.607 . . . . 0.0 110.999 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.41 -34.75 79.02 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 118.118 0.417 . . . . 0.0 111.015 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.57 68.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 O-C-N 122.494 -0.128 . . . . 0.0 111.107 178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.9 t -76.6 -33.6 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.046 0 O-C-N 122.069 -0.395 . . . . 0.0 110.876 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -71.68 -30.8 66.1 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 122.031 -0.418 . . . . 0.0 110.566 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -73.75 -32.93 64.07 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.08 -30.35 69.17 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.635 0.774 . . . . 0.0 111.5 -178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -68.96 -14.91 63.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -109.99 -27.18 9.35 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 114.32 1.229 . . . . 0.0 114.32 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -160.01 153.86 22.93 Favored 'General case' 0 CA--C 1.528 0.096 0 C-N-CA 123.101 0.56 . . . . 0.0 109.587 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -76.72 137.04 39.11 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -81.37 137.61 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.286 13.9 m-85 -90.45 130.8 36.48 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 115.733 1.753 . . . . 0.0 115.733 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.7 mm -128.79 124.43 61.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.62 1.168 . . . . 0.0 108.072 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.46 34.56 6.89 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.192 0.597 . . . . 0.0 112.528 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.88 10.19 76.16 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.871 175.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -135.65 148.8 67.05 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 118.54 1.17 . . . . 0.0 111.4 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -67.15 149.82 81.98 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.175 2.583 . . . . 0.0 111.791 -177.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.78 175.1 13.23 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.162 0.985 . . . . 0.0 109.888 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -128.12 159.71 34.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 144.56 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -146.47 164.37 32.73 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.465 1.106 . . . . 0.0 108.257 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -68.88 150.7 47.48 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 37.4 t -85.12 159.12 20.22 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.883 0.473 . . . . 0.0 111.475 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.87 -2.66 15.74 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 115.611 1.708 . . . . 0.0 115.611 177.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 38.9 t -131.05 152.03 50.79 Favored 'General case' 0 C--O 1.23 0.074 0 C-N-CA 123.199 0.6 . . . . 0.0 110.858 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -82.54 -4.22 57.22 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.093 0.557 . . . . 0.0 112.498 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -158.56 150.37 21.25 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.401 0.546 . . . . 0.0 111.228 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.2 mt -90.36 146.9 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 41.6 t -65.69 136.17 55.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.92 -0.488 . . . . 0.0 110.517 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -91.29 162.95 30.76 Favored Pre-proline 0 CA--C 1.53 0.202 0 C-N-CA 123.093 0.557 . . . . 0.0 110.194 -178.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -66.16 -13.73 41.15 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.718 2.945 . . . . 0.0 112.044 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.75 -3.35 0.08 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-O 119.358 -0.69 . . . . 0.0 112.916 -178.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -65.45 -10.97 38.52 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.0 t 55.19 13.54 0.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.251 1.02 . . . . 0.0 111.841 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . 0.255 14.6 t70 61.3 -33.43 0.09 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.135 2.174 . . . . 0.0 116.293 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -68.17 -26.75 65.91 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.4 t -84.31 -24.45 29.84 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.325 0.25 . . . . 0.0 110.677 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -81.26 -25.43 36.58 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.961 0.505 . . . . 0.0 110.511 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 23.2 t 52.82 22.46 2.35 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.312 1.045 . . . . 0.0 112.593 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.315 0.4 OUTLIER 54.29 12.05 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 114.956 1.465 . . . . 0.0 114.956 -177.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -158.03 74.96 0.74 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.41 0.684 . . . . 0.0 109.368 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 66.0 m . . . . . 0 C--O 1.251 1.148 0 CA-C-O 117.58 -1.2 . . . . 0.0 111.789 179.695 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.752 0 C5'-C4'-C3' 110.071 -3.619 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.589 1 O4'-C1'-N19 114.25 6.05 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.619 1 C5'-C4'-C3' 108.453 -4.698 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.603 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.726 1 C5'-C4'-C3' 108.646 -4.569 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 O4'-C1'-N19 111.178 2.978 . 0.193 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.645 0 C5'-C4'-C3' 109.932 -3.712 . 0.318 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -69.15 158.95 33.87 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.885 0.474 . . . . 0.0 111.189 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -76.37 -2.8 33.56 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.057 0.543 . . . . 0.0 111.608 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -63.65 150.67 43.71 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 116.037 1.866 . . . . 0.0 116.037 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.6 p30 -146.47 154.54 41.7 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -75.64 155.18 85.41 Favored Pre-proline 0 CA--C 1.53 0.194 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -178.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.2 -16.36 45.88 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.168 2.579 . . . . 0.0 112.589 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -80.71 -5.84 57.6 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.769 0.828 . . . . 0.0 112.393 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -66.0 141.62 58.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 118.019 0.372 . . . . 0.0 110.442 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.9 p -74.24 141.28 77.22 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.68 159.11 35.43 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 124.144 3.23 . . . . 0.0 110.212 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.73 143.71 52.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.1 m -152.81 151.17 26.06 Favored Pre-proline 0 CA--C 1.528 0.104 0 C-N-CA 123.265 0.626 . . . . 0.0 110.418 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.98 -1.84 11.76 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.905 3.07 . . . . 0.0 110.599 174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.9 149.73 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.803 0.841 . . . . 0.0 112.391 177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 m -138.41 146.84 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.778 0.799 . . . . 0.0 111.932 -173.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -100.94 137.59 39.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 127.216 2.206 . . . . 0.0 110.058 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.7 mt -115.71 140.65 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.429 1.092 . . . . 0.0 110.25 -174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -144.32 154.3 42.9 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.203 0.601 . . . . 0.0 110.155 -175.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 1.48 82.69 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 119.718 -0.49 . . . . 0.0 112.717 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' C ' HD12 ' A' ' 104' ' ' LEU . 4.1 pp -73.28 173.27 9.73 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 117.758 0.779 . . . . 0.0 110.398 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.545 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.19 160.55 12.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 123.022 0.529 . . . . 0.0 109.831 -178.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -63.15 -18.88 63.94 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -72.35 -10.96 75.62 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.784 -0.454 . . . . 0.0 112.609 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -66.68 146.58 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.5 m -132.66 167.1 27.38 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.052 0 C-N-CA 124.483 1.113 . . . . 0.0 109.376 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -58.83 -32.55 69.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.149 -0.344 . . . . 0.0 111.399 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.18 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.473 0.309 . . . . 0.0 111.178 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -74.89 -31.44 61.59 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.0 mt -71.85 -40.58 68.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 122.247 0.219 . . . . 0.0 110.648 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -71.86 -34.79 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.071 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.04 -22.7 58.24 Favored 'General case' 0 CA--C 1.528 0.111 0 O-C-N 122.267 -0.271 . . . . 0.0 111.421 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.7 -17.07 24.73 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.0 mt -118.92 -9.02 10.17 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.63 -21.73 66.6 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 118.852 0.751 . . . . 0.0 110.834 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -70.59 -12.27 61.46 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.066 -0.396 . . . . 0.0 111.262 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -90.58 -17.87 26.19 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 176.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 157.87 173.86 26.84 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.11 127.75 16.46 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.667 2.912 . . . . 0.0 110.956 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 77.4 mt -95.34 142.95 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.07 0.548 . . . . 0.0 110.542 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.5 t -108.5 -33.21 7.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.23 0.612 . . . . 0.0 112.07 -176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -161.86 159.75 27.24 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.9 t -146.64 145.82 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 C-N-CA 124.102 0.961 . . . . 0.0 109.413 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.78 154.21 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.567 0.747 . . . . 0.0 110.921 175.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.05 141.74 39.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -131.22 84.19 57.75 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 123.293 0.637 . . . . 0.0 110.221 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -66.41 -9.85 25.51 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.758 2.306 . . . . 0.0 110.452 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -64.26 -30.73 71.77 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.15 0.98 . . . . 0.0 110.22 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -117.02 3.73 12.76 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.261 1.025 . . . . 0.0 112.706 177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.2 tpp85 56.5 44.8 23.6 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.341 0.656 . . . . 0.0 110.585 -175.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -140.48 169.54 17.46 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.062 0.945 . . . . 0.0 110.431 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.75 158.36 40.84 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.874 0.47 . . . . 0.0 111.192 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.4 149.64 50.46 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -142.34 144.42 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -124.32 134.53 53.15 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.179 0.592 . . . . 0.0 109.936 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -98.77 154.92 17.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -72.15 -13.72 61.63 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.101 0.409 . . . . 0.0 110.691 175.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -141.28 143.1 33.9 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 125.219 1.407 . . . . 0.0 113.624 177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.76 -22.04 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 111.557 177.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 67.7 tp -69.01 -36.53 77.9 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.378 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.37 -38.35 58.39 Favored Glycine 0 C--N 1.337 0.611 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.02 86.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 50.4 t -71.59 -33.78 69.33 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 123.258 0.623 . . . . 0.0 111.075 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.25 -34.55 78.61 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 118.107 0.412 . . . . 0.0 111.029 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.54 -40.13 70.24 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 122.316 -0.24 . . . . 0.0 110.829 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.7 t -75.13 -33.8 29.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.089 0 O-C-N 122.329 -0.232 . . . . 0.0 110.524 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -70.42 -29.58 66.22 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 118.055 0.389 . . . . 0.0 110.887 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -75.46 -33.05 60.82 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.29 -30.44 71.14 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.236 0.614 . . . . 0.0 111.007 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.99 2.83 3.13 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.545 0.738 . . . . 0.0 112.455 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -135.48 -27.8 1.16 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -157.94 153.95 27.03 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -76.71 142.14 40.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.657 0.265 . . . . 0.0 110.671 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.6 mt -83.88 138.25 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.31 19.2 m-85 -91.37 129.12 37.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.4 mm -128.73 123.49 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 124.508 1.123 . . . . 0.0 108.333 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.44 34.56 6.84 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.219 0.608 . . . . 0.0 112.241 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 9.44 74.75 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.357 -0.69 . . . . 0.0 114.079 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.0 148.94 66.92 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 118.418 1.109 . . . . 0.0 111.394 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.9 148.35 76.35 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.333 2.688 . . . . 0.0 111.278 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.93 175.0 13.4 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.228 1.011 . . . . 0.0 109.822 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -128.15 163.4 24.74 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 6.4 p -142.1 148.12 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 123.321 0.649 . . . . 0.0 111.56 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -155.1 166.5 33.39 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -176.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -68.62 151.01 47.31 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.413 -0.804 . . . . 0.0 112.351 179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 47.2 t -84.7 164.9 18.31 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.773 0.32 . . . . 0.0 111.096 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -71.99 -2.9 19.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 176.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 41.3 t -137.99 156.6 47.67 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.094 0.558 . . . . 0.0 111.312 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -82.46 -0.05 44.53 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -157.56 154.77 29.09 Favored 'General case' 0 C--N 1.337 0.035 0 CA-C-N 118.281 0.491 . . . . 0.0 110.942 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -91.1 138.78 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.5 t -69.01 135.97 51.7 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.367 -0.208 . . . . 0.0 111.319 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 28.4 ptt-85 -164.43 149.34 8.51 Favored Pre-proline 0 C--O 1.231 0.099 0 C-N-CA 123.803 0.841 . . . . 0.0 109.473 177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.98 -14.61 29.33 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.113 2.542 . . . . 0.0 111.309 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -75.48 -8.49 83.98 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 119.813 -0.437 . . . . 0.0 112.643 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -77.57 -4.73 47.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.976 0.888 . . . . 0.0 108.682 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.4 m 54.27 35.09 21.92 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.179 0.992 . . . . 0.0 112.637 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 10.8 p30 -55.04 160.03 2.19 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -176.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.285 6.2 t0 65.17 -58.33 0.28 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -174.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 67.7 m -77.56 9.84 3.05 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.747 0.819 . . . . 0.0 111.933 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -77.12 11.85 1.67 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.946 0.898 . . . . 0.0 113.043 -175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 73.7 m 52.47 28.54 6.02 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.862 0.465 . . . . 0.0 112.239 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.318 1.0 OUTLIER 55.47 14.19 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 178.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -148.86 -16.58 0.31 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.481 -1.247 . . . . 0.0 110.935 178.062 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.596 0 C5'-C4'-C3' 109.949 -3.701 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.89 1 O4'-C1'-N19 112.91 4.71 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.624 2 C5'-C4'-C3' 108.89 -4.407 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.573 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.104 1 C5'-C4'-C3' 108.39 -4.74 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.581 1 C5'-C4'-C3' 109.421 -4.052 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.834 0 C5'-C4'-C3' 110.589 -3.274 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.099 0 N-CA-C 110.831 -0.907 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 57.16 25.87 11.45 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.804 0.842 . . . . 0.0 111.715 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -66.85 157.2 33.65 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.918 -0.488 . . . . 0.0 111.125 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -68.77 158.57 34.07 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -70.98 160.28 33.19 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -63.89 124.7 85.92 Favored Pre-proline 0 N--CA 1.449 -0.482 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -65.9 -14.16 43.22 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.046 2.497 . . . . 0.0 112.952 -175.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -86.62 -11.84 50.24 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 118.077 0.399 . . . . 0.0 111.939 177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -79.51 132.27 36.27 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 117.892 0.314 . . . . 0.0 111.197 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.414 ' HB ' ' HD2' ' A' ' 94' ' ' PRO . 1.1 p -132.33 153.11 81.12 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 124.296 1.039 . . . . 0.0 113.169 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 74.1 Cg_endo -69.93 154.39 67.13 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 123.119 2.546 . . . . 0.0 110.914 -178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.06 146.79 53.95 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.965 0.412 . . . . 0.0 111.87 -177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -153.63 151.99 26.35 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 123.748 0.819 . . . . 0.0 109.665 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.68 6.63 3.56 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.993 3.129 . . . . 0.0 110.908 175.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.5 p -137.62 147.47 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.5 m -133.23 148.12 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.934 0.873 . . . . 0.0 111.426 -174.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -99.1 137.61 37.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.149 1.78 . . . . 0.0 109.866 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.2 mt -114.6 140.47 35.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 123.487 0.715 . . . . 0.0 109.435 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -145.25 153.19 41.05 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.625 0.37 . . . . 0.0 110.613 -174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 81.7 4.16 90.42 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 119.684 -0.509 . . . . 0.0 112.766 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.23 172.46 8.1 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 117.827 0.813 . . . . 0.0 110.961 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.5 pt -99.91 157.29 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.331 0.653 . . . . 0.0 110.289 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -66.82 -22.42 66.01 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.83 -10.95 73.15 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.502 -0.61 . . . . 0.0 112.257 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.41 147.7 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 m -132.57 166.59 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 124.233 1.013 . . . . 0.0 109.804 174.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -57.42 -32.64 67.08 Favored 'General case' 0 CA--C 1.529 0.144 0 O-C-N 122.113 -0.367 . . . . 0.0 111.392 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -31.28 71.69 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.433 0.293 . . . . 0.0 111.184 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.04 -31.11 62.75 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.6 mt -69.59 -43.06 73.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 121.937 0.095 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.03 -34.49 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -75.65 -22.08 57.1 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.949 0.34 . . . . 0.0 111.468 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.09 -17.38 26.28 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.9 mt -120.79 -7.63 9.53 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -175.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -65.57 -21.71 66.62 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.17 0.895 . . . . 0.0 110.884 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -70.53 -12.26 61.45 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 122.214 -0.304 . . . . 0.0 111.488 178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -92.05 -15.43 27.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.39 173.03 23.61 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.85 126.73 15.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.667 2.912 . . . . 0.0 110.804 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.3 mt -93.65 142.29 13.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.993 0.517 . . . . 0.0 110.616 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.0 t -103.6 -34.1 8.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.482 0.713 . . . . 0.0 111.761 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -166.36 159.0 14.35 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 -176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.41 151.19 16.98 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 C-N-CA 124.23 1.012 . . . . 0.0 111.797 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -151.77 155.06 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 123.055 0.542 . . . . 0.0 111.355 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.9 p -138.16 141.76 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -133.87 87.41 35.49 Favored Pre-proline 0 CA--C 1.531 0.229 0 C-N-CA 123.457 0.703 . . . . 0.0 110.027 177.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -67.43 -12.71 36.73 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.944 2.429 . . . . 0.0 111.419 -179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -67.41 -23.85 65.6 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.894 0.478 . . . . 0.0 111.046 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -116.91 4.69 12.88 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.537 0.735 . . . . 0.0 112.258 173.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 19.7 tpp85 56.5 45.74 21.89 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.412 0.685 . . . . 0.0 110.473 -176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -140.5 165.59 27.03 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.892 0.877 . . . . 0.0 111.363 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.57 158.18 40.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.232 0.613 . . . . 0.0 110.647 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mp -128.06 149.88 50.19 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 47.1 t -143.41 139.82 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -121.74 140.91 51.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.83 0.452 . . . . 0.0 110.397 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -103.1 154.81 18.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -71.73 -13.54 61.75 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 117.665 0.211 . . . . 0.0 110.557 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -141.61 143.16 33.53 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.273 1.429 . . . . 0.0 113.553 177.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.07 -21.97 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 CA-C-O 120.816 0.341 . . . . 0.0 111.702 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.3 tp -69.37 -35.34 75.73 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.748 0.419 . . . . 0.0 110.66 178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.12 -38.92 59.16 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.174 -1.171 . . . . 0.0 110.174 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.99 -36.43 83.27 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.906 0.384 . . . . 0.0 109.996 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 52.9 t -70.39 -34.84 73.03 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.87 0.468 . . . . 0.0 110.867 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -66.3 -33.99 76.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.013 0.37 . . . . 0.0 110.928 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.14 -35.32 69.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.545 0.157 . . . . 0.0 111.301 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 97.0 t -81.38 -33.56 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 CA-C-N 117.941 0.337 . . . . 0.0 110.984 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -70.3 -30.64 67.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 122.253 -0.28 . . . . 0.0 110.741 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -78.83 -33.03 46.39 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.33 71.48 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.027 0.531 . . . . 0.0 110.795 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.26 4.5 3.6 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.442 0.697 . . . . 0.0 112.151 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -134.63 -27.8 1.29 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -155.74 155.58 33.36 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -76.73 135.63 39.04 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.635 0.255 . . . . 0.0 110.357 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.11 135.16 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.284 11.2 m-85 -85.85 130.46 34.54 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.4 mm -128.82 126.3 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.43 34.45 6.68 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.96 0.504 . . . . 0.0 112.048 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.63 9.62 80.97 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.322 -0.71 . . . . 0.0 114.053 176.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -136.09 148.94 66.76 Favored Pre-proline 0 CA--C 1.528 0.13 0 CA-C-N 118.558 1.179 . . . . 0.0 111.809 -178.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.06 149.43 89.21 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.594 2.863 . . . . 0.0 111.718 -176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 170.92 19.16 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 124.282 1.033 . . . . 0.0 109.914 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -114.17 158.2 21.63 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 45.3 t -141.61 142.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 C-N-CA 123.583 0.753 . . . . 0.0 109.969 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -155.55 167.64 29.74 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -68.72 147.82 51.27 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 121.392 -0.817 . . . . 0.0 110.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.0 t -77.09 152.46 35.0 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.859 0.362 . . . . 0.0 111.225 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 t -71.03 -2.77 16.55 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 72.8 m -127.85 155.18 44.55 Favored 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 124.183 0.993 . . . . 0.0 109.642 177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -83.92 -4.99 59.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -160.84 156.79 25.65 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.624 0.647 . . . . 0.0 111.516 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.6 mt -90.4 141.16 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 46.7 t -67.88 116.8 8.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.446 ' H ' ' HB2' ' A' ' 179' ' ' ASP . 68.0 mmt-85 -76.5 164.09 61.86 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_exo -59.56 -1.28 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 124.169 3.246 . . . . 0.0 113.602 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -154.96 21.85 0.59 Allowed Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.461 0.553 . . . . 0.0 112.021 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 176' ' ' ARG . 11.1 t0 -60.51 -29.89 69.38 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 68.5 m 56.62 -177.18 0.05 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.415 1.086 . . . . 0.0 113.054 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -158.28 177.3 11.43 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -66.21 0.9 1.76 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 44.7 t -153.07 -16.69 0.15 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -72.12 141.71 49.16 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 118.377 0.535 . . . . 0.0 109.918 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 40.4 t -72.92 146.49 46.07 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.301 0.24 . . . . 0.0 111.047 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 12.0 t -70.56 -18.56 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 N-CA-C 111.684 0.253 . . . . 0.0 111.684 177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -87.84 1.72 53.23 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.236 0.615 . . . . 0.0 111.468 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.2 t . . . . . 0 C--O 1.251 1.178 0 CA-C-O 117.505 -1.236 . . . . 0.0 110.991 179.873 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 C5'-C4'-C3' 109.632 -3.912 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.97 1 O4'-C1'-N19 112.909 4.709 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.636 1 C5'-C4'-C3' 108.649 -4.567 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.606 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.718 1 C5'-C4'-C3' 109.271 -4.153 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.633 0 O4'-C1'-N19 111.697 3.497 . 0.201 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.814 0 C5'-C4'-C3' 110.405 -3.396 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.091 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -71.9 -9.61 58.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.983 0.391 . . . . 0.0 111.041 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -138.95 164.62 29.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.687 1.195 . . . . 0.0 109.11 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.252 11.9 t80 -61.86 147.33 46.93 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -147.04 153.65 40.26 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -66.71 144.82 98.79 Favored Pre-proline 0 N--CA 1.455 -0.223 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -73.81 -9.97 22.86 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.772 2.981 . . . . 0.0 111.67 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -76.38 -12.5 60.07 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.878 0.471 . . . . 0.0 111.574 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.67 135.13 46.74 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 122.433 0.293 . . . . 0.0 110.581 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -85.08 148.15 49.7 Favored Pre-proline 0 CA--C 1.529 0.164 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.42 158.47 48.04 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.722 2.948 . . . . 0.0 110.931 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.94 150.27 45.45 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.905 0.383 . . . . 0.0 111.331 -178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 29.1 t -161.59 148.47 11.48 Favored Pre-proline 0 N--CA 1.457 -0.108 0 C-N-CA 123.296 0.638 . . . . 0.0 110.06 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -71.87 -7.68 21.56 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.1 2.533 . . . . 0.0 110.037 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.0 t -106.08 141.78 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 124.121 0.969 . . . . 0.0 110.569 175.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.95 142.44 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-O 121.802 0.811 . . . . 0.0 112.242 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -99.68 137.67 37.84 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.857 1.663 . . . . 0.0 110.383 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.8 mt -115.53 140.54 36.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 C-N-CA 123.63 0.772 . . . . 0.0 109.782 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -143.26 153.03 42.38 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 122.734 0.414 . . . . 0.0 110.491 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 80.49 6.13 89.47 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-O 119.922 -0.377 . . . . 0.0 112.65 178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.33 170.07 12.56 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.584 0.692 . . . . 0.0 110.854 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -93.39 153.93 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 C-N-CA 122.996 0.518 . . . . 0.0 110.328 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -67.12 -22.29 65.81 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.57 -10.72 82.86 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 123.616 0.626 . . . . 0.0 112.486 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -61.3 147.83 10.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.101 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -177.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.7 m -132.53 168.14 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 123.974 0.91 . . . . 0.0 109.866 175.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.3 -32.74 68.74 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.169 -0.332 . . . . 0.0 111.369 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.41 72.13 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.152 0.181 . . . . 0.0 111.125 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.18 -31.46 62.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 88.6 mt -71.24 -42.85 68.33 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.053 0.141 . . . . 0.0 110.776 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 p -71.93 -34.58 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -75.44 -22.89 56.97 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.137 -0.352 . . . . 0.0 111.256 178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.66 -17.07 27.47 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -120.68 -8.45 9.49 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -175.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.11 -21.84 66.37 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 119.083 0.856 . . . . 0.0 110.979 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -70.48 -11.27 60.82 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.48 0.312 . . . . 0.0 111.584 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -93.72 -14.94 25.73 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 177.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.45 173.29 23.97 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.35 125.86 13.47 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.067 2.512 . . . . 0.0 110.678 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.4 mt -93.31 142.67 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 122.875 0.47 . . . . 0.0 110.197 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.2 t -101.51 -34.2 9.64 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.06 0.544 . . . . 0.0 111.491 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -167.18 160.73 14.03 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.1 m -141.91 150.73 19.01 Favored 'Isoleucine or valine' 0 C--O 1.23 0.077 0 C-N-CA 124.61 1.164 . . . . 0.0 111.929 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -151.09 155.8 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.108 0.563 . . . . 0.0 111.412 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.7 p -138.05 141.93 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 123.103 0.561 . . . . 0.0 112.363 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.3 ptt? -130.77 79.32 72.08 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.837 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.61 -25.95 77.05 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.646 2.897 . . . . 0.0 113.755 -175.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.407 ' H ' ' CD ' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -70.41 -12.0 61.29 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.408 0.549 . . . . 0.0 111.277 -179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -116.76 2.89 12.95 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 123.523 0.729 . . . . 0.0 112.327 172.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 58.77 38.97 24.68 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.259 0.624 . . . . 0.0 110.921 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -140.81 167.28 22.55 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 123.377 0.671 . . . . 0.0 112.114 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.18 40.73 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.286 0.634 . . . . 0.0 111.089 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.1 mp -127.52 152.14 47.97 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -144.77 144.49 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.124 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -124.13 138.03 54.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -99.41 154.12 18.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -71.43 -15.41 62.34 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.125 -0.359 . . . . 0.0 110.148 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -139.24 142.94 37.81 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.487 1.515 . . . . 0.0 113.153 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 5.9 p -62.53 -21.77 28.1 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 CA-C-O 120.774 0.321 . . . . 0.0 111.583 177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.7 tp -69.94 -35.25 74.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.107 0.563 . . . . 0.0 110.79 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.9 -37.9 56.5 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.72 -36.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 109.86 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 51.9 t -69.9 -34.82 74.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.168 0.587 . . . . 0.0 110.832 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -66.78 -34.54 78.05 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 117.973 0.351 . . . . 0.0 111.182 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.92 -35.45 69.68 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.52 0.146 . . . . 0.0 111.38 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 86.1 t -81.32 -33.77 12.88 Favored 'Isoleucine or valine' 0 C--O 1.23 0.053 0 O-C-N 122.111 -0.368 . . . . 0.0 110.856 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -69.94 -33.12 71.71 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.955 -0.466 . . . . 0.0 110.528 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -77.34 -33.0 55.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.65 -30.24 71.23 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.359 0.663 . . . . 0.0 111.188 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -71.48 -15.01 62.3 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.545 0.338 . . . . 0.0 111.865 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.7 -23.58 10.98 Favored 'General case' 0 CA--C 1.527 0.083 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -159.99 155.34 25.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.28 0.632 . . . . 0.0 109.467 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -76.79 133.98 39.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 70.0 mt -82.14 134.49 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.285 10.9 m-85 -84.7 129.83 34.78 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.044 1.868 . . . . 0.0 116.044 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 25.3 mm -129.02 126.12 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 124.737 1.215 . . . . 0.0 107.898 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.31 34.42 6.33 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.058 0.543 . . . . 0.0 112.3 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 85.73 8.48 79.86 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.231 -0.76 . . . . 0.0 114.35 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -136.3 149.05 66.7 Favored Pre-proline 0 CA--C 1.528 0.125 0 CA-C-N 118.481 1.14 . . . . 0.0 111.767 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -65.64 151.05 85.74 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.491 2.794 . . . . 0.0 111.881 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.82 173.41 15.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.329 1.052 . . . . 0.0 109.889 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -118.32 156.98 27.95 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 t -141.3 144.89 25.61 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 C-N-CA 123.582 0.753 . . . . 0.0 110.841 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -155.02 168.91 25.42 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -68.72 148.6 50.13 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.403 -0.811 . . . . 0.0 110.501 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 35.3 t -78.05 154.75 31.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.845 0.355 . . . . 0.0 111.021 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.4 t -71.98 -2.62 18.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.0 t -130.68 149.25 52.42 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 124.01 0.924 . . . . 0.0 110.051 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -83.59 -2.73 56.71 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.981 0.512 . . . . 0.0 111.615 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -149.25 150.57 32.79 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.063 0.545 . . . . 0.0 112.008 -175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.479 HG22 ' H ' ' A' ' 176' ' ' ARG . 48.4 mt -100.51 155.29 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 169.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.6 t -63.58 -30.82 71.88 Favored 'General case' 0 C--O 1.23 0.048 0 O-C-N 121.711 -0.618 . . . . 0.0 112.177 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.479 ' H ' HG22 ' A' ' 174' ' ' ILE . 74.7 mtm-85 42.64 66.31 4.41 Favored Pre-proline 0 CA--C 1.53 0.182 0 C-N-CA 124.565 1.146 . . . . 0.0 112.358 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -64.26 -15.7 50.96 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.708 2.272 . . . . 0.0 111.38 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.49 -3.6 81.17 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.462 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.4 -8.67 58.07 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 32.9 t 51.87 52.23 14.93 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.12 0.968 . . . . 0.0 112.113 177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -58.36 163.06 3.24 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 176.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -66.42 -7.9 22.39 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 97.9 p -102.84 -11.3 18.39 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.424 0.689 . . . . 0.0 111.235 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.7 -8.89 25.4 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.131 0.572 . . . . 0.0 111.39 -178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 37.0 t -156.67 164.06 38.58 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.918 0.487 . . . . 0.0 110.339 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.264 1.0 OUTLIER 59.29 5.25 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -178.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -145.9 7.56 1.08 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.621 0.769 . . . . 0.0 111.803 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.649 -1.167 . . . . 0.0 110.821 -178.833 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.612 0 C5'-C4'-C3' 109.812 -3.792 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . 0.401 H5'' ' C8 ' ' B' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.62 1 O4'-C1'-N19 112.622 4.422 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.06 0 C5'-C4'-C3' 111.79 -2.473 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.535 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.932 1 C5'-C4'-C3' 108.982 -4.345 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.632 1 C5'-C4'-C3' 108.275 -4.816 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.824 0 O4'-C1'-N19 111.587 3.387 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.189 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -151.27 158.33 43.72 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.904 0.481 . . . . 0.0 110.03 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -152.64 37.62 0.52 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 122.65 0.38 . . . . 0.0 109.988 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . 0.261 10.7 t80 -138.65 141.21 39.08 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -120.58 144.43 48.11 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.433 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 35.4 p30 -137.81 168.28 16.95 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 174.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 89' ' ' ASP . 73.5 Cg_endo -70.74 -3.06 11.9 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.631 2.221 . . . . 0.0 113.273 -174.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -102.26 -10.37 19.6 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.302 0.501 . . . . 0.0 111.429 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -72.23 152.88 41.91 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.723 0.809 . . . . 0.0 110.971 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -72.75 149.72 90.55 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.07 153.89 46.97 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.675 2.917 . . . . 0.0 110.26 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.18 146.01 52.77 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 75.0 m -153.53 152.43 27.36 Favored Pre-proline 0 CA--C 1.528 0.13 0 C-N-CA 123.234 0.614 . . . . 0.0 110.21 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.47 3.59 6.68 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.928 3.085 . . . . 0.0 110.646 175.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.6 p -133.91 148.38 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -177.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.72 146.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-O 121.659 0.743 . . . . 0.0 110.672 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -101.37 137.48 39.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.093 1.757 . . . . 0.0 110.562 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.5 mt -114.75 140.67 34.61 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 124.174 0.99 . . . . 0.0 109.651 -176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 23.0 tpt180 -147.29 152.82 38.92 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.328 0.651 . . . . 0.0 110.233 -175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.37 1.28 78.65 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 119.521 -0.6 . . . . 0.0 112.932 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -74.27 176.79 6.34 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.081 0.94 . . . . 0.0 111.271 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.483 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.2 OUTLIER -110.2 154.4 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 123.194 0.598 . . . . 0.0 109.522 177.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.2 p30 -69.43 -4.47 18.69 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.483 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -76.75 -10.86 85.81 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.02 148.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.57 168.42 24.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 C-N-CA 123.984 0.914 . . . . 0.0 109.533 173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -58.75 -32.67 69.47 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 122.158 -0.339 . . . . 0.0 111.496 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -31.42 72.08 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 122.329 0.252 . . . . 0.0 111.123 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -75.1 -30.59 60.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 86.5 mt -72.27 -42.18 65.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.51 -34.61 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -75.19 -23.98 57.74 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 122.125 -0.359 . . . . 0.0 111.218 177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.35 -17.05 31.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.4 mt -123.77 -9.14 7.84 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.96 -21.79 66.44 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.258 0.936 . . . . 0.0 110.632 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -70.5 -11.74 61.12 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 122.154 -0.342 . . . . 0.0 111.389 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -92.26 -15.08 27.94 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.13 173.47 24.75 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -68.42 127.18 15.27 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.426 2.75 . . . . 0.0 110.621 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 70.1 mt -93.56 140.96 15.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 122.843 0.457 . . . . 0.0 110.327 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.3 t -102.12 -34.09 9.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.882 0.873 . . . . 0.0 111.729 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -163.48 161.48 24.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 77.5 t -145.66 145.27 20.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 C-N-CA 123.994 0.918 . . . . 0.0 109.009 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.2 p -149.63 153.42 10.72 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.101 0 C-N-CA 123.168 0.587 . . . . 0.0 111.206 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.28 141.69 37.24 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 C-N-CA 123.261 0.624 . . . . 0.0 111.495 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -135.11 89.55 23.55 Favored Pre-proline 0 N--CA 1.455 -0.21 0 C-N-CA 122.736 0.414 . . . . 0.0 110.435 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.42 -6.55 17.85 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.885 2.39 . . . . 0.0 110.809 177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -64.03 -34.41 77.95 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.387 0.675 . . . . 0.0 110.313 177.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -117.0 7.25 13.09 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.884 0.874 . . . . 0.0 112.471 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp85 57.73 52.96 7.55 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.398 0.679 . . . . 0.0 110.76 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -144.69 169.59 17.72 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.471 0.709 . . . . 0.0 111.57 -178.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.62 158.32 40.96 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.444 0.698 . . . . 0.0 110.324 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 mp -134.0 152.29 51.79 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 121.015 0.435 . . . . 0.0 110.463 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.9 t -143.57 140.58 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -122.39 138.08 54.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -99.09 154.8 17.83 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -72.33 -14.2 61.68 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 117.872 0.305 . . . . 0.0 110.236 175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -139.06 143.23 38.28 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.051 1.34 . . . . 0.0 113.142 176.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.21 -23.05 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-O 120.695 0.283 . . . . 0.0 111.282 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 69.6 tp -68.05 -35.53 78.39 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.766 0.427 . . . . 0.0 110.432 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.27 -37.36 59.36 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.55 88.9 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 96.7 m -70.96 -30.12 66.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -67.62 -35.63 79.3 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.174 0.443 . . . . 0.0 110.892 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.61 76.64 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 121.299 -0.16 . . . . 0.0 110.868 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.86 -33.48 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-N 117.705 0.23 . . . . 0.0 111.492 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -68.8 -31.68 70.86 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.992 0.36 . . . . 0.0 110.651 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -75.05 -32.87 61.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.14 -30.24 70.9 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.34 0.656 . . . . 0.0 111.025 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -70.44 5.5 1.76 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.427 0.691 . . . . 0.0 112.333 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -135.93 -29.52 1.02 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -156.64 153.54 28.71 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -76.77 140.53 40.78 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.6 mt -85.8 135.18 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 176.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.288 10.1 m-85 -84.87 129.5 34.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 33.4 mm -126.25 121.55 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 124.464 1.106 . . . . 0.0 108.359 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 47.33 33.96 2.96 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.67 0.788 . . . . 0.0 112.172 -177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 89.58 12.26 62.94 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 123.34 0.495 . . . . 0.0 112.738 172.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -136.22 139.4 29.86 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.552 0.741 . . . . 0.0 110.516 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.37 143.57 58.58 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.335 2.69 . . . . 0.0 112.183 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -148.74 174.41 12.21 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.521 0.729 . . . . 0.0 110.111 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -120.14 158.77 26.22 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -142.28 148.71 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.648 0.779 . . . . 0.0 111.03 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 -155.2 170.07 22.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -68.6 145.2 54.16 Favored 'General case' 0 C--N 1.332 -0.164 0 O-C-N 121.544 -0.722 . . . . 0.0 109.489 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 29.4 t -74.67 154.29 38.53 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.081 0.467 . . . . 0.0 111.155 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 t -71.34 -2.78 17.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 44.2 t -129.07 156.2 44.23 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.213 1.005 . . . . 0.0 110.018 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -84.91 -6.51 59.34 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -176.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -161.03 156.58 24.87 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.742 0.701 . . . . 0.0 111.734 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 45.6 mt -93.97 143.51 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 174.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.1 t -67.37 122.59 18.25 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 122.126 -0.359 . . . . 0.0 110.881 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -81.51 156.47 70.87 Favored Pre-proline 0 CA--C 1.532 0.26 0 C-N-CA 123.127 0.571 . . . . 0.0 110.244 176.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -71.3 -16.38 31.36 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 122.954 2.436 . . . . 0.0 110.716 175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.42 135.04 1.84 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 177.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.0 p30 -106.57 -1.79 22.56 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 74.3 m -149.08 157.14 43.16 Favored 'General case' 0 C--N 1.338 0.071 0 C-N-CA 123.443 0.697 . . . . 0.0 110.968 -177.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -152.14 101.9 2.75 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 51.52 24.01 2.09 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 69.0 m 53.34 33.09 14.93 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.82 0.448 . . . . 0.0 110.874 -174.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -78.22 154.13 31.32 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.115 0.966 . . . . 0.0 111.512 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.3 m 52.85 38.42 26.68 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 172.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.14 -14.65 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -151.37 24.28 0.71 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.823 0.449 . . . . 0.0 110.557 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 44.1 t . . . . . 0 C--O 1.247 0.948 0 CA-C-O 117.347 -1.311 . . . . 0.0 110.656 -179.066 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C5'-C4'-C3' 109.672 -3.885 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.853 0 O4'-C1'-N19 111.657 3.457 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.519 1 C5'-C4'-C3' 108.825 -4.45 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.609 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.711 1 C5'-C4'-C3' 108.395 -4.737 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.505 0 O4'-C1'-N19 111.006 2.806 . 0.19 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.912 0 C5'-C4'-C3' 110.436 -3.376 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.444 ' HG3' ' H ' ' A' ' 87' ' ' TYR . 42.7 tp10 -69.59 150.45 47.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.573 0.349 . . . . 0.0 110.337 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -74.81 4.67 6.01 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.13 0.572 . . . . 0.0 111.722 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.444 ' H ' ' HG3' ' A' ' 85' ' ' GLU . 16.4 t80 -143.35 151.01 39.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -157.04 166.03 34.46 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -136.91 157.36 74.91 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_exo -61.92 -13.54 31.66 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.725 2.95 . . . . 0.0 113.072 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -78.14 -9.37 59.14 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.081 0.552 . . . . 0.0 112.274 -177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -71.48 145.08 49.43 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 122.774 0.43 . . . . 0.0 110.835 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.82 148.05 36.29 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.57 145.49 42.13 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.3 2.667 . . . . 0.0 110.795 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.12 141.31 57.47 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 67.6 m -155.64 156.27 30.55 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 124.269 1.028 . . . . 0.0 109.799 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.68 0.14 8.59 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.828 3.019 . . . . 0.0 110.917 174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 2.0 p -126.05 145.6 33.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 -178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 m -131.67 147.26 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.451 0.643 . . . . 0.0 111.647 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -105.86 137.52 43.61 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.316 1.846 . . . . 0.0 110.046 -176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.2 mt -116.43 140.73 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 124.234 1.014 . . . . 0.0 109.749 -174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -142.75 153.68 43.53 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.193 0.597 . . . . 0.0 110.159 -176.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.07 0.12 81.18 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 119.652 -0.527 . . . . 0.0 112.694 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.402 HD12 ' C ' ' A' ' 104' ' ' LEU . 4.0 pp -74.12 173.5 10.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 117.816 0.808 . . . . 0.0 110.818 179.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -110.23 157.34 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.049 0 CA-C-O 121.359 0.599 . . . . 0.0 109.599 178.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.0 p30 -68.87 -5.18 19.59 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -77.4 -10.76 86.06 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 176.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.0 p -65.31 146.72 13.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 m -132.67 169.39 22.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 124.383 1.073 . . . . 0.0 109.8 175.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -59.15 -32.71 70.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.176 -0.328 . . . . 0.0 111.516 -177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.57 -31.31 71.29 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.479 0.312 . . . . 0.0 111.045 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -74.1 -31.42 62.79 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.01 -43.6 71.03 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.47 -34.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -75.27 -22.98 57.38 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.972 0.351 . . . . 0.0 111.435 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.92 -17.26 26.72 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 72.8 mt -122.44 -7.58 8.66 Favored 'General case' 0 C--N 1.339 0.135 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -66.55 -21.83 66.15 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.278 0.944 . . . . 0.0 110.725 178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -70.27 -10.6 59.43 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.507 0.323 . . . . 0.0 111.441 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.09 -14.34 27.41 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.21 175.05 24.19 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.53 125.2 12.47 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 123.498 2.799 . . . . 0.0 110.496 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 64.7 mt -93.47 141.62 14.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 C-N-CA 122.877 0.471 . . . . 0.0 110.391 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 t -101.18 -34.15 9.8 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.466 0.706 . . . . 0.0 111.76 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -167.21 160.46 13.72 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.15 150.31 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 124.165 0.986 . . . . 0.0 111.822 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 4.5 p -150.59 156.57 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.087 0 C-N-CA 123.086 0.554 . . . . 0.0 111.683 178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.6 141.84 38.19 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -174.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.99 78.42 65.65 Favored Pre-proline 0 CA--C 1.533 0.292 0 C-N-CA 122.863 0.465 . . . . 0.0 110.813 178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.64 -16.31 42.42 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.437 2.758 . . . . 0.0 111.566 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -64.39 -28.22 69.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.451 1.1 . . . . 0.0 111.319 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -116.88 5.03 12.93 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.124 0.57 . . . . 0.0 111.933 172.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 18.0 tpp85 56.77 51.75 10.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.72 0.808 . . . . 0.0 110.743 -176.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -145.06 171.27 14.71 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.901 0.88 . . . . 0.0 110.671 -179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.56 158.12 40.76 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 122.992 0.517 . . . . 0.0 110.521 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -129.86 152.05 49.76 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 121.152 0.501 . . . . 0.0 110.056 176.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.38 142.03 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.112 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -122.29 139.1 54.2 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.973 -0.381 . . . . 0.0 109.973 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -102.32 155.98 17.88 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -71.58 -11.4 60.84 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.75 0.25 . . . . 0.0 110.622 176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -143.52 145.59 32.68 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.646 1.578 . . . . 0.0 112.843 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.08 -24.99 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.0 tp -65.05 -36.31 83.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 122.204 -0.31 . . . . 0.0 110.896 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -71.61 -37.3 61.94 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.68 89.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 93.5 m -68.95 -32.35 71.87 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 122.491 0.316 . . . . 0.0 111.614 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -67.49 -32.98 74.18 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 117.901 0.318 . . . . 0.0 111.196 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.94 67.47 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.374 -0.204 . . . . 0.0 111.239 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 88.5 t -81.45 -37.78 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.083 0 CA-C-O 119.34 -0.362 . . . . 0.0 111.968 -177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 45.5 p30 -74.43 -19.24 60.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.895 0.77 . . . . 0.0 111.396 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -81.08 -33.02 33.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.125 0.488 . . . . 0.0 110.898 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.53 -30.17 70.42 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.163 0.585 . . . . 0.0 110.969 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.95 -9.17 19.35 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -175.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 p30 -140.87 -0.31 1.51 Allowed 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -159.02 149.06 19.23 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.76 138.39 39.88 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.8 mt -91.54 133.63 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.297 16.9 m-85 -84.84 130.87 34.6 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 31.3 mm -128.96 124.54 61.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.496 1.118 . . . . 0.0 108.228 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.12 34.55 5.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.237 0.615 . . . . 0.0 112.52 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.11 10.75 74.3 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.1 -0.833 . . . . 0.0 113.86 175.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -135.76 148.95 67.46 Favored Pre-proline 0 CA--C 1.529 0.155 0 CA-C-N 118.38 1.09 . . . . 0.0 111.539 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -67.47 150.68 80.52 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.54 2.827 . . . . 0.0 111.504 -177.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.86 174.96 13.43 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.168 0.987 . . . . 0.0 109.925 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -128.02 157.15 41.42 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.6 t -141.94 139.29 30.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -148.21 167.84 24.04 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.517 1.527 . . . . 0.0 108.431 176.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -68.89 151.59 46.37 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 28.7 t -81.9 158.0 24.13 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 122.883 0.473 . . . . 0.0 110.842 178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -9.29 55.72 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 175.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -108.14 161.67 14.76 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.756 0.822 . . . . 0.0 110.173 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -94.12 -5.5 47.11 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -163.1 156.49 19.56 Favored 'General case' 0 C--N 1.338 0.092 0 CA-C-N 118.376 0.534 . . . . 0.0 111.325 178.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 72.9 mt -88.32 140.37 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 174.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.6 m -75.56 89.76 2.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.49 0.316 . . . . 0.0 110.975 177.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 -69.21 154.0 95.41 Favored Pre-proline 0 C--O 1.232 0.161 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.83 -18.64 52.94 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.934 2.423 . . . . 0.0 110.944 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.67 -8.43 62.24 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.552 -0.582 . . . . 0.0 112.462 178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -79.43 0.87 27.62 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 115.356 1.613 . . . . 0.0 115.356 -179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 40.4 t -69.28 146.05 52.58 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.694 0.398 . . . . 0.0 111.23 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -73.32 -7.54 52.0 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -69.98 -9.91 56.77 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 45.2 t -72.69 -14.32 61.55 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.183 0.593 . . . . 0.0 111.09 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 40.0 ttm105 -59.12 128.25 36.26 Favored 'General case' 0 C--O 1.231 0.113 0 C-N-CA 123.147 0.579 . . . . 0.0 110.38 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 67.5 m 52.3 11.24 0.16 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.24 1.016 . . . . 0.0 113.369 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.269 0.9 OUTLIER 56.82 14.4 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -175.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.6 p30 -154.83 8.19 0.3 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.252 1.203 0 CA-C-O 117.351 -1.309 . . . . 0.0 110.781 179.606 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.942 0 O4'-C1'-N19 110.736 2.536 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.61 1 O4'-C1'-N19 113.432 5.232 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.458 1 C5'-C4'-C3' 108.131 -4.913 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.608 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.631 1 C5'-C4'-C3' 108.658 -4.562 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.626 0 O4'-C1'-N19 111.165 2.965 . 0.156 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.659 0 C5'-C4'-C3' 110.755 -3.163 . 0.29 2u . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.021 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.75 -11.35 60.77 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.889 0.476 . . . . 0.0 111.444 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -75.88 -4.54 41.43 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.132 0.573 . . . . 0.0 112.148 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -68.43 140.96 55.79 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 116.088 1.885 . . . . 0.0 116.088 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -120.98 146.09 47.05 Favored 'General case' 0 C--O 1.23 0.069 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -69.42 124.52 90.66 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.2 -16.64 40.05 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.945 2.43 . . . . 0.0 112.493 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -92.09 0.92 57.47 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.961 0.504 . . . . 0.0 111.546 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.39 135.95 49.21 Favored 'General case' 0 N--CA 1.456 -0.144 0 O-C-N 122.231 -0.293 . . . . 0.0 111.224 -178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 94' ' ' PRO . 1.2 p -132.49 154.66 81.62 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 124.487 1.115 . . . . 0.0 112.732 176.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 60.0 Cg_endo -67.06 148.87 82.19 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.663 2.242 . . . . 0.0 110.44 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.68 146.39 53.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.893 0.378 . . . . 0.0 111.587 -176.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 66.6 m -153.59 153.16 28.65 Favored Pre-proline 0 CA--C 1.528 0.133 0 C-N-CA 124.146 0.978 . . . . 0.0 109.457 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.26 -0.28 9.86 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 110.727 176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 138' ' ' GLU . 1.9 p -123.16 145.09 30.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 33.8 m -133.48 147.32 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-O 121.71 0.767 . . . . 0.0 110.529 -176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -101.14 137.78 39.05 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 126.278 1.831 . . . . 0.0 110.697 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 48.1 mt -114.62 140.52 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 123.506 0.722 . . . . 0.0 109.741 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -145.9 152.7 39.87 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.458 0.703 . . . . 0.0 110.295 -176.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.88 0.82 85.49 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.644 -0.531 . . . . 0.0 112.608 178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.437 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.8 pp -70.08 175.16 4.69 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 117.65 0.725 . . . . 0.0 110.687 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.59 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -113.44 160.93 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.063 0 CA-C-O 121.366 0.603 . . . . 0.0 110.089 -178.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -66.77 -9.58 38.35 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -174.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.59 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -78.33 -10.98 85.78 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-O 119.819 -0.434 . . . . 0.0 112.032 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.4 p -63.97 145.05 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.0 m -132.73 166.86 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 C-N-CA 124.138 0.975 . . . . 0.0 109.557 174.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -58.96 -32.82 69.97 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.254 -0.279 . . . . 0.0 111.145 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.42 -31.39 71.55 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 122.381 0.272 . . . . 0.0 111.172 178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.18 -29.06 62.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 178.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.28 -44.26 68.76 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.8 p -71.5 -34.72 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -74.76 -22.37 58.82 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 122.035 -0.415 . . . . 0.0 111.454 178.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.45 -17.12 24.97 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 93.1 mt -121.68 -7.45 9.08 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.85 -21.79 66.49 Favored 'General case' 0 C--N 1.338 0.085 0 CA-C-N 119.195 0.907 . . . . 0.0 111.157 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -70.24 -11.54 60.97 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 119.659 -0.21 . . . . 0.0 111.475 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -92.27 -14.48 28.83 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 153.73 173.37 22.78 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.29 129.06 19.55 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.612 2.874 . . . . 0.0 110.468 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 67.4 mt -95.29 141.57 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 123.202 0.601 . . . . 0.0 110.712 -179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.2 t -101.14 -34.12 9.83 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.457 0.703 . . . . 0.0 112.205 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -166.53 158.27 13.3 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -141.52 148.97 20.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 124.046 0.938 . . . . 0.0 112.083 176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.23 156.34 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 C-N-CA 123.282 0.633 . . . . 0.0 111.181 177.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.3 p -138.14 141.74 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 ptt? -131.05 82.02 64.92 Favored Pre-proline 0 N--CA 1.452 -0.325 0 C-N-CA 123.215 0.606 . . . . 0.0 110.078 177.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.39 -8.67 21.36 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 123.223 2.615 . . . . 0.0 110.39 177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -67.23 -29.73 69.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.882 0.873 . . . . 0.0 110.579 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -116.99 5.29 12.84 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 123.895 0.878 . . . . 0.0 113.09 176.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 58.17 48.64 12.53 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.449 0.7 . . . . 0.0 110.891 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -144.81 170.39 16.21 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.504 0.722 . . . . 0.0 111.488 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.64 158.34 40.97 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.287 0.635 . . . . 0.0 110.67 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 mp -131.33 151.93 51.06 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.949 0.404 . . . . 0.0 110.166 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.7 t -144.94 144.01 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 84.4 tt0 -126.02 137.7 53.67 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.557 0.343 . . . . 0.0 110.193 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -95.34 156.4 16.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -72.04 -14.05 61.77 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 122.221 -0.299 . . . . 0.0 110.224 175.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -139.79 143.12 36.74 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.251 1.42 . . . . 0.0 113.3 177.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.04 -21.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 111.565 178.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.4 tp -69.27 -36.29 76.94 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.941 0.496 . . . . 0.0 110.682 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.78 -37.7 57.14 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.92 -36.22 81.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 42.4 t -70.53 -33.03 70.71 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.977 0.511 . . . . 0.0 110.445 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.84 -33.82 76.45 Favored 'General case' 0 N--CA 1.457 -0.109 0 O-C-N 122.062 -0.399 . . . . 0.0 110.851 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.41 -34.82 70.68 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 117.488 0.131 . . . . 0.0 111.2 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 58.3 t -81.43 -35.15 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 O-C-N 122.198 -0.314 . . . . 0.0 111.441 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -70.76 -28.42 64.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.054 0.388 . . . . 0.0 111.688 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -76.4 -33.1 58.87 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.52 71.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.07 0.548 . . . . 0.0 110.662 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.59 3.42 6.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.352 0.661 . . . . 0.0 112.117 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -132.26 -29.64 1.59 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -154.25 149.22 26.75 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.95 132.87 39.27 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 122.169 -0.332 . . . . 0.0 110.255 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.4 mt -81.18 145.38 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.076 0 C-N-CA 122.68 0.392 . . . . 0.0 110.079 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.252 19.9 m-85 -100.05 132.25 45.53 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 175.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 21.9 mm -128.97 126.99 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.57 34.39 6.96 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.176 0.59 . . . . 0.0 112.406 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 84.21 11.04 79.21 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.731 176.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -136.14 148.88 66.42 Favored Pre-proline 0 CA--C 1.529 0.156 0 CA-C-N 118.439 1.119 . . . . 0.0 111.529 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.5 143.56 69.64 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.717 2.945 . . . . 0.0 111.285 -177.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.88 168.15 26.72 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.852 0.861 . . . . 0.0 110.456 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -112.2 159.21 18.79 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.6 t -141.11 142.5 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.688 0.795 . . . . 0.0 110.964 178.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -156.31 166.34 33.73 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -68.85 150.91 47.27 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 31.5 t -82.8 158.64 22.7 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.128 178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.15 -2.68 10.95 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 42.3 t -124.04 160.42 27.71 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 123.695 0.798 . . . . 0.0 110.085 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -89.39 -5.56 57.34 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -162.39 154.19 18.53 Favored 'General case' 0 C--N 1.339 0.134 0 CA-C-N 118.542 0.61 . . . . 0.0 111.188 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.56 143.83 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 173.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.2 t -67.29 -29.6 69.23 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 57.05 175.06 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 123.532 0.733 . . . . 0.0 111.745 -176.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -60.5 -21.38 68.06 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.917 1.744 . . . . 0.0 110.291 170.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -177.61 123.95 0.91 Allowed Glycine 0 C--N 1.338 0.661 0 N-CA-C 108.429 -1.869 . . . . 0.0 108.429 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -83.23 -6.28 59.42 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 66.9 m -64.37 117.22 6.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 53.61 19.83 1.92 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 7.6 t0 58.09 94.96 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 65.6 m 55.73 21.3 4.57 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.275 1.03 . . . . 0.0 113.629 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -78.71 -15.97 57.81 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 122.017 -0.427 . . . . 0.0 111.337 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 58.4 m -149.73 -179.96 7.53 Favored 'General case' 0 CA--C 1.527 0.071 0 C-N-CA 123.731 0.812 . . . . 0.0 110.807 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.262 1.4 t 62.34 24.38 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 43.1 p30 -149.06 13.13 0.87 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.812 0.445 . . . . 0.0 111.656 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 117.325 -1.322 . . . . 0.0 111.08 -179.732 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.727 0 C5'-C4'-C3' 109.56 -3.96 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.551 0 O4'-C1'-N19 111.699 3.499 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.447 1 C5'-C4'-C3' 109.12 -4.253 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.592 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.96 1 C5'-C4'-C3' 108.618 -4.588 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.675 1 C5'-C4'-C3' 108.503 -4.664 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.423 -2.509 0 O4'-C1'-N19 110.912 2.712 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.155 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -153.46 148.0 26.14 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.517 0.727 . . . . 0.0 109.972 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 58.19 176.26 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.337 1.055 . . . . 0.0 112.572 -175.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -146.32 154.14 41.34 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -153.94 158.05 40.09 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -63.52 147.42 95.45 Favored Pre-proline 0 CA--C 1.529 0.146 0 N-CA-C 113.712 1.004 . . . . 0.0 113.712 -177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -72.17 -13.59 28.49 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.279 2.653 . . . . 0.0 111.291 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -78.15 -7.34 56.93 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.166 0.586 . . . . 0.0 111.673 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -68.47 151.4 46.86 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.97 0.508 . . . . 0.0 110.351 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.83 148.32 61.99 Favored Pre-proline 0 C--O 1.232 0.154 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.83 158.87 46.09 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.583 2.855 . . . . 0.0 110.746 -178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.63 148.4 51.95 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 122.573 0.349 . . . . 0.0 111.366 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 70.5 m -152.83 152.32 28.17 Favored Pre-proline 0 N--CA 1.455 -0.207 0 C-N-CA 123.754 0.822 . . . . 0.0 109.657 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -73.97 -3.7 14.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.399 2.732 . . . . 0.0 110.458 174.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.63 149.48 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 C-N-CA 123.991 0.916 . . . . 0.0 112.246 177.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.3 m -132.71 148.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 CA-C-O 121.56 0.695 . . . . 0.0 112.043 -174.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -105.21 137.41 43.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.068 1.747 . . . . 0.0 109.77 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.34 140.55 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 124.228 1.011 . . . . 0.0 109.575 -174.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -143.01 152.71 42.21 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.89 0.476 . . . . 0.0 111.063 -175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.02 5.01 71.22 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.659 -0.523 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -82.76 -175.78 5.96 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 117.964 0.882 . . . . 0.0 109.58 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.54 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -122.02 158.74 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.1 0 CA-C-O 121.219 0.533 . . . . 0.0 109.766 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.82 -3.52 12.76 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.54 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -79.42 -10.96 85.4 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 176.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -65.99 148.63 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.56 168.77 23.37 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.255 1.022 . . . . 0.0 110.258 175.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -57.8 -33.0 68.1 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.241 -0.287 . . . . 0.0 111.176 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -69.24 -31.43 69.98 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.782 0.433 . . . . 0.0 111.55 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 -33.83 66.62 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.54 -39.86 64.42 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.935 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.54 -34.35 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -75.39 -25.66 57.8 Favored 'General case' 0 N--CA 1.457 -0.102 0 O-C-N 122.019 -0.426 . . . . 0.0 111.187 177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -87.06 -17.13 33.61 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 92.3 mt -121.76 -9.47 8.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -66.44 -21.91 66.21 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.208 0.913 . . . . 0.0 110.974 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -70.55 -11.49 60.96 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.422 -0.174 . . . . 0.0 111.372 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.47 -16.15 26.19 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.5 172.33 23.72 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.63 -0.988 . . . . 0.0 110.63 -178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.86 126.41 14.56 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.58 2.853 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.8 mt -93.99 142.87 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.183 0.593 . . . . 0.0 110.331 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -106.24 -34.15 7.58 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.661 0.784 . . . . 0.0 111.764 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -162.75 161.42 26.25 Favored 'General case' 0 C--N 1.339 0.138 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.3 t -146.75 144.04 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 123.918 0.887 . . . . 0.0 109.389 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.0 p -148.71 150.8 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 C-N-CA 123.19 0.596 . . . . 0.0 111.774 176.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.9 t -129.45 141.74 45.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -173.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -131.65 76.48 74.69 Favored Pre-proline 0 CA--C 1.529 0.146 0 C-N-CA 123.544 0.737 . . . . 0.0 109.493 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.22 -12.5 35.08 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.217 2.611 . . . . 0.0 111.156 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -67.38 -23.11 65.54 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.487 0.715 . . . . 0.0 111.138 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.91 6.82 13.11 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.363 0.665 . . . . 0.0 112.756 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 55.45 43.46 28.61 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 118.364 0.529 . . . . 0.0 111.326 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -139.62 163.9 31.33 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.207 0.603 . . . . 0.0 111.096 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.65 158.22 40.77 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.103 0.561 . . . . 0.0 110.066 178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.9 mp -124.33 149.26 46.78 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 175.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 74.6 t -141.88 143.47 26.86 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.062 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -121.76 135.03 54.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.296 0.638 . . . . 0.0 109.897 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -99.81 154.4 18.36 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -72.07 -13.42 61.58 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 122.199 -0.313 . . . . 0.0 110.17 175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -142.24 143.1 32.71 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.341 1.456 . . . . 0.0 113.57 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.8 p -63.42 -21.9 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.059 0 CA-C-O 120.799 0.333 . . . . 0.0 111.535 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 68.2 tp -69.15 -34.8 75.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 122.945 0.498 . . . . 0.0 110.733 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.89 -38.99 55.83 Favored Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.22 -37.61 87.83 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.092 0.472 . . . . 0.0 109.857 176.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.08 -36.7 77.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.373 0.669 . . . . 0.0 110.613 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -65.05 -33.67 76.6 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.107 -0.371 . . . . 0.0 111.112 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.01 -38.7 72.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 117.675 0.216 . . . . 0.0 110.977 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 99.2 t -75.81 -33.43 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 O-C-N 122.201 -0.312 . . . . 0.0 111.079 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -69.84 -26.6 64.3 Favored 'General case' 0 C--O 1.231 0.096 0 O-C-N 122.002 -0.436 . . . . 0.0 111.641 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -77.38 -33.06 55.29 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -62.46 -30.2 71.08 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.036 0.535 . . . . 0.0 110.81 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.88 3.14 2.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.538 0.735 . . . . 0.0 112.244 178.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -133.8 -28.91 1.36 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -157.53 152.41 25.53 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -76.84 139.36 40.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 88.7 mt -83.31 135.08 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.305 20.4 m-85 -89.01 129.62 35.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 34.3 mm -129.14 123.57 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 124.528 1.131 . . . . 0.0 108.773 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 49.41 34.55 6.73 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.6 74.74 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 119.383 -0.676 . . . . 0.0 113.837 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -135.78 148.8 66.78 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 118.248 1.024 . . . . 0.0 111.192 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -67.92 150.35 78.17 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.134 2.556 . . . . 0.0 111.189 -179.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.8 175.09 13.26 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.078 0.951 . . . . 0.0 110.115 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -130.12 162.21 29.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -142.04 148.33 20.61 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 C-N-CA 123.388 0.675 . . . . 0.0 111.356 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 -155.2 166.85 32.28 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -68.82 145.78 53.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 32.5 t -75.33 155.59 36.4 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.9 t -71.54 -2.59 17.45 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.494 0.717 . . . . 0.0 112.78 175.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 43.5 t -127.36 154.55 44.84 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 123.602 0.761 . . . . 0.0 110.332 176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -87.1 -0.34 56.51 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.37 158.87 33.06 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.275 0.489 . . . . 0.0 111.288 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 64.5 mt -104.61 139.08 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.2 t -72.25 143.87 48.63 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.419 0.288 . . . . 0.0 111.293 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 179' ' ' ASP . 14.1 ptt-85 -155.24 149.28 19.24 Favored Pre-proline 0 CA--C 1.529 0.149 0 C-N-CA 123.663 0.785 . . . . 0.0 109.849 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.77 -12.92 33.86 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.056 3.171 . . . . 0.0 111.84 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -179.37 135.83 2.65 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.423 ' HB3' ' HE ' ' A' ' 176' ' ' ARG . 27.5 p30 -106.44 4.32 28.24 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 35.5 t -156.34 156.69 34.38 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 123.93 0.892 . . . . 0.0 110.74 -178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -74.56 -3.14 29.2 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . 0.281 80.3 m-20 58.7 7.56 0.77 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 39.8 t -163.03 -39.41 0.04 OUTLIER 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -81.42 162.08 23.47 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 89.8 p -68.44 -2.29 8.32 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 124.188 0.995 . . . . 0.0 112.537 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . 0.265 0.9 OUTLIER 57.94 23.58 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -177.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -140.95 17.95 2.3 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.966 0.506 . . . . 0.0 110.461 -178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 C--O 1.25 1.104 0 C-N-CA 124.308 1.043 . . . . 0.0 111.979 -179.045 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.666 0 O4'-C1'-N19 111.838 3.638 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.438 1 O4'-C1'-N19 113.874 5.674 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.45 1 C5'-C4'-C3' 108.364 -4.757 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.601 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.527 1 C5'-C4'-C3' 108.839 -4.44 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.84 0 O4'-C1'-N19 111.211 3.011 . 0.196 2[ . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.723 0 C5'-C4'-C3' 110.084 -3.611 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.047 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -154.03 149.52 27.27 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.169 0.588 . . . . 0.0 110.416 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -146.95 11.16 1.05 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.826 0.45 . . . . 0.0 112.159 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -63.49 146.36 53.79 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -163.39 179.49 7.29 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -55.86 153.97 15.32 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -65.35 -6.91 14.39 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.552 2.835 . . . . 0.0 112.642 -177.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -75.79 -10.62 59.58 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 122.022 -0.424 . . . . 0.0 111.13 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -76.82 136.21 38.93 Favored 'General case' 0 C--N 1.339 0.111 0 C-N-CA 122.969 0.507 . . . . 0.0 111.141 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 94' ' ' PRO . 1.1 p -132.62 154.82 81.64 Favored Pre-proline 0 CA--C 1.529 0.168 0 C-N-CA 124.457 1.103 . . . . 0.0 113.256 176.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 93' ' ' THR . 67.6 Cg_endo -68.11 151.4 77.29 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.886 2.391 . . . . 0.0 111.247 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.14 148.45 51.81 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.066 0.46 . . . . 0.0 111.778 -176.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 30.2 t -163.66 150.57 10.34 Favored Pre-proline 0 N--CA 1.454 -0.227 0 C-N-CA 123.803 0.841 . . . . 0.0 109.699 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.9 -10.47 27.72 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.755 2.304 . . . . 0.0 109.805 172.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.9 t -99.17 141.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.628 0.771 . . . . 0.0 111.36 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.6 m -135.11 141.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.663 0.744 . . . . 0.0 110.952 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -99.23 137.5 37.66 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 110.43 -176.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.3 mt -114.85 140.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.827 0.851 . . . . 0.0 109.73 -177.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -144.57 148.98 35.06 Favored 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 123.11 0.564 . . . . 0.0 111.031 -174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.93 8.63 75.63 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-O 119.973 -0.349 . . . . 0.0 112.733 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 104' ' ' LEU . 3.7 pp -76.19 178.17 6.63 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.565 0.682 . . . . 0.0 110.129 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.536 HG12 ' H ' ' A' ' 107' ' ' GLY . 0.1 OUTLIER -116.07 157.99 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 C-N-CA 123.062 0.545 . . . . 0.0 109.929 -178.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -61.87 -17.94 58.35 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.536 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -71.77 -10.9 72.78 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 119.681 -0.51 . . . . 0.0 112.606 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 p -66.02 146.63 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.9 m -132.67 168.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.071 0 C-N-CA 124.154 0.981 . . . . 0.0 110.071 175.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.42 -32.63 68.85 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 122.306 -0.246 . . . . 0.0 111.337 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.25 -31.5 71.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.529 0.331 . . . . 0.0 111.232 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -73.6 -30.57 63.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.24 -42.51 68.76 Favored 'General case' 0 N--CA 1.456 -0.125 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -71.76 -34.66 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -74.98 -23.11 58.22 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 122.141 -0.349 . . . . 0.0 111.443 178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.1 -17.09 26.76 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 97.2 mt -121.83 -8.24 8.94 Favored 'General case' 0 C--O 1.232 0.147 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -65.93 -21.89 66.46 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 119.367 0.985 . . . . 0.0 110.816 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -69.38 -10.44 57.95 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 122.262 -0.274 . . . . 0.0 111.523 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -95.07 -16.09 22.94 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 155.63 174.03 25.0 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.22 131.48 23.62 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.699 2.932 . . . . 0.0 110.779 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 71.2 mt -99.94 142.19 15.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 C-N-CA 122.968 0.507 . . . . 0.0 110.572 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 34.0 t -103.65 -34.08 8.75 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.453 0.701 . . . . 0.0 112.094 -176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -165.84 156.27 13.0 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.9 149.24 17.97 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.331 1.053 . . . . 0.0 112.052 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 8.9 p -152.05 153.42 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.151 0.58 . . . . 0.0 111.186 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.7 t -126.61 141.76 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.043 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 -173.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.6 ptt? -136.12 79.12 44.81 Favored Pre-proline 0 C--O 1.233 0.197 0 C-N-CA 123.247 0.619 . . . . 0.0 109.686 173.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -67.22 -4.94 12.6 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.288 2.659 . . . . 0.0 111.352 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.27 -27.62 68.08 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.268 0.627 . . . . 0.0 110.538 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -116.96 6.15 12.97 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.891 0.876 . . . . 0.0 112.591 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 55.47 51.38 12.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.405 0.548 . . . . 0.0 110.724 -171.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -142.21 163.88 31.65 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.328 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -153.71 158.1 40.5 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.062 0.545 . . . . 0.0 110.618 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -118.88 143.53 46.93 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.6 t -142.48 144.1 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.078 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -130.24 134.38 47.21 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.779 0.432 . . . . 0.0 110.158 -178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -93.97 155.1 17.32 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -71.5 -13.35 61.78 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.029 -0.419 . . . . 0.0 110.431 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -142.08 143.8 33.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.323 1.449 . . . . 0.0 113.216 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.26 -24.86 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.065 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 65.9 tp -67.08 -36.31 81.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 122.477 0.311 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.05 57.88 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.3 -38.25 89.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.15 -34.95 75.78 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.382 0.673 . . . . 0.0 110.746 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -64.73 -34.51 78.49 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.037 -0.415 . . . . 0.0 110.999 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.1 73.38 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.642 0.201 . . . . 0.0 110.807 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 85.0 t -74.62 -33.68 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 O-C-N 122.193 -0.317 . . . . 0.0 110.791 -178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.31 -26.29 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 118.239 0.472 . . . . 0.0 111.606 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -76.24 -32.87 59.11 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.6 -30.23 69.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.299 0.64 . . . . 0.0 111.076 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -69.79 1.59 4.2 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.295 0.638 . . . . 0.0 112.17 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -130.11 -31.83 1.86 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -156.5 146.31 20.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 122.877 0.471 . . . . 0.0 109.735 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -76.78 134.66 39.06 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -75.01 145.53 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 C-N-CA 122.878 0.471 . . . . 0.0 110.373 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . 0.265 20.6 m-85 -96.95 131.71 43.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 175.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.6 mm -128.92 124.86 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.465 1.106 . . . . 0.0 108.385 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . 48.77 34.64 5.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 86.73 8.28 76.92 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.27 -0.739 . . . . 0.0 113.992 175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -136.1 148.29 64.07 Favored Pre-proline 0 CA--C 1.528 0.111 0 CA-C-N 118.49 1.145 . . . . 0.0 111.306 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.73 141.99 56.48 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.264 2.643 . . . . 0.0 110.964 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.77 159.04 43.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.31 0.644 . . . . 0.0 110.918 178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -91.24 160.06 15.72 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 2.8 p -142.39 140.5 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 171.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -156.72 165.62 35.71 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -68.84 148.18 50.65 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.152 0.887 . . . . 0.0 109.706 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 39.5 t -83.99 159.95 21.13 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.946 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 1.1 p -71.33 -2.75 17.35 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 40.4 t -131.41 152.5 50.59 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.022 0.529 . . . . 0.0 110.961 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -83.26 -4.75 58.74 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -176.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -159.01 147.79 18.39 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.452 0.569 . . . . 0.0 111.472 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 71.8 mt -86.98 145.09 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.3 t -66.18 121.73 15.85 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.074 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 72.1 mmt-85 -83.13 156.7 66.61 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 123.109 0.564 . . . . 0.0 110.379 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -70.25 -14.52 34.64 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.265 2.643 . . . . 0.0 110.122 173.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.39 131.79 1.34 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 176.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -106.47 7.97 31.23 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.0 t 56.95 33.91 24.03 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.872 0.869 . . . . 0.0 112.542 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.0 155.09 14.16 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -68.08 93.12 0.42 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 66.2 m 55.61 13.25 0.95 Allowed 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 70.7 ttp85 -74.69 -25.1 58.93 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 118.575 0.625 . . . . 0.0 110.716 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 69.8 m -67.28 148.72 51.33 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.628 0.371 . . . . 0.0 110.451 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' VAL . . . . . . . . . . . . . 1.3 t 56.78 12.62 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -177.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -137.01 7.97 2.95 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.654 0.782 . . . . 0.0 111.875 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 C--O 1.252 1.2 0 CA-C-O 117.228 -1.367 . . . . 0.0 110.608 -178.343 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.665 0 O4'-C1'-N19 112.003 3.803 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.403 1 O4'-C1'-N19 113.739 5.539 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.726 1 C5'-C4'-C3' 108.822 -4.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' A' . . . . . 0.557 ' C8 ' H5'' ' B' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.826 1 C5'-C4'-C3' 109.041 -4.306 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.424 -2.453 1 C5'-C4'-C3' 109.139 -4.24 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.784 0 C5'-C4'-C3' 110.472 -3.352 . 0.199 2u . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_